{"meta":{"query_hash":"ea2d67b0c0fc","filters":{"venue":"American Journal of Clinical Oncology"},"cohort_total":196,"direct_labels_cover":1,"predictions_cover":196,"exported":196,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ea2d67b0c0fc","api":"https://metacan.xera.ac/api/v1/cohort?venue=American+Journal+of+Clinical+Oncology"},"results":[{"id":"W1854012091","doi":"10.1097/coc.0000000000000202","title":"The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Proportional hazards model; Immunohistochemistry; Epidermal growth factor receptor; Univariate analysis; Population; C-Met; Cancer; Tissue microarray; Oncology; Survival analysis; Multivariate analysis; Gastroenterology; Pathology; Receptor; Hepatocyte growth factor; Confidence interval","score_opus":0.09834555880597058,"score_gpt":0.4301980288299977,"score_spread":0.3318524700240271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1854012091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99348754,0.0006385429,0.0000912519,0.004135827,0.00023428038,0.00022007652,8.135024e-7,0.000004082138,0.0011875663],"genre_scores_gemma":[0.9957829,0.00051224,0.0029040156,0.0003900717,0.00026616963,0.000003994146,5.6380986e-7,0.000008461225,0.00013156868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746877,0.00052467873,0.0013238535,0.00013918089,0.00033471736,0.00020881479],"domain_scores_gemma":[0.9947095,0.0031943936,0.0013898021,0.00016467692,0.0002741938,0.00026745535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024436936,0.000094293,0.0009015837,0.00015303271,0.000020246332,0.0000064745964,0.00016966413,0.000060104026,0.000009409992],"category_scores_gemma":[0.0054164696,0.000055579214,0.00012314836,0.00046574298,0.0006949171,0.00005491146,0.00007878177,0.0005198976,0.0000014695493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033161675,0.00021262464,0.8069033,0.0000133625545,0.00006508848,0.00012497505,0.00010928944,0.000007716294,0.00013933958,0.000048422815,0.002260936,0.1867988],"study_design_scores_gemma":[0.004931926,0.018166846,0.9637024,0.00015549007,0.00011605826,0.00013416425,0.0015655404,0.00004244404,0.00002644618,0.00025150643,0.010855066,0.000052157684],"about_ca_topic_score_codex":0.00008047367,"about_ca_topic_score_gemma":0.00002126635,"teacher_disagreement_score":0.18674664,"about_ca_system_score_codex":0.0000898002,"about_ca_system_score_gemma":0.00072069495,"threshold_uncertainty_score":0.64844114},"labels":[],"label_agreement":null},{"id":"W1969233490","doi":"10.1097/coc.0b013e318256f5dc","title":"Improvements in 5-year Outcomes of Stage II/III Rectal Cancer Relative to Colon Cancer","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Colorectal cancer; Total mesorectal excision; Cancer; Internal medicine; Stage (stratigraphy); Relative survival; Perioperative; Survival rate; Rectum; Oncology; Gastroenterology; Surgery; Cancer registry","score_opus":0.09711184448178406,"score_gpt":0.5148231445701119,"score_spread":0.41771130008832785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969233490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902203,0.00040008646,0.00001685872,0.0044653104,0.0014577856,0.00042735285,0.00002728094,0.000007130291,0.002977888],"genre_scores_gemma":[0.9938828,0.0006164091,0.0017743661,0.0021396617,0.00040791315,0.000052269545,0.0000011614882,0.000023902445,0.0011015363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964613,0.0003934382,0.0019931493,0.0002282893,0.00045478647,0.00046906844],"domain_scores_gemma":[0.9955383,0.0014597402,0.0018313541,0.00018679444,0.00033035167,0.0006534691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001334463,0.00020212155,0.0022554218,0.00021648669,0.000029560826,0.0000022558545,0.00017395885,0.00015502621,0.0007603951],"category_scores_gemma":[0.0012476925,0.00014540531,0.000413651,0.00055251666,0.00040884965,0.00016480303,0.00013811032,0.0007582909,0.000008005215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00733168,0.0016523005,0.8037371,0.0000076054725,0.00070682075,0.00007246454,0.0007315691,0.000012074618,0.00029719443,0.000032532236,0.0002821456,0.18513653],"study_design_scores_gemma":[0.008382803,0.022513676,0.94578236,0.00012697068,0.00031098697,0.00001259315,0.00052831805,0.000004957676,0.00036542903,0.000021550042,0.021818737,0.00013162181],"about_ca_topic_score_codex":0.0018265924,"about_ca_topic_score_gemma":0.00063321437,"teacher_disagreement_score":0.1850049,"about_ca_system_score_codex":0.000905336,"about_ca_system_score_gemma":0.0011116072,"threshold_uncertainty_score":0.83257926},"labels":[],"label_agreement":null},{"id":"W1969418055","doi":"10.1097/coc.0000000000000055","title":"Population-based Analysis of Treatment and Survival in Women Presenting With Brain Metastasis at Initial Breast Cancer Diagnosis","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université de Montréal; Hôpital Maisonneuve-Rosemont; BC Cancer Agency","funders":"","keywords":"Medicine; Brain metastasis; Breast cancer; Metastasis; Internal medicine; Radiation therapy; Oncology; Population; Cancer; Surgery","score_opus":0.05525479307048128,"score_gpt":0.4407750546448139,"score_spread":0.38552026157433267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969418055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927072,0.00006748817,0.00010840425,0.0067833564,0.00007074594,0.00012931535,0.00006646582,0.0000033010763,0.00006372246],"genre_scores_gemma":[0.99635017,0.0002001853,0.0023380967,0.00088748574,0.00014531506,0.000040688068,0.000013118341,0.000013399337,0.00001151269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996916,0.0011197155,0.001277594,0.00022398923,0.0002236222,0.00023907726],"domain_scores_gemma":[0.9927085,0.0051519675,0.0014989364,0.00017071785,0.0001626627,0.00030722722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018534716,0.00015737755,0.0022656017,0.00036790126,0.000030342922,0.0000052171185,0.00006040598,0.000057737958,0.000248894],"category_scores_gemma":[0.00051382364,0.00009843018,0.00033533844,0.00062365655,0.00032235746,0.000041871026,0.000023901848,0.00016858356,3.7758562e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030153284,0.0008931754,0.73202896,0.000007954592,0.003282004,0.00006315128,0.00011739417,0.0007355769,0.0000022438576,0.000009275177,0.000013981557,0.25983095],"study_design_scores_gemma":[0.00710512,0.014217563,0.9724863,0.00003929198,0.0037396213,0.000043669574,0.00023563005,0.0006927771,0.0000133014655,0.000010978382,0.0013338929,0.00008182015],"about_ca_topic_score_codex":0.0027763646,"about_ca_topic_score_gemma":0.002418134,"teacher_disagreement_score":0.25974914,"about_ca_system_score_codex":0.00045913475,"about_ca_system_score_gemma":0.0004046962,"threshold_uncertainty_score":0.41970512},"labels":[],"label_agreement":null},{"id":"W1972303935","doi":"10.1097/coc.0b013e318172b3b6","title":"Minimally Invasive Techniques in Management of Hepatic Neuroendocrine Metastatic Disease","year":2009,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Neuroendocrine tumors; Pathology; Oncology; Surgery","score_opus":0.12094569708228022,"score_gpt":0.5212787936421702,"score_spread":0.40033309655989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972303935","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058358614,0.9882978,0.000011771904,0.002321213,0.00027061705,0.0019925965,0.000019758625,0.000023375858,0.001226964],"genre_scores_gemma":[0.0015487545,0.9804967,0.016884174,0.000563088,0.00020194123,0.00004975626,0.000008623093,0.000060331746,0.0001866011],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99000925,0.0024393976,0.0057086814,0.00048115617,0.0008025025,0.00055898534],"domain_scores_gemma":[0.98718405,0.0052061765,0.005857822,0.00057136186,0.0003324357,0.0008481854],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013059294,0.00045985635,0.008501899,0.0009386625,0.00001491415,0.000007646767,0.00070303015,0.000015814232,0.00006006313],"category_scores_gemma":[0.0045619756,0.0003265763,0.0016310309,0.0009766967,0.0010414616,0.000104055536,0.00021416841,0.0019714164,0.000014118922],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013246645,0.0017279998,0.0004495655,0.008453116,0.00050914596,0.15050817,0.0000026031778,5.8003764e-7,4.048296e-7,0.000022913124,0.00030904743,0.8366918],"study_design_scores_gemma":[0.002332314,0.038006295,0.0014837701,0.025166083,0.0046060267,0.007798519,0.00008724077,0.0000013316604,0.0000063630123,0.00027084566,0.91997254,0.0002686804],"about_ca_topic_score_codex":0.000013448827,"about_ca_topic_score_gemma":0.000009642056,"teacher_disagreement_score":0.9196635,"about_ca_system_score_codex":0.00023101528,"about_ca_system_score_gemma":0.0031400216,"threshold_uncertainty_score":0.99991864},"labels":[],"label_agreement":null},{"id":"W1972848143","doi":"10.1097/00000421-200002000-00025","title":"Standard Dose (Mayo Regimen) 5-Fluorouracil and Low Dose Folinic Acid: Prohibitive Toxicity?","year":2000,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Folinic acid; Medicine; Toxicity; Regimen; Internal medicine; Gastroenterology; Fluorouracil; Population; Surgery; Chemotherapy; Creatinine","score_opus":0.04124735522247907,"score_gpt":0.42022927261315857,"score_spread":0.3789819173906795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972848143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732486,0.0015268605,0.000017289683,0.010105903,0.00029833545,0.0002937049,0.000014869559,0.000017822691,0.014476632],"genre_scores_gemma":[0.9850355,0.006991276,0.0024488647,0.003692535,0.0007805016,0.0000117726595,0.000001832386,0.00002228334,0.0010154684],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99693,0.00042738215,0.0015718316,0.00032714463,0.000381523,0.0003621033],"domain_scores_gemma":[0.9966007,0.0012505783,0.0010486688,0.00020045882,0.00037864182,0.0005209808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013010204,0.00023644796,0.0020930185,0.000090720045,0.00010112173,0.000014404593,0.0001149969,0.00013656745,0.0005489812],"category_scores_gemma":[0.00085992826,0.00016009231,0.00041179804,0.00023683214,0.0012441834,0.00013144386,0.00005542945,0.000749661,0.000026727594],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024741782,0.0009624409,0.016541004,0.000012415069,0.0007793971,0.001063591,0.0006096948,0.0000012887621,0.000055255394,0.000023242696,0.0018405988,0.9533693],"study_design_scores_gemma":[0.03321968,0.25032637,0.43889847,0.00045717534,0.0017507632,0.0028530383,0.0031803334,0.000031860603,0.00042690756,0.00086105993,0.2674642,0.00053016306],"about_ca_topic_score_codex":0.000040483763,"about_ca_topic_score_gemma":0.00006128555,"teacher_disagreement_score":0.95283914,"about_ca_system_score_codex":0.000246936,"about_ca_system_score_gemma":0.0011056006,"threshold_uncertainty_score":0.6528375},"labels":[],"label_agreement":null},{"id":"W1978772228","doi":"10.1097/01.coc.0000225919.35003.88","title":"Is There a Detrimental Effect of Waiting for Radiotherapy for Patients With Localized Prostate Cancer?","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Hazard ratio; Radiation therapy; Prostate cancer; Confidence interval; Proportional hazards model; Multivariate analysis; Prostate; Prostate-specific antigen; Urology; Retrospective cohort study; External beam radiotherapy; Cancer; Surgery; Internal medicine","score_opus":0.02514091257903545,"score_gpt":0.4225659542720606,"score_spread":0.39742504169302517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978772228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944542,0.0013010309,0.00044853456,0.0020949685,0.0002112768,0.0013491904,0.000088335604,0.000005004868,0.000047477977],"genre_scores_gemma":[0.98726624,0.00075954135,0.01052685,0.00083914865,0.00037908772,0.00015637392,0.000012996563,0.000030521725,0.000029247556],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9980991,0.00014984643,0.0011382628,0.00018402793,0.00019085791,0.0002379443],"domain_scores_gemma":[0.9948198,0.0026377505,0.0019107739,0.00010434598,0.00038485753,0.00014244196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006932748,0.00015357856,0.0015250744,0.00006271109,0.00003335064,0.000004379708,0.0000735312,0.00006172644,0.000022594357],"category_scores_gemma":[0.00016233865,0.00008853718,0.0004350197,0.000120922625,0.0003471845,0.00003981776,0.000007667708,0.00014631909,2.15937e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025897916,0.001033328,0.6207157,0.000055095014,0.0006508029,0.000010493318,0.000045542398,0.000012515708,0.000029973204,0.000008751929,0.00090075255,0.35063913],"study_design_scores_gemma":[0.11892879,0.44195434,0.35177392,0.00068093615,0.0018301025,0.000033948934,0.0001351614,0.00036202002,0.0071682828,0.00008953251,0.07680315,0.0002398184],"about_ca_topic_score_codex":0.00013458722,"about_ca_topic_score_gemma":0.000013275642,"teacher_disagreement_score":0.440921,"about_ca_system_score_codex":0.00020907479,"about_ca_system_score_gemma":0.0005371465,"threshold_uncertainty_score":0.3610441},"labels":[],"label_agreement":null},{"id":"W19806037","doi":"10.1097/coc.0b013e3181a6500d","title":"Low Thrust Trajectory Design for CRAFTI","year":2001,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Astro and Planetary Science","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Asteroid; Payload (computing); Near-Earth object; Spacecraft; Trajectory; Aerospace engineering; Space exploration; Ion thruster; Interplanetary spaceflight; Propulsion; Thrust; Orbit (dynamics); Computer science; Astrobiology; Physics; Engineering; Astronomy; Computer security","score_opus":0.08776790651586729,"score_gpt":0.4084649225919118,"score_spread":0.3206970160760445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W19806037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5446372,0.000031299107,0.44681695,0.0013754183,0.0009863207,0.00013984334,0.00001035799,0.000006190815,0.0059964475],"genre_scores_gemma":[0.9626995,0.000022832952,0.03486941,0.000610653,0.0016074474,0.000002340113,0.0000026368157,0.0000069992434,0.00017821224],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982243,0.00032781126,0.00090538163,0.00014586764,0.00013463464,0.00026200232],"domain_scores_gemma":[0.9955378,0.0029502315,0.0010216137,0.0001115033,0.00012741449,0.00025144155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017145376,0.000101415644,0.00067034765,0.000045436267,0.000058450743,0.000010524499,0.00031121704,0.000039228657,0.0005997104],"category_scores_gemma":[0.00011247421,0.00007639172,0.00030400112,0.00013224065,0.0004299253,0.00011666697,0.0000132244095,0.00035625463,0.000026633494],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067984906,0.0003326093,0.10264839,7.634556e-7,0.00009003271,0.000022679033,0.0000622154,0.0010504846,0.00005711488,0.00014337468,0.0042655575,0.89064693],"study_design_scores_gemma":[0.0067091607,0.04760162,0.3716845,0.000046740413,0.000314028,0.00019324008,0.0026124027,0.0037858868,0.00017478279,0.0030422516,0.56323177,0.00060365687],"about_ca_topic_score_codex":0.000025427235,"about_ca_topic_score_gemma":0.0000024333826,"teacher_disagreement_score":0.89004326,"about_ca_system_score_codex":0.000013841005,"about_ca_system_score_gemma":0.0005844028,"threshold_uncertainty_score":0.6566408},"labels":[],"label_agreement":null},{"id":"W1981692336","doi":"10.1097/00000421-200212000-00011","title":"Subsets More Likely to Benefit From Surgery or Prophylactic Cranial Irradiation After Chemoradiation for Localized Non–Small-Cell Lung Cancer","year":2002,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Surgery; Retrospective cohort study; Lung cancer; Radiation therapy; Cancer; Stage (stratigraphy); Internal medicine; Oncology; Myocardial infarction","score_opus":0.07310524551789473,"score_gpt":0.41062819865696104,"score_spread":0.33752295313906633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981692336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791624,0.0006083745,0.0021701155,0.016306242,0.00095835334,0.00068977114,0.000058635414,0.000010214936,0.000035889403],"genre_scores_gemma":[0.9691129,0.00063456484,0.020047365,0.007938833,0.0018894055,0.00012071803,0.00001752423,0.00003804213,0.00020067868],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973008,0.00020719321,0.0015798137,0.00030579485,0.00028433366,0.00032205821],"domain_scores_gemma":[0.99380517,0.0036070265,0.0014617107,0.00021068337,0.00036409224,0.0005513447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008706436,0.00020676917,0.0016183429,0.00015496094,0.000043806154,0.000016291284,0.0000996907,0.00015066328,0.00071764045],"category_scores_gemma":[0.0011817088,0.00014367222,0.00056369166,0.00027647454,0.00013787317,0.000083064595,0.000018981053,0.00033165538,0.000021094529],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024205463,0.0022968636,0.14720263,0.000079694095,0.0007394992,0.0008626503,0.0005142418,0.0001484111,0.000087071334,0.0000013801014,0.0058477605,0.8180143],"study_design_scores_gemma":[0.021399584,0.0236214,0.90480906,0.00025485625,0.004094277,0.00017949256,0.00029882768,0.0057720025,0.00022644672,0.00004552575,0.03884542,0.00045312697],"about_ca_topic_score_codex":0.0002906217,"about_ca_topic_score_gemma":0.0001723199,"teacher_disagreement_score":0.8175612,"about_ca_system_score_codex":0.00031261047,"about_ca_system_score_gemma":0.00078077626,"threshold_uncertainty_score":0.78576595},"labels":[],"label_agreement":null},{"id":"W1982142849","doi":"10.1097/coc.0b013e3181cae782","title":"Immunological Therapies Can Relieve Aromatase Inhibitor-Related Joint Symptoms in Breast Cancer Survivors","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aromatase inhibitor; Breast cancer; Aromatase; Oncology; Internal medicine; Cancer","score_opus":0.02171955216796086,"score_gpt":0.3663197050741852,"score_spread":0.34460015290622437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982142849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98165333,0.00026221835,0.000002750438,0.014293468,0.0032970195,0.00020227906,0.000015200942,0.000023906592,0.00024979954],"genre_scores_gemma":[0.9953692,0.00090277556,0.0004107934,0.0020370358,0.0011997124,0.000011715307,0.0000045383676,0.000029958943,0.00003426876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956928,0.00086178776,0.002360368,0.00027841036,0.00035768165,0.00044898165],"domain_scores_gemma":[0.99565053,0.0014874195,0.0017520079,0.00030051643,0.0003032266,0.0005063074],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0035116412,0.00024431295,0.0019751417,0.00025201926,0.00004520152,0.000009386767,0.00021699921,0.00042720555,0.00039305407],"category_scores_gemma":[0.0012949818,0.00016201763,0.00044501974,0.0003889762,0.0014742424,0.00007890422,0.00006208262,0.002980062,0.000025466414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038446493,0.0011910669,0.6119464,0.000015157237,0.00042175176,0.0019973505,0.0005491838,0.0000064800965,0.008229127,0.00011273942,0.00062127406,0.3710648],"study_design_scores_gemma":[0.0056816963,0.007781279,0.97218454,0.00016429747,0.00014813738,0.0021108447,0.00046120692,0.000037629026,0.00025909863,0.00013843764,0.010823927,0.00020890676],"about_ca_topic_score_codex":0.00088755134,"about_ca_topic_score_gemma":0.0008343748,"teacher_disagreement_score":0.3708559,"about_ca_system_score_codex":0.00014980847,"about_ca_system_score_gemma":0.0013944149,"threshold_uncertainty_score":0.9993201},"labels":[],"label_agreement":null},{"id":"W1985161719","doi":"10.1097/coc.0b013e3181b4b147","title":"Population-Based Analysis of the Frequency of Anemia and its Management Before and During Chemotherapy in Patients With Malignant Lymphoma","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); University of Victoria; BC Cancer Agency","funders":"","keywords":"Medicine; Anemia; Internal medicine; Vincristine; Vinblastine; CHOP; ABVD; Chemotherapy; Gastroenterology; Cyclophosphamide; Lymphoma; Rituximab; Surgery","score_opus":0.010124621850470404,"score_gpt":0.32810638917233337,"score_spread":0.31798176732186295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985161719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830717,0.000023587028,0.000002332095,0.0014084212,0.000049460057,0.00013199226,0.0000029987696,0.0000012499148,0.00007277013],"genre_scores_gemma":[0.99664223,0.00006286301,0.0030101559,0.00024161616,0.000023236504,0.0000011787387,0.0000020762338,0.000006413155,0.000010244791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868196,0.00009471999,0.0008238961,0.00011561993,0.00018847277,0.000095353615],"domain_scores_gemma":[0.99837077,0.0001980194,0.0010870494,0.00013231867,0.00012095422,0.00009089007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003611791,0.00008223278,0.00083326857,0.0001554239,0.000017278318,0.0000014314321,0.000062942076,0.00005651241,0.000024501765],"category_scores_gemma":[0.000086569766,0.000044221175,0.00012612596,0.0003292983,0.00030255393,0.000020430962,0.000016230832,0.00015304034,5.8314125e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007728363,0.0007244702,0.9500958,0.000029520532,0.00045390698,0.000022419168,0.00008242004,0.000008481712,0.00008371742,0.000037533475,0.000001024873,0.047687903],"study_design_scores_gemma":[0.0072610704,0.0037281776,0.9878221,0.0000900447,0.00076476694,0.000010491704,0.0001086239,0.000037755788,0.00010958949,0.00001786808,0.000012213799,0.00003729091],"about_ca_topic_score_codex":0.00008597684,"about_ca_topic_score_gemma":0.0001917275,"teacher_disagreement_score":0.047650613,"about_ca_system_score_codex":0.000037686226,"about_ca_system_score_gemma":0.00010435658,"threshold_uncertainty_score":0.18032871},"labels":[],"label_agreement":null},{"id":"W1985294454","doi":"10.1097/01.coc.0000156919.04133.98","title":"On the Apparent Failure of Adjuvant Pelvic Radiotherapy to Improve Survival for Women With Uterine Sarcomas Confined to the Uterus","year":2005,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Radiation therapy; Uterine sarcoma; Bowel obstruction; Chemotherapy; Stage (stratigraphy); Surgery; Uterus; Sarcoma; Internal medicine; Pathology","score_opus":0.0837942170357247,"score_gpt":0.47037349652279087,"score_spread":0.38657927948706616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985294454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061517894,0.7274117,0.0055345246,0.17931673,0.006342731,0.017404743,0.00079917174,0.000060384646,0.0016121404],"genre_scores_gemma":[0.011672248,0.9645095,0.010148061,0.008050488,0.003877881,0.0005009498,0.000014782299,0.00015080401,0.0010752992],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954523,0.00073890726,0.0024970626,0.000393655,0.00044073132,0.00047737441],"domain_scores_gemma":[0.99093074,0.0045383004,0.0029513435,0.0006858067,0.00033087443,0.00056295976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019809576,0.0004784892,0.0058541424,0.00017168344,0.00005274506,0.0000152039565,0.0006243353,0.0001602413,0.00017832205],"category_scores_gemma":[0.00052082405,0.00019000562,0.0009282812,0.00034066485,0.0003839828,0.00002096755,0.00008821589,0.00081037584,0.000013944671],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005417336,0.0010413417,0.000042374606,0.0002909424,0.0026592705,0.00013135471,0.00017456601,0.0000045769866,0.0000019247436,0.000082664184,0.0018627114,0.98829097],"study_design_scores_gemma":[0.0036055048,0.09767295,0.0004448023,0.0011976969,0.0008673715,0.000348399,0.00015829949,0.0000030035305,9.4510426e-7,0.000008328831,0.8955261,0.00016657292],"about_ca_topic_score_codex":0.000024202232,"about_ca_topic_score_gemma":0.000054097898,"teacher_disagreement_score":0.9881244,"about_ca_system_score_codex":0.0003577204,"about_ca_system_score_gemma":0.0014080139,"threshold_uncertainty_score":0.77482045},"labels":[],"label_agreement":null},{"id":"W1985876383","doi":"10.1097/00000421-200006000-00018","title":"A Phase III Study of High-Dose Intensification Without Hematopoietic Progenitor Cells Support for Patients With High-Risk Primary Breast Carcinoma","year":2000,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Etoposide; Cyclophosphamide; Breast cancer; Internal medicine; Breast carcinoma; Chemotherapy; Oncology; Survival rate; Surgery; Carcinoma; Gastroenterology; Cancer","score_opus":0.016501848803620666,"score_gpt":0.34053085781240133,"score_spread":0.3240290090087807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985876383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985438,0.00003104315,0.0001304974,0.00021774773,0.00025016817,0.0006875755,0.000104116865,0.000004698481,0.000030358397],"genre_scores_gemma":[0.9957076,0.0000847806,0.00341062,0.00022005806,0.0003958508,0.00005656116,0.000055653032,0.000032611504,0.000036311343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973762,0.00035035238,0.0014069305,0.0003652836,0.00024951482,0.00025171516],"domain_scores_gemma":[0.9963752,0.00023350009,0.0020742982,0.0003360118,0.000795449,0.00018556482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050546916,0.00022526669,0.0012468925,0.000058619742,0.00006431163,0.00000571229,0.00020884564,0.00010295643,0.000025771993],"category_scores_gemma":[0.00009337468,0.00016155007,0.00021507948,0.00012702474,0.0005665986,0.0000104414,0.000047680147,0.00020499711,0.0000025653499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059900638,0.02591117,0.5472186,0.000021905704,0.001732121,0.00003101701,0.0005093802,0.000024684648,0.0006496631,0.0000027222884,0.0005402055,0.36345786],"study_design_scores_gemma":[0.066232435,0.1492991,0.77852625,0.000025862322,0.0013394784,0.00016489343,0.0012258872,0.000003919196,0.0012125827,0.000016812115,0.0016759691,0.00027681043],"about_ca_topic_score_codex":0.00017410223,"about_ca_topic_score_gemma":0.000040558534,"teacher_disagreement_score":0.36318105,"about_ca_system_score_codex":0.000059976668,"about_ca_system_score_gemma":0.0005125905,"threshold_uncertainty_score":0.65878206},"labels":[],"label_agreement":null},{"id":"W1987426472","doi":"10.1097/coc.0b013e3181ec63c5","title":"Analysis of Seed Loss and Pulmonary Seed Migration in Patients Treated With Virtual Needle Guidance and Robotic Seed Delivery","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Population; Surgery","score_opus":0.01800040896527811,"score_gpt":0.33869447888821214,"score_spread":0.32069406992293403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987426472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842155,0.0001354327,0.000021157459,0.0010909102,0.00007680151,0.00016757014,0.000007944627,0.0000035193573,0.00007509134],"genre_scores_gemma":[0.99789196,0.00067159516,0.00091796817,0.00041604514,0.000057249024,0.000005097174,0.000014959562,0.000010441993,0.000014693194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811494,0.00020036174,0.0011229916,0.00021093951,0.0001957037,0.00015504248],"domain_scores_gemma":[0.99724853,0.0008289494,0.0011890443,0.00013789943,0.00035017036,0.00024540757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005392256,0.00013772858,0.0014487252,0.00028966897,0.000020631865,0.0000056392364,0.000056384164,0.00009870442,0.0000082460465],"category_scores_gemma":[0.00026568957,0.00009359489,0.0001392449,0.0005561433,0.0006601174,0.00009263246,0.000025011512,0.000372767,4.1576945e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004363658,0.0014425108,0.95223284,0.0000072333487,0.0010466698,0.00016994824,0.00014692507,0.00012805902,0.00024695534,0.0000037481539,0.000005940209,0.040205542],"study_design_scores_gemma":[0.005154969,0.02502911,0.96666145,0.00006687306,0.0015915973,0.00004192817,0.0002451267,0.0009964813,0.00006336303,0.000004420387,0.0000644662,0.0000802163],"about_ca_topic_score_codex":0.00042767718,"about_ca_topic_score_gemma":0.0004242922,"teacher_disagreement_score":0.04012533,"about_ca_system_score_codex":0.00006694079,"about_ca_system_score_gemma":0.000304372,"threshold_uncertainty_score":0.3816689},"labels":[],"label_agreement":null},{"id":"W1987777903","doi":"10.1097/coc.0b013e3181aaca87","title":"Wide Excision or Mohs Micrographic Surgery for the Treatment of Primary Dermatofibrosarcoma Protuberans","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Dermatofibrosarcoma protuberans; Medicine; Mohs surgery; Demographics; Surgery; Retrospective cohort study; Dermatofibrosarcoma; Single Center; Surgical margin; Resection; Dermatology","score_opus":0.09294757353395929,"score_gpt":0.43076728637557304,"score_spread":0.3378197128416138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987777903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98268086,0.0011660681,0.00018161809,0.014299528,0.0007778737,0.00079627003,0.000009004931,0.000008170983,0.00008062696],"genre_scores_gemma":[0.97821546,0.005421295,0.013491281,0.002108161,0.00060274627,0.00009346246,0.0000054278385,0.00002656948,0.000035605615],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99709547,0.00025558608,0.0019330174,0.00019380721,0.00025548664,0.00026663343],"domain_scores_gemma":[0.97242236,0.024923509,0.0016749764,0.00035039373,0.0003525123,0.00027626255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012377076,0.00018605485,0.0019923155,0.00015607542,0.00006606279,0.000007543381,0.00015125086,0.00013282023,0.000059124468],"category_scores_gemma":[0.0009967102,0.00008650413,0.0013529808,0.0002487941,0.0009234427,0.000047104575,0.000015930927,0.00031397256,0.0000031136076],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005216069,0.005951276,0.4292729,0.0000131585575,0.0005696077,0.00020677918,0.0000616532,4.6038645e-7,0.00023886848,0.000008804175,0.0011241375,0.5573363],"study_design_scores_gemma":[0.0059623383,0.03352508,0.713989,0.00007243427,0.0009665004,0.0012277919,0.00012752319,0.000014619247,0.0008354879,0.000064441614,0.24312569,0.00008904276],"about_ca_topic_score_codex":0.00006254617,"about_ca_topic_score_gemma":0.0000818262,"teacher_disagreement_score":0.5572472,"about_ca_system_score_codex":0.00007012905,"about_ca_system_score_gemma":0.0011957851,"threshold_uncertainty_score":0.3527536},"labels":[],"label_agreement":null},{"id":"W1988939498","doi":"10.1097/coc.0b013e31818a6c93","title":"Acute Leukemia in Patients Sixty Years of Age and Older","year":2009,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Leukemia; Acute leukemia; Induction chemotherapy; Myeloid leukemia; Univariate analysis; Internal medicine; Chemotherapy; Acute lymphocytic leukemia; Retrospective cohort study; Surgery; Cytarabine; Population; Chemotherapy regimen; Multivariate analysis; Gastroenterology; Lymphoblastic Leukemia","score_opus":0.03619018415307079,"score_gpt":0.43539085076266326,"score_spread":0.39920066660959247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988939498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962943,0.000048186455,0.000025080122,0.0022186527,0.000119901204,0.00013743297,0.0000021621324,0.0000034852471,0.0011507795],"genre_scores_gemma":[0.9913071,0.00061225385,0.004908574,0.0028885556,0.0001866914,5.9399065e-7,0.0000018692323,0.000010447212,0.00008391408],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973604,0.00035974538,0.0015027522,0.00016723418,0.00034927804,0.00026060647],"domain_scores_gemma":[0.99716467,0.0010936824,0.0009826664,0.00017802071,0.00023955965,0.00034142582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014713954,0.00009834151,0.0013976084,0.00022530793,0.000009658304,0.0000033946246,0.00017258499,0.00014858626,0.00003324513],"category_scores_gemma":[0.0016435813,0.000079510355,0.00018985335,0.0003139054,0.0007413944,0.00006806609,0.000052412444,0.0010704766,0.000005412265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003554841,0.0005108961,0.23369095,0.0000051281622,0.00013989767,0.0015001827,0.00020144449,0.0000030288702,0.00017413091,0.0000203144,0.0015877148,0.7586115],"study_design_scores_gemma":[0.0090354895,0.023920592,0.96217877,0.000062455576,0.000105477666,0.0001202907,0.00011517427,0.000026456322,0.00002411407,0.00011209007,0.0042357543,0.00006332659],"about_ca_topic_score_codex":0.000042002335,"about_ca_topic_score_gemma":0.0000057999164,"teacher_disagreement_score":0.75854814,"about_ca_system_score_codex":0.00041954927,"about_ca_system_score_gemma":0.0015225781,"threshold_uncertainty_score":0.46507478},"labels":[],"label_agreement":null},{"id":"W1989898386","doi":"10.1097/00000421-200308001-00006","title":"Role of Biologic Markers in Patient Selection and Application to Disease Prevention","year":2003,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Letrozole; Oncology; Internal medicine; Estrogen receptor; Exemestane; Biomarker; Cancer; Cancer research","score_opus":0.009047812129546872,"score_gpt":0.3526773065101224,"score_spread":0.34362949438057555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989898386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984065,0.0003879792,0.0007001642,0.00011224507,0.000058671838,0.00012951808,6.9021274e-7,0.0000010385563,0.00020314472],"genre_scores_gemma":[0.9969846,0.0004497809,0.0023598454,0.00014464748,0.000041765084,0.0000059657505,0.0000022490747,0.000004635368,0.000006521801],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99864775,0.000510709,0.00056499324,0.00012878746,0.000054851535,0.000092887625],"domain_scores_gemma":[0.99908394,0.0000889477,0.0005408124,0.00006522145,0.00007497153,0.0001461237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006894009,0.00005895689,0.00026784703,0.000055082954,0.0000117531235,0.0000014697467,0.00004906293,0.00009124608,0.000002404035],"category_scores_gemma":[0.0005813727,0.000046974612,0.00009104235,0.00012400399,0.000110792986,0.0000026681728,0.000017296436,0.0001393299,9.0124206e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026099135,0.0005777818,0.1888349,0.0000045114048,0.00008044963,0.000005144137,0.000028135053,0.00040653133,0.10159162,0.00009939635,0.000060534796,0.70570105],"study_design_scores_gemma":[0.004186566,0.09674836,0.79978734,0.00007884716,0.00021037116,0.00022064158,0.0008478229,0.00034466945,0.032916605,0.0016197136,0.06264667,0.00039237406],"about_ca_topic_score_codex":0.000008619742,"about_ca_topic_score_gemma":0.000011648482,"teacher_disagreement_score":0.7053087,"about_ca_system_score_codex":0.000015094895,"about_ca_system_score_gemma":0.00018156602,"threshold_uncertainty_score":0.19155692},"labels":[],"label_agreement":null},{"id":"W1994362655","doi":"10.1097/coc.0b013e3180653c0d","title":"Improved Survival, Quality of Life, and Quality-Adjusted Survival in Breast Cancer Patients Treated With Efaproxiral (Efaproxyn) Plus Whole-Brain Radiation Therapy for Brain Metastases","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Quality of life (healthcare); Oncology; Brain cancer; Overall survival; Internal medicine; Cancer","score_opus":0.1004793324465885,"score_gpt":0.45342012327607784,"score_spread":0.3529407908294893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994362655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98415667,0.00037020628,0.00077150436,0.01317706,0.00025477575,0.0009088644,0.00031891745,0.000009573354,0.000032459826],"genre_scores_gemma":[0.99399704,0.00026926416,0.0027297924,0.0025054908,0.00031397483,0.000025556186,0.000070734604,0.00003677921,0.000051370185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99315006,0.0023831173,0.0031708623,0.00038958108,0.0004658207,0.0004405735],"domain_scores_gemma":[0.9857638,0.009102652,0.0036041925,0.0002468336,0.0007702904,0.00051221857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010800746,0.00030094784,0.0029293813,0.00024653797,0.000047350226,0.000010615315,0.00013457541,0.00016802293,0.000031124353],"category_scores_gemma":[0.0023609514,0.00019860496,0.00039293917,0.00048549013,0.000755332,0.00012939141,0.000027285534,0.00047215485,3.855083e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04979742,0.0025752843,0.63240576,0.00004598015,0.0009479771,0.00001983108,0.0001468483,0.000008598688,0.00030844173,0.000072803196,0.00012150013,0.31354958],"study_design_scores_gemma":[0.050899312,0.028278274,0.91727036,0.000059473863,0.00025008645,0.000017327453,0.00085506483,0.000043063712,0.000100973826,0.000017574177,0.0020180056,0.0001905106],"about_ca_topic_score_codex":0.0029698769,"about_ca_topic_score_gemma":0.0016780959,"teacher_disagreement_score":0.31335905,"about_ca_system_score_codex":0.00024208371,"about_ca_system_score_gemma":0.0012332019,"threshold_uncertainty_score":0.8098875},"labels":[],"label_agreement":null},{"id":"W1996256198","doi":"10.1097/01.coc.0000180400.18021.ca","title":"Thrombocytopenia","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine","score_opus":0.08929346071015613,"score_gpt":0.5224583237547803,"score_spread":0.43316486304462415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996256198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96785784,0.00052894896,0.00045614835,0.0037278957,0.0008812303,0.000059982765,9.0642556e-7,0.00001101715,0.026476009],"genre_scores_gemma":[0.9875352,0.0006072791,0.0051542963,0.0052550216,0.0011637912,2.0254808e-7,5.9317773e-7,0.0000117811915,0.00027183478],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977361,0.00014820677,0.0015273027,0.00011016135,0.00023549939,0.00024271593],"domain_scores_gemma":[0.9963971,0.0013770519,0.0011895049,0.00014317792,0.00021845741,0.0006747179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022902223,0.00008741755,0.0011836679,0.00010396229,0.00002693054,0.000003223022,0.00012343851,0.0001298531,0.0002189169],"category_scores_gemma":[0.0013144229,0.000056005756,0.00045831242,0.00020213939,0.00074167695,0.000046515954,0.00002668641,0.00069954176,0.00006873724],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042477134,0.0011652668,0.11355316,0.000003614949,0.0003631914,0.0024165004,0.000047718135,0.000001368121,0.00031078438,0.00018473454,0.003937516,0.87376845],"study_design_scores_gemma":[0.0040948153,0.019638153,0.6801664,0.00005509269,0.00048914884,0.0017939679,0.0003989501,0.0000062277977,0.00015045384,0.00017267739,0.29294416,0.00008994733],"about_ca_topic_score_codex":0.000020250662,"about_ca_topic_score_gemma":0.0000057388247,"teacher_disagreement_score":0.8736785,"about_ca_system_score_codex":0.00005856935,"about_ca_system_score_gemma":0.0009168511,"threshold_uncertainty_score":0.30391997},"labels":[],"label_agreement":null},{"id":"W1998414975","doi":"10.1097/coc.0b013e31826b9b1a","title":"Dose Delivery Analysis of Weekly Versus 3-Weekly Cisplatin Concurrent With Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Nasopharyngeal carcinoma; Cisplatin; Radiation therapy; Toxicity; Mucositis; Gastroenterology; Cumulative dose; Internal medicine; Surgery; Urology; Chemotherapy","score_opus":0.0865808263449861,"score_gpt":0.4472235196646666,"score_spread":0.3606426933196805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998414975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922147,0.0031008848,0.00072449533,0.0022644803,0.0009962068,0.0002938393,0.00001666163,0.000007081084,0.00038166344],"genre_scores_gemma":[0.9919973,0.002528168,0.0036315476,0.0010147972,0.0007592104,0.0000150407195,0.000011047857,0.000018206916,0.000024651805],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997239,0.00029595208,0.0015708541,0.000194181,0.0003465298,0.0003535159],"domain_scores_gemma":[0.99314183,0.0035181243,0.0020667694,0.00017589141,0.00068411924,0.00041326054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013271512,0.00018106078,0.0024534345,0.00024795267,0.000047802954,0.0000030637348,0.00012865444,0.00010021823,0.0000443467],"category_scores_gemma":[0.00062502164,0.00012331315,0.00062501925,0.00057100295,0.0005716394,0.00013007702,0.000021629194,0.0003839509,0.0000017156201],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03870351,0.00097076985,0.21780492,0.000012793378,0.0033610384,0.000021875163,0.00045234087,0.000053362193,0.00015155463,0.000026594422,0.0005574901,0.73788375],"study_design_scores_gemma":[0.027405906,0.10000545,0.84898007,0.000053784912,0.0032700126,0.000026147496,0.0009397819,0.00031856087,0.00015025077,0.000002884776,0.018696604,0.0001505522],"about_ca_topic_score_codex":0.000045420235,"about_ca_topic_score_gemma":0.000044164466,"teacher_disagreement_score":0.7377332,"about_ca_system_score_codex":0.00016169951,"about_ca_system_score_gemma":0.0010649032,"threshold_uncertainty_score":0.5028564},"labels":[],"label_agreement":null},{"id":"W1998843791","doi":"10.1097/00000421-200008000-00018","title":"Optic Nerve Sheath Fenestration for a Reversible Optic Neuropathy in Radiation Oncology","year":2000,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Fenestration; Optic neuropathy; Radiation oncology; Surgery; Radiation therapy; Optic nerve; Radiology; Ophthalmology","score_opus":0.056901240496610106,"score_gpt":0.4443909196243589,"score_spread":0.3874896791277488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998843791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987123,0.00021261002,0.0001585547,0.007892989,0.0005855676,0.00042244745,0.0000025477705,0.000010545586,0.003591746],"genre_scores_gemma":[0.97568697,0.00049610774,0.02122104,0.0016223222,0.0006094293,0.000019249408,0.000012534503,0.000019562161,0.00031281402],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99676704,0.0008294295,0.0016703932,0.00026001676,0.00016660521,0.00030651726],"domain_scores_gemma":[0.99621236,0.0020986234,0.0010263629,0.00017870587,0.00018870934,0.00029526072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018982952,0.00015503941,0.0014357893,0.00019601014,0.000049435806,0.000005705962,0.0001291876,0.00026982412,0.00018077697],"category_scores_gemma":[0.0011126893,0.00012767951,0.00039638623,0.00030911603,0.00038489676,0.00014022263,0.000011959328,0.0006289805,0.000041065967],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008199014,0.0031283393,0.12533009,0.0000146944,0.00025901056,0.0035057408,0.00018406344,0.00025747728,0.000075639,0.00011333973,0.00040831594,0.85852426],"study_design_scores_gemma":[0.035424013,0.19439374,0.66878235,0.00012242008,0.0014955328,0.0063926154,0.00049027643,0.0019820225,0.0000725726,0.0007429423,0.089815825,0.00028569342],"about_ca_topic_score_codex":0.000035435303,"about_ca_topic_score_gemma":0.000019700316,"teacher_disagreement_score":0.8582386,"about_ca_system_score_codex":0.00037257132,"about_ca_system_score_gemma":0.0017514641,"threshold_uncertainty_score":0.5206619},"labels":[],"label_agreement":null},{"id":"W2002312553","doi":"10.1097/coc.0b013e31816fc920","title":"Meningiomas in 2009","year":2009,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Meningioma; Radiation therapy; Epidemiology; Translational research; Medical physics; Pathology; Internal medicine","score_opus":0.21918867611229387,"score_gpt":0.549462012006547,"score_spread":0.3302733358942531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002312553","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009292259,0.98302597,0.00004725356,0.0010441423,0.00089523377,0.00040829217,0.0000018546185,0.000011867847,0.013636161],"genre_scores_gemma":[0.00036872167,0.98911273,0.007910148,0.0005341361,0.0013548149,0.0000065457652,0.0000067925007,0.00003848273,0.00066764734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917626,0.001393016,0.0055932384,0.0003635624,0.00045572504,0.0004319088],"domain_scores_gemma":[0.99132615,0.0019977905,0.005565833,0.00039628055,0.00017800345,0.000535935],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0049233735,0.00037531205,0.009423874,0.0008212457,0.000020182137,0.00001174838,0.00042989405,0.00040904395,0.00012208089],"category_scores_gemma":[0.0016548756,0.00025725763,0.002034696,0.00082322804,0.00039023522,0.000058226615,0.00007757951,0.002133637,0.00008035945],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031537953,0.00065466296,0.00015228333,0.00045377863,0.0004806427,0.017796522,0.000021053838,4.1317332e-7,3.9879485e-8,0.00006983669,0.0045210863,0.9755343],"study_design_scores_gemma":[0.0015673414,0.01722537,0.000765787,0.005806068,0.0021280462,0.006717308,0.000046053672,0.0000022530157,2.5444528e-8,0.000063330204,0.9654802,0.0001982001],"about_ca_topic_score_codex":0.00001217758,"about_ca_topic_score_gemma":0.0000028144675,"teacher_disagreement_score":0.9753361,"about_ca_system_score_codex":0.00028627255,"about_ca_system_score_gemma":0.0022987635,"threshold_uncertainty_score":0.99998796},"labels":[],"label_agreement":null},{"id":"W2002925242","doi":"10.1097/coc.0000000000000176","title":"Long-term Outcomes and Complications in Pediatric Ewing Sarcoma","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre; Pediatric Oncology Group; University of British Columbia; BC Children's Hospital; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Sarcoma; Hazard ratio; Proportional hazards model; Ewing's sarcoma; Surgery; Confidence interval; Retrospective cohort study; Internal medicine; Radiation therapy; Pelvis; Thorax (insect anatomy); Chemotherapy; Pathology","score_opus":0.1846806744650215,"score_gpt":0.4918671402861975,"score_spread":0.307186465821176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002925242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825197,0.0009746349,0.00004949345,0.01516077,0.00021921411,0.00011162507,9.438739e-7,0.0000059349713,0.00095769734],"genre_scores_gemma":[0.9920943,0.0010962842,0.0040729386,0.002425779,0.0002800137,0.000005517755,0.0000014267268,0.00000973424,0.000014055307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805635,0.00026126005,0.0011849185,0.00014464725,0.00018453614,0.00016826109],"domain_scores_gemma":[0.9963338,0.002117188,0.0007695113,0.00015138798,0.00017427716,0.0004538456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010541438,0.00009930161,0.0010809471,0.0001741019,0.000017333645,0.0000065018044,0.00009075436,0.00006453108,0.000010051467],"category_scores_gemma":[0.0011736527,0.00006882728,0.00017712022,0.00020221331,0.00026282936,0.000052809857,0.000043562846,0.0003705016,0.000013372998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017666993,0.0013087665,0.7448359,0.000002974938,0.00006582869,0.00043851958,0.000070397,8.867857e-7,5.3539975e-7,0.000036671398,0.00020092815,0.25286192],"study_design_scores_gemma":[0.0055092475,0.005002369,0.9870429,0.000021704123,0.00024147074,0.00060768245,0.00015067824,0.0000069291405,0.000001197698,0.00010696383,0.0012507667,0.000058096433],"about_ca_topic_score_codex":0.000033789216,"about_ca_topic_score_gemma":0.000037140206,"teacher_disagreement_score":0.2528038,"about_ca_system_score_codex":0.00010503914,"about_ca_system_score_gemma":0.0004973,"threshold_uncertainty_score":0.28066948},"labels":[],"label_agreement":null},{"id":"W2005826254","doi":"10.1097/coc.0b013e318165c01d","title":"Identifying Patients at High Risk for Neutropenic Complications During Chemotherapy for Metastatic Breast Cancer With Doxorubicin or Pegylated Liposomal Doxorubicin","year":2008,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Neutropenia; Febrile neutropenia; Doxorubicin; Metastatic breast cancer; Chemotherapy; Internal medicine; Absolute neutrophil count; Oncology; Breast cancer; Surgery; Cancer; Gastroenterology","score_opus":0.07790652895789815,"score_gpt":0.4317302272727096,"score_spread":0.3538236983148114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005826254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99085057,0.000059111622,0.002006889,0.0052253073,0.00050114054,0.0011233034,0.00015146701,0.000026529531,0.000055696095],"genre_scores_gemma":[0.9848816,0.0013490084,0.010537003,0.0019027705,0.000653597,0.00019681489,0.000018751367,0.000068545654,0.00039195397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99695003,0.00025409242,0.0017028042,0.00037222283,0.00028577654,0.0004350538],"domain_scores_gemma":[0.99408466,0.00155572,0.0025881135,0.00028762393,0.0010653674,0.00041848986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047686548,0.00025075118,0.0016567692,0.00017708847,0.00041259598,0.000012487146,0.00021767082,0.00008470683,0.0001814537],"category_scores_gemma":[0.0002139859,0.0001643294,0.0004987298,0.00041660827,0.0005698024,0.00015459736,0.00003755588,0.00053893187,0.000007424392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0708097,0.0034130323,0.827126,0.00010998164,0.0029211396,0.00011187508,0.00042270074,0.00028255075,0.0032961476,0.00004759247,0.0024618912,0.08899736],"study_design_scores_gemma":[0.02937196,0.019231236,0.93844706,0.00014466535,0.0014605026,0.0020351622,0.00015188585,0.00004708019,0.00090077,0.000031409985,0.007958692,0.000219574],"about_ca_topic_score_codex":0.0003694049,"about_ca_topic_score_gemma":0.00044366985,"teacher_disagreement_score":0.11132103,"about_ca_system_score_codex":0.00044737567,"about_ca_system_score_gemma":0.0011350206,"threshold_uncertainty_score":0.6701158},"labels":[],"label_agreement":null},{"id":"W2008982889","doi":"10.1097/coc.0b013e31823a538e","title":"A Pragmatic Contouring Guideline for Salivary Gland Structures in Head and Neck Radiation Oncology","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Contouring; Head and neck; Radiation oncology; Salivary gland; Guideline; Head and neck cancer; Radiation therapy; Oncology; Radiology; Medical physics; Internal medicine; Surgery; Pathology","score_opus":0.07853237659563761,"score_gpt":0.5036404840520283,"score_spread":0.4251081074563907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008982889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97724354,0.0027439112,0.00045035462,0.016542844,0.000812187,0.0002767068,0.000003761217,0.0000064032356,0.0019202873],"genre_scores_gemma":[0.9409961,0.0015463916,0.049411476,0.0059035206,0.002097748,0.000009930573,0.000003167297,0.000013587644,0.000018069346],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99717146,0.00036614254,0.0018893603,0.00012760355,0.00013436511,0.00031105307],"domain_scores_gemma":[0.99534386,0.0028366658,0.0012161908,0.00009142329,0.00017991781,0.00033194112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028320577,0.000118587006,0.0017202127,0.00012894998,0.00003463281,0.000003479334,0.000063235246,0.00012924272,0.000024175912],"category_scores_gemma":[0.0033565585,0.000085068204,0.0001521175,0.00011450634,0.0003215131,0.00009515027,0.000031164618,0.00045133103,0.0000010698142],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033190702,0.00041458983,0.28740308,0.000033281267,0.00017115218,0.00004498087,0.00072865456,0.000005019907,0.00006946308,0.0001080582,0.004806446,0.7028962],"study_design_scores_gemma":[0.012456786,0.02191808,0.534796,0.00010561778,0.00021628244,0.00055971905,0.00081211934,0.00013264862,0.000015033599,0.00034434555,0.42854175,0.00010162688],"about_ca_topic_score_codex":0.00007900249,"about_ca_topic_score_gemma":0.000119735414,"teacher_disagreement_score":0.70279455,"about_ca_system_score_codex":0.00016964586,"about_ca_system_score_gemma":0.0006444885,"threshold_uncertainty_score":0.40183565},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2010082810","doi":"10.1097/01.coc.0000071464.83271.08","title":"Effect of Capecitabine on Mean Corpuscular Volume in Patients With Metastatic Breast Cancer","year":2004,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Capecitabine; Metastatic breast cancer; Mean corpuscular volume; Breast cancer; Oncology; Internal medicine; Cancer; Colorectal cancer; Hemoglobin","score_opus":0.02125211244019987,"score_gpt":0.4226104372930836,"score_spread":0.40135832485288375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010082810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588865,0.00009649171,0.000018851602,0.0030576156,0.00039227324,0.0003005214,0.000015703368,0.0000039635693,0.00022593499],"genre_scores_gemma":[0.99786323,0.00017037091,0.0005781744,0.0011048502,0.00021950561,0.00000990228,0.0000042646325,0.000018939149,0.000030783016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997571,0.0005599617,0.0011487892,0.00017787065,0.00031608745,0.00022632212],"domain_scores_gemma":[0.99712044,0.00091092516,0.0013217191,0.00013823177,0.00025367297,0.0002549828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001005268,0.0001656436,0.0018667935,0.0001789945,0.000013438668,0.0000016010077,0.00010548671,0.00005809596,0.00024324405],"category_scores_gemma":[0.00015950666,0.00009992305,0.00027472866,0.000312449,0.00056184724,0.000046118937,0.000015534766,0.0005339896,0.000007648401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037626393,0.0038270412,0.7214309,0.000027322423,0.0007589797,0.00032457733,0.00010246275,0.00032895617,0.000029552466,0.000007617093,0.00012991026,0.23540628],"study_design_scores_gemma":[0.04258632,0.16515665,0.7895013,0.00017771537,0.0010549062,0.00011522814,0.00003139984,0.00000640038,0.00010087155,0.000012334858,0.0011737553,0.00008311198],"about_ca_topic_score_codex":0.00039608002,"about_ca_topic_score_gemma":0.00015842753,"teacher_disagreement_score":0.23532316,"about_ca_system_score_codex":0.00035929235,"about_ca_system_score_gemma":0.0008052232,"threshold_uncertainty_score":0.40747437},"labels":[],"label_agreement":null},{"id":"W2010224434","doi":"10.1097/01.coc.0000264177.66369.18","title":"Prognostic Significance of Blood Transfusions in Patients With Esophageal Cancer Treated With Combined Chemoradiotherapy","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Blood transfusion and management","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Esophageal cancer; Blood transfusion; Anemia; Hemoglobin; Proportional hazards model; Chemoradiotherapy; Chemotherapy; Gastroenterology; Surgery; Confidence interval; Cancer","score_opus":0.021697913088871906,"score_gpt":0.3624572559212692,"score_spread":0.3407593428323973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010224434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996319,0.000073486015,0.00063965574,0.0017438954,0.00008890775,0.0006490209,0.0000035215114,0.0000095569885,0.00047296338],"genre_scores_gemma":[0.9931381,0.0003723646,0.0050887023,0.0012385611,0.000084158455,0.0000093531835,0.0000020855448,0.000023466639,0.00004324249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975413,0.00021516383,0.0013866316,0.00020397411,0.00038497365,0.00026792558],"domain_scores_gemma":[0.9973463,0.00087134884,0.00094989967,0.00016094837,0.00037125373,0.000300286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011986586,0.00015980545,0.0014903225,0.00020448584,0.000020152367,0.0000023464622,0.00012897402,0.00008400202,0.000103257444],"category_scores_gemma":[0.000115655435,0.00009844299,0.00014691515,0.00062013284,0.0006618065,0.000044248773,0.000006343351,0.0005311834,5.305259e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030354751,0.006634873,0.82939065,0.000023932802,0.0006106698,0.0004103443,0.00016429178,0.000017208962,0.00015079755,0.000023138,0.00002122295,0.13219811],"study_design_scores_gemma":[0.03199825,0.06425667,0.90133494,0.00018857329,0.0008598087,0.000026892958,0.00017579482,0.0000046396626,0.00034870103,0.00000320109,0.000707379,0.00009514867],"about_ca_topic_score_codex":0.0002458961,"about_ca_topic_score_gemma":0.00036871445,"teacher_disagreement_score":0.13210297,"about_ca_system_score_codex":0.00006248773,"about_ca_system_score_gemma":0.0005557548,"threshold_uncertainty_score":0.4014389},"labels":[],"label_agreement":null},{"id":"W2011633310","doi":"10.1097/01.coc.0000214929.01001.16","title":"Lymph Node-Based Prognostics: Limitations With Individualized Cancer Treatment","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Prognostics; Medicine; Cancer; Hazard ratio; Population; Oncology; Lymph node; Epidemiology; Internal medicine; Data mining; Confidence interval; Computer science","score_opus":0.05968720173358793,"score_gpt":0.39984216364182573,"score_spread":0.3401549619082378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011633310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880536,0.00088452257,0.0014444796,0.0073448378,0.00031181527,0.0001555807,0.000047149184,0.0000091219445,0.001748899],"genre_scores_gemma":[0.97559285,0.00076550705,0.021062657,0.001450237,0.0009532409,0.000055046097,0.00003312583,0.000023615341,0.00006373956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821794,0.0002956784,0.0008274988,0.00023868789,0.000180219,0.00023999732],"domain_scores_gemma":[0.9975037,0.0006456552,0.0011809123,0.00017814594,0.00035942424,0.00013215172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028404806,0.00018860021,0.0007391598,0.000060452694,0.00006615388,0.000009967077,0.00014767372,0.00009602718,0.000014254513],"category_scores_gemma":[0.00024653893,0.00012486787,0.00025105852,0.00014328478,0.0007163743,0.000004308033,0.000024484341,0.00010805676,0.0000038222993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029218153,0.0019111406,0.68951684,0.0000033228757,0.0009827346,0.00007343647,0.000043290704,0.0011473346,0.0002321026,0.00003425457,0.0014116287,0.30172208],"study_design_scores_gemma":[0.0142278755,0.017580379,0.76656014,0.000049887843,0.000923807,0.0001103966,0.00030275577,0.000019758652,0.001403456,0.00006244171,0.1984674,0.00029170563],"about_ca_topic_score_codex":0.0003567621,"about_ca_topic_score_gemma":0.0004749424,"teacher_disagreement_score":0.30143037,"about_ca_system_score_codex":0.00012261246,"about_ca_system_score_gemma":0.0015654607,"threshold_uncertainty_score":0.5091964},"labels":[],"label_agreement":null},{"id":"W2012930674","doi":"10.1097/00000421-200102000-00014","title":"Osteoclastic Giant Cell Tumor of the Pancreas","year":2001,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Western University","funders":"","keywords":"Medicine; Giant cell; Pancreas; Pathology; Neoplasm; Laparotomy; Nodule (geology); Cyst; Natural history; Multinucleate; Radiology; Internal medicine","score_opus":0.1708670587541031,"score_gpt":0.5238023298579096,"score_spread":0.3529352711038065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012930674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044690156,0.9752541,0.00007143647,0.0012434082,0.0011685898,0.0007614273,0.000015855403,0.0000070417273,0.017009128],"genre_scores_gemma":[0.0012241916,0.9928167,0.002542059,0.0007189172,0.001392774,0.000013425868,0.0000028307911,0.00004960133,0.0012395378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9901343,0.0032602227,0.005096919,0.00031570237,0.0006980584,0.00049478107],"domain_scores_gemma":[0.9763348,0.012852681,0.008901315,0.00066334294,0.00062082283,0.0006270139],"candidate_categories":["sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00447454,0.00036489873,0.011454015,0.0002592144,0.000052314732,0.000004914873,0.0008145356,0.0004497459,0.00037533665],"category_scores_gemma":[0.0072782044,0.000183403,0.0027657812,0.00082956406,0.0028671084,0.000030253086,0.00020764975,0.0031923929,0.00007649572],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006512661,0.001123517,0.0058947913,0.001718777,0.0009314342,0.0010897234,0.00002400633,1.9421259e-7,8.449366e-7,0.000024470122,0.0028164068,0.98572457],"study_design_scores_gemma":[0.0021051073,0.016784906,0.0037144928,0.0059783803,0.008504558,0.00593598,0.0001259293,0.0000056878844,4.5013314e-7,0.00003906217,0.9566596,0.00014583237],"about_ca_topic_score_codex":0.0000567095,"about_ca_topic_score_gemma":0.00001076129,"teacher_disagreement_score":0.9855787,"about_ca_system_score_codex":0.00028727815,"about_ca_system_score_gemma":0.014031946,"threshold_uncertainty_score":0.9998465},"labels":[],"label_agreement":null},{"id":"W2014560120","doi":"10.1097/coc.0b013e31825d5664","title":"Intermittent LHRH Therapy in the Management of Castrate-resistant Prostate Cancer (CRPCa)","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary; Capital District Health Authority","funders":"","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Quality of life (healthcare); Randomized controlled trial; Testosterone (patch); Castration; Hormone therapy; Androgen suppression; Internal medicine; Cancer; Urology; Surgery; Gynecology; Hormone; Breast cancer","score_opus":0.14756225226109435,"score_gpt":0.5198408230466267,"score_spread":0.3722785707855324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014560120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849919,0.0026656552,0.0000070240094,0.009124583,0.00038278432,0.00036773068,0.00000443898,0.0000024801868,0.0024534138],"genre_scores_gemma":[0.9810069,0.016673904,0.00072064064,0.0010049103,0.00031095612,0.000025988196,0.0000012840019,0.000011386834,0.00024403939],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974291,0.0005076172,0.0012140432,0.00011520233,0.00038391296,0.00035013253],"domain_scores_gemma":[0.99803853,0.00048363858,0.00090346806,0.00018771821,0.0001821615,0.00020449501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002545705,0.00011563777,0.00085006503,0.000104882085,0.000021601152,0.000005010138,0.00021582228,0.000052765627,0.000090178866],"category_scores_gemma":[0.00004443495,0.00005772021,0.00025467025,0.00029367497,0.0006451494,0.00006812556,0.000036911133,0.0005656411,0.000004305427],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010597441,0.0019512431,0.24491076,0.00003679123,0.0006826014,0.00053680356,0.0011043373,0.0000030034216,0.00018689106,0.00008961485,0.00060122256,0.7392993],"study_design_scores_gemma":[0.0077340463,0.019381907,0.92704064,0.0002539578,0.00019498932,0.00013748596,0.0058003007,0.000004742421,0.00023587329,0.00006977598,0.039066795,0.00007951527],"about_ca_topic_score_codex":0.00012711137,"about_ca_topic_score_gemma":0.000021106705,"teacher_disagreement_score":0.7392198,"about_ca_system_score_codex":0.00014894418,"about_ca_system_score_gemma":0.00045949177,"threshold_uncertainty_score":0.24574606},"labels":[],"label_agreement":null},{"id":"W2018978133","doi":"10.1097/coc.0b013e31819fdfc8","title":"Adenoid Cystic Breast Carcinoma","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Lumpectomy; Adenoid cystic carcinoma; Mastectomy; Surgical margin; Radiology; Malignancy; Lymph node; Breast cancer; Axillary lymph nodes; Surgery; Carcinoma; Cancer; Pathology; Internal medicine","score_opus":0.041360279461833946,"score_gpt":0.4241760238769706,"score_spread":0.38281574441513666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018978133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846904,0.000095405994,0.000024810271,0.010127273,0.0014303781,0.00008761079,0.0000051896777,0.000009784964,0.0035291193],"genre_scores_gemma":[0.9908843,0.00009799886,0.0045417966,0.002395707,0.0019791783,0.0000033655024,0.0000025951874,0.0000167431,0.00007833512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978823,0.00022135329,0.0012549933,0.00016859297,0.00024299276,0.00022978295],"domain_scores_gemma":[0.9959767,0.0018617403,0.0010595918,0.00023486663,0.00027720287,0.00058991223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010568646,0.00013091194,0.0012621467,0.00009956492,0.0000326643,0.000006611003,0.0001411004,0.00010813978,0.0004054116],"category_scores_gemma":[0.00087627023,0.00008388477,0.0004491836,0.00015309702,0.00056074053,0.00004520303,0.000030107847,0.0009819597,0.0000750384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014195599,0.0016028949,0.7917662,0.000003676974,0.00018252374,0.0022139826,0.000034812052,4.011305e-7,0.000056125566,0.00016189832,0.001291555,0.20126633],"study_design_scores_gemma":[0.0042295502,0.018616995,0.94357055,0.000022902515,0.00042850635,0.015386128,0.000114250135,0.000010312845,0.000038050115,0.000120741875,0.017384488,0.00007753036],"about_ca_topic_score_codex":0.000066377674,"about_ca_topic_score_gemma":0.000021497439,"teacher_disagreement_score":0.2011888,"about_ca_system_score_codex":0.000042076266,"about_ca_system_score_gemma":0.0008050425,"threshold_uncertainty_score":0.44389728},"labels":[],"label_agreement":null},{"id":"W2021090582","doi":"10.1097/coc.0000000000000084","title":"Patient-reported Long-term Cosmetic Outcomes Following Short Fractionation Whole Breast Radiotherapy With Boost","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Saint John Regional Hospital","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Stage (stratigraphy); Radiation therapy; Chemotherapy; Oncology; Urology; Gynecology; Surgery; Cancer","score_opus":0.02309644594306763,"score_gpt":0.3847027238428795,"score_spread":0.36160627789981187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021090582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907067,0.00017970944,0.0053479327,0.0027569074,0.0006125491,0.00010246884,0.0000046310547,0.0000073974347,0.0002817345],"genre_scores_gemma":[0.9942964,0.00013186,0.003364462,0.0016722402,0.0004462499,0.000009100481,0.000018649547,0.000026007096,0.000035037017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790096,0.0003588998,0.000990071,0.00026737314,0.0002668592,0.00021585148],"domain_scores_gemma":[0.997803,0.0003885538,0.0011375538,0.00023451583,0.0002674153,0.00016899472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006001101,0.00018480695,0.0008520737,0.00006438872,0.00007264712,0.00001207258,0.00013924252,0.00010820316,0.000012774145],"category_scores_gemma":[0.00031951896,0.00012972628,0.00036336464,0.000110227615,0.00036725568,0.000012973961,0.000034918095,0.00023645563,0.0000025725985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007092612,0.0003542066,0.6595117,0.0000012747308,0.0011129235,0.00004130674,0.00002589691,0.000027267719,0.00052479666,0.0000020801413,0.00015394046,0.33753535],"study_design_scores_gemma":[0.0025673108,0.0075003677,0.97889453,0.000022474596,0.00027092153,0.0005470727,0.00009934735,0.0000053538442,0.00014698059,0.000009370865,0.009782039,0.00015425656],"about_ca_topic_score_codex":0.000021894919,"about_ca_topic_score_gemma":0.00005313443,"teacher_disagreement_score":0.3373811,"about_ca_system_score_codex":0.0000765379,"about_ca_system_score_gemma":0.0002874872,"threshold_uncertainty_score":0.52900845},"labels":[],"label_agreement":null},{"id":"W2021935540","doi":"10.1097/coc.0b013e31818c0926","title":"Lipoleiomyosarcoma of the Rectosigmoid Colon","year":2009,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Rectosigmoid Colon; Rectum; General surgery; Internal medicine","score_opus":0.1703578698974657,"score_gpt":0.523724642128763,"score_spread":0.3533667722312973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021935540","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019676574,0.9916309,0.0000030105894,0.002970597,0.0010352526,0.0005087583,0.000008755487,0.000006074187,0.0018689752],"genre_scores_gemma":[0.002608718,0.99318206,0.001697026,0.0013482149,0.0010299681,0.000010856459,0.0000030599792,0.00003380223,0.00008631892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930958,0.0017844326,0.0041269604,0.00026183308,0.00045453315,0.00027642533],"domain_scores_gemma":[0.98485214,0.005638215,0.008278102,0.000568618,0.00032732516,0.0003356136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018842298,0.00033144126,0.008132323,0.00019480234,0.000034921144,0.0000050340964,0.00051176304,0.0003896078,0.00006887036],"category_scores_gemma":[0.0020775837,0.00016326312,0.0037741766,0.0005875716,0.00095770496,0.00002468074,0.00008892906,0.0015566517,0.000019529945],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002592279,0.0024531216,0.0027611703,0.00031983008,0.0011080509,0.00041329043,0.000015461237,9.562594e-8,1.6042101e-7,0.000042220978,0.0026624752,0.9899649],"study_design_scores_gemma":[0.0015555207,0.018153295,0.0074818595,0.0070105796,0.0060697654,0.0025860085,0.000025551268,2.195099e-7,0.0000018047618,0.000037052167,0.95696086,0.00011748084],"about_ca_topic_score_codex":0.00002612148,"about_ca_topic_score_gemma":0.0000065077625,"teacher_disagreement_score":0.9898474,"about_ca_system_score_codex":0.00025465467,"about_ca_system_score_gemma":0.0035462014,"threshold_uncertainty_score":0.67629635},"labels":[],"label_agreement":null},{"id":"W2024642727","doi":"10.1097/01.coc.0000139487.56328.5e","title":"Radiotherapy-Induced ID Reaction","year":2005,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Radiation therapy; Skin reaction; Dermatology; Surgery","score_opus":0.07078119933036933,"score_gpt":0.468992687439074,"score_spread":0.39821148810870466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024642727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9509955,0.00020908099,0.0005191544,0.042537462,0.0006854274,0.000121723526,6.070598e-7,0.000027683176,0.004903353],"genre_scores_gemma":[0.9585444,0.0012857534,0.024238445,0.012147269,0.0035091217,0.0000012404919,9.672882e-7,0.000033239303,0.00023961211],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996871,0.00045493248,0.0018704793,0.00020379057,0.0003365612,0.00026326944],"domain_scores_gemma":[0.99568766,0.0013288371,0.0020186587,0.00026581052,0.0002576135,0.00044141276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021840744,0.00015347412,0.0014633209,0.0001531757,0.00003345007,0.000005546797,0.0001677286,0.0002593236,0.00033421227],"category_scores_gemma":[0.0010221906,0.00011811336,0.00048773503,0.00027495789,0.000410755,0.00011655924,0.000014019402,0.0014495488,0.000053156655],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037444911,0.0011769348,0.0062191584,0.0000025860563,0.00045442165,0.00015473632,0.0001582298,0.000007256907,0.03274294,0.000026034753,0.0031367606,0.95217645],"study_design_scores_gemma":[0.013245716,0.03484513,0.10081222,0.000085237574,0.00036493287,0.004476192,0.000284961,0.00022030468,0.0047068167,0.00012906466,0.84058285,0.000246551],"about_ca_topic_score_codex":0.000029239207,"about_ca_topic_score_gemma":0.000012768674,"teacher_disagreement_score":0.9519299,"about_ca_system_score_codex":0.00037795928,"about_ca_system_score_gemma":0.00082914525,"threshold_uncertainty_score":0.62976485},"labels":[],"label_agreement":null},{"id":"W2027298049","doi":"10.1097/coc.0b013e31819e902d","title":"Primary Tumor Resection in Patients Presenting With Metastatic Colorectal Cancer","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Colorectal cancer; Chemotherapy; Surgery; Cancer; Cohort; Radiation therapy; Cancer registry; Primary tumor; Retrospective cohort study; Resection; Internal medicine; Metastasis","score_opus":0.039402056543300944,"score_gpt":0.4231073212999518,"score_spread":0.3837052647566509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027298049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948574,0.00006120783,0.0000044568465,0.0013540798,0.00074318994,0.00023445782,0.0000029455625,0.0000058795486,0.0027363824],"genre_scores_gemma":[0.9958958,0.0001145098,0.0028894965,0.0006532699,0.0003593269,0.000020390102,0.0000016579475,0.000014331494,0.0000512101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980759,0.00020828281,0.0010051263,0.00017843695,0.00030462048,0.00022764999],"domain_scores_gemma":[0.99738556,0.0008215259,0.0011332545,0.00008622417,0.00039080152,0.00018262304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007811325,0.00012211343,0.0011636991,0.00013075858,0.00004063137,0.000006022621,0.00007993489,0.000039305254,0.00006708199],"category_scores_gemma":[0.0007701501,0.000075646894,0.00015832752,0.0002885801,0.0005178052,0.00008341276,0.000038371036,0.0008919366,0.000002073871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011464522,0.0012445571,0.8489892,0.000011152752,0.00034408816,0.00025826853,0.00016048123,0.000004286605,0.000071731985,0.0000033708977,0.00018834046,0.13726],"study_design_scores_gemma":[0.006981555,0.029530726,0.9588286,0.00003640046,0.0002578881,0.00012750702,0.00020762921,0.000013151652,0.000054787564,0.000020001973,0.0038687424,0.000073005955],"about_ca_topic_score_codex":0.00025778238,"about_ca_topic_score_gemma":0.001753464,"teacher_disagreement_score":0.137187,"about_ca_system_score_codex":0.00018526037,"about_ca_system_score_gemma":0.00091618206,"threshold_uncertainty_score":0.38750702},"labels":[],"label_agreement":null},{"id":"W2029339227","doi":"10.1097/coc.0b013e318199fb84","title":"S9511","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Regimen; Neutropenia; Gastroenterology; Internal medicine; Bolus (digestion); Toxicity; Surgery; Perforation; Stomach; Performance status; Chemotherapy","score_opus":0.06832863086102609,"score_gpt":0.4826672435239714,"score_spread":0.4143386126629453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029339227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9531211,0.000024552379,0.00024183866,0.021549772,0.0025090356,0.00006372825,3.461624e-7,0.000010313571,0.02247931],"genre_scores_gemma":[0.9762343,0.00015202932,0.013678994,0.007024182,0.00202825,7.6085166e-7,4.34257e-7,0.0000093978315,0.00087161426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833775,0.00009313713,0.001083759,0.00010369279,0.00021413593,0.00016753875],"domain_scores_gemma":[0.99744254,0.0008290342,0.0010564557,0.00017060363,0.00019236511,0.00030899877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014827924,0.000076336764,0.00095451705,0.00010896619,0.000017595446,0.0000049259543,0.00015272651,0.00007254403,0.0005012871],"category_scores_gemma":[0.0014827005,0.00005270825,0.00037987067,0.00018532484,0.00050439604,0.000046943547,0.00003755766,0.0009969659,0.000045677883],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006609175,0.0002456628,0.29079208,0.000002740334,0.00012936583,0.00024583875,0.000022439808,3.7644162e-7,0.00008826745,0.00024399007,0.009349568,0.69821876],"study_design_scores_gemma":[0.0021097073,0.007512075,0.4644304,0.000006724517,0.00017479272,0.00034780728,0.00013217432,0.0000067609117,0.000011098542,0.00012160424,0.5251065,0.000040382038],"about_ca_topic_score_codex":0.00001849522,"about_ca_topic_score_gemma":0.000023741846,"teacher_disagreement_score":0.6981784,"about_ca_system_score_codex":0.000023975988,"about_ca_system_score_gemma":0.00048139508,"threshold_uncertainty_score":0.54887426},"labels":[],"label_agreement":null},{"id":"W2029370731","doi":"10.1097/00000421-200010000-00012","title":"Acute Spontaneous Tumor Lysis Syndrome in Adenocarcinoma of the Lung","year":2000,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Tumor lysis syndrome; Adenocarcinoma; Lung; Adenocarcinoma of the lung; Lysis; Pathology; Internal medicine; Oncology; Chemotherapy; Immunology; Cancer","score_opus":0.02485707856460666,"score_gpt":0.37952115369733314,"score_spread":0.35466407513272646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029370731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99108475,0.0002628216,0.000009318632,0.004685435,0.0003142322,0.00016619047,0.0000040414848,0.000005536281,0.0034676439],"genre_scores_gemma":[0.9944528,0.00024602332,0.0024171388,0.0018762954,0.0001645554,0.0000026246164,7.187651e-7,0.000020461954,0.00081939745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995451,0.0008803784,0.0026562982,0.00022883297,0.00046681907,0.00031672243],"domain_scores_gemma":[0.99576765,0.0015318311,0.0017673953,0.0004514729,0.00017189344,0.0003097562],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019326452,0.00017425422,0.002490041,0.00019015139,0.000026889695,0.0000037252958,0.0004490603,0.00010780079,0.0014007572],"category_scores_gemma":[0.0009215265,0.00010614562,0.00089905475,0.0007852797,0.0008425572,0.000050351187,0.000049535356,0.001029219,0.000028352548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069863405,0.0018354271,0.6968331,0.000042033036,0.0015032351,0.08621289,0.0003100561,0.00007176016,0.000450063,0.000059780323,0.0011476949,0.20454766],"study_design_scores_gemma":[0.004147485,0.009957248,0.81277436,0.00017093889,0.0012098314,0.16713572,0.00018535112,0.00011545897,0.00006204693,0.00014081624,0.0039757746,0.00012499135],"about_ca_topic_score_codex":0.000058817972,"about_ca_topic_score_gemma":0.000012309799,"teacher_disagreement_score":0.20442267,"about_ca_system_score_codex":0.00015263069,"about_ca_system_score_gemma":0.00091159035,"threshold_uncertainty_score":0.9995121},"labels":[],"label_agreement":null},{"id":"W2030403305","doi":"10.1097/coc.0b013e318282a830","title":"Sex-based Disparities in Colorectal Cancer Screening","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Sigmoidoscopy; Demography; Fecal occult blood; Colonoscopy; Cohort; Colorectal cancer; Confounding; Population; Logistic regression; Gerontology; Odds ratio; Cancer; Internal medicine; Environmental health","score_opus":0.06352729270048085,"score_gpt":0.4281057249179441,"score_spread":0.3645784322174632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030403305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876464,0.0001889875,0.0013951963,0.008702441,0.0005722196,0.00017674305,0.0000014806436,0.000018960282,0.0012975921],"genre_scores_gemma":[0.9887823,0.0001201888,0.0073039043,0.002940546,0.0007239017,0.000031174663,9.549883e-7,0.000016605863,0.00008041092],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975424,0.00039719915,0.0013156012,0.00018373798,0.0002790774,0.00028198288],"domain_scores_gemma":[0.99670017,0.0016228823,0.000958272,0.000093943505,0.00030182433,0.00032291567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012079991,0.00012850392,0.0012424322,0.00021436237,0.00003321885,0.000013137571,0.000116973904,0.00013515716,0.00023728196],"category_scores_gemma":[0.0010520032,0.00010085232,0.0003116818,0.00036664787,0.0005409778,0.00010852422,0.000026433121,0.0009772343,0.000009964691],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053170477,0.00022232847,0.44992036,0.000006308577,0.00006999306,0.00007167833,0.000039922477,0.00016516991,0.00017980242,0.0000035330245,0.0005555802,0.54344827],"study_design_scores_gemma":[0.0043153544,0.03535772,0.95079166,0.00013908786,0.000096240154,0.00019226651,0.00040502907,0.0028902038,0.0006049574,0.00006195944,0.0050147837,0.00013072812],"about_ca_topic_score_codex":0.0031548955,"about_ca_topic_score_gemma":0.00049277785,"teacher_disagreement_score":0.54331756,"about_ca_system_score_codex":0.00017669112,"about_ca_system_score_gemma":0.00093851454,"threshold_uncertainty_score":0.4769279},"labels":[],"label_agreement":null},{"id":"W2030878921","doi":"10.1097/coc.0b013e3181b0c370","title":"Does a Three-Field Electron/Minitangent Photon Technique Offer Dosimetric Advantages to a Multifield, Photon-Only Technique for Accelerated Partial Breast Irradiation?","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria; BC Cancer Agency","funders":"","keywords":"Medicine; Nuclear medicine; Dosimetry; Breast cancer; Irradiation; Radiation therapy; Photon; Radiology; Cancer; Optics; Internal medicine; Physics","score_opus":0.0231191773281977,"score_gpt":0.40161043696538057,"score_spread":0.3784912596371829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030878921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688682,0.00008873045,0.021891303,0.0061393795,0.0012645869,0.0014438661,0.00008301459,0.000022105918,0.00019878894],"genre_scores_gemma":[0.97120494,0.00021494256,0.024476076,0.0022239245,0.0012912282,0.0004938841,0.000016131924,0.000038854145,0.000040023337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975035,0.00020815077,0.0011926567,0.0004560442,0.0001951469,0.00044445522],"domain_scores_gemma":[0.996826,0.00091417914,0.0010475715,0.00035509767,0.0005395381,0.0003175928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011171378,0.000284202,0.00094231364,0.00019569948,0.000099657824,0.000019390847,0.00041067906,0.00037023556,0.00005478178],"category_scores_gemma":[0.0013897462,0.0001878431,0.00042490303,0.00035168996,0.00026908168,0.000013864402,0.000113257585,0.0006444848,0.000003695907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010682521,0.0016889676,0.11521309,0.000017294908,0.0009286688,0.00004328891,0.00007330554,0.0000040274717,0.5785523,0.000047368074,0.0033290663,0.28942013],"study_design_scores_gemma":[0.0047319722,0.029964095,0.10632805,0.000047485144,0.0004289722,0.000866301,0.0001673777,0.000014521306,0.7376648,0.00033178102,0.118806005,0.0006486389],"about_ca_topic_score_codex":0.0001345963,"about_ca_topic_score_gemma":0.0005812379,"teacher_disagreement_score":0.28877148,"about_ca_system_score_codex":0.00006404475,"about_ca_system_score_gemma":0.0008005576,"threshold_uncertainty_score":0.76600194},"labels":[],"label_agreement":null},{"id":"W2031270583","doi":"10.1097/coc.0b013e31807a2f49","title":"Neuroendocrine Tumors of the Gastrointestinal Tract","year":2008,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Gastrointestinal tract; Neuroendocrine tumors; Internal medicine; Pathology; Gastroenterology","score_opus":0.08907959381622788,"score_gpt":0.4520346795353134,"score_spread":0.3629550857190855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031270583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984571,0.00005271492,0.000038507507,0.012991405,0.0002978263,0.00015144525,0.000002182475,0.000008666255,0.0018863005],"genre_scores_gemma":[0.9917278,0.00025718563,0.0054973033,0.001635436,0.00054014975,0.0000016589528,2.355781e-7,0.000020599437,0.00031961902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99606985,0.00077975745,0.001952042,0.00018300736,0.0006367212,0.0003786244],"domain_scores_gemma":[0.99382937,0.002690252,0.0022159563,0.000334248,0.00047751263,0.0004526849],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.0005759087,0.00014210789,0.0014159582,0.00012513946,0.000050429593,0.0000020413909,0.00043643592,0.0000049342384,0.00009680107],"category_scores_gemma":[0.010041365,0.00008287536,0.00065051607,0.00042098656,0.0027366548,0.000082120816,0.00010922877,0.0014826214,0.000009662763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030702252,0.0017131025,0.9133231,0.00001631723,0.000036303747,0.037459686,0.00001838024,0.000028095816,0.0011048104,0.000030586314,0.0025308584,0.040668543],"study_design_scores_gemma":[0.0025102538,0.032403927,0.67604065,0.00009295825,0.000062950916,0.2698615,0.00012496185,0.000015694817,0.000752872,0.000052809817,0.018028134,0.000053343007],"about_ca_topic_score_codex":0.000024270437,"about_ca_topic_score_gemma":0.0000053675685,"teacher_disagreement_score":0.23728247,"about_ca_system_score_codex":0.000047784946,"about_ca_system_score_gemma":0.0016110163,"threshold_uncertainty_score":0.99997735},"labels":[],"label_agreement":null},{"id":"W2031688279","doi":"10.1097/coc.0000000000000169","title":"Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Radiosurgery; Dose fractionation; Medical physics; Radiation therapy; Radiology","score_opus":0.18220526878716964,"score_gpt":0.5007683855363978,"score_spread":0.31856311674922816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031688279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9453965,0.000978262,0.028731056,0.016263308,0.0021651017,0.0009314893,0.000043084485,0.00003389072,0.0054573165],"genre_scores_gemma":[0.88489085,0.00045901563,0.100522615,0.012180378,0.0015483787,0.00001956629,0.000009799005,0.000046698486,0.0003227143],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605167,0.0007944515,0.0020297873,0.00025149467,0.0005246836,0.00034789197],"domain_scores_gemma":[0.99152607,0.004131575,0.002276529,0.00026745585,0.000789142,0.0010092158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004322447,0.00019948576,0.0019441105,0.00024090463,0.000030930023,0.000016481741,0.00022095616,0.000076600714,0.00018052135],"category_scores_gemma":[0.007942719,0.00015143651,0.0006700199,0.00026371263,0.0006308433,0.00014125988,0.0000326604,0.00046758592,0.000026459296],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046729125,0.006217967,0.03722893,0.0000723241,0.0033158166,0.0023818375,0.0004410002,0.000011596346,0.0000636751,0.0010015273,0.040102188,0.862434],"study_design_scores_gemma":[0.051581275,0.13741866,0.088402644,0.00013022125,0.0042628413,0.0015571687,0.0039588097,0.00052403886,0.000023726881,0.0019205237,0.7097827,0.00043736753],"about_ca_topic_score_codex":0.000012742802,"about_ca_topic_score_gemma":0.0000024552335,"teacher_disagreement_score":0.86199665,"about_ca_system_score_codex":0.00017796908,"about_ca_system_score_gemma":0.0017466937,"threshold_uncertainty_score":0.9508751},"labels":[],"label_agreement":null},{"id":"W2033010643","doi":"10.1097/coc.0b013e3181b20641","title":"The Contents and Readability of Informed Consent Forms for Oncology Clinical Trials","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Readability; Informed consent; Clinical trial; Oncology; MEDLINE; Internal medicine; Medical physics; Family medicine; Alternative medicine; Pathology","score_opus":0.8287529717556347,"score_gpt":0.7598991608982333,"score_spread":0.06885381085740139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033010643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9357123,0.00011295878,0.00033650178,0.056953635,0.0026934566,0.0010027371,0.000016783315,0.000007801398,0.003163844],"genre_scores_gemma":[0.9686481,0.008924608,0.016216254,0.0044817314,0.0013695315,0.000024045881,0.000002237931,0.000021910337,0.0003116234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9809123,0.004590965,0.012614587,0.00040374114,0.00091514445,0.00056320784],"domain_scores_gemma":[0.09515052,0.88689727,0.0110214995,0.0008808969,0.004575165,0.0014746793],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.17123437,0.00019128139,0.0046468866,0.000105182604,0.00012472345,0.000016101905,0.00059329777,0.0010961685,0.00004968296],"category_scores_gemma":[0.79891264,0.000099708326,0.0015004746,0.00018437109,0.013220372,0.00007743545,0.00023289146,0.00668323,0.0000048233146],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028934479,0.0015133806,0.16727674,0.000077015786,0.0007395821,0.00003510978,0.00008234005,1.3672877e-7,0.00025947535,0.004394573,0.0018857769,0.7948014],"study_design_scores_gemma":[0.02141679,0.16706443,0.2601028,0.00027017776,0.0011199095,0.0006610317,0.0030587998,0.00008822663,0.0003432207,0.05399634,0.4916305,0.0002477752],"about_ca_topic_score_codex":0.000052891417,"about_ca_topic_score_gemma":0.0016773941,"teacher_disagreement_score":0.88576186,"about_ca_system_score_codex":0.000100982754,"about_ca_system_score_gemma":0.013419699,"threshold_uncertainty_score":0.9956084},"labels":[],"label_agreement":null},{"id":"W2033387468","doi":"10.1097/01.coc.0000260950.44761.74","title":"Can Serum Markers Be Used to Predict Acute and Late Toxicity in Patients With Lung Cancer?","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pulmonary function testing; Internal medicine; Radiation therapy; Lung cancer; Gastroenterology; Stage (stratigraphy); Pulmonary fibrosis; Lung; Cancer; White blood cell; Pneumonitis; Pulmonary toxicity; DLCO; Oncology; Surgery; Diffusing capacity","score_opus":0.01786665297264441,"score_gpt":0.40190118580411016,"score_spread":0.38403453283146577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033387468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98011667,0.000027528282,0.00009355124,0.018896107,0.00030797702,0.00034081013,0.000015133391,0.00000882515,0.00019342183],"genre_scores_gemma":[0.9889183,0.00006730556,0.0029357504,0.007775219,0.00023542644,0.0000027507988,0.0000020041684,0.000019032492,0.000044235203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768054,0.0002945896,0.0011294177,0.00020350787,0.00037267094,0.00031927467],"domain_scores_gemma":[0.996431,0.0014984091,0.0009872181,0.00014308818,0.00025643178,0.0006838424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023295481,0.00013795635,0.0010997186,0.00021447899,0.000024328774,0.000005398445,0.00011390129,0.00011875426,0.000030015291],"category_scores_gemma":[0.0009292782,0.00010042905,0.000094564515,0.00035542125,0.0003228435,0.00007619651,0.00003327076,0.00069307815,5.9988974e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077818474,0.0003071406,0.867633,0.000008546527,0.00031862274,0.0002549479,0.00023467964,0.00004165458,0.00002689802,0.0000018888824,0.0005657222,0.12282505],"study_design_scores_gemma":[0.007927463,0.02811285,0.9616245,0.0000996846,0.00024846065,0.00003440361,0.00010219645,0.000058819256,0.000026576312,0.0000034281074,0.0016652349,0.000096375916],"about_ca_topic_score_codex":0.000107383756,"about_ca_topic_score_gemma":0.000997472,"teacher_disagreement_score":0.122728676,"about_ca_system_score_codex":0.00027308028,"about_ca_system_score_gemma":0.0006848758,"threshold_uncertainty_score":0.4095378},"labels":[],"label_agreement":null},{"id":"W2034338399","doi":"10.1097/coc.0b013e31819d3684","title":"Optimal Equations for Describing the Relationship Between Prostate Volume, Number of Sources, and Total Activity in Permanent Prostate Brachytherapy","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Nomogram; Brachytherapy; Medicine; Prostate; Linear equation; Volume (thermodynamics); Prostate brachytherapy; Nuclear medicine; Statistics; Mathematics; Radiation therapy; Surgery; Oncology; Mathematical analysis; Internal medicine","score_opus":0.13860465488506815,"score_gpt":0.44171375617570857,"score_spread":0.3031091012906404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034338399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98714,0.00007911912,0.00038240544,0.011560455,0.00017756122,0.0005677042,0.00002698354,0.0000039651245,0.0000617973],"genre_scores_gemma":[0.9924338,0.00016640956,0.0067816926,0.00021595451,0.00027693555,0.000045100176,0.0000058677183,0.000015327514,0.00005889931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981627,0.00025988347,0.0010425344,0.00016500693,0.00016535948,0.00020451371],"domain_scores_gemma":[0.9922637,0.0059487727,0.001248313,0.00014488668,0.00021968914,0.00017467134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018804914,0.0001128468,0.0008091017,0.00006428847,0.00006902881,0.000010787263,0.000071100025,0.00008346225,0.00001377765],"category_scores_gemma":[0.0016157712,0.000072753435,0.00019462648,0.00015567007,0.0006989609,0.00010748787,0.000027458005,0.0007335074,0.0000013638536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011423959,0.00044119052,0.79708433,0.000011264738,0.00010822784,0.000011424957,0.0006781123,0.00003191314,0.000084917854,0.00011123107,0.00004608471,0.20024891],"study_design_scores_gemma":[0.0041026575,0.0069547687,0.9858807,0.000068729845,0.00019887359,0.000110236164,0.00033355225,0.00018857482,0.000088968474,0.00025654776,0.0017470184,0.00006941268],"about_ca_topic_score_codex":0.0000878587,"about_ca_topic_score_gemma":0.000053685166,"teacher_disagreement_score":0.2001795,"about_ca_system_score_codex":0.00007078282,"about_ca_system_score_gemma":0.00061280676,"threshold_uncertainty_score":0.31867653},"labels":[],"label_agreement":null},{"id":"W2037321725","doi":"10.1097/01.coc.0000258084.55036.9e","title":"A Population-Based Analysis of Second Primary Cancers After Irradiation for Rectal Cancer","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Cancer registry; Prostate cancer; Population; Cancer; Internal medicine; Incidence (geometry); Colorectal cancer; Cohort; Confidence interval; Oncology; Prostate; Epidemiology; Gynecology; Urology","score_opus":0.04742313306440697,"score_gpt":0.45107602988796874,"score_spread":0.40365289682356176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037321725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948097,0.000323449,0.0020197537,0.0011507941,0.0006614293,0.00021058193,0.00006635054,0.0000053418316,0.00075261097],"genre_scores_gemma":[0.98105407,0.00012294404,0.009892513,0.008178901,0.0006018479,0.000012181796,0.000042462634,0.000015718015,0.00007938277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970828,0.00015807198,0.002053146,0.00019846557,0.0002690071,0.00023846226],"domain_scores_gemma":[0.99402994,0.002667019,0.0023792444,0.00016545985,0.00046748942,0.00029082806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022011644,0.00012398254,0.0018250414,0.0004982207,0.000024383504,0.000003073538,0.00010104217,0.00013420997,0.00075687736],"category_scores_gemma":[0.00054269127,0.000102813836,0.0009049784,0.00065025396,0.00026499448,0.00008230577,0.000009040243,0.0003560922,4.9676106e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013323166,0.00016616446,0.6043904,0.000035431643,0.0018297299,0.000028876591,0.000105557796,0.00065984967,0.00020977392,0.0000037759457,0.00036933887,0.37887797],"study_design_scores_gemma":[0.0037190972,0.0055737956,0.9677724,0.000032547516,0.0024420612,0.000008783766,0.00011171719,0.0008831611,0.000051665254,0.000009489918,0.0192974,0.00009785828],"about_ca_topic_score_codex":0.00056610204,"about_ca_topic_score_gemma":0.002734137,"teacher_disagreement_score":0.3787801,"about_ca_system_score_codex":0.000887296,"about_ca_system_score_gemma":0.0031231588,"threshold_uncertainty_score":0.8287276},"labels":[],"label_agreement":null},{"id":"W2037683381","doi":"10.1097/01.coc.0000175290.65929.3b","title":"Acute Proctocolitis With Commencement of Neoadjuvant Chemoradiation for Rectal Cancer","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"","keywords":"Medicine; Colorectal cancer; Neoadjuvant therapy; Chemotherapy; Oncology; Internal medicine; Cancer; Surgery","score_opus":0.05996344512944724,"score_gpt":0.4813663481641092,"score_spread":0.421402903034662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037683381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98960453,0.00013626824,0.00050832884,0.006633229,0.00030093815,0.00087935186,0.000021837543,0.000007865355,0.0019076307],"genre_scores_gemma":[0.9857685,0.00021644529,0.01224872,0.0008414378,0.00061631884,0.00014382678,0.000008355268,0.000017348964,0.00013903248],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977604,0.0001313616,0.0013980475,0.00017640914,0.00030295065,0.00023082292],"domain_scores_gemma":[0.9960293,0.0010126907,0.0020577249,0.0001202903,0.0005799699,0.00020003383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058923673,0.00013317743,0.0014463253,0.00007969751,0.000025029229,0.0000035415537,0.00009951068,0.00007730873,0.00007396696],"category_scores_gemma":[0.00018663748,0.00008778106,0.0003096442,0.00026547266,0.00047291446,0.000057573285,0.000018961991,0.00025629453,0.0000011062799],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031536486,0.0021061255,0.20630112,0.000037170837,0.0010223585,0.00023145745,0.000072136136,0.000062963234,0.00032713026,0.00014657518,0.0013338397,0.75682265],"study_design_scores_gemma":[0.03390747,0.18813539,0.64591634,0.00036500563,0.0021550674,0.00075919105,0.00022450517,0.00024390679,0.0032552367,0.0004379214,0.12433435,0.0002656057],"about_ca_topic_score_codex":0.0003114435,"about_ca_topic_score_gemma":0.00012263478,"teacher_disagreement_score":0.75655705,"about_ca_system_score_codex":0.00033650058,"about_ca_system_score_gemma":0.0011961894,"threshold_uncertainty_score":0.35796076},"labels":[],"label_agreement":null},{"id":"W2038083383","doi":"10.1097/01.coc.0000203757.52100.fa","title":"Metastatic Synovial Sarcoma of the Foot to the Throat","year":2008,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Foot (prosody); Synovial sarcoma; Internal medicine; Throat; Sarcoma; General surgery; Family medicine; Oncology; Surgery; Pathology","score_opus":0.13523882103533955,"score_gpt":0.4547688675458058,"score_spread":0.31953004651046624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038083383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9453467,0.0003701391,0.0000945961,0.052285068,0.00064171455,0.00022438257,0.0000038819257,0.0000031273757,0.0010304045],"genre_scores_gemma":[0.9880969,0.00032399487,0.0029785698,0.008012928,0.00048732705,0.0000067457113,3.2448352e-7,0.000011658559,0.00008152948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972557,0.00066992413,0.0013623176,0.00012818651,0.00039154588,0.00019236],"domain_scores_gemma":[0.9944357,0.0034907921,0.0012492323,0.000347825,0.0002490358,0.00022737068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011596222,0.00011321065,0.001211443,0.000053534648,0.000072672265,0.0000023448797,0.00030326293,0.000039524562,0.0000756576],"category_scores_gemma":[0.0018952338,0.000047895013,0.0006709414,0.00031927312,0.000990259,0.000023265164,0.00007808048,0.0004447186,0.000029005518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013206488,0.0029388224,0.5547465,0.0000042405136,0.00081277464,0.0005653873,0.0004327184,0.000020473746,0.00004005739,0.00011270141,0.01284025,0.42616543],"study_design_scores_gemma":[0.0028962758,0.0173583,0.86660945,0.000052268624,0.0006415355,0.0024640055,0.00054520456,0.000006968706,0.0001625806,0.00007099221,0.10913504,0.000057381756],"about_ca_topic_score_codex":0.000089397894,"about_ca_topic_score_gemma":0.00004290972,"teacher_disagreement_score":0.42610806,"about_ca_system_score_codex":0.000068564674,"about_ca_system_score_gemma":0.0008073284,"threshold_uncertainty_score":0.36486503},"labels":[],"label_agreement":null},{"id":"W2038286567","doi":"10.1097/00000421-200102000-00012","title":"Malignant Lymphoma of Mucosa-Associated Lymphoid Tissue of the Lacrimal Gland","year":2001,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Lacrimal gland; MALT lymphoma; Radiation therapy; Lymphoma; Pathology; Mucosa-associated lymphoid tissue; Lymphatic system; Lacrimal apparatus; Salivary gland; Thyroid; Radiology; Internal medicine","score_opus":0.1181665783926455,"score_gpt":0.47604372562490727,"score_spread":0.35787714723226177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038286567","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.075046025,0.92051655,0.0000038758744,0.00069072633,0.0012435002,0.0005466714,0.00007536809,0.000006970258,0.0018703208],"genre_scores_gemma":[0.066599086,0.931903,0.0003439658,0.00036159984,0.0005728929,0.000010689422,0.000016122212,0.000044600183,0.0001480118],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924186,0.0016569116,0.0047300295,0.0002908457,0.0005616566,0.00034197196],"domain_scores_gemma":[0.9839683,0.00446421,0.010273854,0.00049055595,0.0004688207,0.00033422973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020066206,0.00038977462,0.008634249,0.00018913184,0.000034663033,0.000004288646,0.00047936232,0.00039576177,0.00014545304],"category_scores_gemma":[0.001961273,0.00019487577,0.0024599074,0.0006689413,0.0009971429,0.00002902059,0.000119453005,0.0005050806,0.000010186562],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004907937,0.0040864423,0.057065804,0.00053745846,0.0023784798,0.000935851,0.000030180017,2.826393e-7,2.7495457e-7,0.000032733555,0.0010303943,0.9334113],"study_design_scores_gemma":[0.0065487153,0.02435832,0.045859437,0.009560695,0.009744563,0.0055716494,0.000066921784,7.8914826e-7,0.000010938631,0.000036396978,0.89804465,0.00019691214],"about_ca_topic_score_codex":0.00024558266,"about_ca_topic_score_gemma":0.00002755907,"teacher_disagreement_score":0.93321437,"about_ca_system_score_codex":0.0003451586,"about_ca_system_score_gemma":0.0039574923,"threshold_uncertainty_score":0.79468036},"labels":[],"label_agreement":null},{"id":"W2039440309","doi":"10.1097/01.coc.0000236006.54867.f7","title":"Metastatic Midgut Carcinoid to the Heart Demonstrated on Cardiac Magnetic Resonance Imaging","year":2009,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; Alberta Cancer Foundation","funders":"","keywords":"Medicine; Magnetic resonance imaging; Midgut; Carcinoid Heart Disease; Radiology; Cardiac magnetic resonance; Carcinoid syndrome; Cardiology; Internal medicine","score_opus":0.05700696874890271,"score_gpt":0.45941140065302044,"score_spread":0.40240443190411773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039440309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8258539,0.0023668476,0.00003631434,0.16848126,0.0005179705,0.00040425727,0.000005275163,0.000017595434,0.00231657],"genre_scores_gemma":[0.9648634,0.00042577618,0.006541819,0.0272193,0.0006890028,0.0000056233634,5.9504725e-7,0.000018037625,0.0002364379],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9958871,0.0013516621,0.001350366,0.00027895148,0.0006182056,0.00051369856],"domain_scores_gemma":[0.9951399,0.002885999,0.0005365762,0.00037762805,0.00038276194,0.00067712564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017362554,0.00017339831,0.0013982021,0.00017247065,0.00006739078,0.000016008069,0.00032467738,0.0000091352995,0.000049099166],"category_scores_gemma":[0.0047691693,0.00010524456,0.00041029154,0.0005711414,0.00065435783,0.00006746373,0.00003911454,0.001263882,0.00007870364],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036294104,0.00056592486,0.055673923,0.000003828597,0.000038110793,0.005204291,0.000039648497,0.000038528717,0.0008478808,0.000045846784,0.018527927,0.91538465],"study_design_scores_gemma":[0.0019675088,0.05435039,0.5223903,0.00008299017,0.0001612097,0.0034315484,0.0004539428,0.000046935013,0.0003019844,0.00015410509,0.4165394,0.000119709024],"about_ca_topic_score_codex":0.000025227768,"about_ca_topic_score_gemma":0.000007988838,"teacher_disagreement_score":0.91526496,"about_ca_system_score_codex":0.00009509452,"about_ca_system_score_gemma":0.00086789235,"threshold_uncertainty_score":0.57094854},"labels":[],"label_agreement":null},{"id":"W2039779593","doi":"10.1097/01.coc.0000143049.05090.12","title":"The Effects of Age and Comorbidity on Treatment and Outcomes in Women With Endometrial Cancer","year":2005,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Comorbidity; Endometrial cancer; Cohort; Cancer; Lymphadenectomy; Population; Internal medicine; Cancer registry; Hysterectomy; Charlson comorbidity index; Incidence (geometry); Surgery; Gynecology","score_opus":0.05067664852646503,"score_gpt":0.4393041282844591,"score_spread":0.38862747975799405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039779593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358886,0.0008910559,0.0000020298937,0.0047781887,0.00023920169,0.00022949264,0.0000027852996,0.0000022437969,0.00026614903],"genre_scores_gemma":[0.986727,0.011471591,0.00033038165,0.0010343227,0.00033584758,0.000020311092,1.6942253e-7,0.000007535689,0.000072860756],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983674,0.0003318693,0.0007886614,0.00013322195,0.00018631607,0.00019251397],"domain_scores_gemma":[0.98861325,0.0102625685,0.00070531556,0.000103587714,0.000058728918,0.00025652404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007068787,0.00012524032,0.0014622086,0.00012439948,0.000027385468,0.000004805819,0.00005911278,0.000054156742,0.000013007721],"category_scores_gemma":[0.0014793107,0.000053965272,0.000099577774,0.0002425119,0.0006580409,0.000028094077,0.000019572604,0.0002647863,5.428817e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018798051,0.0009805982,0.24388398,0.00000807636,0.000462368,0.00018801464,0.00015715885,0.0000015128508,0.000027593815,0.000012270185,0.00001433775,0.73546606],"study_design_scores_gemma":[0.031439453,0.10162548,0.8547727,0.0000699221,0.00022045086,0.0000427386,0.0001531103,0.0000013249365,0.000101921156,0.000044468765,0.01147582,0.00005262961],"about_ca_topic_score_codex":0.0003139854,"about_ca_topic_score_gemma":0.00034157778,"teacher_disagreement_score":0.73541343,"about_ca_system_score_codex":0.00030144473,"about_ca_system_score_gemma":0.00026820033,"threshold_uncertainty_score":0.24245793},"labels":[],"label_agreement":null},{"id":"W2046401073","doi":"10.1097/coc.0b013e318165c036","title":"A Comparison of Treatment Outcomes by Radiochemotherapy and Postoperative Radiotherapy in Locally Advanced Squamous Cell Carcinomas of Head and Neck","year":2008,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Neck dissection; Radiation therapy; Surgery; Stage (stratigraphy); Concomitant; Port (circuit theory); Head and neck; Head and neck cancer; Adjuvant; Retrospective cohort study; Hazard ratio; Oncology; Cancer; Internal medicine","score_opus":0.06438859198682809,"score_gpt":0.4560576032786439,"score_spread":0.39166901129181586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046401073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854461,0.009867912,0.000051952975,0.0041139843,0.00007774316,0.00019972716,0.000004769124,0.0000023771554,0.00023543848],"genre_scores_gemma":[0.9793651,0.013396549,0.0058787856,0.0012501794,0.000037601443,0.000003126486,6.074977e-7,0.000012211388,0.00005581216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782914,0.00025756372,0.0014442257,0.00016808363,0.00013667208,0.00016432304],"domain_scores_gemma":[0.99730355,0.0012890337,0.0009694578,0.00010735253,0.00014549337,0.00018511806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030266997,0.00015468009,0.0029133623,0.000092186114,0.000024228744,9.605629e-7,0.000055045683,0.000078046956,0.000008441477],"category_scores_gemma":[0.00014856983,0.00010352968,0.00016246826,0.00012328364,0.0011104826,0.00003397613,0.0000111100135,0.00025089248,1.0783608e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052632955,0.0016268705,0.8135119,0.0000124160015,0.00015088092,0.00005678982,0.0036028682,0.000008933866,0.0024735732,0.0000022524018,0.0002492398,0.17304096],"study_design_scores_gemma":[0.028721066,0.16284479,0.7961754,0.00006998272,0.000078631856,0.00019531879,0.0016902093,0.00008377562,0.0021017496,0.0000041283324,0.007924971,0.000109960034],"about_ca_topic_score_codex":0.00024681978,"about_ca_topic_score_gemma":0.00007399452,"teacher_disagreement_score":0.17293099,"about_ca_system_score_codex":0.00013537733,"about_ca_system_score_gemma":0.0005874854,"threshold_uncertainty_score":0.4221818},"labels":[],"label_agreement":null},{"id":"W2047293775","doi":"10.1097/coc.0b013e31805c13f0","title":"The Influence of Mentorship on Research Productivity in Oncology","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Mentoring and Academic Development","field":"Psychology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"American Association for Cancer Research","keywords":"Mentorship; Medicine; Productivity; Medical education; Translational research; Clinical Oncology; Oncology; Family medicine; Internal medicine; Pathology; Cancer","score_opus":0.247257875317649,"score_gpt":0.5920795632103625,"score_spread":0.3448216878927135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047293775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96924555,0.00011178716,0.00001653105,0.008079477,0.003668793,0.00015054278,4.4723095e-7,0.0000043405744,0.018722536],"genre_scores_gemma":[0.99723834,0.00022842945,0.0005879905,0.0004797534,0.00082385645,0.000007541744,1.3878618e-7,0.000011068486,0.0006228568],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.991426,0.0041809664,0.0027260345,0.00029910638,0.0006419464,0.0007259791],"domain_scores_gemma":[0.9701328,0.026760107,0.0020500664,0.00033519705,0.00043420674,0.0002876206],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06875178,0.00011818156,0.00093291193,0.00030723246,0.000078650985,0.0000048251068,0.0007245144,0.0002365887,0.000039441213],"category_scores_gemma":[0.011072676,0.00007646113,0.00013808504,0.00064437324,0.0019270646,0.000047757872,0.00009950741,0.002776509,0.000044292643],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051673064,0.0014266635,0.14187194,0.0000033532037,0.00012636428,0.00021704313,0.0019814095,0.0000331413,0.00019154944,0.0032085234,0.003006316,0.8427664],"study_design_scores_gemma":[0.0011166037,0.0112222815,0.5970782,0.00004300647,0.000009549075,0.000049062182,0.0021262476,3.1941832e-7,0.00009948786,0.00075243384,0.38743874,0.00006404658],"about_ca_topic_score_codex":0.00015704875,"about_ca_topic_score_gemma":0.00009663158,"teacher_disagreement_score":0.8427023,"about_ca_system_score_codex":0.00040864872,"about_ca_system_score_gemma":0.0009699721,"threshold_uncertainty_score":0.9995241},"labels":[],"label_agreement":null},{"id":"W2052762622","doi":"10.1097/coc.0b013e3181574084","title":"Sorafenib for Metastatic Renal Cancer","year":2008,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Sorafenib; Rash; Internal medicine; Adverse effect; Population; Placebo; Common Terminology Criteria for Adverse Events; Oncology; Surgery; Cancer; Cohort; Gastroenterology; Hepatocellular carcinoma; Pathology","score_opus":0.22788009951966287,"score_gpt":0.5035995736530775,"score_spread":0.27571947413341463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052762622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98658866,0.0007265958,0.0018349864,0.008673614,0.000605118,0.00027702135,0.000007018611,0.0000092078935,0.0012777827],"genre_scores_gemma":[0.9561794,0.001243676,0.03762687,0.0031240704,0.0011296968,0.000023087425,0.0000026595367,0.000024670733,0.00064586004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972223,0.00031241972,0.0016876064,0.00019243638,0.0003050206,0.00028023287],"domain_scores_gemma":[0.9948056,0.0023225513,0.0016855665,0.0001824713,0.00051869324,0.00048516324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011291326,0.00014796112,0.001776852,0.00011701792,0.000052078518,0.0000025807096,0.00013468633,0.000065417385,0.00015018527],"category_scores_gemma":[0.0011401607,0.00009857511,0.00076880533,0.00017745263,0.00079880713,0.000052458792,0.000021371872,0.0004588771,0.000015635358],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01640881,0.0027633402,0.093388826,0.000036687838,0.0024579389,0.005261813,0.000349957,0.00010507351,0.0010347686,0.00009059479,0.021819722,0.8562825],"study_design_scores_gemma":[0.02781839,0.13408658,0.35066557,0.00016618008,0.003513582,0.013552295,0.0005135775,0.00022727277,0.0019075122,0.000486715,0.46669462,0.00036769797],"about_ca_topic_score_codex":0.0000526346,"about_ca_topic_score_gemma":0.000014691241,"teacher_disagreement_score":0.8559148,"about_ca_system_score_codex":0.0001988367,"about_ca_system_score_gemma":0.0021968253,"threshold_uncertainty_score":0.40197766},"labels":[],"label_agreement":null},{"id":"W2053643895","doi":"10.1097/coc.0000000000000099","title":"Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Aegera Therapeutics (Canada)","funders":"Chinese University of Hong Kong; University of Hong Kong","keywords":"Sorafenib; Medicine; Hepatocellular carcinoma; Clinical endpoint; Internal medicine; Adverse effect; Response Evaluation Criteria in Solid Tumors; Oncology; Combination therapy; Randomized controlled trial; Surgery; Phases of clinical research; Gastroenterology; Clinical trial","score_opus":0.014248113666293308,"score_gpt":0.31433472358678255,"score_spread":0.30008660992048924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053643895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984935,0.00002636434,0.0005192735,0.00012692492,0.00016634616,0.00064216106,0.0000016946636,9.98077e-7,0.000022769655],"genre_scores_gemma":[0.9989313,0.000042247535,0.00088253565,0.000056103487,0.000050055805,0.0000078766225,0.000006782146,0.000013889194,0.00000924479],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996725,0.0012512782,0.0014281442,0.00019942729,0.00025584848,0.0001402981],"domain_scores_gemma":[0.9968035,0.0002645187,0.0022736755,0.00022897491,0.00036354296,0.00006576007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001636497,0.0001344126,0.0012185302,0.00010589279,0.000027630618,0.0000022788288,0.0001665182,0.00010954343,0.0000029181206],"category_scores_gemma":[0.00043885678,0.00007777007,0.00016330749,0.0002441817,0.00042590426,0.000008676068,0.000059587328,0.00022703392,7.97245e-8],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31315738,0.017699255,0.49525574,0.00002381272,0.00028591763,0.0000076227516,0.00067099446,0.0009528702,0.040083736,0.00005053541,0.000010804788,0.13180134],"study_design_scores_gemma":[0.6553365,0.14599335,0.17096576,0.00012061191,0.00025515823,0.0000070640144,0.00075498095,0.0010090892,0.025054919,0.000076591146,0.00020232363,0.00022364224],"about_ca_topic_score_codex":0.000050503062,"about_ca_topic_score_gemma":0.000058923735,"teacher_disagreement_score":0.34217912,"about_ca_system_score_codex":0.000021185966,"about_ca_system_score_gemma":0.00018075979,"threshold_uncertainty_score":0.31713715},"labels":[],"label_agreement":null},{"id":"W2056504493","doi":"10.1097/coc.0b013e31828aab2a","title":"Outcomes of Small Cell Lung Cancer Patients Treated With Cisplatin-Etoposide Versus Carboplatin-Etoposide","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Carboplatin; Internal medicine; Population; Gastroenterology; Cisplatin; Retrospective cohort study; Chemotherapy; Surgery","score_opus":0.05152157600792551,"score_gpt":0.4453391437418046,"score_spread":0.3938175677338791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056504493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900039,0.00030258147,0.00002193032,0.0032243861,0.00047635013,0.0005625466,0.000010004165,0.000013522159,0.005384815],"genre_scores_gemma":[0.99400973,0.0006165898,0.0038685242,0.00075527147,0.00028143602,0.000035129204,0.0000032331097,0.00003787756,0.0003922158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961617,0.0004289626,0.0019857124,0.0002864067,0.0006593048,0.00047791],"domain_scores_gemma":[0.99123013,0.003809376,0.0025463027,0.00029813978,0.0015732382,0.00054280227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006657493,0.00026470487,0.002419539,0.00019325457,0.000051856063,0.000009280794,0.00027083195,0.00012741532,0.00022010114],"category_scores_gemma":[0.0014828267,0.00016212021,0.00039481104,0.0003697676,0.0010814487,0.00010857906,0.0001041227,0.00090038136,0.000009812659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005467705,0.0009051577,0.94094026,0.000052905107,0.0015551095,0.000099554374,0.00022857892,0.000028367871,0.0001443561,0.0000048909505,0.001888281,0.048684802],"study_design_scores_gemma":[0.016003102,0.03433858,0.94618297,0.00015813927,0.0010108647,0.000016718406,0.00042115356,0.00008947235,0.00050934695,0.000007185166,0.0010969682,0.00016552699],"about_ca_topic_score_codex":0.0026107677,"about_ca_topic_score_gemma":0.0003252227,"teacher_disagreement_score":0.048519276,"about_ca_system_score_codex":0.00038535835,"about_ca_system_score_gemma":0.0014931157,"threshold_uncertainty_score":0.661107},"labels":[],"label_agreement":null},{"id":"W2056948196","doi":"10.1097/coc.0b013e31818b9486","title":"Bladder Conservation Treatment in the Elderly Population","year":2009,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Univariate analysis; Bladder cancer; Radiation therapy; Surgery; Chemotherapy; Carcinoma; Medical record; Cancer; Multivariate analysis; Internal medicine","score_opus":0.08724261910795172,"score_gpt":0.4652728854638044,"score_spread":0.3780302663558527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056948196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95550036,0.00011067265,0.00006157615,0.040904004,0.00020529781,0.00019482731,9.894353e-7,0.0000046770597,0.0030176102],"genre_scores_gemma":[0.9865631,0.00030526277,0.0013327978,0.011202322,0.0005131718,0.0000034732318,0.0000041295802,0.000004958799,0.00007081968],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981494,0.0004342333,0.0009788354,0.000106783635,0.00019467965,0.00013605523],"domain_scores_gemma":[0.99832565,0.0006721461,0.00066615525,0.0001358692,0.000100748344,0.000099411445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007697785,0.000092264214,0.0006904529,0.00007655357,0.000023934334,0.0000060785815,0.000078746656,0.000069226284,0.000041386007],"category_scores_gemma":[0.00025823922,0.00005005647,0.00021768692,0.00019654499,0.000120077464,0.000058800124,0.0000026427972,0.00025937005,0.0000071686827],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014403755,0.0012255993,0.19353426,6.5402503e-7,0.00008985324,0.00018499944,0.00025185608,0.00000413794,0.000013515634,0.000080691425,0.00055336126,0.8026207],"study_design_scores_gemma":[0.0046885232,0.07238084,0.89771855,0.000017192046,0.0002238867,0.00032134564,0.00039287403,0.00001648354,0.000008081016,0.00064597797,0.02354278,0.000043465003],"about_ca_topic_score_codex":0.00040822075,"about_ca_topic_score_gemma":0.00012105795,"teacher_disagreement_score":0.80257726,"about_ca_system_score_codex":0.00015108193,"about_ca_system_score_gemma":0.00046859644,"threshold_uncertainty_score":0.20412436},"labels":[],"label_agreement":null},{"id":"W2057110064","doi":"10.1097/01.coc.0000180384.40865.f7","title":"A Spermatocytic Seminoma With Rhabdomyosarcoma Transformation and Extensive Metastases","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rhabdomyosarcoma; Seminoma; Transformation (genetics); Malignant transformation; Radiology; Pathology; Internal medicine; Sarcoma; Chemotherapy","score_opus":0.04173647213736187,"score_gpt":0.42705227651371597,"score_spread":0.3853158043763541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057110064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412555,0.0008273442,0.002276289,0.0019231229,0.0000729837,0.00015830742,0.0000033686758,0.0000077986115,0.00060525344],"genre_scores_gemma":[0.9853237,0.00019803135,0.012723039,0.0015854872,0.0001458352,0.000001127249,0.0000028173101,0.000010168017,0.0000097500815],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99847186,0.00012358926,0.0009051312,0.00011209094,0.00020887442,0.00017845815],"domain_scores_gemma":[0.99721974,0.0011098427,0.00083485193,0.000100382116,0.0002645975,0.0004706071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070301036,0.00011003495,0.0008700645,0.00009866944,0.000028463872,0.00000558342,0.000042657262,0.000045469213,0.000019974448],"category_scores_gemma":[0.00044407853,0.00006675038,0.00018284765,0.00013720409,0.00051980297,0.00008739075,0.000008971412,0.00024516325,0.000004804859],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062201214,0.00093572406,0.18353744,0.000020656607,0.0006545523,0.004853763,0.00018731039,0.0000018841793,0.000041246218,0.00012149222,0.00006905162,0.80335677],"study_design_scores_gemma":[0.008952642,0.030369313,0.9367684,0.000121229525,0.0016653914,0.013925081,0.001496029,0.000037470927,0.00009570352,0.00008050676,0.0063910508,0.00009718301],"about_ca_topic_score_codex":0.000018956096,"about_ca_topic_score_gemma":0.000010681397,"teacher_disagreement_score":0.80325955,"about_ca_system_score_codex":0.000054429947,"about_ca_system_score_gemma":0.0004552453,"threshold_uncertainty_score":0.27220014},"labels":[],"label_agreement":null},{"id":"W2059793948","doi":"10.1097/01.coc.0000195092.25516.19","title":"Examining Time Intervals Between Diagnosis and Treatment in the Management of Patients With Limited Stage Small Cell Lung Cancer","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; BC Cancer Agency","funders":"","keywords":"Medicine; Lung cancer; Confidence interval; Odds ratio; Stage (stratigraphy); Internal medicine; Radiation therapy; Proportional hazards model; Chemotherapy; Cancer; Logistic regression; Oncology","score_opus":0.09451095105498074,"score_gpt":0.44607742118003774,"score_spread":0.351566470125057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059793948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590045,0.00052272173,0.000016251026,0.0018194687,0.000036975605,0.0004582725,0.000014725564,0.0000027076023,0.0012284343],"genre_scores_gemma":[0.99543446,0.0022581914,0.001620088,0.0002684284,0.00015821311,0.000046617428,0.0000032840492,0.0000117505615,0.00019894357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787146,0.0004575146,0.0009979488,0.00016086425,0.0002957303,0.00021647532],"domain_scores_gemma":[0.99633926,0.002283646,0.0009702433,0.0001424534,0.00016680581,0.00009757031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010552168,0.00012207926,0.0010646973,0.00011289849,0.000022565398,0.0000053616263,0.00013271984,0.000038316975,0.000030361025],"category_scores_gemma":[0.000078626465,0.00006376376,0.00009408568,0.00022778298,0.00047640447,0.000033414373,0.000063097745,0.00028196015,6.5228744e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094386755,0.0008904032,0.8278975,0.000047626207,0.0005762308,0.00014023035,0.00030626345,0.000011471238,0.0000013516067,0.0000015312175,0.00026541806,0.16891812],"study_design_scores_gemma":[0.006001768,0.021812364,0.9654805,0.00026601914,0.0006409341,0.0000017763974,0.0007418382,0.000009752815,0.000015861177,0.0000030383233,0.0049692653,0.000056846304],"about_ca_topic_score_codex":0.0005298852,"about_ca_topic_score_gemma":0.00013008034,"teacher_disagreement_score":0.16886128,"about_ca_system_score_codex":0.00024442555,"about_ca_system_score_gemma":0.00019449291,"threshold_uncertainty_score":0.26002106},"labels":[],"label_agreement":null},{"id":"W2061574831","doi":"10.1097/coc.0b013e3181ec60b8","title":"Integrating Radioembolization (90Y Microspheres) Into Current Treatment Options for Liver Tumors","year":2010,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nordion (Canada)","funders":"","keywords":"Medicine; Microsphere; Selective internal radiation therapy; Liver cancer; Radiology; Toxicity; Hepatocellular carcinoma; Internal medicine","score_opus":0.2800039921853348,"score_gpt":0.5061857362013176,"score_spread":0.2261817440159828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061574831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021492434,0.9928901,0.001509463,0.00031991,0.001487272,0.0014234754,0.000025948813,0.000018071558,0.00017651352],"genre_scores_gemma":[0.0007603494,0.9564057,0.03966595,0.00011623771,0.002584208,0.00014217745,0.00014689939,0.00007138673,0.00010708524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99482286,0.000843991,0.0033757796,0.00039663416,0.00022028573,0.000340429],"domain_scores_gemma":[0.9910478,0.0031857255,0.004364122,0.00032062645,0.00051958766,0.0005621669],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013597024,0.0004822696,0.006005776,0.00023574074,0.000099990204,0.000023875278,0.00023869563,0.00045902183,0.00009739933],"category_scores_gemma":[0.0013741428,0.0003023356,0.0031387792,0.0003311785,0.00055270805,0.00006455093,0.000037229765,0.0013307161,0.00003409029],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002555444,0.0014338332,0.0031412574,0.00078231853,0.0008272469,0.00020366501,0.000117809235,7.9585064e-8,9.662729e-7,0.000090500725,0.0004264659,0.9927203],"study_design_scores_gemma":[0.0021722459,0.020326622,0.00008114957,0.0034637582,0.0074751293,0.00078007014,0.00006969838,0.000063155894,0.0000028493098,0.000029009178,0.96531355,0.000222769],"about_ca_topic_score_codex":0.000050221002,"about_ca_topic_score_gemma":0.000045294906,"teacher_disagreement_score":0.99249756,"about_ca_system_score_codex":0.0005945953,"about_ca_system_score_gemma":0.0041350657,"threshold_uncertainty_score":0.9999429},"labels":[],"label_agreement":null},{"id":"W2064927794","doi":"10.1097/coc.0b013e3181beac33","title":"A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Lapatinib; Medicine; Internal medicine; Prostate cancer; Rash; Oncology; Clinical endpoint; Cancer; Prostate-specific antigen; Breast cancer; Population; Phases of clinical research; Adverse effect; Clinical trial; Trastuzumab","score_opus":0.09440197135542061,"score_gpt":0.5517576730823424,"score_spread":0.45735570172692175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064927794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98878926,0.00022638895,0.0000064113424,0.0075908857,0.0016355598,0.00092218164,0.000026277154,0.000009870896,0.00079318683],"genre_scores_gemma":[0.9892575,0.0040977034,0.004309431,0.00076752185,0.0010084508,0.000041346197,0.0000100522775,0.000029412397,0.0004785531],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99408424,0.0007513135,0.0038528796,0.00035271415,0.0004984225,0.0004604249],"domain_scores_gemma":[0.99309117,0.002387189,0.0027388267,0.00031894428,0.0008469002,0.00061698933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038744276,0.00021675052,0.002449996,0.0002486719,0.000041183517,0.0000058924957,0.0002697436,0.00025969406,0.00027124808],"category_scores_gemma":[0.003630958,0.0001416124,0.0006352985,0.00042412875,0.0016757891,0.00012211688,0.000096239906,0.002151007,0.000007726986],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3591224,0.008830518,0.082099974,0.000011166232,0.000329092,0.00038819967,0.00016854766,0.0000018279814,0.0012485819,0.000007852894,0.00031770038,0.54747415],"study_design_scores_gemma":[0.57006687,0.25720736,0.12190379,0.0002310429,0.00043479286,0.00007260865,0.0003575606,0.00012754716,0.00056882907,0.00006785093,0.048760988,0.0002007788],"about_ca_topic_score_codex":0.00014463536,"about_ca_topic_score_gemma":0.0002591468,"teacher_disagreement_score":0.54727334,"about_ca_system_score_codex":0.000110589746,"about_ca_system_score_gemma":0.0033083574,"threshold_uncertainty_score":0.9345175},"labels":[],"label_agreement":null},{"id":"W2065008784","doi":"10.1097/coc.0b013e3181e841ec","title":"Prospective Evaluation of a 12-Week Walking Exercise Program and Its Effect on Fatigue in Prostate Cancer Patients Undergoing Radical External Beam Radiotherapy","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Tolerability; Prospective cohort study; External beam radiotherapy; Quality of life (healthcare); Physical therapy; Radiation therapy; Adverse effect; Surgery; Internal medicine; Cancer","score_opus":0.047203938295134924,"score_gpt":0.4465187186582216,"score_spread":0.3993147803630867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065008784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657935,0.00059962494,0.000009918006,0.00047323783,0.0010041937,0.0011682627,0.000003770446,0.000008384849,0.00015326725],"genre_scores_gemma":[0.99760735,0.0009615334,0.00066452887,0.00026336554,0.00037541045,0.00009285104,0.0000017370639,0.000023222292,0.000009980033],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968786,0.00067181175,0.001229213,0.00026932624,0.000704992,0.00024605374],"domain_scores_gemma":[0.99614334,0.0015354991,0.0013791126,0.00012495667,0.0005493352,0.00026777605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036428585,0.00016912623,0.0012809576,0.00019192089,0.000028623148,0.000009687381,0.000108916145,0.000129599,0.00005157823],"category_scores_gemma":[0.0016731791,0.0001246437,0.00020717063,0.00024054295,0.00045113394,0.00009209239,0.000022338672,0.0011250285,4.532122e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006038387,0.0010282439,0.45063072,0.000030653875,0.000075532495,0.000022299513,0.0007492384,0.00001504274,0.00038504612,0.0000049542878,0.000009345257,0.5410105],"study_design_scores_gemma":[0.017509606,0.071860045,0.9069504,0.0009870253,0.00037304338,0.000050463786,0.00022698591,0.0005569467,0.00085102965,0.00008807823,0.00040599724,0.00014036235],"about_ca_topic_score_codex":0.00015518394,"about_ca_topic_score_gemma":0.0007789138,"teacher_disagreement_score":0.5408702,"about_ca_system_score_codex":0.00026027835,"about_ca_system_score_gemma":0.0011739773,"threshold_uncertainty_score":0.5082823},"labels":[],"label_agreement":null},{"id":"W2065940966","doi":"10.1097/coc.0b013e3182568f7a","title":"Randomized Feasibility Study of De-escalated (Every 12 wk) Versus Standard (Every 3 to 4 wk) Intravenous Pamidronate in Women With Low-risk Bone Metastases From Breast Cancer","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; Regional Municipality of Durham; University Health Network; St. Michael's Hospital; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Breast cancer; Bone pain; Bisphosphonate; Surgery; N-terminal telopeptide; Confidence interval; Bone disease; Internal medicine; Cancer; Osteoporosis; Alkaline phosphatase","score_opus":0.050315859666884274,"score_gpt":0.42938422032831985,"score_spread":0.37906836066143557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065940966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966205,0.00043037534,0.000057719215,0.0009759815,0.00059522083,0.0010586096,0.00018612502,0.000013408845,0.000062093204],"genre_scores_gemma":[0.9959519,0.0010122451,0.0018804468,0.00083481445,0.00021862837,0.0000583808,0.0000046526643,0.000030833213,0.000008135158],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99352723,0.0023973759,0.0025859661,0.000283754,0.00051133195,0.00069435965],"domain_scores_gemma":[0.9920927,0.003992844,0.0019643104,0.0003171581,0.00034334054,0.0012896346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005322701,0.00027194998,0.0042638667,0.00021049888,0.00004019546,0.000005375335,0.00013788139,0.0001412908,0.00016693129],"category_scores_gemma":[0.001234447,0.0001787202,0.00024085528,0.00040062255,0.0006239971,0.00013134406,0.000048958744,0.00093801174,0.0000043856435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4962648,0.0051037064,0.35554007,0.000011300387,0.0013798535,0.00023981211,0.0011803342,0.000047074558,0.0000053956187,3.6921836e-7,0.000046240875,0.14018106],"study_design_scores_gemma":[0.26435912,0.03558387,0.6964928,0.000105648236,0.0010813549,0.00009578817,0.0019567618,0.0000090431895,0.000009356976,0.000026257458,0.00016239921,0.00011763757],"about_ca_topic_score_codex":0.0048943846,"about_ca_topic_score_gemma":0.001916106,"teacher_disagreement_score":0.3409527,"about_ca_system_score_codex":0.0011327404,"about_ca_system_score_gemma":0.0021292274,"threshold_uncertainty_score":0.73988783},"labels":[],"label_agreement":null},{"id":"W2067425644","doi":"10.1097/01.coc.0000091359.11281.f4","title":"Influence of Oxygen on the Radiosensitivity of Human Glioma Cell Lines","year":2003,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Radiosensitivity; ERCC1; Radioresistance; Glioma; Cell culture; Biology; Clonogenic assay; DNA repair; Cancer research; Molecular biology; Nucleotide excision repair; Medicine; Genetics; Gene; Radiation therapy; Internal medicine","score_opus":0.03153943899472396,"score_gpt":0.3750174377133877,"score_spread":0.34347799871866375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067425644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708116,0.00047097084,0.000050221668,0.00039373347,0.0004516128,0.00007041303,0.0000059552854,0.0000011296461,0.0014748058],"genre_scores_gemma":[0.99680716,0.0008682467,0.0005399127,0.0008733914,0.0008424339,0.0000011984893,8.950818e-7,0.000010923168,0.000055843044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975294,0.00085831224,0.001111886,0.00016008387,0.00017500299,0.00016532178],"domain_scores_gemma":[0.9967669,0.0005735018,0.0018591526,0.00029577705,0.00038418922,0.000120475626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018855245,0.000115587914,0.0007926153,0.000052039224,0.000032780994,0.000002344781,0.00025838352,0.0001273089,0.000011126821],"category_scores_gemma":[0.0016944816,0.00007757917,0.00036583937,0.00014860362,0.00097065786,0.0000036315596,0.000038332477,0.0002890661,0.0000013373356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008799939,0.00078673,0.0047589904,0.0000113602255,0.00020258052,0.0000131971365,0.0000856335,0.00044572048,0.96272486,0.00044741068,0.0021694454,0.02747405],"study_design_scores_gemma":[0.0030661626,0.021995887,0.10358777,0.000044908604,0.00021493949,0.00020435573,0.0004411398,0.000003656227,0.63276184,0.00033902793,0.23709789,0.00024243296],"about_ca_topic_score_codex":0.000030834435,"about_ca_topic_score_gemma":0.000017769135,"teacher_disagreement_score":0.32996306,"about_ca_system_score_codex":0.000009024388,"about_ca_system_score_gemma":0.00048041725,"threshold_uncertainty_score":0.35764295},"labels":[],"label_agreement":null},{"id":"W2070107163","doi":"10.1097/01.coc.0000200044.81711.57","title":"A Phase I Dose Finding Study of Cisplatin, Gemcitabine, and Weekly Docetaxel for Patients With Advanced Transitional Cell Cancer","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Gemcitabine; Cisplatin; Oncology; Internal medicine; Chemotherapy","score_opus":0.03829447789951697,"score_gpt":0.4331444057135976,"score_spread":0.3948499278140806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070107163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977782,0.00015208885,0.00031990488,0.0006286403,0.0001662045,0.00059539103,0.00006431852,0.0000039781753,0.00029130498],"genre_scores_gemma":[0.99348503,0.00007806471,0.0056943307,0.00034877597,0.00028366654,0.000029458448,0.000008269379,0.000018787461,0.000053620683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981143,0.000116502066,0.0011279756,0.00019139479,0.0002686784,0.00018113833],"domain_scores_gemma":[0.9973596,0.00072563346,0.001210619,0.00009268569,0.00044107216,0.00017040159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030383162,0.00014076964,0.0011190587,0.00009087029,0.000041577307,0.0000035512248,0.000062637686,0.000053552154,0.000037181435],"category_scores_gemma":[0.000073527146,0.0000950382,0.00015020164,0.00014589881,0.00027334524,0.0000777215,0.000008857629,0.00023460017,3.027607e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04229304,0.029719153,0.5828975,0.000043547283,0.000554943,0.00007413624,0.00039678815,0.000072569266,0.00021058519,0.000008651259,0.00036539647,0.34336373],"study_design_scores_gemma":[0.12300718,0.20148447,0.67157805,0.00008407008,0.0011884207,0.000029580748,0.0006778756,0.000030592266,0.00006228999,0.00005256484,0.0016828455,0.00012205163],"about_ca_topic_score_codex":0.00011654474,"about_ca_topic_score_gemma":0.00006929369,"teacher_disagreement_score":0.3432417,"about_ca_system_score_codex":0.000059883365,"about_ca_system_score_gemma":0.00051914796,"threshold_uncertainty_score":0.38755456},"labels":[],"label_agreement":null},{"id":"W2070148052","doi":"10.1097/01.coc.0000245473.41035.c4","title":"Simultaneous Infield Boost With Helical Tomotherapy for Patients With 1 to 3 Brain Metastases","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Tomotherapy; Medicine; Radiosurgery; Nuclear medicine; Radiation therapy; Radiation treatment planning; Imaging phantom; Stereotaxis; Stereotactic radiation therapy; Dose fractionation; Radiology","score_opus":0.017801389357539377,"score_gpt":0.4166439268012715,"score_spread":0.3988425374437321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070148052","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4610766,0.000008891554,0.53681177,0.0014767576,0.00007452003,0.00029038393,0.000016677084,0.00001259483,0.00023181981],"genre_scores_gemma":[0.69811577,0.000005039802,0.29673913,0.0045224596,0.00053933525,0.000008255086,0.0000032599112,0.000029686702,0.000037049304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812627,0.00014469131,0.0009747135,0.00020689098,0.00021620691,0.00033125194],"domain_scores_gemma":[0.9914061,0.006560007,0.0010934162,0.00017613129,0.0004274163,0.0003369564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009728386,0.00017557062,0.0009388758,0.000095723524,0.000047810216,0.0000109851235,0.0002385443,0.00005070533,0.0000885386],"category_scores_gemma":[0.00026010617,0.00011089681,0.00018425118,0.00020643602,0.00034529244,0.000086839646,0.000015430212,0.00037804333,0.0000011027518],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009090355,0.0010231815,0.12778427,0.0000015872563,0.00037540737,0.000026281423,0.0001005329,0.00015193195,0.0000490735,0.00034231,0.00090752565,0.86014754],"study_design_scores_gemma":[0.010118355,0.1742374,0.013267808,0.00007276135,0.00015235669,0.000033472974,0.00048100346,0.00003982952,0.0011218871,0.0006104517,0.7993344,0.0005302499],"about_ca_topic_score_codex":0.000025845138,"about_ca_topic_score_gemma":0.000019051855,"teacher_disagreement_score":0.8596173,"about_ca_system_score_codex":0.000046683177,"about_ca_system_score_gemma":0.00023856848,"threshold_uncertainty_score":0.45222408},"labels":[],"label_agreement":null},{"id":"W2076298506","doi":"10.1097/coc.0b013e31815e456d","title":"Antineoplastic Properties of Bacteriocins","year":2008,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Probiotics and Fermented Foods","field":"Agricultural and Biological Sciences","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Bacteriocin; Colicin; Antimicrobial; Bacteria; Microbiology; Medicine; Peptide; Antimicrobial peptides; Pharmacology; Biology; Biochemistry; Escherichia coli; Gene; Genetics","score_opus":0.20098938294223406,"score_gpt":0.4178537484140202,"score_spread":0.2168643654717861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076298506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031520534,0.9667655,0.0000019025337,0.00024620534,0.00082372694,0.00017360675,0.000027325932,0.0000073183855,0.00043383855],"genre_scores_gemma":[0.014884473,0.98380554,0.0002545843,0.00011018849,0.0008931506,0.0000017639154,0.0000061432465,0.0000025914571,0.00004155693],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953771,0.00080457114,0.0031120072,0.00021658912,0.00023188307,0.0002578072],"domain_scores_gemma":[0.99227595,0.0016577462,0.0055137575,0.00007310678,0.00025710606,0.00022230066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007881676,0.00025187928,0.0044464953,0.0000409358,0.000047244288,0.000008676153,0.0006238288,0.00031449323,0.00006699915],"category_scores_gemma":[0.0008120413,0.000075270334,0.0014377628,0.0003965849,0.0009582842,0.000047920814,0.00011819529,0.0008669385,0.000015671278],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008149212,0.0003964771,0.000094435534,0.00016057002,0.00022824125,0.000046281133,0.000010900266,1.0735808e-7,0.000044732686,0.000008066185,0.00020542397,0.99872327],"study_design_scores_gemma":[0.00015636653,0.0108602755,0.0007465917,0.0022260353,0.00030653115,0.0006071307,0.000041802232,6.9515e-7,0.0000027162203,0.000005011034,0.9848894,0.00015744343],"about_ca_topic_score_codex":0.000021071017,"about_ca_topic_score_gemma":0.0000129273,"teacher_disagreement_score":0.99856585,"about_ca_system_score_codex":0.00003611079,"about_ca_system_score_gemma":0.0005162258,"threshold_uncertainty_score":0.37664646},"labels":[],"label_agreement":null},{"id":"W2077590802","doi":"10.1097/coc.0b013e3181b2043f","title":"A Phase I Study of Flavopiridol in Combination With Gemcitabine and Irinotecan in Patients With Metastatic Cancer","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Gemcitabine; Irinotecan; Oncology; Internal medicine; Cancer; Phases of clinical research; Chemotherapy; Colorectal cancer","score_opus":0.02715845203865139,"score_gpt":0.4104983521347776,"score_spread":0.3833399000961262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077590802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992558,0.000030308842,0.00014297674,0.0002178838,0.00011883018,0.0002124923,0.000003830526,5.83028e-7,0.000017311539],"genre_scores_gemma":[0.9985662,0.0000742102,0.0010759503,0.00021283368,0.00004462688,0.000009173217,0.0000021349915,0.000010235495,0.0000046089017],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99879426,0.00017176817,0.00063549087,0.00014946375,0.00013112658,0.000117890886],"domain_scores_gemma":[0.99877125,0.00008295476,0.00076109363,0.00011426341,0.0001899488,0.00008049984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005774512,0.00008818647,0.0005292292,0.000089841305,0.00000932656,0.0000031775533,0.000098425015,0.000044049237,0.000005821234],"category_scores_gemma":[0.000070119764,0.000061231,0.000030517356,0.00013871661,0.00022301316,0.0000055000355,0.000025488525,0.0002970378,5.1334055e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011103903,0.013266593,0.47761053,0.000007738468,0.00023734705,0.000026026522,0.00033698394,0.000050907915,0.008103869,0.00002587342,0.0000060488205,0.4892242],"study_design_scores_gemma":[0.07304246,0.30159187,0.61976564,0.00004208315,0.00017491575,0.000018980067,0.0010856206,0.00005640809,0.0019102532,0.00007035376,0.0020385755,0.00020279174],"about_ca_topic_score_codex":0.00019068907,"about_ca_topic_score_gemma":0.003963439,"teacher_disagreement_score":0.4890214,"about_ca_system_score_codex":0.000014817179,"about_ca_system_score_gemma":0.0002987292,"threshold_uncertainty_score":0.24969278},"labels":[],"label_agreement":null},{"id":"W2078978524","doi":"10.1097/01.coc.0000258081.70643.3d","title":"Correlation Between Saliva Production and Quality of Life Measurements in Head and Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Medicine; Saliva; Head and neck cancer; Radiation therapy; Quality of life (healthcare); Grading (engineering); Internal medicine; Toxicity; Head and neck; Cancer; Surgery","score_opus":0.1268325691945153,"score_gpt":0.43849231888889506,"score_spread":0.31165974969437976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078978524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978287,0.00021305305,0.0003602948,0.0011749071,0.00016694373,0.00017488684,0.0000017495414,0.0000043636096,0.00007506603],"genre_scores_gemma":[0.9981793,0.00038404114,0.0007834878,0.00045126007,0.00017841544,6.6763033e-7,0.000004840802,0.00000809087,0.000009879045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981386,0.00022739219,0.0011741648,0.00014530034,0.00019723352,0.00011732129],"domain_scores_gemma":[0.9978077,0.00037785157,0.0010888502,0.0000736209,0.00046278382,0.0001892166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015121507,0.000086105356,0.0009458671,0.00013879636,0.000022457256,0.0000021036883,0.000021067666,0.00008530416,0.000008514425],"category_scores_gemma":[0.001093564,0.000059212947,0.000052338582,0.00026288177,0.00034686216,0.0000636301,0.000006860291,0.0002834538,1.1659572e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011358062,0.0006205391,0.9238392,0.000009684831,0.00022291152,0.0000027926924,0.00016650873,0.000016675185,0.000078795376,8.4524356e-7,0.000042694064,0.06364128],"study_design_scores_gemma":[0.0070438017,0.012295393,0.97998565,0.000099681616,0.00012661086,0.000013771948,0.00018138195,0.000021661497,0.00001718396,0.0000075282724,0.00014989919,0.000057433466],"about_ca_topic_score_codex":0.00096272863,"about_ca_topic_score_gemma":0.000431375,"teacher_disagreement_score":0.06358385,"about_ca_system_score_codex":0.00006644988,"about_ca_system_score_gemma":0.00020023166,"threshold_uncertainty_score":0.24146338},"labels":[],"label_agreement":null},{"id":"W2079094353","doi":"10.1097/01.coc.0000256103.21797.e5","title":"Oral Versus Intravenous Administration of Vinorelbine as a Single Agent for the First-Line Treatment of Metastatic Nonsmall Cell Lung Carcinoma (NSCLC)","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Hôpital Charles-Le Moyne; McGill University; Royal Victoria Hospital","funders":"","keywords":"Vinorelbine; Medicine; Internal medicine; Chemotherapy; Gastroenterology; Carcinoma; Surgery","score_opus":0.10356668326748363,"score_gpt":0.4792282221413577,"score_spread":0.37566153887387405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079094353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868992,0.00080711435,0.0062466287,0.0036644973,0.00065928017,0.0006275061,0.00002235337,0.000003864284,0.0010695616],"genre_scores_gemma":[0.98877513,0.0003515561,0.010102249,0.00033659674,0.00029529593,0.000012700829,0.000011797031,0.00001564665,0.000099014214],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9977369,0.00009632499,0.0016089395,0.00014066312,0.00021183958,0.00020536465],"domain_scores_gemma":[0.9937338,0.0035723583,0.001909634,0.00018881839,0.00042244003,0.00017295415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007412189,0.00013963302,0.0010710487,0.000094016075,0.00004615141,0.0000033491508,0.00009840872,0.000056446643,0.00004254343],"category_scores_gemma":[0.000354141,0.000082251114,0.00046515043,0.00017143608,0.0004196287,0.00003132702,0.000010836617,0.00013003293,0.0000015142267],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047075525,0.013795392,0.016162185,0.000081435275,0.002740336,0.0004949728,0.0016350432,0.00010220404,0.0004749179,0.000110814326,0.00026622188,0.917061],"study_design_scores_gemma":[0.06046395,0.7333446,0.1133016,0.00013243669,0.015773647,0.00067275594,0.004813445,0.00056739943,0.007294333,0.000093445204,0.063303635,0.00023872049],"about_ca_topic_score_codex":0.00024954372,"about_ca_topic_score_gemma":0.00031638145,"teacher_disagreement_score":0.91682225,"about_ca_system_score_codex":0.00032421746,"about_ca_system_score_gemma":0.001497104,"threshold_uncertainty_score":0.3354103},"labels":[],"label_agreement":null},{"id":"W2082636073","doi":"10.1097/coc.0000000000000193","title":"Eligibility of Metastatic Pancreatic Cancer Patients for First-Line Palliative Intent nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"FOLFIRINOX; Medicine; Gemcitabine; Internal medicine; Performance status; Regimen; Oncology; Pancreatic cancer; Chemotherapy; Irinotecan; Gastroenterology; Cancer; Colorectal cancer","score_opus":0.30297252008093706,"score_gpt":0.559154466054304,"score_spread":0.2561819459733669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082636073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98855096,0.0006216867,0.0024197116,0.0053052073,0.0010867973,0.0009222818,0.000060269893,0.000009616633,0.0010234403],"genre_scores_gemma":[0.9791971,0.0014332191,0.017868971,0.0007194187,0.0004947068,0.000078112804,0.000015303145,0.000028923563,0.0001642443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99441856,0.00079500716,0.0031981154,0.00035060386,0.0007249649,0.0005127617],"domain_scores_gemma":[0.9810595,0.010945902,0.0031189818,0.0003650558,0.0035458186,0.0009647404],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004577465,0.00025629168,0.0038609265,0.0001976549,0.000049570775,0.000005305822,0.00032108187,0.00016268293,0.00008803023],"category_scores_gemma":[0.026183961,0.00017884748,0.0006650653,0.0003760275,0.0016242107,0.000095244,0.00011168127,0.00073355826,0.000011215633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.071759075,0.004193436,0.8250226,0.00018561745,0.003159664,0.000065987224,0.00087430864,0.00006884741,0.000011259716,0.00013712907,0.0045196097,0.090002514],"study_design_scores_gemma":[0.09960578,0.25245073,0.61337256,0.00050647516,0.0061094225,0.000049355098,0.003285505,0.0026006845,0.000073196294,0.0022865848,0.019277899,0.0003818315],"about_ca_topic_score_codex":0.00040525652,"about_ca_topic_score_gemma":0.00025887231,"teacher_disagreement_score":0.2482573,"about_ca_system_score_codex":0.00087738206,"about_ca_system_score_gemma":0.004799802,"threshold_uncertainty_score":0.9820189},"labels":[],"label_agreement":null},{"id":"W2083379775","doi":"10.1097/coc.0b013e3181131d62","title":"Angiosarcomas of the Breast","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Angiosarcoma; Breast cancer; Mastectomy; Radiation therapy; Incidence (geometry); Breast carcinoma; Population; Hemangiosarcoma; Cancer registry; Adjuvant therapy; Cancer; Surgery; Oncology; Internal medicine","score_opus":0.04150870458100532,"score_gpt":0.42823016395404523,"score_spread":0.3867214593730399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083379775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98499167,0.00024421513,0.0004980082,0.009355111,0.0005943448,0.00007741325,0.0000016228591,0.000004394583,0.0042332304],"genre_scores_gemma":[0.99283224,0.00007139065,0.0038033614,0.002304905,0.00084343995,1.9394561e-7,3.0222145e-7,0.000011981383,0.00013218177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974761,0.00026688396,0.00158854,0.000103172446,0.00034538461,0.00021990719],"domain_scores_gemma":[0.9965017,0.0009602966,0.0016689688,0.00026242135,0.00033094207,0.00027567073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033726988,0.00009116743,0.0010770701,0.000083843835,0.000027121514,0.0000018927472,0.00024487454,0.000080373095,0.000059658993],"category_scores_gemma":[0.00084279646,0.000049795068,0.0011111795,0.00033595716,0.000968152,0.000030868316,0.000059665035,0.0005866064,0.0000058800388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010308325,0.00080850394,0.5127126,0.0000068385652,0.00026605438,0.00033898244,0.00007355392,0.0000012871573,0.00058255665,0.0002950045,0.0011611942,0.4827226],"study_design_scores_gemma":[0.0022244107,0.0054300204,0.92945063,0.00007892393,0.00026441197,0.0064725494,0.0004171262,0.0000053466433,0.0002679528,0.00013778472,0.055193745,0.000057106867],"about_ca_topic_score_codex":0.000026322059,"about_ca_topic_score_gemma":0.00001158404,"teacher_disagreement_score":0.4826655,"about_ca_system_score_codex":0.000038907805,"about_ca_system_score_gemma":0.0005765149,"threshold_uncertainty_score":0.35671964},"labels":[],"label_agreement":null},{"id":"W2086540370","doi":"10.1097/01.coc.0000021042.55557.2b","title":"Cost Utility Analysis of First-Line Hormonal Therapy in Advanced Breast Cancer","year":2003,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tamoxifen; Letrozole; Anastrozole; Randomized controlled trial; Oncology; Breast cancer; Internal medicine; Clinical trial; Antiestrogen; Cancer","score_opus":0.04048766813107931,"score_gpt":0.42129993607378313,"score_spread":0.38081226794270384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086540370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99675775,0.0016661388,0.0002909727,0.0005467876,0.00021372127,0.00009886535,0.000020449448,0.0000014858314,0.00040385974],"genre_scores_gemma":[0.9873506,0.011301991,0.0008267379,0.0003724211,0.000107884414,0.0000052465275,0.0000070207284,0.000010205319,0.000017919523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975231,0.00065204786,0.0012368171,0.00021799092,0.00015121343,0.00021878697],"domain_scores_gemma":[0.9977636,0.00035759434,0.0012360506,0.00020150462,0.0002623001,0.0001789496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014573833,0.00013358891,0.001069021,0.00014073437,0.00002146262,0.0000025534318,0.00019681238,0.00020707917,0.00007513983],"category_scores_gemma":[0.00042983523,0.00009986696,0.0005548889,0.0005895432,0.0005009799,0.0000052586156,0.000024885241,0.0004174598,7.427651e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039033308,0.000986222,0.51930135,0.0000024014764,0.0017746635,0.000032077227,0.000031162654,0.0015787412,0.0040974068,0.000012304914,0.00011540226,0.46816495],"study_design_scores_gemma":[0.0061613168,0.014752052,0.9363196,0.000026109541,0.00063907466,0.00011727522,0.00020128384,0.00037507218,0.0046600816,0.00004826712,0.03645141,0.0002484491],"about_ca_topic_score_codex":0.0000574737,"about_ca_topic_score_gemma":0.00014631175,"teacher_disagreement_score":0.4679165,"about_ca_system_score_codex":0.000029648067,"about_ca_system_score_gemma":0.0004741328,"threshold_uncertainty_score":0.4072456},"labels":[],"label_agreement":null},{"id":"W2087772648","doi":"10.1097/01.coc.0000138965.97476.0f","title":"Preliminary Reliability and Validity Testing of a New Skin Toxicity Assessment Tool (STAT) in Breast Cancer Patients Undergoing Radiotherapy","year":2004,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Toxicity; Radiation therapy; Breast cancer; Acute toxicity; Surgery; Internal medicine; Cancer","score_opus":0.042995942553570046,"score_gpt":0.42978023574963425,"score_spread":0.3867842931960642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087772648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902786,0.00008525044,0.00075972435,0.008255825,0.00025441934,0.00027515632,0.0000062860618,0.0000072198154,0.000077506586],"genre_scores_gemma":[0.9411536,0.00046007414,0.05677761,0.0012628369,0.00032239428,0.0000028695376,9.09203e-7,0.0000146289585,0.0000050603094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968013,0.0006525996,0.0017637997,0.0002300534,0.0003401366,0.00021210322],"domain_scores_gemma":[0.9922113,0.0049044923,0.0020408176,0.00017266434,0.00037441123,0.00029636218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025166061,0.0001402206,0.0012793803,0.000120699384,0.000024744535,0.000005213086,0.00011386604,0.00012524924,0.000023904595],"category_scores_gemma":[0.0037736879,0.00011329055,0.00016951693,0.00030724937,0.00041786386,0.00014254954,0.000035766432,0.000715104,2.877338e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019072454,0.0014057007,0.74990064,0.000037405956,0.0000693744,0.00003849187,0.00020610658,0.0010364087,0.00011149769,0.0000068355353,0.00011609883,0.24516422],"study_design_scores_gemma":[0.010139188,0.032222208,0.95624113,0.00027781402,0.00009741772,0.00014151674,0.000109355955,0.00019940887,0.00004736839,0.00025201112,0.00018098834,0.00009158743],"about_ca_topic_score_codex":0.00049588794,"about_ca_topic_score_gemma":0.000064828266,"teacher_disagreement_score":0.24507263,"about_ca_system_score_codex":0.0006364467,"about_ca_system_score_gemma":0.0037277157,"threshold_uncertainty_score":0.66128075},"labels":[],"label_agreement":null},{"id":"W2090589423","doi":"10.1097/01.coc.0000178031.69209.47","title":"A Multicenter Phase II Study of “Adjuvant” Irinotecan Following Resection of Colorectal Hepatic Metastases","year":2005,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Irinotecan; Internal medicine; Colorectal cancer; Regimen; Tolerability; Gastroenterology; Hepatectomy; Univariate analysis; Adjuvant therapy; Chemotherapy; Toxicity; Oncology; Surgery; Adjuvant; Cancer; Multivariate analysis; Resection; Adverse effect","score_opus":0.1306705066118074,"score_gpt":0.4518752882036163,"score_spread":0.3212047815918089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090589423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798125,0.0002463134,0.000059186517,0.00071457174,0.00032206133,0.0004536119,0.0000055432934,0.0000072703187,0.00021018965],"genre_scores_gemma":[0.9942207,0.000094298666,0.0052084816,0.0001519164,0.0002714775,0.000008533357,0.0000035454982,0.000017956454,0.000023127786],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9958523,0.00093637785,0.0023859632,0.00019342321,0.00041501073,0.00021696302],"domain_scores_gemma":[0.99560297,0.0014276198,0.0021756869,0.00019251107,0.00033289302,0.0002683385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019747978,0.00016020804,0.0020520615,0.00025064786,0.000047187412,0.0000027283459,0.00013371461,0.00008705017,0.0000888828],"category_scores_gemma":[0.0012191485,0.00011741577,0.0007680183,0.00032502937,0.0003204192,0.000098152195,0.000057321206,0.000439603,0.0000030353044],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013675825,0.023469092,0.59821534,0.00001529531,0.0015616245,0.0004568427,0.0009075883,0.0000050873036,0.0015490726,0.0000013507429,0.00006924493,0.36007366],"study_design_scores_gemma":[0.051371273,0.80427384,0.12115846,0.000192609,0.0053493828,0.00022939978,0.004491934,0.001420867,0.007787295,0.000007156677,0.0035293445,0.00018846744],"about_ca_topic_score_codex":0.00018001566,"about_ca_topic_score_gemma":0.00014455133,"teacher_disagreement_score":0.78080475,"about_ca_system_score_codex":0.00009982697,"about_ca_system_score_gemma":0.00041324642,"threshold_uncertainty_score":0.47880763},"labels":[],"label_agreement":null},{"id":"W2091417780","doi":"10.1097/01.coc.0000258125.97090.3f","title":"Survival Differences Observed in Metastatic Breast Cancer Patients Treated With Capecitabine When Compared With Vinorelbine After Pretreatment With Anthracycline and Taxane","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Statistics Canada; Alberta Cancer Foundation; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Vinorelbine; Capecitabine; Medicine; Anthracycline; Taxane; Metastatic breast cancer; Internal medicine; Oncology; Chemotherapy; Breast cancer; Cancer; Surgery; Colorectal cancer","score_opus":0.0626830552519413,"score_gpt":0.40415889236326363,"score_spread":0.34147583711132234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091417780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609673,0.00032315994,0.000055961966,0.0027115114,0.00012461183,0.00049904943,0.000046424262,0.000010829128,0.00013170889],"genre_scores_gemma":[0.9947754,0.0005651566,0.0036472175,0.0006226788,0.00020688018,0.0000335419,0.000020376403,0.000031056094,0.00009768434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971209,0.0003774038,0.0013191435,0.0003567194,0.00039495193,0.0004308625],"domain_scores_gemma":[0.9961466,0.001299836,0.0014284926,0.00015292251,0.00046004876,0.00051210576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000634951,0.00033578507,0.002250278,0.00020186683,0.000033929562,0.000009484542,0.00009950846,0.00007015147,0.0002983796],"category_scores_gemma":[0.000045174034,0.00017207873,0.00009893964,0.00038111745,0.0011564402,0.00011111837,0.000025699726,0.0005098564,0.0000010999366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.098147176,0.005891879,0.8420247,0.000020291658,0.0014075463,0.0018965714,0.00028234714,0.000008361495,0.000021864565,9.4874486e-7,0.000034806097,0.05026353],"study_design_scores_gemma":[0.03614856,0.070863396,0.8897025,0.0002317645,0.0016078125,0.00052378525,0.0003854653,0.000025355037,0.000028340846,0.0000032205505,0.000300168,0.00017963524],"about_ca_topic_score_codex":0.0018475722,"about_ca_topic_score_gemma":0.012360993,"teacher_disagreement_score":0.06497152,"about_ca_system_score_codex":0.00028253137,"about_ca_system_score_gemma":0.0005916275,"threshold_uncertainty_score":0.70171666},"labels":[],"label_agreement":null},{"id":"W2092816732","doi":"10.1097/coc.0b013e3182868e82","title":"Rare Presentations of Primary Melanoma and Special Populations","year":2013,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute on Minority Health and Health Disparities; National Center for Research Resources; National Cancer Institute","keywords":"Medicine; Melanoma; Mucosal melanoma; Genitourinary system; Dermatology; Head and neck; Internal medicine; Surgery; Cancer research","score_opus":0.18486749970874297,"score_gpt":0.4858452699134193,"score_spread":0.3009777702046763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092816732","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034125305,0.95886797,0.00025012685,0.0012627371,0.0031095177,0.0012130492,0.000015900043,0.00001556948,0.03185261],"genre_scores_gemma":[0.0004166245,0.9901971,0.004773139,0.00027516455,0.0031461446,0.00001112424,0.000017613882,0.000026011394,0.0011370563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959874,0.00059373653,0.0028168405,0.00019115163,0.0002612637,0.00014958298],"domain_scores_gemma":[0.993913,0.0013441823,0.0039553917,0.00021770556,0.00026377934,0.00030593123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006460408,0.00019063974,0.004043136,0.00033243277,0.000033306518,0.000008409631,0.00013891619,0.0002020293,0.00042346635],"category_scores_gemma":[0.0007887186,0.00013584683,0.0008334192,0.0002607977,0.0005527661,0.000047192134,0.00008334328,0.000754183,0.0000247642],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012823535,0.00031757995,0.0008251255,0.000742163,0.0004845092,0.00019009995,0.000025484966,2.625314e-7,1.7740845e-7,0.00016355563,0.010549908,0.9865729],"study_design_scores_gemma":[0.0008016355,0.0053944243,0.00400646,0.0007232967,0.002674199,0.0028820396,0.00011533473,0.000001254779,5.5148778e-8,0.000058843278,0.98324263,0.00009984244],"about_ca_topic_score_codex":0.000021330092,"about_ca_topic_score_gemma":0.000012507517,"teacher_disagreement_score":0.9864731,"about_ca_system_score_codex":0.00008069399,"about_ca_system_score_gemma":0.0009882189,"threshold_uncertainty_score":0.5539673},"labels":[],"label_agreement":null},{"id":"W2094784241","doi":"10.1097/01.coc.0000054890.69365.3e","title":"Tolerance of Radiotherapy and Chemotherapy in Elderly Patients With Bladder Cancer","year":2004,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Cystectomy; Radiation therapy; Bladder cancer; Chemotherapy; Surgery; Neutropenia; Toxicity; Urinary bladder; Urology; Retrospective cohort study; Urinary system; Cancer; Internal medicine","score_opus":0.025108387793313806,"score_gpt":0.397683006252059,"score_spread":0.3725746184587452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094784241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376076,0.0006945027,0.00015798725,0.004768081,0.00015623744,0.00018368887,0.000003869063,0.0000030271813,0.00027184145],"genre_scores_gemma":[0.98661536,0.0030792025,0.0062357574,0.0038143243,0.00021153608,0.000004931367,5.2481323e-7,0.00001823074,0.000020114507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847996,0.00009733483,0.00089141284,0.0001523803,0.00021409804,0.00016482148],"domain_scores_gemma":[0.99846226,0.00020731318,0.0008382366,0.00011319241,0.00020444475,0.00017455676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028702794,0.00012050249,0.0011599973,0.00008794118,0.000011434411,0.000002470359,0.000074844844,0.00007464154,0.000067144356],"category_scores_gemma":[0.00004978346,0.00007791479,0.00011255436,0.00019495339,0.000556791,0.000060542756,0.000005742215,0.00032116275,4.2318783e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064073834,0.0010820553,0.5817926,0.000006264218,0.00027240152,0.00003719606,0.00029981066,0.00003234578,0.000026729822,0.0000073640995,0.00003589121,0.40999997],"study_design_scores_gemma":[0.031591043,0.040936254,0.9220066,0.00014899214,0.00010747674,0.000046260717,0.00009843031,0.0000026859911,0.0000914908,0.000074602554,0.0048181373,0.00007803959],"about_ca_topic_score_codex":0.00033508765,"about_ca_topic_score_gemma":0.000112053036,"teacher_disagreement_score":0.4099219,"about_ca_system_score_codex":0.00013032212,"about_ca_system_score_gemma":0.0009323894,"threshold_uncertainty_score":0.31772727},"labels":[],"label_agreement":null},{"id":"W2281671786","doi":"10.1097/coc.0000000000000274","title":"A Meta-Analysis of the Association Between Radiation Therapy and Survival for Surgically Resected Soft-Tissue Sarcoma","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Queen's University","funders":"","keywords":"Medicine; Odds ratio; Hazard ratio; Confidence interval; Soft tissue sarcoma; Radiation therapy; Confounding; Meta-analysis; Internal medicine; Population; Sarcoma; Surgery; Soft tissue; Pathology","score_opus":0.32452958089877754,"score_gpt":0.521202957292902,"score_spread":0.19667337639412447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281671786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040205335,0.9898057,0.00009741575,0.0046604574,0.00028689462,0.0008630106,0.00018338647,0.000005108131,0.00007750887],"genre_scores_gemma":[0.0066798213,0.9916674,0.00054939935,0.00025197654,0.0006350441,0.00005339403,0.000029483463,0.000029351833,0.000104123275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920523,0.0033544868,0.0035037142,0.00030090206,0.0005494815,0.0002390821],"domain_scores_gemma":[0.94963866,0.039321184,0.009802914,0.00034135964,0.000675542,0.00022033777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058212723,0.0002855743,0.012307704,0.00033100013,0.000047499314,0.000010443442,0.00025279578,0.0004060949,0.00009389438],"category_scores_gemma":[0.0038688255,0.00012438121,0.0066229156,0.00077068154,0.0003100907,0.000036077752,0.000045720546,0.00051980803,0.0000018307243],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018247857,0.00045196735,0.023594648,0.000065135864,0.23906472,0.0000108379745,0.000013087286,1.0412672e-7,1.04762215e-7,0.000017937477,0.00013256227,0.7364664],"study_design_scores_gemma":[0.0016635805,0.0039217225,0.05349378,0.00012983293,0.34887183,0.000014630537,0.0000054615057,4.969453e-7,6.5723054e-7,0.000027999584,0.59179467,0.00007537293],"about_ca_topic_score_codex":0.000037302405,"about_ca_topic_score_gemma":0.000022139733,"teacher_disagreement_score":0.73639107,"about_ca_system_score_codex":0.00028792876,"about_ca_system_score_gemma":0.0011571102,"threshold_uncertainty_score":0.84133005},"labels":[],"label_agreement":null},{"id":"W2312366830","doi":"10.1097/coc.0b013e318210f9ce","title":"Impact and Feasibility of a Comprehensive Geriatric Assessment in the Oncology Setting","year":2011,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Geriatric oncology; MEDLINE; Oncology; Medical physics; Intensive care medicine; Internal medicine; Cancer","score_opus":0.18752569596741567,"score_gpt":0.5315478851114135,"score_spread":0.34402218914399785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312366830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901194,0.00016133516,0.00010413454,0.0050015748,0.00027541345,0.0003011704,0.0000035116216,0.0000038461762,0.0040296162],"genre_scores_gemma":[0.9781923,0.0003338148,0.01940939,0.0018072205,0.00023620807,0.0000030311742,8.5701276e-7,0.000009736667,0.0000074231857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99501234,0.002074505,0.0021726973,0.00019983653,0.0002804534,0.00026016176],"domain_scores_gemma":[0.9900243,0.0065245163,0.0024945163,0.00028064073,0.00043558032,0.00024038901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041695656,0.000141225,0.0017528875,0.00016280873,0.000022087523,0.0000030122371,0.00023606868,0.00014910556,0.000083220526],"category_scores_gemma":[0.0019055456,0.00008267247,0.00034440003,0.00033866608,0.0012435695,0.0000651442,0.00007318859,0.0013281463,0.0000018179102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021670181,0.0018190732,0.7008426,0.000017546306,0.00017665226,0.00042073126,0.0015455891,0.0000022258287,0.00010187045,0.000021997494,0.00042770637,0.29245695],"study_design_scores_gemma":[0.0048576863,0.04693367,0.9399323,0.00004657291,0.00020679877,0.0016297386,0.0041810814,0.000041458312,0.0000052475407,0.00025027455,0.0018504153,0.00006476189],"about_ca_topic_score_codex":0.0002788449,"about_ca_topic_score_gemma":0.00006324403,"teacher_disagreement_score":0.2923922,"about_ca_system_score_codex":0.00022975498,"about_ca_system_score_gemma":0.001903951,"threshold_uncertainty_score":0.5770209},"labels":[],"label_agreement":null},{"id":"W2312903109","doi":"10.1097/coc.0b013e3182439068","title":"Impact of Asian Ethnicity on Colorectal Cancer Screening","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Vietnamese; Demography; Odds; Logistic regression; Ethnic group; Odds ratio; Confounding; Population; Multivariate analysis; Gerontology; Cohort; Environmental health; Internal medicine","score_opus":0.1101335112731579,"score_gpt":0.5045825546756414,"score_spread":0.3944490434024835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312903109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926809,0.00022738255,0.00072088593,0.0010947715,0.000866256,0.00010434532,0.0000053043254,0.000013751175,0.0042863744],"genre_scores_gemma":[0.9944178,0.00017897478,0.003017827,0.0004902829,0.0018395443,0.0000036016645,8.231947e-7,0.000018458213,0.000032693],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99736094,0.0004962897,0.0013076162,0.000141407,0.00035890628,0.0003348265],"domain_scores_gemma":[0.99569917,0.001245403,0.0019801573,0.00013571516,0.00036545758,0.00057410996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020464808,0.0001480274,0.0014280765,0.00018297326,0.000035293306,0.0000030111232,0.00011754907,0.00016292951,0.00019360297],"category_scores_gemma":[0.0016580337,0.0001029942,0.0008545762,0.00039435978,0.00052172155,0.000096781274,0.00003249202,0.0010671584,0.000005708815],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025478855,0.00056149723,0.40807372,0.0000037590758,0.0003747181,0.000017312977,0.00016410608,0.000050262417,0.00037089255,0.0000052916516,0.0004521068,0.56444746],"study_design_scores_gemma":[0.0022341837,0.10187257,0.89201975,0.00009442304,0.00023584164,0.00033652055,0.00021517578,0.00006824204,0.0004783182,0.000007698622,0.0023498053,0.000087474844],"about_ca_topic_score_codex":0.00064516213,"about_ca_topic_score_gemma":0.00005025521,"teacher_disagreement_score":0.56436,"about_ca_system_score_codex":0.00027130477,"about_ca_system_score_gemma":0.00087671634,"threshold_uncertainty_score":0.46363315},"labels":[],"label_agreement":null},{"id":"W2312995441","doi":"10.1097/coc.0000000000000184","title":"A Patient-centered Approach to Evaluate the Information Needs of Women With Ductal Carcinoma In Situ","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; Queen's University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Timeline; Focus group; Ductal carcinoma; Set (abstract data type); Family medicine; Cancer; Internal medicine; Breast cancer","score_opus":0.15238951793087577,"score_gpt":0.42794872088618696,"score_spread":0.2755592029553112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312995441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99059486,0.000032688247,0.0003461106,0.002489588,0.00014864668,0.00019309235,9.988727e-7,0.000002409341,0.006191578],"genre_scores_gemma":[0.99349093,0.000009278475,0.0025474983,0.0038033728,0.00013221503,0.0000074478885,0.0000011338432,0.000004565278,0.0000035778157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976164,0.00035327193,0.0012726872,0.000054887434,0.0004641393,0.00023858921],"domain_scores_gemma":[0.9977033,0.0002551186,0.0008961721,0.00015015685,0.00059356797,0.00040165495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028571787,0.000085222404,0.00081833126,0.000164414,0.0000120987,0.000005657097,0.00015548925,0.000049072754,0.000005556558],"category_scores_gemma":[0.0013682465,0.0000469478,0.000084922714,0.0005204302,0.0003135251,0.00017209741,0.000046717498,0.00040280996,0.000004696884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034424838,0.0006549146,0.507993,0.000013855764,0.00019179267,0.0000751595,0.036891036,0.0007338095,0.0000632734,0.00007464649,0.0015020913,0.4173816],"study_design_scores_gemma":[0.010766052,0.10372113,0.70065576,0.00012811231,0.00016286684,0.0014010372,0.16969377,0.00023487389,0.00005114719,0.00006927218,0.01297782,0.00013815147],"about_ca_topic_score_codex":0.00017895062,"about_ca_topic_score_gemma":0.00001786305,"teacher_disagreement_score":0.41724345,"about_ca_system_score_codex":0.0003483867,"about_ca_system_score_gemma":0.0014546661,"threshold_uncertainty_score":0.25805154},"labels":[],"label_agreement":null},{"id":"W2313859996","doi":"10.1097/00000421-200202000-00015","title":"A Phase II Study of Etoposide, Doxorubicin, and Carboplatin in the Treatment of Advanced Gastric Cancer","year":2002,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Etoposide; Carboplatin; Regimen; Gastroenterology; Internal medicine; Leukopenia; Nausea; Toxicity; Progressive disease; Surgery; Phases of clinical research; Chemotherapy; Vomiting; Doxorubicin; Cisplatin","score_opus":0.08909568021714441,"score_gpt":0.467989818956733,"score_spread":0.37889413873958855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313859996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99466515,0.0009932732,0.000006955305,0.0032523493,0.00017445155,0.00038140404,0.0000020276836,0.000001903415,0.0005224717],"genre_scores_gemma":[0.9937687,0.0049371766,0.00052582915,0.000490043,0.00016425826,0.000011109525,2.6584502e-7,0.0000067112933,0.000095908945],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997682,0.00030622433,0.0014675687,0.00013416568,0.00025521783,0.0001548626],"domain_scores_gemma":[0.99704975,0.0010862874,0.0014855412,0.00016894765,0.00011257758,0.00009691839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006158191,0.0001137954,0.0013852306,0.00019132286,0.000020087093,0.0000017351327,0.00011134924,0.000036062003,0.00007479058],"category_scores_gemma":[0.0002190319,0.0000652987,0.0001716908,0.00044719412,0.00030067735,0.00003489415,0.000021947222,0.0002203249,2.5466397e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020066178,0.012840004,0.22169907,0.00000804419,0.00026446336,0.00016491037,0.0031643424,0.000033025804,0.00008383247,0.0000046327536,0.00022085644,0.7595102],"study_design_scores_gemma":[0.05116485,0.4398363,0.48292592,0.000063929816,0.001038324,0.000097163495,0.013379758,0.000121376295,0.000037188453,0.000015281143,0.011238935,0.00008095107],"about_ca_topic_score_codex":0.0003956873,"about_ca_topic_score_gemma":0.0003023011,"teacher_disagreement_score":0.7594292,"about_ca_system_score_codex":0.00008028076,"about_ca_system_score_gemma":0.00010763605,"threshold_uncertainty_score":0.26628038},"labels":[],"label_agreement":null},{"id":"W2313979980","doi":"10.1097/coc.0000000000000077","title":"Primary and Radiation-induced Breast Angiosarcoma","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Histopathology; Malignancy; Grading (engineering); Breast cancer; Angiosarcoma; Adjuvant radiotherapy; Radiation therapy; Context (archaeology); Radiology; Oncology; Surgery; Internal medicine; Cancer; Pathology","score_opus":0.0729620257128847,"score_gpt":0.41371646145324054,"score_spread":0.34075443574035585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313979980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98077047,0.0006861112,0.00014264636,0.015102466,0.0004367768,0.00007932766,0.0000015526733,0.000010029066,0.0027705934],"genre_scores_gemma":[0.9893415,0.00024246523,0.004622248,0.004374646,0.0013302483,8.949657e-7,0.0000024928154,0.0000151772865,0.000070353344],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99798226,0.000357216,0.001038317,0.00014548929,0.00028837964,0.00018831265],"domain_scores_gemma":[0.9973582,0.0005256478,0.00088724,0.0001566129,0.0003091181,0.0007631763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019146552,0.00010637157,0.0011415547,0.00010976626,0.000022953844,0.000007856561,0.00010068101,0.00008741515,0.000019884797],"category_scores_gemma":[0.0008317856,0.00007672427,0.00034512946,0.00017951426,0.00035414903,0.00008378883,0.00004395812,0.0004679844,0.000016469074],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009465498,0.00048979325,0.1955163,0.0000054552547,0.00021905164,0.0006695939,0.00012064916,6.3700617e-7,0.00015196064,0.000086479326,0.0031130938,0.7986804],"study_design_scores_gemma":[0.0073312037,0.016492292,0.88068795,0.00004834447,0.00031984184,0.013468128,0.0005832184,0.000046095316,0.000020519312,0.00018924622,0.080688536,0.00012464328],"about_ca_topic_score_codex":0.00002424346,"about_ca_topic_score_gemma":0.0000020652008,"teacher_disagreement_score":0.7985558,"about_ca_system_score_codex":0.00007664445,"about_ca_system_score_gemma":0.0011670172,"threshold_uncertainty_score":0.3128725},"labels":[],"label_agreement":null},{"id":"W2314709406","doi":"10.1097/coc.0b013e3182143cce","title":"Wait Times in Diagnostic Evaluation and Treatment for Patients With Stage III Non-Small Cell Lung Cancer in British Columbia","year":2011,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Neoplasm staging; Oncology; Cancer; Intensive care medicine; Internal medicine","score_opus":0.04201635644396122,"score_gpt":0.39316747585261536,"score_spread":0.3511511194086541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314709406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751735,0.00046985134,0.000012774186,0.00025181336,0.00018332525,0.0011947266,0.000021468051,0.000002272955,0.0003464387],"genre_scores_gemma":[0.99424523,0.0032501821,0.0017044912,0.00031694127,0.00010534509,0.00024961124,0.0000064995884,0.000016539416,0.00010513339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982293,0.00018232116,0.0009805376,0.0002260235,0.00017084244,0.00021094667],"domain_scores_gemma":[0.99671614,0.0018869003,0.0008347542,0.0000972774,0.00027245082,0.00019250214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072447985,0.00009982858,0.0009812276,0.00006118073,0.000021442633,0.000011945316,0.000051037052,0.0000718357,0.00018930167],"category_scores_gemma":[0.0003838475,0.00009292923,0.000104942155,0.0001163771,0.0001735657,0.000053196312,0.00001356716,0.0001653143,5.575506e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009464249,0.0030367952,0.7016286,0.000014909476,0.00014049863,0.00011601004,0.00030758654,0.000009454931,2.0443643e-7,3.413455e-7,0.00017915829,0.29362],"study_design_scores_gemma":[0.029867876,0.034066223,0.93369496,0.00036317811,0.00068492495,0.000009564103,0.0002494539,0.00020993846,0.000004047677,0.0000127539,0.0007511023,0.00008598137],"about_ca_topic_score_codex":0.021183414,"about_ca_topic_score_gemma":0.13455485,"teacher_disagreement_score":0.29353398,"about_ca_system_score_codex":0.00077837694,"about_ca_system_score_gemma":0.0010810443,"threshold_uncertainty_score":0.98533463},"labels":[],"label_agreement":null},{"id":"W2318711118","doi":"10.1097/coc.0000000000000034","title":"A Phase I Study of Tomotherapy in Patients With Primary Benign and Low-grade Brain Tumors","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; London Health Sciences Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Tomotherapy; Nausea; Quality of life (healthcare); Radiation therapy; Statistical significance; Performance status; Neurotoxicity; Toxicity; Whole brain radiotherapy; Internal medicine; Surgery; Nuclear medicine; Overall survival; Metastasis; Brain metastasis; Cancer","score_opus":0.029548250902858512,"score_gpt":0.41319229308486044,"score_spread":0.38364404218200193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318711118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974588,0.00003298926,0.00008467379,0.0019395186,0.000058994203,0.0003203333,0.0000023709902,0.000002575174,0.00009974856],"genre_scores_gemma":[0.99426407,0.000028103885,0.0031450838,0.002440464,0.00009518458,0.0000031490308,0.0000021358096,0.000013574743,0.000008214318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733704,0.00084400206,0.001228396,0.00016999285,0.0002655994,0.00015498683],"domain_scores_gemma":[0.99659574,0.0016535727,0.0012247555,0.00016523061,0.00012625083,0.00023445462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016526511,0.000118391086,0.0015008643,0.00013148024,0.0000137387315,0.000002618404,0.00007454826,0.00004095029,0.000017261496],"category_scores_gemma":[0.0004152177,0.0000725518,0.000105786865,0.00017726564,0.00038606155,0.00003805573,0.000018358507,0.0003396911,5.10399e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074393875,0.0224611,0.5539196,0.000007814131,0.00025473261,0.00013126916,0.00030845375,0.0000037074751,0.000007178735,0.0000076130277,0.00005998651,0.41539913],"study_design_scores_gemma":[0.05459867,0.2492,0.69463146,0.00006184234,0.00014277591,0.00004007161,0.00046242226,0.00001199289,0.000004134419,0.000023725017,0.00077107834,0.000051805782],"about_ca_topic_score_codex":0.000053657106,"about_ca_topic_score_gemma":0.000026172333,"teacher_disagreement_score":0.4153473,"about_ca_system_score_codex":0.000048289534,"about_ca_system_score_gemma":0.00025289532,"threshold_uncertainty_score":0.29585764},"labels":[],"label_agreement":null},{"id":"W2319098184","doi":"10.1097/coc.0000000000000192","title":"Stage IIIC Endometrial Cancer","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Endometrial cancer; Proportional hazards model; Stage (stratigraphy); Internal medicine; Chemotherapy; Oncology; Cohort; Cancer; Urology; Gynecology","score_opus":0.228678672495576,"score_gpt":0.5295284305313788,"score_spread":0.3008497580358028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319098184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731197,0.0013930586,0.00017968786,0.008402389,0.004030331,0.000190586,0.000012376031,0.000017023744,0.012654883],"genre_scores_gemma":[0.9849421,0.0013510414,0.0037416606,0.004397093,0.004486185,0.000007423651,0.0000020414188,0.000020123747,0.0010523301],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99662447,0.0005143763,0.0017801906,0.0001980037,0.00058918115,0.00029379516],"domain_scores_gemma":[0.9940195,0.0022929031,0.0017028272,0.00018765927,0.0006346347,0.0011624625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024516059,0.00015008959,0.0019690716,0.0002029101,0.000021932208,0.0000076833785,0.00019035148,0.00012794844,0.00058114546],"category_scores_gemma":[0.006721302,0.00009743552,0.00056873204,0.00085294567,0.00051518774,0.00008225372,0.000052182895,0.00071061804,0.000054460317],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020420669,0.001252167,0.15856265,0.000006517936,0.0007117121,0.0007115299,0.00007648802,0.00001192686,0.00003330889,0.00006077575,0.003212111,0.81494015],"study_design_scores_gemma":[0.062221583,0.085722625,0.099301815,0.00006900759,0.0009789532,0.0003772389,0.0007295183,0.000013752287,0.00015344146,0.0002906912,0.7499441,0.00019729552],"about_ca_topic_score_codex":0.0003260192,"about_ca_topic_score_gemma":0.00002924048,"teacher_disagreement_score":0.81474286,"about_ca_system_score_codex":0.00036472638,"about_ca_system_score_gemma":0.002741873,"threshold_uncertainty_score":0.8046512},"labels":[],"label_agreement":null},{"id":"W2319511858","doi":"10.1097/00000421-200112000-00014","title":"Thymidylate Synthase Expression in Stage II and III Colon Cancer","year":2001,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Thymidylate synthase; Chemotherapy; Internal medicine; Adjuvant; Colorectal cancer; Grading (engineering); Fluorouracil; Stage (stratigraphy); Gastroenterology; Adjuvant therapy; Adjuvant chemotherapy; Retrospective cohort study; Surgery; Oncology; Cancer","score_opus":0.07275299460736473,"score_gpt":0.4744815850383554,"score_spread":0.4017285904309907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319511858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875201,0.0019602,0.000014039782,0.0071678306,0.00036739584,0.00013260765,0.0000032081398,0.0000055371906,0.0028290676],"genre_scores_gemma":[0.98094493,0.01596955,0.0006384218,0.001479815,0.00031067902,0.0000104767105,4.6532813e-7,0.000009426446,0.00063624454],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99828166,0.00018851829,0.0009785907,0.00017395143,0.00016795304,0.00020931636],"domain_scores_gemma":[0.99801993,0.0007323627,0.0007906811,0.00009378719,0.0001236726,0.00023957413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069743727,0.00011775451,0.0012655056,0.0000991514,0.00006065369,0.0000036670983,0.0000618331,0.00007840988,0.00017733514],"category_scores_gemma":[0.00039686033,0.00007717999,0.00014014145,0.00017802048,0.00048404164,0.000058987927,0.00007536668,0.00045082325,0.0000011964727],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011124754,0.0009364866,0.4073446,0.000006683234,0.00016935226,0.0015154245,0.00054951577,0.000008461831,0.0003977181,0.0000070596507,0.00060115865,0.5773388],"study_design_scores_gemma":[0.0128146345,0.04039745,0.73850816,0.00028319962,0.00024856726,0.00036086,0.0017660132,0.00004992361,0.00013885308,0.00005006965,0.20523828,0.00014397256],"about_ca_topic_score_codex":0.00032688002,"about_ca_topic_score_gemma":0.00054343586,"teacher_disagreement_score":0.5771948,"about_ca_system_score_codex":0.0001634548,"about_ca_system_score_gemma":0.00042615877,"threshold_uncertainty_score":0.31473088},"labels":[],"label_agreement":null},{"id":"W2319904351","doi":"10.1097/01.coc.0000077940.05196.86","title":"Inducible Nitric Oxide Synthase and Nitrotyrosine in Mice With Radiation-Induced Lung Damage","year":2003,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Nitrotyrosine; Nitric oxide synthase; Pathology; Lung; Nitric oxide; Medicine; Immunostaining; Respiratory epithelium; Pathogenesis; Immunohistochemistry; Epithelium; Molecular biology; Andrology; Biology; Endocrinology; Internal medicine","score_opus":0.03604392762972686,"score_gpt":0.3931742984545507,"score_spread":0.35713037082482385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319904351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569833,0.00039282665,0.00018223684,0.0015153934,0.00013809535,0.00021582555,0.0000010737704,0.000008821203,0.0018473857],"genre_scores_gemma":[0.98856264,0.0005006709,0.0084571205,0.0021587075,0.00023372204,0.000005261525,9.5172027e-7,0.000023647042,0.00005728132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971285,0.0008262682,0.001261166,0.0002347132,0.0002469412,0.0003024315],"domain_scores_gemma":[0.9944632,0.0036311345,0.0010971348,0.00018052873,0.00018650177,0.00044148834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027268874,0.00016477815,0.0013499382,0.00038087944,0.000032705633,0.0000094404,0.00009620072,0.00013973664,0.000043423322],"category_scores_gemma":[0.004692479,0.00011790984,0.00012667904,0.00074543396,0.00031142004,0.00012349716,0.000017063965,0.0010161462,0.000007087661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00409235,0.0014534572,0.8300473,0.00003892724,0.0002894693,0.002202478,0.00011156714,0.000024314586,0.009457782,0.00012490568,0.00048756538,0.15166986],"study_design_scores_gemma":[0.023055369,0.020442944,0.9393099,0.0002815066,0.0006736877,0.0031903484,0.0010262833,0.00018318513,0.0038049424,0.00016466453,0.00753924,0.00032790785],"about_ca_topic_score_codex":0.00012359752,"about_ca_topic_score_gemma":0.000017696435,"teacher_disagreement_score":0.15134194,"about_ca_system_score_codex":0.00011936972,"about_ca_system_score_gemma":0.0010670495,"threshold_uncertainty_score":0.56176746},"labels":[],"label_agreement":null},{"id":"W2320487245","doi":"10.1097/coc.0b013e318248da66","title":"Factors Associated With Suboptimal Colorectal Cancer Screening in US Immigrants","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Sigmoidoscopy; Odds ratio; Fecal occult blood; Confidence interval; Colonoscopy; Demography; Residence; Colorectal cancer; Odds; Immigration; Logistic regression; Gerontology; Internal medicine; Cancer","score_opus":0.12137843319455338,"score_gpt":0.4349463914394331,"score_spread":0.3135679582448797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320487245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975705,0.00025930715,0.0002521898,0.0006117859,0.0006472695,0.00012181851,0.0000039360375,0.000019802057,0.0005133588],"genre_scores_gemma":[0.9976564,0.0000789493,0.0010351128,0.00052917126,0.00064105797,0.0000064303604,0.0000026028204,0.000023546841,0.000026723495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997383,0.0004669188,0.00115961,0.00016782433,0.0003679552,0.0004546652],"domain_scores_gemma":[0.9960589,0.0016226561,0.0014847242,0.000085655694,0.00026882978,0.00047925126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019117192,0.0001736956,0.0014060497,0.00021450427,0.000041970798,0.0000064881306,0.000104575505,0.0001465737,0.00007701569],"category_scores_gemma":[0.0016180977,0.00011706551,0.00028680437,0.0005985304,0.00044588812,0.00016485102,0.000027379701,0.0011289469,0.0000016302016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013204581,0.0004932081,0.85827565,0.0000021574706,0.00028923756,0.00006484325,0.00026589492,0.000068152265,0.00007046321,0.0000010538802,0.00006872125,0.12719601],"study_design_scores_gemma":[0.00397212,0.030268447,0.96283895,0.00014616216,0.00023114531,0.00013419671,0.00071036344,0.0001361289,0.00023844997,0.0000015755534,0.0011938807,0.00012858154],"about_ca_topic_score_codex":0.0009241883,"about_ca_topic_score_gemma":0.0014332162,"teacher_disagreement_score":0.12706743,"about_ca_system_score_codex":0.00025337478,"about_ca_system_score_gemma":0.0006582767,"threshold_uncertainty_score":0.49047753},"labels":[],"label_agreement":null},{"id":"W2320599978","doi":"10.1097/coc.0b013e3181f47583","title":"Radioembolization for the Treatment of Liver Tumors","year":2010,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nordion (Canada)","funders":"","keywords":"Medicine; Microsphere; Embolization; Radiology; Concomitant; Selective internal radiation therapy; Liver function; Magnetic resonance imaging; Nuclear medicine; Hepatocellular carcinoma; Surgery; Internal medicine","score_opus":0.3324402411097796,"score_gpt":0.49262732612599613,"score_spread":0.16018708501621653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320599978","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015280545,0.99563867,0.0002778729,0.00044003097,0.00070214545,0.0011993732,0.000018392986,0.0000048225993,0.00019062609],"genre_scores_gemma":[0.0019294373,0.9921414,0.0036953643,0.00012219361,0.001836331,0.00006191172,0.000024939542,0.000039042196,0.00014937016],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99629945,0.0005482592,0.0025640882,0.00019119981,0.00019966377,0.00019733151],"domain_scores_gemma":[0.98710126,0.007612996,0.0043843696,0.000306201,0.00035554357,0.00023960414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011884266,0.0002682133,0.005408319,0.00015234484,0.000039414885,0.0000049944474,0.00019861433,0.00033569083,0.00006785287],"category_scores_gemma":[0.00071561814,0.00012732222,0.0029900563,0.00022467329,0.0006696011,0.000023002542,0.000011905028,0.00049511826,0.000008571509],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042322424,0.0013549224,0.0035963927,0.0004139603,0.0014611778,0.00017380068,0.000066556306,5.1869023e-8,1.7415461e-7,0.0000303001,0.00024114843,0.9922383],"study_design_scores_gemma":[0.0018458761,0.04083123,0.00041662378,0.0008538808,0.011860262,0.00060839177,0.00002478848,0.00003070954,0.0000023285463,0.0000071908294,0.9434284,0.00009033744],"about_ca_topic_score_codex":0.000025377163,"about_ca_topic_score_gemma":0.000008280905,"teacher_disagreement_score":0.992148,"about_ca_system_score_codex":0.00014633007,"about_ca_system_score_gemma":0.0022806786,"threshold_uncertainty_score":0.5192049},"labels":[],"label_agreement":null},{"id":"W2320853964","doi":"10.1097/00000421-200212001-00003","title":"Efficacy of Bisphosphonates in the Management of Skeletal Complications of Bone Metastases and Selection of Clinical Endpoints","year":2002,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Zoledronic acid; Clinical trial; Bisphosphonate; Breast cancer; Prostate cancer; Multiple myeloma; Bone metastasis; Oncology; Clinical endpoint; Internal medicine; Cancer; Surgery; Osteoporosis","score_opus":0.19155596160046878,"score_gpt":0.539495382071859,"score_spread":0.3479394204713902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320853964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08634272,0.90994847,0.00004444084,0.0008081428,0.0002852269,0.0014457158,0.00007748703,0.0000041413373,0.0010436665],"genre_scores_gemma":[0.10499978,0.88792306,0.0068482854,0.00011548144,0.000049832295,0.000012257229,0.000012391934,0.000016670434,0.000022256672],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98985857,0.0016623919,0.007630815,0.00025043197,0.00039394968,0.0002038507],"domain_scores_gemma":[0.98098046,0.007537441,0.01066014,0.0002893091,0.0003245421,0.00020810544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003984005,0.00022780267,0.0067403615,0.00028928762,0.000017996806,0.0000012247402,0.00021392325,0.00022452054,0.00004876065],"category_scores_gemma":[0.0010373698,0.00013682434,0.0012001033,0.00067516573,0.001389043,0.00002881388,0.000059880138,0.00090000813,0.0000020440507],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007855833,0.005599811,0.006649492,0.0029403043,0.0018177934,0.000058208756,0.00003347747,5.4101054e-7,2.4330413e-7,0.00013559125,0.00015274777,0.9818262],"study_design_scores_gemma":[0.013588728,0.04256863,0.35483542,0.012470799,0.014418787,0.0011570458,0.0003232694,0.000012438246,0.000005126434,0.000089432346,0.56031865,0.000211682],"about_ca_topic_score_codex":0.00012956452,"about_ca_topic_score_gemma":0.000019207971,"teacher_disagreement_score":0.98161453,"about_ca_system_score_codex":0.00004636054,"about_ca_system_score_gemma":0.00071739254,"threshold_uncertainty_score":0.5579535},"labels":[],"label_agreement":null},{"id":"W2322229085","doi":"10.1097/coc.0000000000000107","title":"Function Preservation After Conservative Resection and Radiotherapy for Soft-tissue Sarcoma of the Distal Extremity","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Wound dehiscence; Surgery; Amputation; Soft tissue sarcoma; Adverse effect; Complication; Soft tissue; Sarcoma; Dehiscence; Radiation therapy; Forefoot; Cellulitis; Lymphedema; Current Procedural Terminology; Ankle; Cancer; Breast cancer; Internal medicine","score_opus":0.055735465324442714,"score_gpt":0.416092564456979,"score_spread":0.3603570991325363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322229085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98046553,0.00042654568,0.00854412,0.009781001,0.00038140363,0.00029348632,0.0000041675257,0.0000032811279,0.00010043428],"genre_scores_gemma":[0.99368656,0.000213346,0.0038662942,0.0017030688,0.0004472805,0.000021647022,0.0000014882145,0.000009423543,0.000050901333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831516,0.00048580297,0.00080899335,0.00012731309,0.00015940459,0.00010331949],"domain_scores_gemma":[0.9952018,0.0031171143,0.0011187311,0.00014457185,0.0003180137,0.00009975783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011799384,0.00008320472,0.0006788217,0.00004170881,0.000038097085,0.0000043714745,0.00005676272,0.00007738325,0.000019596739],"category_scores_gemma":[0.0015219868,0.000048568552,0.00020858708,0.00010885812,0.0005275069,0.00007389992,0.000017470955,0.00020487366,2.7771304e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071129915,0.0005470935,0.57583606,0.000010819807,0.0001861642,0.0000030754645,0.00008361709,0.0000017762372,0.0002632767,0.00010245974,0.0004237937,0.4154289],"study_design_scores_gemma":[0.0042959484,0.018286187,0.9209019,0.00005658063,0.00026454692,0.000072594405,0.00010915922,0.00020864051,0.00024744138,0.0005979222,0.054917425,0.000041677325],"about_ca_topic_score_codex":0.000055476397,"about_ca_topic_score_gemma":0.0000612311,"teacher_disagreement_score":0.4153872,"about_ca_system_score_codex":0.000065840555,"about_ca_system_score_gemma":0.00016556708,"threshold_uncertainty_score":0.1980568},"labels":[],"label_agreement":null},{"id":"W2324258684","doi":"10.1097/coc.0000000000000091","title":"Asian Versus Non-Asian Outcomes in Nasopharyngeal Carcinoma: A North American Population-based Analysis","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Nasopharyngeal carcinoma; Internal medicine; Proportional hazards model; Hazard ratio; Stage (stratigraphy); Survival analysis; Multivariate analysis; Population; Retrospective cohort study; Oncology; Radiation therapy; Confidence interval","score_opus":0.049414887521933654,"score_gpt":0.43132924567618386,"score_spread":0.38191435815425023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324258684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98077166,0.000026257854,0.00023191738,0.0154190045,0.00060904096,0.00012845141,0.0000044656217,0.000012546942,0.0027966269],"genre_scores_gemma":[0.9914563,0.000040846164,0.0044092173,0.0034507115,0.0005741028,0.0000074884892,0.0000111463805,0.000022154298,0.000028067065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959897,0.0006561635,0.0021464375,0.00033722314,0.0004367985,0.00043367737],"domain_scores_gemma":[0.99455166,0.002405284,0.0018935642,0.00033070386,0.00025623856,0.0005625664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013266553,0.00023992457,0.0040146387,0.00061143556,0.00006002598,0.00000798316,0.00022541385,0.000081611615,0.000034810342],"category_scores_gemma":[0.002076271,0.00018090339,0.00094353827,0.0016258454,0.0006559719,0.00006203251,0.000038653456,0.00085669523,0.000009432682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027861139,0.0005261386,0.7265338,0.000005808899,0.0007215737,0.00015212024,0.00013225581,0.000059168648,8.684731e-7,0.0000052312644,0.00008585323,0.26899108],"study_design_scores_gemma":[0.008037912,0.023401795,0.9636212,0.000017211021,0.0012743416,0.000011936646,0.000476192,0.00058126217,0.0000012895032,0.0000045772554,0.0024163069,0.000155995],"about_ca_topic_score_codex":0.0017075519,"about_ca_topic_score_gemma":0.012199592,"teacher_disagreement_score":0.2688351,"about_ca_system_score_codex":0.00030092648,"about_ca_system_score_gemma":0.0008471992,"threshold_uncertainty_score":0.7377026},"labels":[],"label_agreement":null},{"id":"W2327192765","doi":"10.1097/coc.0000000000000284","title":"Age Bias in Time From Diagnosis Comparisons of Prostate Cancer Treatment","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Observational study; Randomized controlled trial; Hazard ratio; Radiation therapy; Cohort; Survival analysis; Cohort study; Proportional hazards model; Prostate; Epidemiology; Cancer; Oncology; Surgery; Internal medicine; Confidence interval","score_opus":0.13724191495587953,"score_gpt":0.46373678657197276,"score_spread":0.32649487161609325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327192765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799238,0.0012462419,0.00000780659,0.017877165,0.00029676536,0.0002763584,0.00010576879,0.000005889264,0.00026022783],"genre_scores_gemma":[0.9702438,0.026642283,0.0017127922,0.00084407546,0.00030515992,0.00007660191,0.000004532668,0.000018114011,0.00015261344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969861,0.0004119408,0.0018601039,0.00023190629,0.00025351378,0.00025643178],"domain_scores_gemma":[0.99316996,0.004280113,0.001820685,0.00021623562,0.0001722152,0.00034076715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062159635,0.00017245671,0.0021725358,0.00012913368,0.000013174116,0.000003907324,0.00013246073,0.000087433145,0.00042007887],"category_scores_gemma":[0.0005056578,0.00009100576,0.0004153085,0.00019360906,0.00065232883,0.000056393837,0.000034636396,0.00019681323,0.000026515805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016985094,0.0023399312,0.5698702,0.0000023823886,0.00041351255,0.0004585302,0.00012856361,0.0000031336444,0.00008170757,0.0000041020267,0.0012426376,0.4237568],"study_design_scores_gemma":[0.01212335,0.03110195,0.8697466,0.0005495396,0.0004863633,0.000020145757,0.000103687795,0.000004235416,0.0015162199,0.0001015524,0.08414634,0.00010000365],"about_ca_topic_score_codex":0.0015189153,"about_ca_topic_score_gemma":0.00041841005,"teacher_disagreement_score":0.42365682,"about_ca_system_score_codex":0.0005834875,"about_ca_system_score_gemma":0.0009990992,"threshold_uncertainty_score":0.45995688},"labels":[],"label_agreement":null},{"id":"W2328073063","doi":"10.1097/00000421-200002000-00012","title":"Pyomyositis After Chemotherapy for Breast Cancer","year":2000,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Infectious Diseases and Tuberculosis","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Pyomyositis; Medicine; Myositis; Malignancy; Chemotherapy; Venous thrombosis; Breast cancer; Complication; Thrombosis; Surgery; Cancer; Internal medicine; Abscess","score_opus":0.022095474975394408,"score_gpt":0.43398240162820045,"score_spread":0.411886926652806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328073063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700095,0.00021441543,0.00010590998,0.027018568,0.00037931505,0.00015652287,0.00003760053,0.000010137713,0.0020680446],"genre_scores_gemma":[0.967252,0.0023874901,0.0016490995,0.025965145,0.002340763,0.000021761924,0.0000010399467,0.000023280018,0.00035942032],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99844515,0.0001156199,0.00092296075,0.00014458598,0.0001465407,0.00022512942],"domain_scores_gemma":[0.9982278,0.00049788505,0.0004936568,0.00012404405,0.00030011788,0.00035652088],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004784224,0.00010842933,0.0009750753,0.000053436634,0.000029357354,0.0000060308216,0.00007388105,0.000092238166,0.0059474567],"category_scores_gemma":[0.00007736213,0.00007831464,0.0006970384,0.00012622848,0.00035443567,0.000050408285,0.0000056415465,0.0002979622,0.000022627479],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009189869,0.0007263416,0.1501576,0.0000083846235,0.0003963283,0.0000935038,0.00003776596,0.0000043283517,0.000008317266,0.000006511969,0.0031314923,0.8362396],"study_design_scores_gemma":[0.0052709966,0.01006773,0.78296745,0.00006032087,0.0004898276,0.0011193876,0.000041277366,0.00003458927,0.000008545942,0.00009278189,0.19975227,0.00009480765],"about_ca_topic_score_codex":0.000085793894,"about_ca_topic_score_gemma":0.000017016302,"teacher_disagreement_score":0.83614475,"about_ca_system_score_codex":0.00009420701,"about_ca_system_score_gemma":0.00060950924,"threshold_uncertainty_score":0.99496126},"labels":[],"label_agreement":null},{"id":"W2328785997","doi":"10.1097/coc.0000000000000155","title":"Locally Advanced Malignant Myoepithelioma of the Parotid Gland Treated With Radiotherapy","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Island University; BC Cancer Agency","funders":"","keywords":"Medicine; Myoepithelioma; Radiation therapy; Parotid gland; Salivary gland; Surgery; Parotidectomy; Retrospective cohort study; Radiology; Pathology; Immunohistochemistry; Myoepithelial cell","score_opus":0.025323506714727113,"score_gpt":0.37068422629497727,"score_spread":0.34536071958025016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328785997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930005,0.00021757251,0.00030812612,0.005180747,0.00019120763,0.0002068922,0.0000027102617,0.000006527413,0.00088571507],"genre_scores_gemma":[0.99219364,0.0007265027,0.0044849785,0.002210542,0.00030390912,0.0000060601055,0.0000010394463,0.000019192132,0.00005416564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975528,0.00059026695,0.0011995343,0.00016755467,0.00029091374,0.00019894342],"domain_scores_gemma":[0.99581945,0.0016248649,0.0017469496,0.00030253886,0.00026257048,0.0002436473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009400679,0.00015375343,0.0014898033,0.000069646165,0.0000319386,0.0000035699113,0.00017422596,0.00006677203,0.000053879143],"category_scores_gemma":[0.00035761655,0.000066926514,0.00037457646,0.00026549443,0.00073155324,0.000031532007,0.000016985834,0.00029773408,0.0000026245084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005643198,0.001299602,0.8126895,0.000006596829,0.00052615895,0.00015888285,0.000045982622,0.000036509522,0.00007689783,0.000075047115,0.00014983086,0.17929178],"study_design_scores_gemma":[0.012853109,0.06721874,0.907057,0.00024061269,0.0004255641,0.0011623552,0.0000901691,0.0000449822,0.0009302296,0.000048021993,0.009843157,0.00008609353],"about_ca_topic_score_codex":0.00005483225,"about_ca_topic_score_gemma":0.000018295523,"teacher_disagreement_score":0.17920569,"about_ca_system_score_codex":0.00005554768,"about_ca_system_score_gemma":0.00042699333,"threshold_uncertainty_score":0.2729184},"labels":[],"label_agreement":null},{"id":"W2329158748","doi":"10.1097/00000421-200110000-00020","title":"Interstitial Fluid Pressure in Cervical Cancer","year":2001,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Angiogenesis; Oxygenation; Perfusion; Radiation therapy; Radioresistance; Hypoxia (environmental); Tumor hypoxia; Cervical cancer; Cancer; Internal medicine; Pathology; Cancer research; Oxygen","score_opus":0.08403186207789642,"score_gpt":0.47538515284573357,"score_spread":0.39135329076783715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329158748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711663,0.0013421741,0.000119147844,0.017193398,0.0015379216,0.00015109962,0.0000047900803,0.000010723277,0.008474444],"genre_scores_gemma":[0.9881203,0.0029104603,0.0009791332,0.0055188932,0.0021263452,0.000007727327,0.0000013848779,0.000014938274,0.00032080212],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971709,0.00038650032,0.0016139995,0.00020645547,0.00032724874,0.00029486965],"domain_scores_gemma":[0.9971778,0.001202466,0.00077141996,0.00014900784,0.00022605676,0.0004732825],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009186107,0.0001391144,0.0015716278,0.0001947026,0.00001719496,0.000005495505,0.0001832226,0.00015020224,0.0013990466],"category_scores_gemma":[0.0011257669,0.00009537921,0.0004148315,0.0005674008,0.00043443628,0.00007316227,0.00005015294,0.0008136802,0.000024627449],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013387571,0.001301707,0.3873283,0.000009523724,0.00036114518,0.0013563229,0.0000666994,0.000020772133,0.00004823538,0.000033159493,0.0007568465,0.59532976],"study_design_scores_gemma":[0.01628078,0.027402436,0.62171525,0.00016365226,0.00058413116,0.0007692559,0.000255304,0.00007045745,0.000036547168,0.00018651104,0.33239755,0.00013813358],"about_ca_topic_score_codex":0.0005463706,"about_ca_topic_score_gemma":0.00024598028,"teacher_disagreement_score":0.5951916,"about_ca_system_score_codex":0.0001754219,"about_ca_system_score_gemma":0.0007930272,"threshold_uncertainty_score":0.9995138},"labels":[],"label_agreement":null},{"id":"W2329439009","doi":"10.1097/coc.0b013e31829e19fb","title":"Outcome of Adjuvant Therapy in Biliary Tract Cancers","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Hazard ratio; Biliary tract cancer; Radiation therapy; Confidence interval; Surgery; Proportional hazards model; Chemotherapy; Internal medicine; Biliary tract; Oncology; Gemcitabine","score_opus":0.11798332655424212,"score_gpt":0.4637876789343794,"score_spread":0.3458043523801373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329439009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867573,0.0015061686,0.000011694894,0.0087554995,0.0005549185,0.00017434136,0.0000014727369,0.0000042014453,0.0022344068],"genre_scores_gemma":[0.99179715,0.0028343003,0.0011791317,0.0036978729,0.00040927515,0.000006949133,4.0565547e-7,0.000012514832,0.00006237955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971209,0.00025626487,0.0020249013,0.00014820075,0.00023281827,0.00021687706],"domain_scores_gemma":[0.99677086,0.001271931,0.0012820328,0.00017403327,0.0002895325,0.00021160344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010330275,0.000121345365,0.0018759752,0.00015682714,0.000011980396,0.0000024729147,0.00015061312,0.00008423603,0.00020923295],"category_scores_gemma":[0.0006515393,0.000079302896,0.00044335087,0.00024928976,0.0006731226,0.000076874996,0.000025653095,0.0006517558,0.000009790917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006218168,0.00035758648,0.6110812,0.0000055081805,0.00012481345,0.00009727323,0.00022267335,0.0000036108645,0.00009540418,0.000003153234,0.00096470123,0.38642228],"study_design_scores_gemma":[0.004345477,0.015898379,0.96915495,0.000048755017,0.00006835847,0.00014608447,0.0012087435,0.000012379037,0.00003936495,0.00005956622,0.008945853,0.000072069044],"about_ca_topic_score_codex":0.0014313019,"about_ca_topic_score_gemma":0.00011869195,"teacher_disagreement_score":0.3863502,"about_ca_system_score_codex":0.00016002748,"about_ca_system_score_gemma":0.00080835924,"threshold_uncertainty_score":0.32338783},"labels":[],"label_agreement":null},{"id":"W2331674475","doi":"10.1097/coc.0b013e3182467a13","title":"Phase I Trial of AEG35156 an Antisense Oligonucleotide to XIAP Plus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"Medicine; Gemcitabine; Pancreatic ductal adenocarcinoma; Oncology; Adenocarcinoma; Pancreatic cancer; Internal medicine; Cancer research; XIAP; Chemotherapy; Pancreatic carcinoma; Cancer; Apoptosis","score_opus":0.03633009900065996,"score_gpt":0.3926177608916083,"score_spread":0.35628766189094835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331674475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979247,0.000108932094,0.0010022642,0.00011994732,0.00046110796,0.0003142953,0.000008280329,0.0000019062202,0.00005859597],"genre_scores_gemma":[0.9889353,0.00007720246,0.010146502,0.00024219259,0.0005333369,0.0000038210746,0.000022558179,0.000021247928,0.000017853921],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99743253,0.0005625792,0.0012931699,0.00019620666,0.00022841284,0.00028710652],"domain_scores_gemma":[0.99784327,0.00014888639,0.0011809383,0.00023527084,0.0002236084,0.0003680306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012819691,0.00015181141,0.0009476561,0.00012536721,0.000020831454,0.0000048160173,0.00016514011,0.00008833469,0.00001844911],"category_scores_gemma":[0.0004406529,0.00011060228,0.00017413037,0.00018372916,0.00023778895,0.000018509847,0.000049425656,0.00019074365,0.0000022257589],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37411204,0.020689769,0.28284177,0.000034717486,0.0009222941,0.00010982103,0.00060683413,0.00048630752,0.03345365,0.00017188347,0.00022197506,0.2863489],"study_design_scores_gemma":[0.18402919,0.253739,0.5534066,0.000056781762,0.00057588064,0.00014956987,0.00058722706,0.00009788001,0.003792423,0.000043708533,0.0031140572,0.000407672],"about_ca_topic_score_codex":0.000034776738,"about_ca_topic_score_gemma":0.000017601691,"teacher_disagreement_score":0.28594124,"about_ca_system_score_codex":0.00003486732,"about_ca_system_score_gemma":0.00034610106,"threshold_uncertainty_score":0.45102304},"labels":[],"label_agreement":null},{"id":"W2331897577","doi":"10.1097/coc.0000000000000281","title":"Chemotherapy is of Value in Second Line and Beyond, Relapsed High-grade, Serous Epithelial Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Serous fluid; Hazard ratio; Internal medicine; Proportional hazards model; Chemotherapy; Progression-free survival; Population; Univariate analysis; Oncology; Ovarian cancer; Surgery; Multivariate analysis; Confidence interval; Cancer","score_opus":0.03879162495960458,"score_gpt":0.40089231286677424,"score_spread":0.36210068790716965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331897577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91691566,0.0005267314,0.00008241292,0.08137906,0.0005728314,0.00016671921,0.000040241786,0.0000040617388,0.00031230843],"genre_scores_gemma":[0.9768486,0.008557216,0.0052428516,0.008352577,0.00075429183,0.000008957873,6.7367733e-7,0.000023732744,0.00021111155],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99733895,0.00030365237,0.0016380007,0.00025674765,0.0002262631,0.00023639396],"domain_scores_gemma":[0.99616927,0.001599618,0.0015187613,0.00021112016,0.00019857041,0.0003026818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001063918,0.00016313698,0.0017235148,0.00014372199,0.000015846805,0.0000033586596,0.000113613314,0.00016308049,0.0006961521],"category_scores_gemma":[0.00027083757,0.00009635033,0.0002466688,0.00020734165,0.00063148345,0.000065115746,0.00002665277,0.00037006117,0.000004243992],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004056511,0.001580076,0.18885872,0.000015357851,0.00063303305,0.00025477595,0.00028345053,0.0000026322207,0.00084117946,0.00021683998,0.0011187375,0.8021387],"study_design_scores_gemma":[0.0443817,0.035063975,0.85946035,0.0003886776,0.00045347988,0.0002764802,0.00017163026,0.000014414607,0.0040221876,0.0012871923,0.054290954,0.00018897495],"about_ca_topic_score_codex":0.0004423935,"about_ca_topic_score_gemma":0.00015044227,"teacher_disagreement_score":0.8019497,"about_ca_system_score_codex":0.00018894505,"about_ca_system_score_gemma":0.0009483881,"threshold_uncertainty_score":0.7622377},"labels":[],"label_agreement":null},{"id":"W2332772114","doi":"10.1097/00000421-200308001-00005","title":"Emerging Role of Aromatase Inhibitors in the Adjuvant Setting","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Exemestane; Anastrozole; Medicine; Tamoxifen; Letrozole; Breast cancer; Oncology; Aromatase inhibitor; Internal medicine; Aromatase; Metastatic breast cancer; Adjuvant therapy; Selective estrogen receptor modulator; Pharmacology; Cancer","score_opus":0.028193737216965196,"score_gpt":0.43078381918006087,"score_spread":0.40259008196309565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332772114","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01539932,0.9830698,0.000006770026,0.00010525298,0.00044841575,0.00021604296,0.000009260804,0.0000013509213,0.000743808],"genre_scores_gemma":[0.0051861107,0.99315107,0.00073928054,0.00023739671,0.0006138195,0.0000070107244,0.000024150606,0.000030122488,0.000011043557],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935448,0.002969156,0.002742147,0.0002540628,0.00021077342,0.00027904846],"domain_scores_gemma":[0.99423546,0.0009693482,0.004246842,0.00032192434,0.00009215395,0.00013429132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041345395,0.00026343745,0.0025532292,0.00013479292,0.000029040244,0.0000059724334,0.0005381766,0.0005017388,0.0000052597115],"category_scores_gemma":[0.0011016547,0.00015496972,0.0011800632,0.00030954438,0.0004802147,0.0000035457097,0.00008342481,0.0013493297,0.0000047131457],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008190716,0.00027120108,0.00017881778,0.00015390778,0.0002945998,0.000116987874,0.00003923066,0.000004848432,0.000050298397,0.000010100454,0.00089383626,0.99790424],"study_design_scores_gemma":[0.00052034715,0.005021143,0.000029776207,0.0011010118,0.00051809027,0.0007581099,0.00039797067,0.0000012953543,0.000034785426,0.000019823054,0.99143875,0.00015889642],"about_ca_topic_score_codex":0.000009359361,"about_ca_topic_score_gemma":0.0000028745658,"teacher_disagreement_score":0.9977454,"about_ca_system_score_codex":0.00002806819,"about_ca_system_score_gemma":0.0011372431,"threshold_uncertainty_score":0.6319482},"labels":[],"label_agreement":null},{"id":"W2333432525","doi":"10.1097/coc.0000000000000140","title":"Dose-escalated Hypofractionated Intensity-modulated Radiation Therapy With Concurrent Chemotherapy for Inoperable or Unresectable Non-Small Cell Lung Cancer","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Radiation therapy; Lung cancer; Toxicity; Chemotherapy; Nuclear medicine; Cumulative dose; Cumulative incidence; Dose fractionation; Oncology; Internal medicine; Cohort","score_opus":0.043467876988290965,"score_gpt":0.4170678090021223,"score_spread":0.37359993201383135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333432525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986035,0.0004942174,0.0016542209,0.009723279,0.0009601372,0.00081770675,0.000006284,0.00002163152,0.00028752512],"genre_scores_gemma":[0.9827695,0.0068915994,0.0022337001,0.006865333,0.0008056697,0.00007872854,0.00001731163,0.000045199675,0.0002929581],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99768203,0.00024356668,0.001180013,0.00031714022,0.00024053095,0.0003367404],"domain_scores_gemma":[0.99514633,0.0016451322,0.0015857513,0.00020454134,0.0010648855,0.00035337472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009999869,0.00023189571,0.0016004029,0.00012554822,0.000078203055,0.000017775654,0.00012983633,0.00016280304,0.00020118878],"category_scores_gemma":[0.00024526595,0.00013503451,0.00028035822,0.0003487135,0.00023652334,0.000113099726,0.000012197858,0.0005326883,0.0000033362946],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027019026,0.0031223744,0.23399721,0.000045970784,0.001715913,0.000046318248,0.00020652697,0.00046394372,0.00058941176,0.0000056645426,0.006275293,0.7265124],"study_design_scores_gemma":[0.0757327,0.09835421,0.58665997,0.0004475288,0.0011892727,0.00021159548,0.00021042814,0.0123374285,0.0055129034,0.00001988786,0.21891795,0.00040614326],"about_ca_topic_score_codex":0.00042110003,"about_ca_topic_score_gemma":0.0000792702,"teacher_disagreement_score":0.7261062,"about_ca_system_score_codex":0.00055579096,"about_ca_system_score_gemma":0.0016391777,"threshold_uncertainty_score":0.55065477},"labels":[],"label_agreement":null},{"id":"W2333456198","doi":"10.1097/00000421-200210000-00019","title":"Carboplatin and Vinblastine for the Treatment of Metastatic Transitional Cell Carcinoma of the Urothelial Tract","year":2002,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Vinblastine; Carboplatin; Transitional cell carcinoma; Urothelial carcinoma; Transitional Cell; Metastatic Urothelial Carcinoma; Chemotherapy; Oncology; Urology; Carcinoma; Internal medicine; Cisplatin; Bladder cancer; Cancer","score_opus":0.09289857469421467,"score_gpt":0.3973515386408462,"score_spread":0.30445296394663157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333456198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991802,0.0012318162,0.00027578816,0.005360642,0.00028299075,0.00040833137,0.000069354595,0.000001265599,0.0005678418],"genre_scores_gemma":[0.9964595,0.0007061666,0.0018973519,0.00045368375,0.00031892266,0.000011442504,6.3283915e-7,0.000011970127,0.00014037425],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982883,0.00022793954,0.0010397825,0.00010951274,0.00020595267,0.00012853206],"domain_scores_gemma":[0.9956767,0.0028874387,0.0010091832,0.00014406307,0.0001693715,0.000113236514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034540592,0.00011592413,0.0009616803,0.000039293613,0.000038318103,0.0000018051918,0.00009212077,0.000041221676,0.0001424175],"category_scores_gemma":[0.00014201397,0.000053509757,0.0005074444,0.00010518122,0.00073486986,0.000020601261,0.0000057281313,0.00015194659,6.7172124e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008752132,0.010721561,0.12770446,0.000074140255,0.0014303111,0.000083292725,0.0026411184,0.00007673497,0.0018561097,0.00006224043,0.0005455968,0.8460523],"study_design_scores_gemma":[0.037791073,0.16115049,0.76154935,0.00007695837,0.0060847653,0.0008620293,0.0011954567,0.0010224998,0.0053495173,0.0001939169,0.024564454,0.00015948461],"about_ca_topic_score_codex":0.000082178354,"about_ca_topic_score_gemma":0.000014899726,"teacher_disagreement_score":0.84589285,"about_ca_system_score_codex":0.000045587985,"about_ca_system_score_gemma":0.000333046,"threshold_uncertainty_score":0.27076587},"labels":[],"label_agreement":null},{"id":"W2333550047","doi":"10.1097/coc.0b013e3182a533ea","title":"Pancreatectomy Versus Conservative Management for Pancreatic Cancer","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Pancreatic cancer; Pancreatectomy; Cohort; Occult; Cancer; Population; Surgery; Pancreas; Stage (stratigraphy); Survival analysis; Internal medicine; Pathology","score_opus":0.15983487796767606,"score_gpt":0.5218794553148332,"score_spread":0.3620445773471571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333550047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644765,0.00030626115,0.001035171,0.013759614,0.00069296575,0.000977877,0.0000051152997,0.000014719119,0.01873174],"genre_scores_gemma":[0.9269536,0.0036517135,0.061477497,0.0042308033,0.0010417937,0.00032876484,0.000004070878,0.000032873675,0.0022788553],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99690723,0.0004483391,0.0016330944,0.00024175108,0.00032112672,0.00044848231],"domain_scores_gemma":[0.9916431,0.0053856885,0.0013182663,0.00024030873,0.0009521608,0.00046051916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017871798,0.0001732858,0.00228449,0.00015668696,0.0000645428,0.000010253614,0.00022190422,0.00014877062,0.0007584275],"category_scores_gemma":[0.0017613495,0.000120220764,0.00044922478,0.00026668512,0.0011193216,0.00009037365,0.000055122848,0.00057660544,0.00007816029],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015135973,0.00083788397,0.3367048,0.0000743225,0.0036591995,0.00021678659,0.0001316038,0.0000020880702,0.000048038943,0.0004962791,0.022190446,0.6205026],"study_design_scores_gemma":[0.030489473,0.05363498,0.7560259,0.00023477631,0.003145332,0.00020146015,0.0027078516,0.00052938826,0.00003150627,0.00077494397,0.15199624,0.0002281551],"about_ca_topic_score_codex":0.00029208176,"about_ca_topic_score_gemma":0.000019080508,"teacher_disagreement_score":0.6202744,"about_ca_system_score_codex":0.0002443771,"about_ca_system_score_gemma":0.0011212956,"threshold_uncertainty_score":0.8304249},"labels":[],"label_agreement":null},{"id":"W2333789445","doi":"10.1097/coc.0b013e318209d36c","title":"Real-world Impact of Availability of Adjuvant Therapy on Outcomes in Patients With Resected Pancreatic Adenocarcinoma","year":2011,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Medicine; Gemcitabine; Adjuvant therapy; Pancreatic cancer; Referral; Adenocarcinoma; Cancer; Internal medicine; Surgery; General surgery; Family medicine","score_opus":0.12946154596548323,"score_gpt":0.4731822632168055,"score_spread":0.34372071725132225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333789445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482846,0.00004207342,0.000006769946,0.00021104167,0.000070868315,0.00043693653,0.000009558466,0.000004460144,0.0043898034],"genre_scores_gemma":[0.99626356,0.00036228087,0.0030711328,0.00014691458,0.000046690144,0.000005727124,0.000002635033,0.000018553419,0.00008251546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99496603,0.0013176153,0.0026007507,0.00023344942,0.00054025906,0.00034192068],"domain_scores_gemma":[0.9914237,0.0043572886,0.0025449477,0.0004600024,0.0008575158,0.0003565063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027214426,0.00019448272,0.0037822544,0.00043987113,0.000016009339,0.000001147083,0.00026127585,0.00014119633,0.00053013273],"category_scores_gemma":[0.0026199692,0.00010562783,0.00046966862,0.00055075967,0.0017304228,0.00005522432,0.000037232196,0.00087021175,0.000004562459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052737206,0.006585146,0.9154714,0.000016154676,0.00095960445,0.00009951123,0.0004614071,0.0000012645168,0.000025715488,0.000016098173,0.00007941713,0.02354713],"study_design_scores_gemma":[0.01192641,0.1444779,0.8429169,0.00012898254,0.00020707655,0.000010898441,0.00012093223,0.000012805145,0.00003389035,0.00007841423,0.0000136878625,0.00007211922],"about_ca_topic_score_codex":0.002281873,"about_ca_topic_score_gemma":0.00020854254,"teacher_disagreement_score":0.13789277,"about_ca_system_score_codex":0.00026611154,"about_ca_system_score_gemma":0.0023213997,"threshold_uncertainty_score":0.63758147},"labels":[],"label_agreement":null},{"id":"W2334974730","doi":"10.1097/coc.0b013e31820dbdcc","title":"A Phase II Trial of Erlotinib as Maintenance Treatment After Gemcitabine Plus Platinum-based Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma","year":2011,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Erlotinib; Medicine; Gemcitabine; Carboplatin; Internal medicine; Chemotherapy; Oncology; Progressive disease; Regimen; Nasopharyngeal carcinoma; Erlotinib Hydrochloride; Cisplatin; Gastroenterology; Cancer; Radiation therapy; Epidermal growth factor receptor","score_opus":0.08404970786032828,"score_gpt":0.41959301545087513,"score_spread":0.33554330759054685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334974730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739367,0.00017541321,0.000027035021,0.0011923022,0.00027031556,0.0006686654,0.00001342509,0.0000040880213,0.00025508527],"genre_scores_gemma":[0.9932544,0.0002874232,0.005051739,0.0011515522,0.00015273773,0.00004076573,0.0000023178816,0.00001911521,0.000039913328],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9973232,0.00030603795,0.0016091183,0.00023098032,0.00026267456,0.00026796394],"domain_scores_gemma":[0.99721676,0.00073681347,0.0013511718,0.00016046684,0.0002550619,0.00027974028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066913234,0.00020525485,0.0023374923,0.00013999204,0.000023883054,0.0000016407977,0.000078427096,0.00005349458,0.00013152008],"category_scores_gemma":[0.00043691008,0.000112824644,0.00021568612,0.00020238323,0.00067982124,0.00004798819,0.00002101344,0.00031058054,0.0000010420616],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5956151,0.012660583,0.06087846,0.000017240154,0.00030317725,0.0003546532,0.001238918,3.510005e-7,0.0000022959653,0.0000028682575,0.00004823309,0.3288781],"study_design_scores_gemma":[0.34203026,0.48216474,0.17394312,0.00015537196,0.00027333503,0.000027616526,0.00021715062,0.000026297663,0.000026166017,0.000008954278,0.0010434294,0.00008355544],"about_ca_topic_score_codex":0.000120985125,"about_ca_topic_score_gemma":0.00009965638,"teacher_disagreement_score":0.46950415,"about_ca_system_score_codex":0.00019413981,"about_ca_system_score_gemma":0.0014518646,"threshold_uncertainty_score":0.46008554},"labels":[],"label_agreement":null},{"id":"W2340840224","doi":"10.1097/coc.0000000000000215","title":"ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma","year":2015,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Appropriate Use Criteria; Guideline; Medical physics; Positron emission tomography; Radiation therapy; Diffuse large B-cell lymphoma; Appropriateness criteria; Multidisciplinary approach; Lymphoma; Radiology; Internal medicine; Pathology","score_opus":0.17736043082327232,"score_gpt":0.5224009550491343,"score_spread":0.34504052422586196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340840224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004614613,0.98812383,0.000027569507,0.0007088272,0.0026439177,0.0005861801,0.00005726749,0.000024729146,0.0032130831],"genre_scores_gemma":[0.0023009726,0.9904075,0.0024989138,0.0013695202,0.0028993213,0.000046404515,0.000049388425,0.00009936172,0.00032857605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913608,0.0019574703,0.0048397044,0.0005460542,0.00066880713,0.00062717014],"domain_scores_gemma":[0.9876246,0.0027924916,0.006795042,0.0006811371,0.0007497206,0.0013570426],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003826395,0.0006398245,0.012173026,0.00030334888,0.000051579034,0.000027131164,0.000544825,0.00073018234,0.000115479845],"category_scores_gemma":[0.0013127568,0.00038401404,0.0030276708,0.00044906707,0.0006761239,0.0000827159,0.00021416652,0.00080823194,0.0002675985],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006625177,0.026139839,0.00043491935,0.0010804444,0.0013143654,0.006932244,0.000051503615,1.8969093e-8,3.5091578e-8,0.000025991514,0.0067605074,0.9565976],"study_design_scores_gemma":[0.02530758,0.01624694,0.00034776705,0.0028672914,0.007343692,0.005360677,0.00011699624,0.0000013751733,3.3060175e-7,0.000028327479,0.9420694,0.0003095936],"about_ca_topic_score_codex":0.000027150934,"about_ca_topic_score_gemma":0.000003429035,"teacher_disagreement_score":0.95628804,"about_ca_system_score_codex":0.00093021576,"about_ca_system_score_gemma":0.008690882,"threshold_uncertainty_score":0.9998612},"labels":[],"label_agreement":null},{"id":"W2432804309","doi":"10.1097/coc.0000000000000294","title":"ACR Appropriateness Criteria® Hodgkin Lymphoma—Unfavorable Clinical Stage I and II","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Guideline; Stage (stratigraphy); Appropriate Use Criteria; Intensive care medicine; Delphi method; Medical physics; Internal medicine; Pathology","score_opus":0.19357822069068492,"score_gpt":0.5475453707828247,"score_spread":0.3539671500921398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432804309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011667382,0.98011667,0.000050577917,0.0020547737,0.0030761573,0.0007537296,0.00007489424,0.000028732775,0.0021771125],"genre_scores_gemma":[0.0015931635,0.98829466,0.0040322933,0.0015146402,0.0034772847,0.000042534513,0.00001613751,0.00009757685,0.00093173725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9876818,0.0030718849,0.0072211195,0.0008333732,0.00054537825,0.0006464596],"domain_scores_gemma":[0.9804922,0.008804359,0.008106221,0.00073823857,0.000497062,0.001361953],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0066951783,0.0007079315,0.013357861,0.00030356288,0.00012647189,0.00003507473,0.00048600652,0.0009807129,0.00033358354],"category_scores_gemma":[0.0031431739,0.0003865355,0.0028773497,0.0003364379,0.002019446,0.00013003734,0.00039006246,0.0009326318,0.00010504978],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009874529,0.0038532321,0.0024912897,0.00086517655,0.002513924,0.0029211817,0.000025442912,1.7451814e-8,1.0792202e-7,0.00008633722,0.0030087982,0.98324704],"study_design_scores_gemma":[0.008815678,0.031031692,0.0032833808,0.0075982967,0.0044747735,0.0033177286,0.000064891385,0.0000010365277,3.6904592e-7,0.000043711527,0.9410086,0.0003598283],"about_ca_topic_score_codex":0.0000431426,"about_ca_topic_score_gemma":0.000004999445,"teacher_disagreement_score":0.9828872,"about_ca_system_score_codex":0.000497321,"about_ca_system_score_gemma":0.00657473,"threshold_uncertainty_score":0.9998587},"labels":[],"label_agreement":null},{"id":"W2434288623","doi":"10.1097/coc.0000000000000307","title":"Cost-effectiveness of Management Options for Small Renal Mass","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Renal mass; Nephrectomy; Cost effectiveness; Surgery; Variety (cybernetics); Intensive care medicine; General surgery; Medical physics; Kidney; Risk analysis (engineering); Internal medicine","score_opus":0.3131896401851001,"score_gpt":0.5322940023700894,"score_spread":0.2191043621849893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2434288623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003330631,0.9801159,0.011332111,0.00033214592,0.0011858835,0.0034459794,0.0000727542,0.000011201801,0.003170986],"genre_scores_gemma":[0.00022494074,0.9648971,0.03328683,0.00008848282,0.0008143553,0.00023444982,0.000023895698,0.00006338004,0.00036657284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929162,0.002162153,0.003828032,0.00039662578,0.00033060258,0.000366343],"domain_scores_gemma":[0.98098546,0.011524256,0.005936859,0.00047306318,0.0006034704,0.00047686487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048838016,0.00039582045,0.007962124,0.0004015705,0.000029512952,0.000004944388,0.00037937338,0.00033789582,0.00005457827],"category_scores_gemma":[0.000863373,0.00022861194,0.003376266,0.0002800354,0.00080022746,0.000031266365,0.000081370184,0.0007130504,0.00002577804],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024679652,0.00085381046,0.00009111674,0.0052564307,0.0038791627,0.0005938933,0.000004419274,0.0000012853905,0.0000019614426,0.00029068504,0.00024089412,0.98631835],"study_design_scores_gemma":[0.0047647334,0.027657896,0.0007999307,0.018608844,0.009154862,0.000855311,0.000027353397,6.5533544e-7,0.000005662342,0.00017917396,0.93776155,0.0001840175],"about_ca_topic_score_codex":0.0000043882765,"about_ca_topic_score_gemma":0.0000011413217,"teacher_disagreement_score":0.98613435,"about_ca_system_score_codex":0.000694512,"about_ca_system_score_gemma":0.0018871281,"threshold_uncertainty_score":0.9322524},"labels":[],"label_agreement":null},{"id":"W2468525182","doi":"10.1097/coc.0000000000000310","title":"Secondary Surgery Versus Chemotherapy for Recurrent Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"National Cancer Institute","keywords":"Medicine; Debulking; Hazard ratio; Chemotherapy; Ovarian cancer; Surgery; Proportional hazards model; Confidence interval; Survival analysis; Cancer; Internal medicine","score_opus":0.13024568978278558,"score_gpt":0.4824705152351497,"score_spread":0.3522248254523641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468525182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7434495,0.0016268359,0.0010276644,0.24207771,0.009501109,0.0004562228,0.00005851238,0.000020502204,0.0017819111],"genre_scores_gemma":[0.97076446,0.012461216,0.0063784844,0.006270713,0.0038312536,0.000055946344,0.0000024541969,0.00003596824,0.00019950196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772686,0.000193901,0.001381201,0.00022959833,0.00019161493,0.00027680356],"domain_scores_gemma":[0.9903384,0.0072236205,0.0015008958,0.00019672565,0.0003426401,0.0003977129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013880433,0.00014496071,0.0015347047,0.00009836363,0.000030433623,0.000005102268,0.00010069235,0.000106940526,0.00078211894],"category_scores_gemma":[0.00096660515,0.00008155351,0.0007756759,0.0001259212,0.00038501894,0.00006269801,0.0000144733995,0.0002541776,0.000011295705],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020433614,0.0008807757,0.04232699,0.000009249551,0.0009816139,0.00008172371,0.00002854012,1.6308023e-7,0.000020300105,0.00008236675,0.027544174,0.9076105],"study_design_scores_gemma":[0.021966346,0.028612262,0.20102826,0.00022473602,0.00047776196,0.00008010487,0.00005772144,0.0000018924967,0.00016076185,0.00014751409,0.7471222,0.00012038769],"about_ca_topic_score_codex":0.000029413093,"about_ca_topic_score_gemma":0.000037151396,"teacher_disagreement_score":0.9074901,"about_ca_system_score_codex":0.00033841757,"about_ca_system_score_gemma":0.0028462843,"threshold_uncertainty_score":0.8563654},"labels":[],"label_agreement":null},{"id":"W2519254806","doi":"10.1097/coc.0000000000000329","title":"Stereotactic Ablative Radiotherapy (SABR) for Large Renal Tumors","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; SABR volatility model; Common Terminology Criteria for Adverse Events; Renal cell carcinoma; Nephrectomy; Response Evaluation Criteria in Solid Tumors; Ablative case; Progressive disease; Confidence interval; Radiation therapy; Nausea; Pneumonitis; Surgery; Adverse effect; Radiology; Internal medicine; Kidney; Chemotherapy; Lung","score_opus":0.07778116298228616,"score_gpt":0.4458222962025069,"score_spread":0.36804113322022075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519254806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97262746,0.00031313414,0.0098872855,0.014801751,0.0005340627,0.00038288545,0.000012583642,0.000013446811,0.0014273633],"genre_scores_gemma":[0.9760523,0.00043493084,0.018409267,0.0029289243,0.0012502979,0.000012570324,0.0000012950728,0.000035186637,0.00087521615],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99672985,0.00054299465,0.0017714016,0.00025785563,0.00030242075,0.0003954724],"domain_scores_gemma":[0.9911417,0.0054588653,0.0021606912,0.0002569663,0.00045293552,0.00052884454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020942558,0.00018919572,0.0017984231,0.00014346004,0.000040797124,0.0000056032345,0.00016697694,0.00011125021,0.0002561172],"category_scores_gemma":[0.0016972808,0.00009997426,0.00076970854,0.00014958193,0.00048478175,0.00009920816,0.000023219514,0.0003655493,0.000020955404],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024666965,0.0022272472,0.1463278,0.000014857788,0.0025698785,0.001408812,0.00028982383,0.0000011998974,0.00341022,0.0003946286,0.0049547125,0.8137339],"study_design_scores_gemma":[0.03884109,0.1787439,0.4112792,0.00033249706,0.001035764,0.0033243296,0.0004435759,0.000042129766,0.0015609062,0.00060939253,0.36346588,0.00032133987],"about_ca_topic_score_codex":0.000007495203,"about_ca_topic_score_gemma":0.0000054807138,"teacher_disagreement_score":0.81341255,"about_ca_system_score_codex":0.00040011323,"about_ca_system_score_gemma":0.0011132939,"threshold_uncertainty_score":0.40768322},"labels":[],"label_agreement":null},{"id":"W2547683025","doi":"10.1097/coc.0000000000000342","title":"Impact of Postoperative Adjuvant Chemotherapy Following Long-course Chemoradiotherapy in Stage II Rectal Cancer","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Memorial University of Newfoundland; University of Ottawa; University of Calgary; BC Cancer Agency; Ottawa Hospital; University of British Columbia","funders":"","keywords":"Medicine; Lymphovascular invasion; Perineural invasion; Carcinoembryonic antigen; Internal medicine; Colorectal cancer; Oxaliplatin; Oncology; Stage (stratigraphy); Regimen; Chemoradiotherapy; Univariate analysis; Chemotherapy; Multivariate analysis; Surgery; Cancer; Metastasis","score_opus":0.05552703053806801,"score_gpt":0.5047770831299755,"score_spread":0.4492500525919075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547683025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895008,0.00078838074,0.00006459937,0.00822967,0.000519489,0.00028625946,0.000016629483,0.0000092357595,0.000584934],"genre_scores_gemma":[0.99470174,0.0023656646,0.0010778813,0.0011355951,0.00030238114,0.0000117216705,8.183191e-7,0.00003637553,0.00036784456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99668133,0.00046041334,0.0017891343,0.00029524823,0.0003909469,0.00038290568],"domain_scores_gemma":[0.9959406,0.0014847259,0.0016227503,0.00023547714,0.00030008834,0.00041632153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012459569,0.00024771213,0.0027760365,0.00016072494,0.00002720552,0.0000033784504,0.00019922682,0.00015952661,0.0008896952],"category_scores_gemma":[0.0006036387,0.0001347334,0.0011975963,0.0004457348,0.0006508572,0.00014104383,0.000036577214,0.00049953396,0.000003391561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010233433,0.0014931015,0.54889345,0.0000022648012,0.0009022568,0.00062375976,0.00025975358,0.0000075012485,0.002007951,0.0000017282355,0.00011129749,0.43546352],"study_design_scores_gemma":[0.019600304,0.05771142,0.9190187,0.00028135258,0.00014666861,0.00016780446,0.00009734922,0.000012365218,0.0007965595,0.000016832186,0.0020015242,0.00014911187],"about_ca_topic_score_codex":0.0004579506,"about_ca_topic_score_gemma":0.00016685668,"teacher_disagreement_score":0.43531442,"about_ca_system_score_codex":0.0010089127,"about_ca_system_score_gemma":0.002708329,"threshold_uncertainty_score":0.9741538},"labels":[],"label_agreement":null},{"id":"W2603488693","doi":"10.1097/coc.0000000000000385","title":"Predictive Impact of Clinical Benefit in Chemotherapy-treated Advanced Pancreatic Cancer Patients in Northern Alberta","year":2017,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Covenant Health; University of Alberta; University of Manitoba","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Pancreatic cancer; Disease; Quality of life (healthcare); Cancer; Performance status; Clinical endpoint; Oncology; Clinical trial; Surgery","score_opus":0.06483734788493076,"score_gpt":0.5155751278823387,"score_spread":0.45073777999740794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603488693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942093,0.000095743286,0.000007715463,0.0015813591,0.00026460757,0.00047957862,0.000012573824,0.0000033389317,0.0033457933],"genre_scores_gemma":[0.9947454,0.003581203,0.0007786575,0.00032082523,0.00031904218,0.000019431825,0.0000046096407,0.00002886469,0.00020201456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940352,0.0007897524,0.003917986,0.00034889203,0.00042127355,0.00048690295],"domain_scores_gemma":[0.98816687,0.005267095,0.0047070994,0.00052537106,0.00081508834,0.00051848666],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003145252,0.00023407306,0.0043935287,0.000253292,0.00004760169,0.000006720248,0.00049056223,0.00035088963,0.00017377906],"category_scores_gemma":[0.010783753,0.00016102099,0.00072289346,0.0002412836,0.0017914077,0.00015347623,0.00008970894,0.001407178,0.000008405247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018331109,0.003058549,0.7333289,0.000011690097,0.00067372696,0.00010514812,0.0002115137,0.000031886037,0.000010849625,0.0000023142027,0.000048183225,0.24418616],"study_design_scores_gemma":[0.021452134,0.04054503,0.9363513,0.00038527173,0.000278416,0.000019311701,0.00014698574,0.00038469516,0.0000073315787,0.00009326247,0.00022194565,0.00011432465],"about_ca_topic_score_codex":0.013359383,"about_ca_topic_score_gemma":0.017272973,"teacher_disagreement_score":0.24407183,"about_ca_system_score_codex":0.00046987835,"about_ca_system_score_gemma":0.0030635488,"threshold_uncertainty_score":0.9975488},"labels":[],"label_agreement":null},{"id":"W2790914546","doi":"10.1097/coc.0000000000000435","title":"Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Radiosurgery; Toxicity; Radiology; Ascites; Cohort; Magnetic resonance imaging; Nuclear medicine; Target lesion; Radiation therapy; Surgery; Internal medicine","score_opus":0.15870054531556246,"score_gpt":0.41966979684214756,"score_spread":0.2609692515265851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790914546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915589,0.0006792698,0.00059573137,0.0047457903,0.0009139208,0.000518403,0.0000037763775,0.000015534832,0.00096868677],"genre_scores_gemma":[0.9895888,0.0006540516,0.0037826532,0.0025765598,0.0031760917,0.000019354671,0.000009475674,0.00003417397,0.00015882203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713784,0.0004863588,0.0015359565,0.00024782663,0.00026798298,0.00032405343],"domain_scores_gemma":[0.9953894,0.001643257,0.0015853113,0.00025745478,0.0006881429,0.00043645932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018511292,0.0001866245,0.0013687534,0.0001705748,0.000077277335,0.000013251201,0.00016085304,0.00016646844,0.00018090388],"category_scores_gemma":[0.0008315628,0.00013515197,0.00073145574,0.00025390388,0.0005873988,0.00010153137,0.00001918847,0.00036967907,0.000051536073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037054303,0.00061520515,0.6740325,0.000005755895,0.00037499092,0.00020359187,0.00012530237,1.3990678e-8,0.00022929792,0.000028742157,0.0011378089,0.31954134],"study_design_scores_gemma":[0.012393772,0.116739005,0.5377892,0.000030242136,0.0007416843,0.0005842808,0.00013066891,0.0014093012,0.0021644284,0.00018171474,0.3276333,0.00020238671],"about_ca_topic_score_codex":0.0000310552,"about_ca_topic_score_gemma":0.0000022809352,"teacher_disagreement_score":0.3264955,"about_ca_system_score_codex":0.00015132132,"about_ca_system_score_gemma":0.0009978858,"threshold_uncertainty_score":0.55113375},"labels":[],"label_agreement":null},{"id":"W2792603138","doi":"10.1097/coc.0000000000000429","title":"Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Chugai Pharmaceutical; National Institutes of Health; Astellas Pharma; University of Pennsylvania; Ariad Pharmaceuticals; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Pembrolizumab; Discontinuation; Internal medicine; Response Evaluation Criteria in Solid Tumors; Adverse effect; Gastroenterology; Carcinoma; Surgery; Oncology; Progressive disease; Cancer; Disease; Immunotherapy","score_opus":0.08574078329257076,"score_gpt":0.4604282430723585,"score_spread":0.3746874597797878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792603138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911855,0.0011030083,0.000115518866,0.0053938483,0.0008118607,0.00035119522,0.000011533535,0.00000484641,0.0010227166],"genre_scores_gemma":[0.9910496,0.0021897892,0.0039936914,0.0008952226,0.0017420908,0.000023339351,0.0000032025318,0.000015886002,0.000087219654],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998072,0.00017447314,0.0012166122,0.00015737208,0.00017415876,0.00020538084],"domain_scores_gemma":[0.9933497,0.0045114495,0.0012633419,0.00026055827,0.0003996335,0.00021534936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050493446,0.00013856926,0.0013291141,0.00006292645,0.000055271383,0.0000031364696,0.00012109994,0.00006195909,0.0000773736],"category_scores_gemma":[0.00036921306,0.000067546076,0.00061788346,0.00012422541,0.0008532041,0.00002897762,0.000012193542,0.00011745896,0.0000060671778],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013718674,0.0031422132,0.47656277,0.0000063484745,0.00073333096,0.00013693114,0.00025927267,0.000002467201,0.000012962688,0.00009795836,0.00089713803,0.50442994],"study_design_scores_gemma":[0.015274054,0.21028733,0.6792327,0.000031037365,0.00096154725,0.00046882,0.00034997758,0.000039010767,0.00035381547,0.00011121656,0.09282976,0.000060710157],"about_ca_topic_score_codex":0.00007564044,"about_ca_topic_score_gemma":0.000025661135,"teacher_disagreement_score":0.5043692,"about_ca_system_score_codex":0.00010322223,"about_ca_system_score_gemma":0.0005685371,"threshold_uncertainty_score":0.3143666},"labels":[],"label_agreement":null},{"id":"W2800002034","doi":"10.1097/coc.0000000000000448","title":"Mohs Micrographic Surgery Volume and Payment Patterns Among Dermatologists in the Medicare Population, 2013","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Medicine; Reimbursement; Medicare Part B; Decile; Payment; Population; Family medicine; Health care; Finance; Environmental health; Statistics","score_opus":0.05118055452259984,"score_gpt":0.41532199879458953,"score_spread":0.3641414442719897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800002034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96850246,0.00068381504,0.00005563114,0.029870933,0.00062385947,0.00013684572,0.000002344063,0.000005127631,0.00011897212],"genre_scores_gemma":[0.9915902,0.002575741,0.000560646,0.004405969,0.00083492533,0.000008108709,0.0000026510002,0.000011291102,0.000010439027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678886,0.000826042,0.0016121945,0.00019412933,0.00031184242,0.00026692366],"domain_scores_gemma":[0.99523634,0.002768045,0.0013639398,0.0002108032,0.00022839753,0.00019250158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026233376,0.00013377357,0.0012993086,0.0001777837,0.000057153215,0.000008730013,0.00016400505,0.00011028729,0.000055517874],"category_scores_gemma":[0.0011860104,0.00008044854,0.00023359923,0.0002769097,0.0020829032,0.00006187915,0.00006110002,0.0005862272,0.000004886119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025191673,0.00023390667,0.8679797,0.000010376147,0.00013730407,0.00039360402,0.00034905382,1.9055456e-7,5.795913e-7,0.0000030305823,0.0071797105,0.12346062],"study_design_scores_gemma":[0.00097344763,0.0035371159,0.976775,0.00011718601,0.00012566506,0.0009590877,0.0013408401,0.000012945685,0.0000016627838,0.000055007316,0.01602507,0.00007697075],"about_ca_topic_score_codex":0.00077509216,"about_ca_topic_score_gemma":0.0013639409,"teacher_disagreement_score":0.12338365,"about_ca_system_score_codex":0.00006176516,"about_ca_system_score_gemma":0.00022975518,"threshold_uncertainty_score":0.7674543},"labels":[],"label_agreement":null},{"id":"W2801876087","doi":"10.1097/coc.0000000000000451","title":"Nivolumab in the Treatment of Metastatic Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Nivolumab; Medicine; Renal cell carcinoma; Quality-adjusted life year; Willingness to pay; Cost effectiveness; Oncology; Cost–utility analysis; Everolimus; Cost–benefit analysis; Cohort; Quality of life (healthcare); Internal medicine; Cancer; Intensive care medicine; Immunotherapy; Risk analysis (engineering); Nursing","score_opus":0.10691684125219736,"score_gpt":0.4359489687321487,"score_spread":0.32903212747995136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801876087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905904,0.00051007693,0.000058139056,0.0024749949,0.00027133245,0.00025176076,0.0000025237364,0.0000025436966,0.005838212],"genre_scores_gemma":[0.9916708,0.00035115815,0.006380854,0.00076907506,0.0006605174,0.000006601187,0.0000016136012,0.000014554249,0.00014482884],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961616,0.0010735778,0.00192896,0.00019019457,0.0003815664,0.0002641343],"domain_scores_gemma":[0.9951417,0.002254905,0.0017112922,0.00035671672,0.0003148592,0.0002205338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014876972,0.0001689498,0.0016619866,0.00017550784,0.00002585831,0.0000039292445,0.00021509956,0.00006344122,0.00011389763],"category_scores_gemma":[0.0002761897,0.00008925025,0.0005802169,0.00034487294,0.0012492024,0.00003665087,0.000015656704,0.00031036517,0.000024536565],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010060944,0.012953616,0.33873,0.00002340957,0.0005155154,0.0043147695,0.0034803622,0.0000066833654,0.0010785953,0.000041493255,0.0014045096,0.6273901],"study_design_scores_gemma":[0.011866569,0.3240867,0.6243166,0.000035232646,0.0010643895,0.0014087866,0.0021389488,0.000033443794,0.003222087,0.00011396377,0.03161018,0.00010314415],"about_ca_topic_score_codex":0.00025390022,"about_ca_topic_score_gemma":0.00008536837,"teacher_disagreement_score":0.627287,"about_ca_system_score_codex":0.0002577649,"about_ca_system_score_gemma":0.0010078615,"threshold_uncertainty_score":0.46027383},"labels":[],"label_agreement":null},{"id":"W2811214182","doi":"10.1097/coc.0000000000000474","title":"Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bevacizumab; Irinotecan; Internal medicine; Capecitabine; Oncology; Colorectal cancer; Oxaliplatin; Chemotherapy; Progression-free survival; Vascular endothelial growth factor; Gastroenterology; Placental growth factor; Surgery; Cancer","score_opus":0.022705154419738784,"score_gpt":0.41521285634739813,"score_spread":0.3925077019276593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811214182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99530226,0.00015040895,0.000022893872,0.0035356511,0.00030997625,0.0004118953,0.000018656894,0.0000056938534,0.00024257998],"genre_scores_gemma":[0.995537,0.00015118926,0.0027834664,0.0013061238,0.00010862977,0.00002080981,0.0000012962973,0.000022503971,0.00006897323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974888,0.00037711466,0.0012544672,0.00022789455,0.00038226633,0.0002694811],"domain_scores_gemma":[0.9968214,0.000997256,0.0010797948,0.00014679918,0.0006785854,0.00027618642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091946113,0.00017145736,0.0016043735,0.00022632202,0.000028253362,0.000003035284,0.00013741956,0.000057034376,0.00018031358],"category_scores_gemma":[0.00087325927,0.000109330926,0.0002396286,0.0005447118,0.0007491571,0.000046215162,0.0000405004,0.00026603194,0.000007523199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21107915,0.001638347,0.603755,0.0000073945266,0.0011791047,0.00009203738,0.0010297023,0.0000045141055,0.00017492726,0.0000014083199,0.00016632976,0.18087208],"study_design_scores_gemma":[0.013419899,0.14655262,0.83660614,0.000107404616,0.000337773,0.00003709647,0.00037797517,0.000013360362,0.000093656694,0.000016508797,0.002350504,0.000087070286],"about_ca_topic_score_codex":0.00019457626,"about_ca_topic_score_gemma":0.0006337946,"teacher_disagreement_score":0.23285113,"about_ca_system_score_codex":0.0004452961,"about_ca_system_score_gemma":0.0015668012,"threshold_uncertainty_score":0.44583857},"labels":[],"label_agreement":null},{"id":"W2893411854","doi":"10.1097/coc.0000000000000483","title":"Comparison of Clinical Characteristics and Outcomes in Relapsed Versus De Novo Metastatic Non–Small Cell Lung Cancer","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Cohort; Oncology; Hazard ratio; Cancer; Lung cancer; Metastasis; Multivariate analysis; Proportional hazards model; Confidence interval","score_opus":0.12714203529253765,"score_gpt":0.5401090070464296,"score_spread":0.41296697175389196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893411854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940254,0.00030334256,0.00008959906,0.0034158432,0.0014658945,0.00020516556,0.000010046813,0.0000037348789,0.0004809681],"genre_scores_gemma":[0.9868904,0.0016360258,0.009578669,0.00124726,0.00057825114,0.000009326709,0.0000014641682,0.000017995484,0.00004060746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956661,0.0005259282,0.0030908615,0.00023069931,0.00021370949,0.00027268945],"domain_scores_gemma":[0.9907764,0.0055070906,0.0027919153,0.00020146633,0.00032290746,0.00040017976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021550527,0.00016262374,0.0030659323,0.00011187799,0.000022601474,0.0000050546946,0.00013485638,0.00012743178,0.000077983736],"category_scores_gemma":[0.0017239726,0.0001148672,0.00035320758,0.00016270207,0.0009343534,0.000028433438,0.000051371437,0.0007031657,0.000003592122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005610605,0.0028732778,0.8668173,0.000043970926,0.0006560104,0.00020103277,0.00035075247,0.0000024612805,0.0000135370365,0.000007661811,0.00037446775,0.1230489],"study_design_scores_gemma":[0.017402217,0.03144686,0.94583154,0.00018707624,0.0015289992,0.00003049142,0.00041217194,0.00039980045,0.00007594952,0.000008379163,0.0025809011,0.000095617674],"about_ca_topic_score_codex":0.0002256255,"about_ca_topic_score_gemma":0.00038800846,"teacher_disagreement_score":0.12295328,"about_ca_system_score_codex":0.00023629963,"about_ca_system_score_gemma":0.0016272378,"threshold_uncertainty_score":0.46841484},"labels":[],"label_agreement":null},{"id":"W2900369182","doi":"10.1097/coc.0000000000000489","title":"Role of Stereotactic Body Radiation Therapy in Early Stage Small Cell Lung Cancer in the Era of Lung Cancer Screening","year":2018,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Lung cancer; Stage (stratigraphy); Radiation therapy; Cancer; Lung cancer screening; Oncology; Chemotherapy; Radiology; Metastasis; Internal medicine","score_opus":0.10745501994803246,"score_gpt":0.5305652655606843,"score_spread":0.4231102456126518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900369182","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13198417,0.86551017,0.000008845194,0.0007550994,0.0003124678,0.0010813011,0.00003697092,0.0000028180339,0.00030814484],"genre_scores_gemma":[0.053550765,0.9447125,0.00023526602,0.0003217123,0.0009794876,0.00010010775,0.0000026607013,0.000044634933,0.000052847055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918645,0.0029082706,0.0037376727,0.00034057756,0.0006819451,0.00046701264],"domain_scores_gemma":[0.98702353,0.0054513495,0.0064132824,0.00039326044,0.0005382434,0.00018035035],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005212133,0.00033139583,0.0052818554,0.00043172584,0.000029624614,0.000009574352,0.00063917553,0.00027099432,0.000115143834],"category_scores_gemma":[0.0010946399,0.00019833111,0.00083988777,0.00090863067,0.000903732,0.00009513643,0.00010080214,0.0029068412,7.431593e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012884225,0.0004618837,0.18344975,0.0017681775,0.0011055423,0.0000822809,0.0011606291,0.000005837839,0.0000033262515,0.0000022865563,0.00020234828,0.8104695],"study_design_scores_gemma":[0.0097979205,0.024248125,0.34658945,0.026253179,0.003006727,0.000060565064,0.0009756565,0.00017324316,0.000009980302,0.000008911241,0.5884339,0.00044235121],"about_ca_topic_score_codex":0.0052071707,"about_ca_topic_score_gemma":0.0009929748,"teacher_disagreement_score":0.8100272,"about_ca_system_score_codex":0.00070030324,"about_ca_system_score_gemma":0.0057129385,"threshold_uncertainty_score":0.99992377},"labels":[],"label_agreement":null},{"id":"W2902720924","doi":"10.1097/coc.0000000000000500","title":"Outcomes and Characteristics of Patients Receiving Second-line Therapy for Advanced Pancreatic Cancer","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Gemcitabine; Medicine; FOLFIRINOX; Chemotherapy; Internal medicine; Oncology; Pancreatic cancer; Cancer; Irinotecan","score_opus":0.09085758571509699,"score_gpt":0.5029794401867757,"score_spread":0.41212185447167865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902720924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594414,0.00017238592,0.0003237593,0.0022206174,0.00046912683,0.00035870707,0.000023656576,0.0000043886685,0.0004832118],"genre_scores_gemma":[0.98176277,0.0030215108,0.012274925,0.002023017,0.00058702606,0.000016594817,0.0000038202297,0.000018111548,0.0002922123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997345,0.00029305601,0.0017160323,0.00017232577,0.00021625747,0.0002573603],"domain_scores_gemma":[0.9919414,0.0044603166,0.0019698949,0.00016402194,0.0011807202,0.000283661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016710013,0.00013069573,0.0023607626,0.00010866735,0.00004573673,0.0000031561876,0.00012568176,0.00012435915,0.0002334565],"category_scores_gemma":[0.00409733,0.00008655861,0.00022194072,0.00012425114,0.0013925892,0.000055157547,0.000034309047,0.0003544958,0.000001953777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005795255,0.00044422946,0.5852822,0.000020364823,0.00034871692,0.000005145464,0.00011884272,2.6507863e-8,0.00010026877,0.0000084220965,0.00015858447,0.40771794],"study_design_scores_gemma":[0.009141222,0.046915352,0.9320327,0.00009071124,0.0002833327,0.000017330867,0.00014098776,0.00004837892,0.00006972593,0.000098076096,0.011090145,0.00007204135],"about_ca_topic_score_codex":0.000016279251,"about_ca_topic_score_gemma":0.000021257802,"teacher_disagreement_score":0.4076459,"about_ca_system_score_codex":0.000064601205,"about_ca_system_score_gemma":0.00093448727,"threshold_uncertainty_score":0.51310533},"labels":[],"label_agreement":null},{"id":"W2907792399","doi":"10.1097/coc.0000000000000510","title":"Factors Influencing Clinical and Setting Pathways After Discharge From an Acute Palliative/Supportive Care Unit","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Palliative care; Referral; Delirium; Hospital admission; Emergency medicine; Acute care; Intensive care medicine; Acute hospital; Health care; Internal medicine; Nursing","score_opus":0.2317270329303146,"score_gpt":0.538092441989873,"score_spread":0.30636540905955845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907792399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725425,0.00061055354,0.000093570394,0.00067419535,0.0006526045,0.00017897256,0.00008649908,0.000012859976,0.0004364647],"genre_scores_gemma":[0.9898266,0.0012705633,0.005886585,0.0022357097,0.0007024558,0.0000023254056,0.000025972939,0.000028759221,0.000020996764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99534065,0.0009859889,0.0026123736,0.00037958223,0.0003605417,0.00032087858],"domain_scores_gemma":[0.99095887,0.004718695,0.0026966652,0.00028400877,0.00068294455,0.0006588071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012840021,0.00025449265,0.0024830915,0.000120486446,0.00003197133,0.000010159625,0.00020121265,0.0002596133,0.0001491812],"category_scores_gemma":[0.002011471,0.00017387902,0.0005266404,0.00017538918,0.0009586901,0.00022911538,0.000108828775,0.0012326974,0.000014063039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019621637,0.00024295005,0.91490567,0.000021116934,0.00073719386,0.00019813812,0.007870554,0.0000010654883,0.00015317988,0.000013449784,0.000029902585,0.0738646],"study_design_scores_gemma":[0.003350383,0.018782012,0.9356241,0.0005099004,0.00062732864,0.000010888604,0.034127016,0.000021572418,0.00019758038,0.000085112544,0.006487521,0.00017657045],"about_ca_topic_score_codex":0.00010719829,"about_ca_topic_score_gemma":0.00003654129,"teacher_disagreement_score":0.07368803,"about_ca_system_score_codex":0.00006328697,"about_ca_system_score_gemma":0.0008927348,"threshold_uncertainty_score":0.70905805},"labels":[],"label_agreement":null},{"id":"W2908711030","doi":"10.1097/coc.0000000000000490","title":"MGMT Testing in Glioblastomas","year":2018,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Epigenetics; DNA methylation; Oncology; Methylation; EPIC; Bioinformatics; Gene; Genetics; Biology","score_opus":0.2533946580244729,"score_gpt":0.5438179933644874,"score_spread":0.2904233353400145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908711030","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005598934,0.9899719,0.0000039148363,0.0005740671,0.000988278,0.00034639842,0.000004196242,0.000010385576,0.0025019357],"genre_scores_gemma":[0.0012912363,0.99018246,0.005700693,0.0005303053,0.0022048438,0.00001645329,0.0000032126975,0.000048639347,0.0000221652],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936184,0.0010198591,0.004346213,0.00033973786,0.000310261,0.00036551972],"domain_scores_gemma":[0.9845473,0.008633039,0.005592252,0.00032614224,0.00039498007,0.000506294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026409207,0.0003393442,0.007849649,0.0005132014,0.00002297349,0.000008978921,0.00027061164,0.00037823565,0.00006697094],"category_scores_gemma":[0.0068567307,0.00021365752,0.0014925054,0.0008983126,0.0007728323,0.000038792296,0.00008456627,0.0014595456,0.0001200343],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014807878,0.0015805791,0.0070849555,0.00041322736,0.0005748241,0.0035077336,0.0000114143195,1.6337071e-7,6.879403e-8,0.0000071459563,0.0015151947,0.9851566],"study_design_scores_gemma":[0.0021227149,0.027358754,0.0029281366,0.0115419915,0.0023665824,0.002989285,0.000026925896,0.0000020201373,2.0555676e-7,0.00002244182,0.95048916,0.00015175487],"about_ca_topic_score_codex":0.000033892105,"about_ca_topic_score_gemma":0.00003853346,"teacher_disagreement_score":0.98500484,"about_ca_system_score_codex":0.0003677967,"about_ca_system_score_gemma":0.0032462492,"threshold_uncertainty_score":0.87127006},"labels":[],"label_agreement":null},{"id":"W2910133491","doi":"10.1097/coc.0000000000000513","title":"Survival Implications of De Novo Versus Recurrent Metastatic Non–Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cohort; Internal medicine; Oncology; Retrospective cohort study; Lung cancer; Cancer; Performance status; Multivariate analysis; Stage (stratigraphy); Radiation therapy; Disease","score_opus":0.08079565904110957,"score_gpt":0.517913950960586,"score_spread":0.43711829191947643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910133491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984638,0.0005032209,0.00082577043,0.004754134,0.0014805791,0.00027924465,0.000023723349,0.0000047639983,0.0074906023],"genre_scores_gemma":[0.98752004,0.001064333,0.010267649,0.0005922586,0.00027561703,0.000014907041,0.0000043361115,0.00001613257,0.000244723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981089,0.00021060594,0.0011526257,0.00015359865,0.00016255348,0.00021171653],"domain_scores_gemma":[0.9959775,0.0016142494,0.0014853579,0.00020943533,0.0004256283,0.0002878099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068789814,0.000108064654,0.0010561671,0.000092655064,0.000021902677,0.0000033609203,0.00014049803,0.00005184116,0.00023669578],"category_scores_gemma":[0.00026925767,0.00007991533,0.0003426112,0.00022586464,0.00021359799,0.000039673738,0.0000257059,0.0003702421,0.000011040091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042028893,0.0023904082,0.6326207,0.00008893335,0.0020053969,0.00006515775,0.0006490397,0.00019165622,0.0006824925,0.00019217053,0.0011517215,0.35575947],"study_design_scores_gemma":[0.02748046,0.03743086,0.88213503,0.00022973176,0.0067358543,0.00016905779,0.00214504,0.00025534647,0.0002195136,0.00011224756,0.042854622,0.00023225452],"about_ca_topic_score_codex":0.0001716358,"about_ca_topic_score_gemma":0.00008284945,"teacher_disagreement_score":0.3555272,"about_ca_system_score_codex":0.00029487343,"about_ca_system_score_gemma":0.0033256735,"threshold_uncertainty_score":0.5899602},"labels":[],"label_agreement":null},{"id":"W2911948934","doi":"10.1097/coc.0000000000000523","title":"Dual Modality Radiation With External Beam Radiation Therapy and Transarterial Radioembolization for Hepatocellular Carcinoma With Gross Vascular Invasion","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"National Cancer Institute","keywords":"Medicine; Hepatocellular carcinoma; Proportional hazards model; Radiation therapy; External beam radiation; Hazard ratio; External beam radiotherapy; Nuclear medicine; Internal medicine; Surgery; Confidence interval; Radiology; Brachytherapy","score_opus":0.07422255893670243,"score_gpt":0.33393653532564405,"score_spread":0.2597139763889416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911948934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885656,0.0006725059,0.008432286,0.00091857463,0.00027172512,0.001090047,0.00000718807,0.000012679674,0.000029392368],"genre_scores_gemma":[0.9924858,0.0011201536,0.005020151,0.00046413927,0.00079176365,0.000026526313,0.00004209351,0.00003567393,0.000013705235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976129,0.00042409587,0.0010126897,0.00032235228,0.00037707694,0.0002508897],"domain_scores_gemma":[0.99749494,0.00056643365,0.0011046152,0.00020065252,0.0003207667,0.00031259432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014234359,0.00021954991,0.0012688772,0.00013294259,0.000064684726,0.00002486377,0.00007545016,0.00016654203,0.000035565095],"category_scores_gemma":[0.00006610041,0.0001445418,0.00028355196,0.00019157086,0.00029884191,0.00021410415,0.0000073943006,0.0002892731,0.000002287958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011723634,0.00044581672,0.78910047,0.000025231642,0.0003900826,0.00009300381,0.0003429071,0.000012409006,0.0013006385,0.00002776947,0.00000957763,0.19652846],"study_design_scores_gemma":[0.033897694,0.07952341,0.87165546,0.00008630045,0.00095221226,0.00063926907,0.00021618149,0.005468775,0.0033966831,0.000066602595,0.003839036,0.00025836876],"about_ca_topic_score_codex":0.00006087124,"about_ca_topic_score_gemma":0.000004101382,"teacher_disagreement_score":0.1962701,"about_ca_system_score_codex":0.00010394115,"about_ca_system_score_gemma":0.00067631877,"threshold_uncertainty_score":0.5894244},"labels":[],"label_agreement":null},{"id":"W2912542243","doi":"10.1097/coc.0000000000000512","title":"Metformin Use and Kidney Cancer Survival Outcomes","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Health Sciences Centre; London Health Sciences Centre; Sunnybrook Health Science Centre; Western University; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hazard ratio; Meta-analysis; Metformin; Confidence interval; Publication bias; Internal medicine; Cancer; Oncology; Kidney cancer; Proportional hazards model; Relative risk","score_opus":0.2496114612423718,"score_gpt":0.5258678647893239,"score_spread":0.27625640354695213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912542243","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027031593,0.9930343,0.00003834091,0.00008295611,0.0036717355,0.00020634211,0.00010239232,0.0000030354456,0.00015775672],"genre_scores_gemma":[0.00002896312,0.9939808,0.001036181,0.002400062,0.0019964124,0.000016511647,0.000028950228,0.000059331003,0.00045276852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952652,0.0012618784,0.0023820854,0.00045493542,0.0002552034,0.00038070013],"domain_scores_gemma":[0.9937582,0.0010933655,0.003830388,0.00042845745,0.0003040216,0.0005855731],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002071297,0.00041442586,0.005718006,0.00011569732,0.00003137102,0.00002919635,0.00049617596,0.00056930305,0.00008829703],"category_scores_gemma":[0.0029320647,0.00027697114,0.0014106389,0.00014709482,0.00065083156,0.000012703912,0.00019413762,0.000860583,0.000011055338],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009997318,0.00010636247,0.0025261566,0.00038197797,0.00133462,0.000016711128,0.0000060721404,3.809192e-7,0.0000010537195,0.000015112914,0.004769459,0.99074215],"study_design_scores_gemma":[0.0009360882,0.0022536826,0.00033185066,0.0005373803,0.0019354863,0.00006699705,0.0000201886,3.5552276e-7,0.0000020633493,0.0000067353694,0.99360216,0.0003070038],"about_ca_topic_score_codex":0.000062156396,"about_ca_topic_score_gemma":0.000031398467,"teacher_disagreement_score":0.9904351,"about_ca_system_score_codex":0.00004870286,"about_ca_system_score_gemma":0.0037213604,"threshold_uncertainty_score":0.99996823},"labels":[],"label_agreement":null},{"id":"W2917225635","doi":"10.1097/coc.0000000000000530","title":"Effects of Social and Contextual Factors Including Marital Status and Children on the Use of Palliative Chemotherapy in Metastatic Colorectal Cancer","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Odds ratio; Colorectal cancer; Chemotherapy; Marital status; Performance status; Confidence interval; Oncology; Cancer; Cohort; Population","score_opus":0.11866741414800781,"score_gpt":0.45659374509340894,"score_spread":0.33792633094540114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917225635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956876,0.0002009791,0.000007038629,0.0034590324,0.00017065296,0.00042547937,0.00001998591,0.0000023890962,0.000026858293],"genre_scores_gemma":[0.996806,0.0007978492,0.00036426997,0.0018917526,0.00011460999,0.000002951646,0.0000012751804,0.000015318408,0.0000059195945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703664,0.0009838545,0.0012827665,0.00017411461,0.00031980878,0.00020279404],"domain_scores_gemma":[0.98458505,0.013094361,0.0019577427,0.000072517425,0.00014333663,0.00014698139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011749914,0.00014964903,0.001799065,0.0001095085,0.000023560859,0.0000052300074,0.00008724057,0.00008026655,0.00003932212],"category_scores_gemma":[0.002195069,0.00009586323,0.00018741486,0.00017665018,0.0011117702,0.00006961441,0.000053124444,0.0006413495,2.926602e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054229116,0.00056659663,0.95166063,0.000047244084,0.00079217984,0.0000090895355,0.006388431,0.000002570988,0.00035376658,0.000103388695,0.00008162215,0.03457159],"study_design_scores_gemma":[0.0067215012,0.013568878,0.9764916,0.00019000146,0.00017152818,0.000007976161,0.0020388586,0.000018346964,0.0004461444,0.000044714263,0.00021902686,0.000081460385],"about_ca_topic_score_codex":0.001305911,"about_ca_topic_score_gemma":0.0002981601,"teacher_disagreement_score":0.03449013,"about_ca_system_score_codex":0.00009347576,"about_ca_system_score_gemma":0.00055430114,"threshold_uncertainty_score":0.40963632},"labels":[],"label_agreement":null},{"id":"W2929106448","doi":"10.1097/coc.0000000000000533","title":"Adjuvant Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (TKIs) in Resected Non–Small Cell Lung Cancer (NSCLC)","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Oncology; Odds ratio; Lung cancer; Epidermal growth factor receptor; Adjuvant; Randomized controlled trial; Subgroup analysis; Confidence interval; Cancer","score_opus":0.08513669810114843,"score_gpt":0.49292264131819974,"score_spread":0.4077859432170513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2929106448","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013935727,0.97724766,0.000038379738,0.0016870354,0.0038929381,0.0016094263,0.00016456268,0.000018635623,0.0014056473],"genre_scores_gemma":[0.004490713,0.9890706,0.0018678334,0.0009698196,0.0025052354,0.00008839885,0.00007549229,0.00011984809,0.0008120686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922821,0.0012606294,0.0047348235,0.00062756956,0.0004510918,0.00064377947],"domain_scores_gemma":[0.9892835,0.0031075,0.0057546534,0.00043122954,0.0006655296,0.000757559],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011298127,0.0006124049,0.008080258,0.0006351655,0.00004791856,0.000018105684,0.00039277584,0.0006301291,0.00042007744],"category_scores_gemma":[0.0011116958,0.00041186475,0.0017501025,0.00089923956,0.00046667384,0.00011713027,0.00011161684,0.0026760974,0.000068179936],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006912355,0.0014188554,0.010245682,0.0027202163,0.0011324885,0.00077099353,0.00017487777,0.0000020978596,0.0000058719584,0.0000029637417,0.0053739324,0.9774608],"study_design_scores_gemma":[0.007519595,0.011016592,0.004416091,0.015645547,0.0070661246,0.00021883754,0.0001417538,0.000010961862,0.000008512161,0.000002598302,0.9534971,0.00045625825],"about_ca_topic_score_codex":0.0006262595,"about_ca_topic_score_gemma":0.00010280683,"teacher_disagreement_score":0.9770045,"about_ca_system_score_codex":0.001569636,"about_ca_system_score_gemma":0.012536577,"threshold_uncertainty_score":0.99983335},"labels":[],"label_agreement":null},{"id":"W2953134807","doi":"10.1097/coc.0000000000000562","title":"Can Statins be Protagonists in Our Approach to Cancer Treatment?","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Foothills Medical Centre","funders":"","keywords":"Foothills; Medicine; Family medicine; Cartography","score_opus":0.048891188786232366,"score_gpt":0.4296239645610091,"score_spread":0.3807327757747767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953134807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98464376,0.00029335014,0.000099409925,0.0069475444,0.0051038465,0.0003797696,0.000032974924,0.00000304256,0.0024963296],"genre_scores_gemma":[0.9785193,0.0017579801,0.004484502,0.0041845175,0.00976166,0.000052109874,0.000011163754,0.000027386963,0.0012013336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978352,0.00038130532,0.00098659,0.0003187573,0.00015451753,0.000323615],"domain_scores_gemma":[0.9984592,0.00006446164,0.0007475297,0.0002504961,0.00015549222,0.00032279338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007251933,0.00016639123,0.00097194064,0.00008712686,0.000019109122,0.000009297196,0.0002553413,0.00013658516,0.000015227494],"category_scores_gemma":[0.00024677455,0.00012947769,0.00026587688,0.0001734809,0.00012089076,0.000004560243,0.000054344084,0.00026872245,0.00000590173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042198724,0.002229874,0.15876424,0.000017157587,0.00048847694,0.000004438186,0.0008886589,0.0008801082,0.016902184,0.0001060331,0.025578951,0.78992003],"study_design_scores_gemma":[0.0034152009,0.01147038,0.038724855,0.000013519311,0.000053693293,0.00004466277,0.0013607695,0.000013053811,0.00041546472,0.000018093431,0.9442862,0.00018405843],"about_ca_topic_score_codex":0.0007123513,"about_ca_topic_score_gemma":0.0011108655,"teacher_disagreement_score":0.9187073,"about_ca_system_score_codex":0.000114048016,"about_ca_system_score_gemma":0.0017222555,"threshold_uncertainty_score":0.5279947},"labels":[],"label_agreement":null},{"id":"W2961148344","doi":"10.1097/coc.0000000000000571","title":"Long-Term Vitamin K Antagonists and Cancer Risk","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; NOSM University; Laurentian University; Institute of Health Services and Policy Research; Health Sciences North","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Incidence (geometry); Hazard ratio; Confidence interval; Cancer; Internal medicine; Meta-analysis; Vitamin k; Observational study; Randomized controlled trial; Oncology","score_opus":0.12233796374679566,"score_gpt":0.5178873721666691,"score_spread":0.39554940841987346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961148344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005034045,0.9903361,0.000028001044,0.0009811888,0.0021353264,0.0006218355,0.000023217732,0.000009403581,0.00083087536],"genre_scores_gemma":[0.0006739478,0.99487174,0.0008291392,0.0013235896,0.0019317912,0.000020073096,0.000008355411,0.000060266244,0.00028113133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948848,0.0009689943,0.0030335668,0.00041526006,0.00033378403,0.000363625],"domain_scores_gemma":[0.98997366,0.002414625,0.006500804,0.00038449097,0.00020766648,0.00051877747],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022010184,0.00037722164,0.0100332955,0.0002495226,0.000043820848,0.000019201021,0.00029319967,0.00035945475,0.00019626474],"category_scores_gemma":[0.0007079086,0.00024804572,0.0013791047,0.00023006974,0.0007667436,0.00005336001,0.00016931834,0.001758579,0.00006362177],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013125049,0.00087578176,0.012590231,0.0027904315,0.0023557143,0.0005983408,0.000027264909,2.0981722e-7,3.5554116e-8,0.000019170164,0.004492828,0.97611874],"study_design_scores_gemma":[0.0014778844,0.010816624,0.04163748,0.00692321,0.013427865,0.0006227263,0.000026969557,6.271761e-7,4.8007397e-8,0.00000505264,0.9248485,0.00021301408],"about_ca_topic_score_codex":0.0000947863,"about_ca_topic_score_gemma":0.000027958073,"teacher_disagreement_score":0.9759057,"about_ca_system_score_codex":0.00023113143,"about_ca_system_score_gemma":0.0021745788,"threshold_uncertainty_score":0.9999972},"labels":[],"label_agreement":null},{"id":"W2963197408","doi":"10.1097/coc.0000000000000579","title":"Statins as Potential Therapeutics for Lung Cancer","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Lung cancer; Statin; Malignancy; Cancer; Downregulation and upregulation; Oncology; Adjuvant; Chemotherapy; Bioinformatics; Internal medicine; Pharmacology","score_opus":0.10720463013442146,"score_gpt":0.5318358649780958,"score_spread":0.4246312348436743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963197408","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002028457,0.96692014,0.0018738612,0.00030051236,0.029752266,0.0005263378,0.00014276624,0.000003465077,0.00027783622],"genre_scores_gemma":[0.000027873462,0.9461284,0.002139178,0.0019033488,0.048642863,0.000043859065,0.00005176253,0.00007623808,0.0009864611],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99589187,0.0007209354,0.0023472153,0.000421042,0.00021947915,0.00039945563],"domain_scores_gemma":[0.9939163,0.0005990353,0.004391688,0.00037133708,0.00046187206,0.00025976822],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013593776,0.00036070924,0.0038532922,0.00009850573,0.00004400148,0.00001735745,0.0005964818,0.0005826536,0.0000521114],"category_scores_gemma":[0.0004389253,0.000268277,0.0022245029,0.00012302624,0.00046210308,0.000004760518,0.000102299055,0.0007548489,0.0000067939836],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005162755,0.00016839725,0.000028265838,0.00054081285,0.0016709523,0.0000011326038,0.000014357579,0.000011401301,0.000020103771,0.000021444708,0.024870614,0.97213626],"study_design_scores_gemma":[0.0013924101,0.005848075,0.000016353359,0.00046881125,0.0037936664,0.00015011583,0.000048032936,0.00000797555,0.0000020763969,0.000013595445,0.9879662,0.00029269524],"about_ca_topic_score_codex":0.000036255005,"about_ca_topic_score_gemma":0.000026481699,"teacher_disagreement_score":0.97184354,"about_ca_system_score_codex":0.00007702057,"about_ca_system_score_gemma":0.006753284,"threshold_uncertainty_score":0.99997693},"labels":[],"label_agreement":null},{"id":"W2963703029","doi":"10.1097/coc.0000000000000577","title":"Association Between Smoking and Survival Benefit of Immunotherapy in Advanced Malignancies","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Hazard ratio; Confidence interval; Internal medicine; Immunotherapy; Meta-analysis; Randomized controlled trial; Oncology; Clinical trial; Cancer","score_opus":0.11228883707839485,"score_gpt":0.4767912794818843,"score_spread":0.3645024424034895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963703029","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051608704,0.9463054,0.000010309674,0.00043938198,0.00092525786,0.00032637097,0.000019003597,0.000003925474,0.00036166605],"genre_scores_gemma":[0.0031361547,0.99534655,0.0006106927,0.00022090651,0.00044318705,0.0000041342782,0.000007888916,0.000034763743,0.00019573337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99452215,0.00073407125,0.0038774887,0.00023035394,0.00037968342,0.00025626677],"domain_scores_gemma":[0.9854838,0.0056151072,0.008334559,0.00021305597,0.00024971506,0.00010376651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004832202,0.00025038002,0.006978116,0.00030442135,0.000014940138,0.000006081249,0.00020628372,0.00046944353,0.00004188263],"category_scores_gemma":[0.00078068214,0.00018300212,0.0011139738,0.00041364686,0.00032240053,0.000063983665,0.00003707999,0.0011232517,0.0000015440544],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013721822,0.0001378654,0.073116854,0.0007007513,0.0021458692,0.000020967362,0.000047664587,2.5385722e-7,0.000004135236,0.000004753269,0.000036076217,0.92241263],"study_design_scores_gemma":[0.0047382764,0.009511859,0.0833287,0.008877326,0.0016621237,0.00007058358,0.00011712685,2.2863625e-7,0.000001146423,0.00002110591,0.8915043,0.00016724637],"about_ca_topic_score_codex":0.00007509553,"about_ca_topic_score_gemma":0.000020368809,"teacher_disagreement_score":0.9222454,"about_ca_system_score_codex":0.0005002956,"about_ca_system_score_gemma":0.0014575953,"threshold_uncertainty_score":0.746261},"labels":[],"label_agreement":null},{"id":"W2969467201","doi":"10.1097/coc.0000000000000584","title":"The Role of Partial Breast Radiation in the Previously Radiated Breast","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lumpectomy; Breast cancer; Radiation therapy; Mastectomy; Radiology; Cancer; Nuclear medicine; Internal medicine","score_opus":0.01145468675319999,"score_gpt":0.35199994752706704,"score_spread":0.34054526077386704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969467201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932394,0.0012719239,0.000012390663,0.0043445905,0.0003164066,0.00014603914,0.000011503649,0.0000014118767,0.0006563231],"genre_scores_gemma":[0.9974395,0.0014337245,0.00008111425,0.00048285106,0.0005295866,0.000006838312,0.000005104402,0.000009014965,0.000012243784],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976646,0.00085501873,0.00094796513,0.0001498132,0.00017082572,0.00021179237],"domain_scores_gemma":[0.99754024,0.0007472678,0.0012476908,0.00024871918,0.00015152688,0.00006457555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016458827,0.00010751637,0.00051656616,0.000028212466,0.000039634582,0.000007238539,0.000359057,0.000085412954,0.000011045455],"category_scores_gemma":[0.0002569695,0.00005801595,0.00023768265,0.00014809948,0.0005434239,0.0000057653906,0.00005190263,0.00024878935,0.0000067048636],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020014357,0.00033283627,0.39744467,0.0000016047687,0.00024381184,0.0000051671814,0.00017985461,0.000049692717,0.0004914552,0.000076820106,0.0002884667,0.59888417],"study_design_scores_gemma":[0.0027275456,0.0044374233,0.92200816,0.00001739391,0.00010375603,0.000641778,0.001580313,0.00003074788,0.00026008888,0.000120896875,0.06797575,0.00009613412],"about_ca_topic_score_codex":0.000102313395,"about_ca_topic_score_gemma":0.0000668425,"teacher_disagreement_score":0.598788,"about_ca_system_score_codex":0.00003336512,"about_ca_system_score_gemma":0.00040800343,"threshold_uncertainty_score":0.23658219},"labels":[],"label_agreement":null},{"id":"W2972579615","doi":"10.1097/coc.0000000000000600","title":"Clinical Outcomes of Surgically Unresectable Endometrial Cancers","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Radiation therapy; Chemotherapy; Histology; Stage (stratigraphy); Multivariate analysis; Endometrial cancer; Internal medicine; Proportional hazards model; Surgery; Odds ratio; Cancer; Oncology","score_opus":0.0918264800486993,"score_gpt":0.48334566626677505,"score_spread":0.39151918621807574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972579615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97945607,0.00033098512,0.00005584577,0.002125767,0.0040464457,0.00032665144,0.000011783078,0.00001161989,0.013634836],"genre_scores_gemma":[0.9897051,0.0018191751,0.0041702893,0.002196017,0.0013610689,0.000003638132,0.0000031164843,0.000025262945,0.0007163571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929126,0.0010627261,0.004491522,0.00033964566,0.0007846293,0.00040888746],"domain_scores_gemma":[0.978444,0.01600878,0.0036882567,0.0003893375,0.0007067773,0.0007628975],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005061324,0.00022319231,0.00478343,0.00034892402,0.000021730371,0.000006247542,0.00035712408,0.00026467902,0.0015872902],"category_scores_gemma":[0.009203973,0.00014166617,0.0019338474,0.0010181855,0.00087737676,0.00009515741,0.00009438958,0.0011102044,0.00008006154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015914634,0.0012117237,0.69053,0.000013426595,0.0014148509,0.00016250898,0.000014917191,0.000009250959,0.00002717434,0.00007051014,0.00037632792,0.29025468],"study_design_scores_gemma":[0.039751824,0.071284264,0.8103576,0.00007697317,0.00078259065,0.00013874097,0.00018937979,0.000009270785,0.000050753377,0.0001452998,0.077057526,0.0001558022],"about_ca_topic_score_codex":0.000421834,"about_ca_topic_score_gemma":0.000031687538,"teacher_disagreement_score":0.29009888,"about_ca_system_score_codex":0.00026537644,"about_ca_system_score_gemma":0.0028080903,"threshold_uncertainty_score":0.9993254},"labels":[],"label_agreement":null},{"id":"W2973123957","doi":"10.1097/coc.0000000000000599","title":"Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada","funders":"National Cancer Institute","keywords":"Medicine; Nelfinavir; Gemcitabine; Chemoimmunotherapy; Pancreatic cancer; Internal medicine; FOLFIRINOX; Adenocarcinoma; Oncology; Surgery; Gastroenterology; Cancer; Irinotecan; Immunotherapy; Immunology","score_opus":0.04319597588248913,"score_gpt":0.45250995121326015,"score_spread":0.409313975330771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973123957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98797876,0.0018898094,0.0022731428,0.005345543,0.00047365273,0.0017550398,0.000015717305,0.00001148818,0.0002568324],"genre_scores_gemma":[0.97899556,0.0018234812,0.015496521,0.0027470896,0.00034054418,0.00004792072,0.000010670422,0.000051414365,0.00048680473],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9953345,0.0007124862,0.002592362,0.00037374467,0.00047085516,0.0005160289],"domain_scores_gemma":[0.98949105,0.006297188,0.0026683162,0.00044282296,0.0005136894,0.00058692653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032431674,0.00028065522,0.0040532667,0.00019586993,0.000068276015,0.00000870906,0.00029005422,0.00027527794,0.00017338344],"category_scores_gemma":[0.0021886835,0.00020643721,0.00063932565,0.0002548369,0.0011726294,0.000101277394,0.0000321738,0.0007222294,0.0000030920537],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5658086,0.009885711,0.08741748,0.0000897145,0.0015781773,0.000110420435,0.00021113294,0.0000019690804,0.015482096,0.000030546238,0.0013416094,0.31804252],"study_design_scores_gemma":[0.46609396,0.49410126,0.014785804,0.00021280632,0.0008694931,0.00022708981,0.00026067678,0.0015017455,0.0003617761,0.000058931484,0.021318434,0.00020803108],"about_ca_topic_score_codex":0.00003714415,"about_ca_topic_score_gemma":0.0000022362274,"teacher_disagreement_score":0.48421553,"about_ca_system_score_codex":0.00021386222,"about_ca_system_score_gemma":0.0036230339,"threshold_uncertainty_score":0.8418265},"labels":[],"label_agreement":null},{"id":"W2984732432","doi":"10.1097/coc.0000000000000625","title":"Real-world Outcomes Among Patients Treated With Gemcitabine-based Therapy Post-FOLFIRINOX Failure in Advanced Pancreatic Cancer","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; CancerCare Manitoba","funders":"","keywords":"Medicine; Gemcitabine; FOLFIRINOX; Internal medicine; Interquartile range; Regimen; Proportional hazards model; Pancreatic cancer; Population; Survival analysis; Oncology; Gastroenterology; Surgery; Chemotherapy; Cancer; Irinotecan","score_opus":0.03950336415771432,"score_gpt":0.4347694346585533,"score_spread":0.39526607050083895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984732432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99177104,0.00005243057,0.000009274809,0.0043571214,0.00018015105,0.0008480878,0.000008025793,0.000018314582,0.002755531],"genre_scores_gemma":[0.99206436,0.00073778967,0.003537839,0.0025204308,0.00013053304,0.000047594913,0.000012059316,0.000044103428,0.00090530596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955969,0.0008921912,0.0019712423,0.00037609183,0.0005970198,0.0005665615],"domain_scores_gemma":[0.99257064,0.0038210573,0.0017814008,0.00040026777,0.00091560243,0.00051103893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013559177,0.00029771973,0.00343845,0.0004772584,0.000036039848,0.000008811647,0.00028257412,0.00019120234,0.00061131694],"category_scores_gemma":[0.00083042914,0.00017886849,0.00035933472,0.000724556,0.0009180276,0.00013907955,0.000032968634,0.0011757867,0.000029982955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015036859,0.001691619,0.900073,0.000019551991,0.00058395835,0.00028059958,0.0000840195,0.0000383454,0.0000569338,0.000008009691,0.00012286156,0.082004234],"study_design_scores_gemma":[0.027382154,0.03745468,0.9320895,0.00025442196,0.00024388012,0.000015393884,0.00025753866,0.000113936556,0.00002312212,0.000008854426,0.0019797883,0.0001766984],"about_ca_topic_score_codex":0.0022159077,"about_ca_topic_score_gemma":0.0029834292,"teacher_disagreement_score":0.08182753,"about_ca_system_score_codex":0.0004333008,"about_ca_system_score_gemma":0.0025461449,"threshold_uncertainty_score":0.7294045},"labels":[],"label_agreement":null},{"id":"W2994379966","doi":"10.1097/coc.0000000000000650","title":"Analysis of Heterogeneity in Survival Benefit of Immunotherapy in Oncology According to Patient Demographics and Performance Status","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Confidence interval; Meta-analysis; Randomized controlled trial; Subgroup analysis; Oncology","score_opus":0.1313721123070089,"score_gpt":0.4929832975669688,"score_spread":0.3616111852599599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994379966","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5899094,0.40927082,0.000011361406,0.00007624383,0.0003439493,0.00030880838,0.000019058862,0.000001247763,0.000059121034],"genre_scores_gemma":[0.17813385,0.82067436,0.0008095453,0.00028913756,0.000053372903,0.000007394945,0.000007491128,0.000022596454,0.0000022698325],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9923578,0.0010828982,0.005500949,0.00034054377,0.0003467297,0.00037106758],"domain_scores_gemma":[0.98966247,0.0035300222,0.0059569916,0.0003623686,0.00027663048,0.00021153066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003837657,0.00030402467,0.0098009845,0.0020273302,0.0000122458505,0.000003346384,0.0002725393,0.00043025755,0.000023429233],"category_scores_gemma":[0.00039302977,0.00022723737,0.0016321243,0.0026991928,0.00063000614,0.000051441162,0.000085782645,0.0010840945,5.0408164e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064861956,0.0005687892,0.29688722,0.00048182067,0.0030996099,0.0000272803,0.00012485692,0.000028584294,0.0000051670413,0.0000013964426,0.0000017752544,0.6922873],"study_design_scores_gemma":[0.007195726,0.075653635,0.4652822,0.0071953423,0.006113051,0.0001416428,0.0008973837,0.000066229615,0.0000038731537,0.0000025814154,0.43704107,0.00040726503],"about_ca_topic_score_codex":0.00039372675,"about_ca_topic_score_gemma":0.00066792633,"teacher_disagreement_score":0.69188005,"about_ca_system_score_codex":0.00042710657,"about_ca_system_score_gemma":0.0020553397,"threshold_uncertainty_score":0.9266471},"labels":[],"label_agreement":null},{"id":"W2994816936","doi":"10.1097/coc.0000000000000655","title":"Molecular Determinants of Statin-sensitivity in Cancer","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Foothills; Family medicine; Gerontology; Library science; Cartography","score_opus":0.029869205101394205,"score_gpt":0.42211075749555327,"score_spread":0.3922415523941591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994816936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388075,0.0005697926,0.00014374651,0.00022572484,0.0046634264,0.0000874472,0.000009799679,0.0000010342112,0.0004182834],"genre_scores_gemma":[0.9938842,0.0017104406,0.001113093,0.0008841679,0.0023283937,0.000002237765,0.00000135846,0.000014029196,0.00006204784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977699,0.00048632888,0.001171967,0.00020109107,0.00015633044,0.0002143995],"domain_scores_gemma":[0.9978153,0.00022299984,0.0013924232,0.00020839073,0.00022592327,0.00013493434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014813363,0.00011192347,0.001018735,0.00006946172,0.0000072459725,0.0000024403557,0.0001606865,0.0001313891,0.00002792288],"category_scores_gemma":[0.0004839514,0.00009594401,0.00027935187,0.00012319442,0.00035573397,0.0000052452065,0.000065111235,0.00028219647,0.0000031347943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001424322,0.00036710154,0.49624848,0.000013502462,0.00009635344,0.000009573906,0.00006042776,0.00030991816,0.09673899,0.000019349496,0.00094790215,0.4037641],"study_design_scores_gemma":[0.004992006,0.0111342855,0.616042,0.00008491112,0.0001037728,0.00013490213,0.00043076364,0.00009785877,0.021043407,0.00006946031,0.34557462,0.00029198526],"about_ca_topic_score_codex":0.00028539167,"about_ca_topic_score_gemma":0.0006471256,"teacher_disagreement_score":0.4034721,"about_ca_system_score_codex":0.000023681327,"about_ca_system_score_gemma":0.00091453467,"threshold_uncertainty_score":0.39124832},"labels":[],"label_agreement":null},{"id":"W2995696129","doi":"10.1097/coc.0000000000000630","title":"Targeting the Mevalonate Pathway for Treating Lung Cancer","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Lung cancer; Mevalonate pathway; Cancer; Signal transduction; Cancer research; Lung; Cancer cell; Bioinformatics; Limiting; Treatment of lung cancer; Pharmacology; Enzyme; Oncology; Cell biology; Internal medicine; Biology; Biochemistry; Biosynthesis","score_opus":0.07649159286793035,"score_gpt":0.4788333153143113,"score_spread":0.40234172244638094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995696129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018156155,0.9755776,0.0005635572,0.00032667414,0.022371711,0.0005765665,0.00008164282,0.0000036106508,0.0003170583],"genre_scores_gemma":[0.00004178648,0.9414775,0.0013796465,0.0008197426,0.05536289,0.00008035202,0.000037248603,0.00006893913,0.00073189696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952586,0.0011189193,0.0025766792,0.0004218148,0.00020204508,0.00042191267],"domain_scores_gemma":[0.9920074,0.0015991903,0.005436326,0.00036353184,0.00040065552,0.00019293764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033977295,0.00035914642,0.0036270216,0.00006867862,0.00009204692,0.00001965832,0.0007047395,0.00043425034,0.00002648543],"category_scores_gemma":[0.002023727,0.00021075114,0.002136235,0.00015102814,0.00044473604,0.0000050491417,0.0001363929,0.00084829377,0.0000036787678],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020713489,0.00006916782,0.00005015844,0.00055559666,0.000886302,5.9677865e-7,0.000023327426,0.000018025747,0.000030046878,0.00001668092,0.031596553,0.9665464],"study_design_scores_gemma":[0.00088643504,0.0021488562,0.000009790218,0.0007737961,0.0018010715,0.00006156919,0.00007865168,0.000016902746,0.0000032528797,0.0000065875142,0.99396724,0.00024584463],"about_ca_topic_score_codex":0.000037368292,"about_ca_topic_score_gemma":0.00002303547,"teacher_disagreement_score":0.96630055,"about_ca_system_score_codex":0.000082004735,"about_ca_system_score_gemma":0.0041343793,"threshold_uncertainty_score":0.85941815},"labels":[],"label_agreement":null},{"id":"W2996673269","doi":"10.1097/coc.0000000000000657","title":"Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Lung cancer; Guideline; Chemotherapy; Radiation therapy; Proportional hazards model; Stage (stratigraphy); Cancer; Oncology; Surgery; Confidence interval","score_opus":0.1688143842316305,"score_gpt":0.5700223225478211,"score_spread":0.4012079383161906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996673269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9370202,0.00047746146,0.00048296145,0.048417065,0.0019334377,0.0015641849,0.000028453593,0.000020474265,0.010055757],"genre_scores_gemma":[0.892201,0.006449659,0.070357285,0.013344007,0.0032207286,0.0002316724,0.0000067210367,0.00006824324,0.014120685],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966374,0.0002895615,0.0019759564,0.00032626945,0.0002904388,0.00048037752],"domain_scores_gemma":[0.9938794,0.003006053,0.0012723567,0.0003066537,0.00088509446,0.0006504561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017285855,0.0002002299,0.0019875115,0.0001923656,0.000040753413,0.000008384152,0.00025776046,0.000072571325,0.00038343182],"category_scores_gemma":[0.0008572827,0.00013441581,0.000557119,0.0003179991,0.00017999011,0.0000413561,0.00008449283,0.00043501408,0.000034812543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007990696,0.0010096517,0.3437327,0.00006213103,0.00097427727,0.00009117906,0.0003268438,0.00007382536,0.00045007467,0.000027293449,0.08902679,0.55623454],"study_design_scores_gemma":[0.015549591,0.12124424,0.04802488,0.00025708496,0.00080854795,0.000034402914,0.0008056799,0.00031069125,0.0005424504,0.000046739195,0.81211984,0.00025583693],"about_ca_topic_score_codex":0.0014887744,"about_ca_topic_score_gemma":0.0013879479,"teacher_disagreement_score":0.7230931,"about_ca_system_score_codex":0.0010689411,"about_ca_system_score_gemma":0.0031159145,"threshold_uncertainty_score":0.5527499},"labels":[],"label_agreement":null},{"id":"W3003778095","doi":"10.1097/coc.0000000000000633","title":"Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Cancer Institute","keywords":"Medicine; Gemcitabine; Erlotinib; Hazard ratio; Internal medicine; Pancreatic cancer; Oncology; Adverse effect; Chemotherapy; Confidence interval; Surgery; Cancer; Epidermal growth factor receptor","score_opus":0.1517376473785678,"score_gpt":0.522276700143894,"score_spread":0.3705390527653263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003778095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8479226,0.00033189915,0.0002204782,0.14833605,0.0005564341,0.0009083069,0.000056810157,0.000008775239,0.0016586098],"genre_scores_gemma":[0.9836495,0.0016507156,0.0057124128,0.0074094962,0.00105003,0.00003694994,0.0000030144683,0.0000309929,0.0004568806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933572,0.0020538482,0.0032722906,0.00030253668,0.00060857297,0.00040556723],"domain_scores_gemma":[0.98497397,0.008340362,0.0043233503,0.0004984716,0.0014524445,0.0004113913],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.0042516203,0.00020845479,0.0031165797,0.000080898266,0.00008615581,0.0000031874038,0.0006900701,0.00029601596,0.00011466338],"category_scores_gemma":[0.017808877,0.00010702713,0.00083759706,0.0007191906,0.002846014,0.00004418952,0.00012827046,0.0012774044,0.0000027455374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07478608,0.0026300857,0.6213181,0.00020374192,0.0021534734,0.000054298762,0.0019569749,0.000046129135,0.0059193885,0.00026790888,0.025172058,0.26549172],"study_design_scores_gemma":[0.027880464,0.055354144,0.83121926,0.0006120901,0.0015442679,0.00015493175,0.0011514411,0.00066362025,0.0015630075,0.00034405373,0.07935553,0.0001572011],"about_ca_topic_score_codex":0.0005256239,"about_ca_topic_score_gemma":0.00017028986,"teacher_disagreement_score":0.26533455,"about_ca_system_score_codex":0.00025852048,"about_ca_system_score_gemma":0.006419509,"threshold_uncertainty_score":0.9998677},"labels":[],"label_agreement":null},{"id":"W3012066456","doi":"10.1097/coc.0000000000000685","title":"Twitter","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Marketing buzz; Medicine; Scopus; Radiation oncology; Impact factor; Citation; Bibliometrics; Clinical Oncology; Library science; Internal medicine; MEDLINE; World Wide Web; Radiation therapy","score_opus":0.4525055894671902,"score_gpt":0.6121880681730625,"score_spread":0.15968247870587227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012066456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6741061,0.000057638394,0.00019046069,0.3097595,0.0065635676,0.00013864014,2.6302283e-7,0.000012402772,0.009171397],"genre_scores_gemma":[0.95425737,0.0004820267,0.0054936176,0.027752096,0.011982226,0.0000069306575,1.4989908e-7,0.0000073107744,0.000018300721],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644,0.001758534,0.0011464157,0.000103951745,0.00032896388,0.00022215475],"domain_scores_gemma":[0.9865579,0.010686146,0.0015923639,0.00005946762,0.00033279174,0.0007713573],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0033880628,0.000051609397,0.00061484904,0.000033878572,0.000091517395,0.00000921674,0.00030422094,0.00010509351,0.00028751805],"category_scores_gemma":[0.036961596,0.000045344506,0.00018006844,0.0003708467,0.0012225084,0.000093838746,0.000018174094,0.00058615464,0.000094004026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018493536,0.000120684555,0.118914075,0.0000019076272,0.000026651502,0.000020187059,0.022148376,9.803205e-7,0.000002636377,0.00063113566,0.012931876,0.84501654],"study_design_scores_gemma":[0.0003518971,0.0029667425,0.061506804,0.000005436822,0.000024217781,0.0000025282457,0.010806626,0.0000024822036,0.0000012568595,0.00030122712,0.9239822,0.000048574155],"about_ca_topic_score_codex":0.00044313355,"about_ca_topic_score_gemma":0.0000686131,"teacher_disagreement_score":0.9110503,"about_ca_system_score_codex":0.00010907925,"about_ca_system_score_gemma":0.0030917854,"threshold_uncertainty_score":0.97115046},"labels":[],"label_agreement":null},{"id":"W3014500359","doi":"10.1097/coc.0000000000000691","title":"A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":250,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Welichem Biotech (Canada); SignalChem (Canada); Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Sanofi; GlaxoSmithKline; Servier; Pfizer; Eli Lilly and Company; Genentech; PTC Therapeutics; American Association for Cancer Research","keywords":"Medicine; Tolerability; Cmax; Discontinuation; Internal medicine; Pharmacokinetics; Nausea; Adverse effect; Dosing; Cohort; Vomiting; Gastroenterology; Response Evaluation Criteria in Solid Tumors; Pharmacology; Phases of clinical research; Toxicity","score_opus":0.027762532162020494,"score_gpt":0.37617253892835273,"score_spread":0.3484100067663322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014500359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899095,0.000027378686,0.00024736245,0.00027476007,0.00013557091,0.00019447027,0.000010921032,0.0000019188126,0.000116667055],"genre_scores_gemma":[0.99818534,0.000026792488,0.0007909938,0.0007752641,0.00019144369,0.0000036049987,0.000008853966,0.000013712482,0.0000039754295],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9976666,0.00025569566,0.0015086838,0.00021353793,0.00020800257,0.00014748733],"domain_scores_gemma":[0.9972967,0.00010841067,0.001915678,0.0001444049,0.0003474291,0.00018736499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004292363,0.0001217985,0.000875919,0.00007101232,0.000011573954,0.0000018608167,0.00013985293,0.00008044611,0.000012822243],"category_scores_gemma":[0.00077616883,0.00009574477,0.0001463316,0.00024336849,0.00030318648,0.000009557219,0.000052017636,0.0002940797,4.986261e-7],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09276463,0.07045126,0.46572545,0.000057623838,0.00081098423,0.00010953783,0.0015377068,0.001767725,0.23338048,0.000014161723,0.0011527304,0.13222772],"study_design_scores_gemma":[0.09346637,0.7624163,0.10355402,0.00014208049,0.00021662799,0.000022951046,0.0044223177,0.00014037798,0.031556047,0.000006132755,0.003675335,0.00038145742],"about_ca_topic_score_codex":0.000014731007,"about_ca_topic_score_gemma":0.000031000003,"teacher_disagreement_score":0.69196504,"about_ca_system_score_codex":0.000019135261,"about_ca_system_score_gemma":0.0004000257,"threshold_uncertainty_score":0.39043584},"labels":[],"label_agreement":null},{"id":"W3018565988","doi":"10.1097/coc.0000000000000694","title":"The Population-based Impact of Adjuvant Chemotherapy on Outcomes in T2N0M0 Non–Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Internal medicine; Interquartile range; Hazard ratio; Lung cancer; Oncology; Proportional hazards model; Chemotherapy; Population; Cohort; Confidence interval","score_opus":0.04726510851326197,"score_gpt":0.4697619957226392,"score_spread":0.4224968872093772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018565988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9558396,0.00030160556,0.00002430742,0.043147963,0.00022957094,0.00024110673,0.0000069566067,0.0000034283387,0.00020549294],"genre_scores_gemma":[0.9901932,0.0012148615,0.0005146332,0.0077430364,0.0002882467,0.000011196727,0.0000015686155,0.000017151177,0.000016121516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978835,0.0002259797,0.0013187628,0.00015584093,0.0002224312,0.00019351301],"domain_scores_gemma":[0.9951953,0.0027382406,0.0014963482,0.00016043909,0.00014062955,0.0002690191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005726655,0.00013913614,0.0014085656,0.000055947443,0.000022891,0.000004402524,0.0001442636,0.000069974405,0.00007944168],"category_scores_gemma":[0.00038508323,0.00007090738,0.00063353573,0.00019385872,0.0001567245,0.000018885054,0.0000112979,0.00043666814,0.0000021076967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029843422,0.001009968,0.8911648,0.000013284134,0.00036283355,0.00006193061,0.000116598276,0.0008380833,0.000012035747,0.0000032267596,0.00076249376,0.10267041],"study_design_scores_gemma":[0.007724817,0.02023356,0.96997875,0.00010432674,0.0002164179,0.0000031591678,0.000069171656,0.000723926,0.000082017345,0.0000072605367,0.0007943375,0.00006226029],"about_ca_topic_score_codex":0.0010994958,"about_ca_topic_score_gemma":0.00018955502,"teacher_disagreement_score":0.10260815,"about_ca_system_score_codex":0.00049019704,"about_ca_system_score_gemma":0.0014996965,"threshold_uncertainty_score":0.2891519},"labels":[],"label_agreement":null},{"id":"W3020350434","doi":"10.1097/coc.0000000000000703","title":"Characterizing Urban-Rural Differences in Colon Cancer Outcomes","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Confidence interval; Hazard ratio; Proportional hazards model; Residence; Colorectal cancer; Demography; Rural area; Population; Cancer; Multivariate analysis; Surgery; Internal medicine; Environmental health","score_opus":0.28341152782406254,"score_gpt":0.5104588487067819,"score_spread":0.2270473208827194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020350434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9329923,0.0002740866,0.000039801547,0.06538321,0.00052020856,0.00008702315,0.000002770394,0.000009016281,0.00069162465],"genre_scores_gemma":[0.96441114,0.00070417847,0.00097353826,0.032865256,0.000997483,0.000003907031,7.0945947e-7,0.000009436148,0.00003433598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738115,0.00029368306,0.0015655413,0.00016149724,0.00032309318,0.00027501033],"domain_scores_gemma":[0.9970375,0.00091687625,0.001327262,0.00008822223,0.00017158184,0.00045860032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080304436,0.00013250732,0.0018229667,0.00007045778,0.000022332131,0.00000909608,0.00021434345,0.000100214704,0.00019720048],"category_scores_gemma":[0.0017517677,0.00009244158,0.0003205343,0.00029848862,0.00038363677,0.00012007316,0.000048280268,0.000895873,0.000011762373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002005025,0.00010648252,0.8120955,0.000006069966,0.00009932046,0.00037968322,0.000423266,0.0000017186895,0.00029603028,0.000014362877,0.0006738756,0.18389864],"study_design_scores_gemma":[0.0024141932,0.010596866,0.96792483,0.00013862184,0.00011289172,0.000075075055,0.0016706364,0.00007070171,0.000029880513,0.000014115477,0.016855907,0.00009629651],"about_ca_topic_score_codex":0.0002878381,"about_ca_topic_score_gemma":0.0000669488,"teacher_disagreement_score":0.18380235,"about_ca_system_score_codex":0.00012188849,"about_ca_system_score_gemma":0.000862726,"threshold_uncertainty_score":0.38921723},"labels":[],"label_agreement":null},{"id":"W3025456390","doi":"10.1097/coc.0000000000000705","title":"Eligibility Criteria and Endpoints in Metastatic Renal Cell Carcinoma Trials","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Clinical trial; Clinical endpoint; Renal cell carcinoma; Intensive care medicine; Surrogate endpoint; Internal medicine; Disease; Oncology","score_opus":0.23265778802584905,"score_gpt":0.5115335604306447,"score_spread":0.27887577240479566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025456390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98536134,0.00064802036,0.00013052023,0.011953383,0.00021355433,0.0002959326,0.0000063194425,0.000005985124,0.0013849507],"genre_scores_gemma":[0.9819101,0.00029101782,0.01316406,0.0040907525,0.0005023947,0.000004216648,0.0000022363129,0.000017215785,0.00001801283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926782,0.0028798422,0.003513538,0.0003403949,0.00031626984,0.0002717445],"domain_scores_gemma":[0.9915804,0.005054011,0.002123845,0.00020055384,0.00019900654,0.00084216514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061082398,0.00019656608,0.0035268408,0.00012531503,0.000017634835,0.000010150836,0.00013654874,0.00008687037,0.00019628006],"category_scores_gemma":[0.007418781,0.00013501692,0.0005223598,0.00025828482,0.0005709513,0.000072629016,0.000068008325,0.0007679478,0.00001490873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029355312,0.00245439,0.54095995,0.00013706503,0.00045890294,0.009924792,0.0013190915,0.000007612579,0.01014919,0.000020085758,0.0026131263,0.40260047],"study_design_scores_gemma":[0.018486755,0.06928058,0.89635986,0.00006145423,0.0011789599,0.001081241,0.0010345981,0.0001490154,0.0038425918,0.0002819114,0.008039969,0.00020305127],"about_ca_topic_score_codex":0.000064913,"about_ca_topic_score_gemma":0.000010513512,"teacher_disagreement_score":0.40239742,"about_ca_system_score_codex":0.00013195656,"about_ca_system_score_gemma":0.0010021307,"threshold_uncertainty_score":0.888151},"labels":[],"label_agreement":null},{"id":"W3025793877","doi":"10.1097/coc.0000000000000706","title":"ACR–ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Medical physics; Radiation oncology; Timeline; Documentation; Radiosurgery; Workflow; Stereotactic radiation therapy; Medical physicist; Radiation therapy; Nuclear medicine; Radiology; Database; Computer science","score_opus":0.11296292720294071,"score_gpt":0.47217885969907764,"score_spread":0.3592159324961369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025793877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9073797,0.00035626558,0.002679822,0.08833238,0.00039897521,0.00051491975,0.0000036533086,0.0000059000063,0.00032840457],"genre_scores_gemma":[0.95789194,0.0021137611,0.012540568,0.02681045,0.0005859864,0.000010052335,0.0000017057911,0.000014937424,0.00003062166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735326,0.0005421474,0.0014493003,0.00014121726,0.00034810064,0.0001659837],"domain_scores_gemma":[0.98602504,0.010159819,0.0029455326,0.00020206391,0.00041218527,0.00025533666],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002630641,0.00010489542,0.00091334374,0.000046391648,0.00002976129,0.000007631466,0.00020747124,0.0000395104,0.00009096768],"category_scores_gemma":[0.011021554,0.00006289952,0.00036404692,0.00017843606,0.0003641846,0.00016132212,0.00002635934,0.00042626512,0.0000067743235],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027501255,0.0011110645,0.03510184,0.000060597493,0.0014098078,0.000044853034,0.00038928524,0.00002909892,0.00008372826,0.000045311484,0.0041604186,0.9300627],"study_design_scores_gemma":[0.016021637,0.10703872,0.3150146,0.000057535104,0.0027522016,0.00013808918,0.002182978,0.0080256155,0.00012883467,0.000027457087,0.5484605,0.00015186697],"about_ca_topic_score_codex":0.00000377299,"about_ca_topic_score_gemma":1.437921e-7,"teacher_disagreement_score":0.9299109,"about_ca_system_score_codex":0.000028177075,"about_ca_system_score_gemma":0.00051378424,"threshold_uncertainty_score":0.997309},"labels":[],"label_agreement":null},{"id":"W3030965370","doi":"10.1097/coc.0000000000000716","title":"Population-based Treatment Patterns and Outcomes for Stage III Non–Small Cell Lung Cancer Patients","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); Alberta Health Services","funders":"","keywords":"Medicine; Stage (stratigraphy); Cancer registry; Internal medicine; Population; Chemoradiotherapy; Radiation therapy; Confidence interval; Cohort; Lung cancer; Cancer; Medical record; Palliative care; Oncology","score_opus":0.05548615419366075,"score_gpt":0.43925876907400935,"score_spread":0.3837726148803486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030965370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837044,0.000096736505,0.00040940274,0.014766262,0.00034167996,0.0005490009,0.00006818017,0.0000065689587,0.00005780605],"genre_scores_gemma":[0.9880685,0.00054095266,0.0022489796,0.0086154,0.00037029415,0.00005660951,0.000019411073,0.00002038512,0.000059434686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983011,0.00010059173,0.0010349965,0.0002234965,0.00015057619,0.00018925393],"domain_scores_gemma":[0.99675256,0.0013560591,0.0011465664,0.000099741854,0.00018708271,0.0004579889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018842878,0.00016090019,0.0013566434,0.000044163568,0.000036914957,0.000007566627,0.00006207594,0.00006840523,0.00006696754],"category_scores_gemma":[0.00016197983,0.000103099155,0.0003760093,0.000063838874,0.00007236985,0.000030245412,0.000015075516,0.00015459619,9.0619943e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013903879,0.0014036685,0.892567,0.000050414317,0.00041571836,0.00003693629,0.0001637958,0.000050800634,0.0000012288224,0.0000019633396,0.00030483745,0.10361324],"study_design_scores_gemma":[0.019202799,0.030366184,0.9430716,0.000059849983,0.0010349557,0.00000125356,0.00010661112,0.000489492,0.000041316176,0.0000017256159,0.005533374,0.000090852554],"about_ca_topic_score_codex":0.0009443759,"about_ca_topic_score_gemma":0.0002415732,"teacher_disagreement_score":0.10352239,"about_ca_system_score_codex":0.00039835117,"about_ca_system_score_gemma":0.0006193245,"threshold_uncertainty_score":0.42042613},"labels":[],"label_agreement":null},{"id":"W3031320380","doi":"10.1097/coc.0000000000000704","title":"The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Proportional hazards model; Chemotherapy; Hazard ratio; Internal medicine; Propensity score matching; Oncology; Urology; Surgery; Confidence interval","score_opus":0.05299939664535952,"score_gpt":0.38595632455785617,"score_spread":0.33295692791249665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031320380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927536,0.00030969415,0.00002339811,0.006084423,0.00019540168,0.00048219052,0.000005153616,0.000002483676,0.00014363075],"genre_scores_gemma":[0.9973158,0.00027616922,0.00016537867,0.0020574208,0.0001345913,0.0000067790365,6.8432337e-7,0.000020048068,0.000023121294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657124,0.0013334431,0.0012808566,0.00015688268,0.0004901445,0.00016740999],"domain_scores_gemma":[0.99436915,0.0034300296,0.0016392757,0.00023463767,0.00016810036,0.00015881442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009000359,0.00015318008,0.0014977315,0.000041005856,0.00002667512,0.0000022505917,0.00025991566,0.000052534164,0.000029447894],"category_scores_gemma":[0.00060569716,0.000058611728,0.00031241597,0.000331446,0.0008481936,0.000024706891,0.000027135446,0.00047090868,0.0000018973935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.093570456,0.00080207316,0.8588848,0.00005099951,0.000954755,0.00008355571,0.00024890585,0.00002374192,0.000008443778,0.000008407408,0.00033328534,0.04503056],"study_design_scores_gemma":[0.025704654,0.19334501,0.77786195,0.00033266243,0.00059006206,0.00011776572,0.00045005546,0.000016303919,0.00011303164,0.000009398677,0.0013905925,0.00006847941],"about_ca_topic_score_codex":0.00004296405,"about_ca_topic_score_gemma":0.00000783382,"teacher_disagreement_score":0.19254294,"about_ca_system_score_codex":0.00007096548,"about_ca_system_score_gemma":0.0007659458,"threshold_uncertainty_score":0.31252044},"labels":[],"label_agreement":null},{"id":"W3080188819","doi":"10.1097/coc.0000000000000757","title":"Cancer Management During the COVID-19 Pandemic in the United States","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Pandemic; Specialty; Family medicine; Coronavirus disease 2019 (COVID-19); MEDLINE; Cancer; Radiation oncology; Radiation therapy; Disease; Internal medicine; Infectious disease (medical specialty)","score_opus":0.3017747871706211,"score_gpt":0.5751222812276002,"score_spread":0.2733474940569791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080188819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62545425,0.00016170398,0.00010618379,0.37384272,0.00012841124,0.00017139905,0.0000023186285,0.00000754318,0.0001254667],"genre_scores_gemma":[0.6896225,0.006175799,0.00011021143,0.30352232,0.00053337327,0.000005687883,0.000001295608,0.0000073507535,0.000021445623],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99688345,0.0011161685,0.0012450014,0.00014975286,0.00032569675,0.00027994794],"domain_scores_gemma":[0.9934311,0.0047371276,0.00093482836,0.0001779297,0.00010952432,0.0006095161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002908416,0.00010592789,0.00075836055,0.0001135447,0.00007098707,0.000008866734,0.000324233,0.00006412786,0.0001056699],"category_scores_gemma":[0.0029706226,0.000052004336,0.00018868336,0.00069646665,0.0004970273,0.000030985517,0.000058273872,0.001207697,0.0000073958436],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050027594,0.0002711713,0.84249246,0.00012740205,0.00025789056,0.0017048857,0.0051096366,0.0007767882,0.0000104075325,0.000063845204,0.0069519547,0.1372308],"study_design_scores_gemma":[0.0031389322,0.004233209,0.48194224,0.00003657806,0.00013439686,0.0002611594,0.0056931945,0.000106741834,5.508854e-7,0.00008516295,0.5043153,0.00005250431],"about_ca_topic_score_codex":0.0014523019,"about_ca_topic_score_gemma":0.00044369316,"teacher_disagreement_score":0.49736336,"about_ca_system_score_codex":0.00034841412,"about_ca_system_score_gemma":0.0014837779,"threshold_uncertainty_score":0.5246909},"labels":[],"label_agreement":null},{"id":"W3082718662","doi":"10.1097/coc.0000000000000754","title":"Eligibility for Second-line Therapy in Patients With Advanced Hepatocellular Carcinoma","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Sorafenib; Hepatocellular carcinoma; Internal medicine; Proportional hazards model; Oncology; Surgery","score_opus":0.12563893260768216,"score_gpt":0.39175020678182276,"score_spread":0.2661112741741406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082718662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930243,0.00025188306,0.00025178827,0.005334513,0.00013209047,0.0008334244,0.000011952528,0.000010402139,0.00014968494],"genre_scores_gemma":[0.9875614,0.000099968296,0.007624985,0.0043090144,0.0003276265,0.000019830472,0.000018165072,0.000028567702,0.000010447523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972662,0.0003337822,0.0015448452,0.00031283102,0.00025579214,0.00028658635],"domain_scores_gemma":[0.9967445,0.0009825458,0.001093973,0.00019167642,0.00047892032,0.00050839415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090738473,0.00019500151,0.0017150565,0.00008095076,0.000024829002,0.000005200806,0.00014811808,0.000118525895,0.000101644786],"category_scores_gemma":[0.0006584172,0.00012985003,0.00043565436,0.00029692167,0.00031209795,0.000083647894,0.00002115615,0.0005114691,0.000005296856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02175474,0.0011723413,0.75229776,0.000015978536,0.00015428018,0.00017025981,0.00013234217,0.0000010789335,0.000040840274,0.000003914145,0.00009215775,0.22416432],"study_design_scores_gemma":[0.024889756,0.13564265,0.82194495,0.000027488039,0.00014699162,0.000013821534,0.00010695518,0.00042171404,0.00048075986,0.000031678435,0.016155927,0.00013727897],"about_ca_topic_score_codex":0.00000946728,"about_ca_topic_score_gemma":0.0000059987824,"teacher_disagreement_score":0.22402704,"about_ca_system_score_codex":0.00009192783,"about_ca_system_score_gemma":0.00074860954,"threshold_uncertainty_score":0.52951306},"labels":[],"label_agreement":null},{"id":"W3083996699","doi":"10.1097/coc.0000000000000756","title":"Is There a Role for Statins and Metformin in Cancer Therapy?","year":2020,"lang":"en","type":"editorial","venue":"American Journal of Clinical Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Metformin; Family medicine; Cancer; Alternative medicine; Cancer therapy; Oncology; MEDLINE; Internal medicine; Pathology; Law","score_opus":0.041764502572484916,"score_gpt":0.4437940500946438,"score_spread":0.40202954752215886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083996699","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046403147,0.030854752,0.00018656836,0.002723992,0.91860557,0.00039355166,0.00049332203,0.0000039068177,0.0003352005],"genre_scores_gemma":[0.0021888604,0.10997875,0.0019016875,0.0019731072,0.8835523,0.000042820735,0.000037297483,0.000050425784,0.00027473495],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727476,0.00035338884,0.001428831,0.0004041186,0.00024464825,0.00029427523],"domain_scores_gemma":[0.9960928,0.0011005846,0.0019721852,0.00018458553,0.00038604304,0.00026383225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012838896,0.0002555519,0.0017140643,0.00007074765,0.000027648246,0.000014733651,0.00034943572,0.0006520886,0.000028279732],"category_scores_gemma":[0.0018819934,0.00020210551,0.00047402602,0.000101569894,0.0004351773,0.000005843724,0.00008117502,0.0009235285,8.221743e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027655838,0.0001205921,0.0005837618,0.000013341254,0.00028340763,0.0000011415476,0.00014070135,0.0000017289702,0.00038351843,0.0000026984615,0.62406766,0.37163585],"study_design_scores_gemma":[0.004120493,0.010841617,0.0006348227,0.000036848858,0.0001229999,0.000007176194,0.00033987412,0.0000056404037,0.00010368708,0.00010744684,0.9834685,0.00021094971],"about_ca_topic_score_codex":0.00028229016,"about_ca_topic_score_gemma":0.00050917803,"teacher_disagreement_score":0.3714249,"about_ca_system_score_codex":0.000043099717,"about_ca_system_score_gemma":0.0032660766,"threshold_uncertainty_score":0.82416236},"labels":[],"label_agreement":null},{"id":"W3089262302","doi":"10.1097/coc.0000000000000766","title":"Effect of Age on Cancer-specific Mortality in Patients With Urothelial Carcinoma of the Urinary Bladder","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Hazard ratio; Internal medicine; Proportional hazards model; Epidemiology; Cancer; Stage (stratigraphy); Urology; Relative risk; Gastroenterology; Confidence interval","score_opus":0.053662678147619436,"score_gpt":0.40163046573874844,"score_spread":0.347967787591129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089262302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967481,0.000089636706,0.000004823958,0.0015190571,0.0003121333,0.00038617104,0.000024959454,0.0000025330723,0.00091257214],"genre_scores_gemma":[0.9981048,0.00009326792,0.000088739405,0.001358116,0.00032016676,0.000006345315,0.0000011582621,0.000017903265,0.000009513964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971894,0.0008038372,0.0012068443,0.00019004165,0.00043892037,0.00017095987],"domain_scores_gemma":[0.9972579,0.00079539703,0.0013601555,0.00022740498,0.0001518004,0.00020733866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055652094,0.00015484705,0.0015325261,0.00005278795,0.000015039775,0.0000014952772,0.00020748592,0.00007933127,0.000084376974],"category_scores_gemma":[0.0002747011,0.00008042025,0.00034116575,0.00029884474,0.00075775135,0.000029857409,0.0000398169,0.00058465963,0.0000017221496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026057493,0.0013502282,0.897409,0.000032088512,0.0003259522,0.00016165007,0.00020957508,0.000020072137,0.000042542306,0.0000050657054,0.00016581004,0.0742205],"study_design_scores_gemma":[0.012101466,0.119530484,0.86613566,0.00010142907,0.00032174814,0.000009121878,0.000040300183,0.0000028786994,0.0006443669,0.000005004384,0.0010519507,0.000055612934],"about_ca_topic_score_codex":0.00019395186,"about_ca_topic_score_gemma":0.000017453145,"teacher_disagreement_score":0.11818025,"about_ca_system_score_codex":0.00009154662,"about_ca_system_score_gemma":0.000684803,"threshold_uncertainty_score":0.32794425},"labels":[],"label_agreement":null},{"id":"W3089314974","doi":"10.1097/coc.0000000000000763","title":"Population-based Assessment of Intermittent Androgen Deprivation Therapy Utilization for Relapsed, Nonmetastatic, Hormone-sensitive Adenocarcinoma of the Prostate","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba; Canadian Mennonite University","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Odds ratio; Population; Confidence interval; Cohort; Internal medicine; Oncology; Retrospective cohort study; Prostate-specific antigen; Gynecology; Hormone therapy; Cancer; Urology; Breast cancer","score_opus":0.12694714096734777,"score_gpt":0.44492201640483353,"score_spread":0.31797487543748576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089314974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814475,0.00023871586,0.006152574,0.011186253,0.0001514739,0.00075137883,0.0000421418,0.0000032095097,0.000026707046],"genre_scores_gemma":[0.98705655,0.00055532204,0.009815333,0.0024156913,0.000099019475,0.000019242058,0.000022563238,0.000014145628,0.000002131352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766535,0.00033542266,0.0014800164,0.00015196156,0.00025658862,0.00011066422],"domain_scores_gemma":[0.99522907,0.0011779183,0.0027472917,0.00013995476,0.00057488895,0.0001308694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066225464,0.000105957355,0.00096474396,0.000050876963,0.000025328078,0.0000028798684,0.00009039131,0.00004928774,0.000007569662],"category_scores_gemma":[0.0006901698,0.000064766566,0.00038787985,0.0002070598,0.00023137436,0.00004522626,0.000019807112,0.00018620383,1.8240065e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035217777,0.0007334794,0.77345,0.000025957293,0.00040402962,0.000011502301,0.00024233799,0.00026118432,0.00044438636,0.00006715152,0.00012547946,0.2207127],"study_design_scores_gemma":[0.0074372697,0.02707817,0.9589523,0.00008067894,0.000347043,0.000012098432,0.00032998246,0.002371665,0.002720725,0.000068992034,0.0005480365,0.000053004587],"about_ca_topic_score_codex":0.000030086136,"about_ca_topic_score_gemma":0.000004021549,"teacher_disagreement_score":0.22065969,"about_ca_system_score_codex":0.000119637414,"about_ca_system_score_gemma":0.0008087991,"threshold_uncertainty_score":0.2641104},"labels":[],"label_agreement":null},{"id":"W3093548028","doi":"10.1097/coc.0000000000000773","title":"Outcome of Locally Advanced Esophageal Cancer Patients Treated With Perioperative Chemotherapy and Chemoradiotherapy Followed by Surgery","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Medicine; Perioperative; Esophageal cancer; Hazard ratio; Chemoradiotherapy; Chemotherapy; Neoadjuvant therapy; Esophagectomy; Proportional hazards model; Cancer; Internal medicine; Surgery; Radiation therapy; Positron emission tomography; Gastroenterology; Nuclear medicine; Confidence interval","score_opus":0.047929063335342435,"score_gpt":0.42944304758274027,"score_spread":0.38151398424739785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093548028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883832,0.002139188,0.00007119663,0.008884886,0.000055546014,0.00031888176,0.000022991671,0.000008592172,0.0001155329],"genre_scores_gemma":[0.9888978,0.003283971,0.0016289612,0.0059068254,0.0001639819,0.000013809065,0.0000063956304,0.000029788585,0.00006845433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750215,0.00027692394,0.0012965671,0.0002603191,0.00040229768,0.00026175438],"domain_scores_gemma":[0.99670255,0.000872854,0.0011404563,0.00011101299,0.00048365063,0.00068948994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040686503,0.00020220985,0.0022814095,0.00006404708,0.000030327776,0.0000065348954,0.00010075461,0.00008089695,0.00020953061],"category_scores_gemma":[0.00036657223,0.00012595447,0.00027301363,0.00029611075,0.00082645874,0.00008742301,0.000015348876,0.0004558043,0.0000016719216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021715153,0.0008520427,0.7760041,0.000023228753,0.0006689697,0.00025347364,0.0002124371,0.0000031323436,0.00016389156,0.0000010684746,0.0007944461,0.19930808],"study_design_scores_gemma":[0.03551284,0.12039742,0.835663,0.00013003407,0.00031081506,0.00006667966,0.00031190013,0.000049671213,0.0030742073,0.0000019960187,0.0042666327,0.00021475923],"about_ca_topic_score_codex":0.000071061244,"about_ca_topic_score_gemma":0.00001171257,"teacher_disagreement_score":0.19909333,"about_ca_system_score_codex":0.0001434212,"about_ca_system_score_gemma":0.00092560373,"threshold_uncertainty_score":0.5136274},"labels":[],"label_agreement":null},{"id":"W3104600821","doi":"10.1097/coc.0000000000000775","title":"Systematic Review and Meta-Analysis on the Use of Photon-based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma","year":2020,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiosurgery; Stereotactic radiotherapy; Enucleation; Confidence interval; Radiation therapy; Internal medicine; Oncology; Surgery","score_opus":0.3280721946622167,"score_gpt":0.49513510739544503,"score_spread":0.16706291273322832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104600821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036438604,0.99037933,0.00007926574,0.0052241418,0.00029830897,0.003548752,0.00009146773,0.000004796884,0.0000095713995],"genre_scores_gemma":[0.0015341573,0.9950128,0.0008005922,0.0021673038,0.00010347126,0.00027330706,0.000018020522,0.00004148175,0.000048830472],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9898162,0.0047445586,0.004485855,0.00035177803,0.0003883196,0.00021331516],"domain_scores_gemma":[0.90426177,0.083222196,0.011257373,0.0006780644,0.00036984775,0.00021074057],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0022650962,0.0004905785,0.02039512,0.00027172998,0.00006724654,0.0000098490955,0.00025198108,0.00026772282,0.00017124624],"category_scores_gemma":[0.0035749204,0.00019526598,0.008878358,0.0007307705,0.0007506224,0.00004595593,0.00001242261,0.0006150359,0.0000026447426],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004143459,0.002415841,0.00014601584,0.040562812,0.831847,0.00027355962,0.000038273967,0.00000390653,4.7598842e-8,0.000009184901,0.00015171796,0.12040819],"study_design_scores_gemma":[0.0025463407,0.034470845,0.00005169374,0.0029702447,0.75669897,0.00019062034,0.000022821698,0.000032337553,4.0507055e-7,8.7150926e-7,0.20291272,0.000102119135],"about_ca_topic_score_codex":0.000029304345,"about_ca_topic_score_gemma":0.000007341475,"teacher_disagreement_score":0.202761,"about_ca_system_score_codex":0.00036312768,"about_ca_system_score_gemma":0.0016202643,"threshold_uncertainty_score":0.99414814},"labels":[],"label_agreement":null},{"id":"W3113817951","doi":"10.1097/coc.0000000000000777","title":"Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database","year":2020,"lang":"en","type":"letter","venue":"American Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Neuroendocrine tumors; Colorectal cancer; Oncology; Internal medicine; Database; General surgery; Cancer","score_opus":0.06803966288764587,"score_gpt":0.41078314383523173,"score_spread":0.3427434809475859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113817951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69357437,0.00003354157,0.00007134578,0.30504984,0.00052397593,0.00051546865,0.00015026357,0.000008390619,0.000072808645],"genre_scores_gemma":[0.8418586,0.0013563755,0.0010055808,0.15249638,0.002770333,0.000017433887,0.00034121374,0.000074531265,0.000079523765],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99135023,0.0022586563,0.0039609224,0.0005028213,0.0013415916,0.00058575807],"domain_scores_gemma":[0.98857516,0.0040171053,0.0060714385,0.0005241237,0.00052754505,0.00028461218],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0008162571,0.00039960787,0.003685328,0.0005059935,0.000028737895,0.000012588755,0.0009820836,0.00005883,0.00016151113],"category_scores_gemma":[0.004274149,0.00027111062,0.0006928311,0.00091444195,0.0018211422,0.00016378106,0.00025957872,0.0061632222,0.000007912252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034856398,0.020586554,0.12779069,0.002740924,0.002781552,0.31298685,0.00048137922,0.0000326626,0.17486157,0.0000893857,0.29111233,0.03167971],"study_design_scores_gemma":[0.024858778,0.09297883,0.21725339,0.0013521638,0.0018722019,0.023100274,0.00044573046,0.00028649147,0.009594789,0.00007758181,0.6274274,0.0007523872],"about_ca_topic_score_codex":0.000191784,"about_ca_topic_score_gemma":0.000041049756,"teacher_disagreement_score":0.33631507,"about_ca_system_score_codex":0.000086585336,"about_ca_system_score_gemma":0.0013648329,"threshold_uncertainty_score":0.99997413},"labels":[],"label_agreement":null},{"id":"W3115667044","doi":"10.1097/coc.0000000000000789","title":"Second-line Chemotherapy Prolongs Survival in Real World Patients With Advanced Biliary Tract and Gallbladder Cancers","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Gallbladder cancer; Internal medicine; Hazard ratio; Gallbladder; Biliary tract; Gastroenterology; Population; Chemotherapy; Surgery; Survival analysis; Confidence interval","score_opus":0.04834031077639483,"score_gpt":0.38259637408280156,"score_spread":0.3342560633064067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115667044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98073244,0.00028044207,0.000012960409,0.016513318,0.00022459292,0.0002655281,0.0000057500824,0.000011182669,0.0019537855],"genre_scores_gemma":[0.98775846,0.0010895112,0.001659808,0.008862889,0.000545812,0.0000065828704,0.000002950724,0.00002655849,0.000047456542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777645,0.00020875211,0.0011544403,0.00030213714,0.00028262893,0.0002755821],"domain_scores_gemma":[0.9975515,0.0007256815,0.00094283064,0.00012100359,0.00024267708,0.00041630442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005334483,0.00019013428,0.0016211497,0.00010875953,0.000024896453,0.0000059612717,0.00011226584,0.000068953064,0.00010293985],"category_scores_gemma":[0.00028652058,0.0001304879,0.00016387376,0.0003971749,0.00062081584,0.00010692704,0.000032236476,0.0008301784,0.0000014868723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011881893,0.0003880383,0.7575899,0.000018206245,0.00022961167,0.00019831421,0.000627087,0.000009965689,0.000015198514,0.0000024923866,0.00042415588,0.22861515],"study_design_scores_gemma":[0.013419675,0.02659828,0.94375527,0.000060318478,0.00012271939,0.000025668993,0.00055495556,0.000020261707,0.000012298178,0.000008099672,0.0152900955,0.0001323846],"about_ca_topic_score_codex":0.00010323675,"about_ca_topic_score_gemma":0.0009823306,"teacher_disagreement_score":0.22848275,"about_ca_system_score_codex":0.00014586587,"about_ca_system_score_gemma":0.00087679666,"threshold_uncertainty_score":0.53211415},"labels":[],"label_agreement":null},{"id":"W3132127201","doi":"10.1097/coc.0000000000000799","title":"Outcomes of Ramucirumab Plus Paclitaxel Among Patients With Previously Treated Metastatic Gastric/Lower Esophageal Cancer","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ramucirumab; Hazard ratio; Internal medicine; Proportional hazards model; Odds ratio; Cancer registry; Confidence interval; Retrospective cohort study; Cohort; Paclitaxel; Cancer; Oncology; Chemotherapy","score_opus":0.05346937309322012,"score_gpt":0.44030375532445065,"score_spread":0.3868343822312305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132127201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582,0.0016390369,0.0000961516,0.0014119574,0.00023918643,0.0003731267,0.00003711183,0.000009429846,0.00037401885],"genre_scores_gemma":[0.9930245,0.0007145542,0.004692168,0.0009432586,0.0001365419,0.000022596561,0.000014980951,0.000031703494,0.00041966143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99579644,0.00078643387,0.00182933,0.00030993097,0.00080646476,0.00047142792],"domain_scores_gemma":[0.9939131,0.0016528687,0.0019548049,0.00032992195,0.0013740687,0.0007752088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084609113,0.0002399518,0.0026377803,0.00015455256,0.000039693565,0.000009531694,0.00017422732,0.00007841785,0.00054204505],"category_scores_gemma":[0.001417523,0.00014523414,0.0005688804,0.00053899596,0.00095667515,0.00011657079,0.000060939772,0.00071969046,0.000006698566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006616516,0.0028098726,0.85485095,0.00003221575,0.0024129527,0.0034840573,0.0000927298,0.000025500123,0.0000019612844,0.000008132666,0.00038443704,0.12928066],"study_design_scores_gemma":[0.019191138,0.042919002,0.9355423,0.00013874141,0.0012320839,0.00012901834,0.00019225563,0.000012792504,0.0000661842,0.000021185957,0.00045596337,0.00009934723],"about_ca_topic_score_codex":0.00040629596,"about_ca_topic_score_gemma":0.00024359551,"teacher_disagreement_score":0.12918131,"about_ca_system_score_codex":0.00042996308,"about_ca_system_score_gemma":0.0035980472,"threshold_uncertainty_score":0.6382781},"labels":[],"label_agreement":null},{"id":"W3140522824","doi":"10.1097/coc.0000000000000812","title":"Clinical Uncertainty and Equipoise in the Management of Recurrent Glioblastoma","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Alberta; University of Alberta Hospital; Centre Hospitalier de l’Université de Montréal; Health Sciences Centre","funders":"","keywords":"Medicine; Clinical equipoise; Confidence interval; Glioblastoma; Randomized controlled trial; Magnetic resonance imaging; MEDLINE; Surgery; Physical therapy; Internal medicine; Radiology","score_opus":0.0746135353584897,"score_gpt":0.470644307905219,"score_spread":0.3960307725467293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140522824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814247,0.0009053222,0.000014766216,0.01601341,0.0004239763,0.0001389234,0.0000022206832,0.000002085289,0.001074605],"genre_scores_gemma":[0.98847884,0.006281269,0.003066374,0.0019244369,0.0002231732,0.0000055252312,0.0000011989898,0.0000069610005,0.000012250198],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99611247,0.0010835945,0.0021210683,0.00020179986,0.0002996744,0.00018141225],"domain_scores_gemma":[0.99520546,0.0028937685,0.0012068399,0.00024997233,0.00023329828,0.00021066229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033621541,0.00010913015,0.0013157977,0.00007625178,0.00001743731,0.000005383753,0.00013613891,0.0000808905,0.000044908513],"category_scores_gemma":[0.0005932218,0.000057421563,0.0004076237,0.00033034777,0.0006397736,0.000026286682,0.00008329081,0.00053468905,0.0000032568576],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021805791,0.004118713,0.18341585,0.000024282384,0.00054436503,0.0039568767,0.000105521794,0.0000064621427,0.0000051169163,0.00037746094,0.00064963155,0.80461514],"study_design_scores_gemma":[0.010152399,0.03992262,0.8888927,0.00040485925,0.00091071357,0.0008828738,0.0031298941,0.00004902889,0.000028469693,0.00042231206,0.055117287,0.000086859116],"about_ca_topic_score_codex":0.0000111406835,"about_ca_topic_score_gemma":0.00005436777,"teacher_disagreement_score":0.8045283,"about_ca_system_score_codex":0.000050348506,"about_ca_system_score_gemma":0.0003346093,"threshold_uncertainty_score":0.23572725},"labels":[],"label_agreement":null},{"id":"W3165150297","doi":"10.1097/coc.0000000000000834","title":"Real-world Patterns of Adjuvant Chemotherapy Following Neoadjuvant Chemoradiation for Patients With Resected Rectal Adenocarcinoma","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Oxaliplatin; Hazard ratio; Internal medicine; Proportional hazards model; Chemotherapy; Oncology; Colorectal cancer; Odds ratio; Regimen; Surgery; Confidence interval; Cancer","score_opus":0.04186623095062805,"score_gpt":0.41075068191978464,"score_spread":0.36888445096915656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165150297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960517,0.00011984695,0.00011870352,0.0016864769,0.00060111965,0.00039564617,0.000018616534,0.000012430379,0.0009954572],"genre_scores_gemma":[0.98982847,0.00022200833,0.008613078,0.0006370668,0.00042071228,0.00001673768,0.000040847135,0.000040991043,0.00018010224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967726,0.0003559697,0.0017505682,0.0003223646,0.0004883985,0.0003101125],"domain_scores_gemma":[0.9941927,0.0021603531,0.0020392209,0.0002623021,0.000983765,0.00036166533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007116394,0.00020014077,0.0021200865,0.00015513349,0.00003523531,0.000006616621,0.0001337962,0.00011331552,0.00010243104],"category_scores_gemma":[0.0011696111,0.00014432095,0.0007167509,0.0005182854,0.00019614426,0.00008780365,0.000034157038,0.00043472523,0.0000014889114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012854307,0.0015448426,0.7186935,0.000020050848,0.00076412875,0.00034145152,0.00010315329,0.0000034170362,0.000074135925,0.000009869671,0.00009772139,0.26549345],"study_design_scores_gemma":[0.020155035,0.044651665,0.9294809,0.00021135325,0.00053521374,0.00006794124,0.00016077152,0.00003265876,0.0006657675,0.000043682747,0.0038642199,0.00013076034],"about_ca_topic_score_codex":0.0001344934,"about_ca_topic_score_gemma":0.00013382899,"teacher_disagreement_score":0.26536268,"about_ca_system_score_codex":0.00034874503,"about_ca_system_score_gemma":0.0016229855,"threshold_uncertainty_score":0.58852375},"labels":[],"label_agreement":null},{"id":"W3180861062","doi":"10.1097/coc.0000000000000850","title":"Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MacEwan University; University of Alberta","funders":"","keywords":"Capecitabine; Medicine; Concomitant; Internal medicine; Chemoradiotherapy; Hazard ratio; Oncology; Colorectal cancer; Fluorouracil; Cancer; Radiation therapy; Surgery; Confidence interval","score_opus":0.07194702185611679,"score_gpt":0.43029819684358467,"score_spread":0.3583511749874679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180861062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892029,0.00046787946,0.0014407049,0.00705529,0.00057585014,0.0010294471,0.00003154624,0.00001395327,0.00018241609],"genre_scores_gemma":[0.94981945,0.0008084355,0.045688752,0.0027857106,0.00055848697,0.00014878034,0.000008282763,0.000053732812,0.00012835613],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9964745,0.00037359676,0.001974631,0.00036690343,0.0004581313,0.00035224343],"domain_scores_gemma":[0.99209046,0.003361019,0.002258348,0.00027632006,0.0015320863,0.000481741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000735981,0.0002526672,0.002764192,0.00010206376,0.000032056327,0.000008826614,0.0001253022,0.00015169384,0.00018171045],"category_scores_gemma":[0.0016303273,0.00017035751,0.0006311005,0.0004903262,0.00085216097,0.00011607146,0.000025145948,0.0005522169,8.622338e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0826031,0.0029027713,0.22166383,0.00009324627,0.0011891281,0.0015360728,0.00009169074,0.00033719253,0.0056551667,0.000009732505,0.00024247303,0.6836756],"study_design_scores_gemma":[0.11723426,0.2954268,0.18530282,0.0023929104,0.001980568,0.0019034132,0.0006937217,0.001616933,0.10088962,0.00006043876,0.29165992,0.0008386029],"about_ca_topic_score_codex":0.00007847745,"about_ca_topic_score_gemma":0.00011669185,"teacher_disagreement_score":0.682837,"about_ca_system_score_codex":0.00046327803,"about_ca_system_score_gemma":0.0050480505,"threshold_uncertainty_score":0.8955025},"labels":[],"label_agreement":null},{"id":"W3187087408","doi":"10.1097/coc.0000000000000857","title":"A Population-based Study of Treatment Patterns and Survival of Patients With De Novo Stage IV Non–Small Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); Alberta Health Services","funders":"","keywords":"Medicine; Internal medicine; Anaplastic lymphoma kinase; Oncology; Lung cancer; Population; Chemotherapy; Targeted therapy; Cancer registry; Radiation therapy; Immunotherapy; Cancer; Cohort; Stage (stratigraphy)","score_opus":0.03589171005346983,"score_gpt":0.4420942888196092,"score_spread":0.4062025787661394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187087408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989661,0.00004757821,0.00017849184,0.00025042242,0.00013228813,0.00028144356,0.000045529476,0.0000019606437,0.0000961937],"genre_scores_gemma":[0.9980378,0.00009814863,0.00150765,0.00017979923,0.00006755692,0.000010827495,0.000012844189,0.000013188306,0.00007219286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984172,0.00024863638,0.0008848295,0.00014693697,0.00017526056,0.00012714283],"domain_scores_gemma":[0.9973725,0.00063294027,0.0012244518,0.0001373355,0.00045555527,0.00017722823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021113094,0.000106516876,0.0010219136,0.00006510707,0.000021243046,0.0000025053987,0.000041855557,0.00004149688,0.000060352166],"category_scores_gemma":[0.000074481075,0.00006968906,0.00010935168,0.00013181556,0.00008030533,0.00002374273,0.000012465738,0.00013104174,8.378598e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016469725,0.006179225,0.95594287,0.000043513337,0.00080102135,0.000112076385,0.00064539915,0.0004086097,0.000011044749,6.966549e-7,0.0000025822371,0.034206003],"study_design_scores_gemma":[0.016627723,0.038372148,0.9415433,0.00008122434,0.0016300365,0.000004377441,0.0014666539,0.00007680805,0.000046476005,5.599677e-7,0.00009760702,0.000053103937],"about_ca_topic_score_codex":0.002078257,"about_ca_topic_score_gemma":0.0017148787,"teacher_disagreement_score":0.0341529,"about_ca_system_score_codex":0.0002754896,"about_ca_system_score_gemma":0.0021231528,"threshold_uncertainty_score":0.3766382},"labels":[],"label_agreement":null},{"id":"W3190815019","doi":"10.1097/coc.0000000000000856","title":"Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-line Chemotherapy","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"FOLFIRINOX; Medicine; Hazard ratio; Internal medicine; Interquartile range; Confidence interval; Oncology; Pancreatic cancer; Progression-free survival; Olaparib; Chemotherapy; Gastroenterology; Surgery; Cancer; Irinotecan","score_opus":0.028545416360479522,"score_gpt":0.3923611423485976,"score_spread":0.36381572598811807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190815019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881647,0.00075599225,0.00044320477,0.009417965,0.0003549701,0.00055223244,0.000023477669,0.000010421668,0.00027701777],"genre_scores_gemma":[0.9891244,0.002631217,0.0024843048,0.005195398,0.00033424204,0.00006183021,0.0000067618926,0.000041935844,0.0001198769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961896,0.00055106246,0.0020211863,0.0003541903,0.0005340143,0.00034996858],"domain_scores_gemma":[0.99258095,0.0031710018,0.0025506276,0.00032534992,0.00085727836,0.0005147818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074706285,0.00022375968,0.0020142612,0.00011621991,0.00003733581,0.000004689709,0.00015887922,0.00009767307,0.0004873905],"category_scores_gemma":[0.0020761893,0.00017246205,0.00029623782,0.00041955337,0.0007465755,0.000098110555,0.00002466834,0.00059123535,0.000004761135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04116133,0.0019543788,0.8192672,0.000053776374,0.0003793744,0.00023896503,0.00011263229,0.00050341146,0.00021775856,0.0000043506197,0.00012037902,0.13598643],"study_design_scores_gemma":[0.033696044,0.020357307,0.93856984,0.0010651499,0.0003687441,0.00003126623,0.000081902945,0.000042002397,0.00035415005,0.000101119695,0.0051547787,0.00017769301],"about_ca_topic_score_codex":0.000048597438,"about_ca_topic_score_gemma":0.00015820921,"teacher_disagreement_score":0.13580874,"about_ca_system_score_codex":0.0004935759,"about_ca_system_score_gemma":0.0024398617,"threshold_uncertainty_score":0.70327985},"labels":[],"label_agreement":null},{"id":"W3200804649","doi":"10.1097/coc.0000000000000866","title":"Trends in Diagnosis and Treatment of Metastatic Cancer in the United States","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Centre for Family Medicine","funders":"National Cancer Institute","keywords":"Medicine; Epidemiology; Internal medicine; Cancer; Incidence (geometry); Colorectal cancer; Oncology; Cancer registry; Surveillance, Epidemiology, and End Results; Metastatic breast cancer; Prostate; Metastasis; Prostate cancer; Kidney cancer; Breast cancer","score_opus":0.1264741920221116,"score_gpt":0.4957059781453322,"score_spread":0.3692317861232206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200804649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97353375,0.0028436126,0.000003272647,0.023355186,0.000108033324,0.00004878678,0.0000071104873,7.571139e-7,0.0000995086],"genre_scores_gemma":[0.9426429,0.05420273,0.00043756416,0.002600887,0.000063808475,0.000010487914,0.0000040351583,0.000004696309,0.00003284008],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979839,0.0006765061,0.0010225744,0.00008922173,0.000117128526,0.00011070467],"domain_scores_gemma":[0.9967207,0.0024436673,0.00059747224,0.00009195407,0.00008642986,0.000059820715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008606585,0.00007051638,0.0008690172,0.00021272768,0.000007605761,0.0000026996768,0.000050939027,0.00003084225,0.00016665453],"category_scores_gemma":[0.00019443517,0.000039119976,0.00017378156,0.0007371623,0.00041662165,0.00001972262,0.0000068290824,0.00017229057,1.4028682e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002680338,0.0011550331,0.30482972,0.0000035325586,0.00024900897,0.00044661897,0.000979509,0.000017145456,0.000032506337,0.0000036566644,0.00014773298,0.6894552],"study_design_scores_gemma":[0.008671824,0.018454166,0.8971537,0.00009376088,0.00025173425,0.00020517703,0.0047312933,0.000050768784,0.00011437981,0.000035051355,0.070190646,0.000047512793],"about_ca_topic_score_codex":0.0018297436,"about_ca_topic_score_gemma":0.0021528925,"teacher_disagreement_score":0.6894077,"about_ca_system_score_codex":0.000104579,"about_ca_system_score_gemma":0.00040066545,"threshold_uncertainty_score":0.2766037},"labels":[],"label_agreement":null},{"id":"W3204935647","doi":"10.1097/coc.0000000000000869","title":"Stereotactic Body Radiotherapy for Prostate Cancer","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Prostate cancer; Citation; Specialty; Radiation oncology; Bibliometrics; Medical physics; Oncology; Cancer; Radiation therapy; Family medicine; Internal medicine; Library science","score_opus":0.06958080656621164,"score_gpt":0.4855860037090525,"score_spread":0.4160051971428409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204935647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.941641,0.005864134,0.00027647722,0.049866565,0.0015230164,0.0003639754,0.000023189954,0.000009087312,0.00043260818],"genre_scores_gemma":[0.9368842,0.03310374,0.013322667,0.014173474,0.00174962,0.00007720759,0.0000065442373,0.00003557542,0.00064695394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979488,0.00022741349,0.001196411,0.00020669411,0.00017439736,0.00024625083],"domain_scores_gemma":[0.9960036,0.001598447,0.0012261111,0.00017342703,0.0006510137,0.0003473662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070554967,0.00012268069,0.0013666282,0.000050720635,0.000031632237,0.000010269897,0.00007262905,0.00006733592,0.00018849016],"category_scores_gemma":[0.0005868684,0.000086673,0.0004920436,0.00016076473,0.0002759769,0.000057860274,0.000015035066,0.0003294519,0.0000029457663],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003934388,0.0014773526,0.2326357,0.00002284617,0.0014896158,0.00083213195,0.0001503522,0.000005479636,0.0002496418,0.00004399098,0.0049096243,0.75424886],"study_design_scores_gemma":[0.014273597,0.041715387,0.20511462,0.00017356756,0.0008555093,0.00081976526,0.00030303135,0.000049516904,0.0009359283,0.00016010267,0.7354622,0.00013676635],"about_ca_topic_score_codex":0.000029097826,"about_ca_topic_score_gemma":0.000019089786,"teacher_disagreement_score":0.7541121,"about_ca_system_score_codex":0.00029497224,"about_ca_system_score_gemma":0.0027509446,"threshold_uncertainty_score":0.48800576},"labels":[],"label_agreement":null},{"id":"W3206694174","doi":"10.1097/coc.0000000000000867","title":"Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"","keywords":"Radiation therapy; Prophylactic cranial irradiation; Brain metastasis; Neurocognitive; Lung cancer; Radiosurgery; Central nervous system; Conventional PCI; Chemotherapy","score_opus":0.11089184346273195,"score_gpt":0.5429156578752207,"score_spread":0.4320238144124887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206694174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97865844,0.0065447865,0.00007518471,0.013729413,0.00014173282,0.00013899342,0.0000060880548,0.000001839118,0.00070353143],"genre_scores_gemma":[0.97819424,0.015306871,0.0051826504,0.0005705948,0.0002163481,0.000010588735,0.0000013596685,0.0000085068605,0.0005088376],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978098,0.00073771103,0.0010116617,0.00014572221,0.00013140435,0.00016366065],"domain_scores_gemma":[0.99656075,0.0021100263,0.0007758014,0.00010511959,0.00027798352,0.00017033606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010232534,0.00008335475,0.0012400951,0.00009552939,0.000012541172,0.0000025133022,0.000049144444,0.000043053868,0.00007398663],"category_scores_gemma":[0.0013834222,0.000058028767,0.00021376123,0.00021284416,0.00041061844,0.000031058014,0.000047956066,0.00028032277,4.0039254e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016769258,0.0012628947,0.4238491,0.000075717,0.00065697095,0.0006875561,0.00034165208,0.000012465624,0.00094266335,0.000019751918,0.00079906697,0.5696752],"study_design_scores_gemma":[0.027729815,0.0737419,0.8251795,0.0006620437,0.0018107464,0.00061575504,0.0041376157,0.000113385315,0.004949282,0.000293891,0.06055806,0.00020801827],"about_ca_topic_score_codex":0.00031376645,"about_ca_topic_score_gemma":0.0007230186,"teacher_disagreement_score":0.5694672,"about_ca_system_score_codex":0.00023087938,"about_ca_system_score_gemma":0.0021857691,"threshold_uncertainty_score":0.38774607},"labels":[],"label_agreement":null},{"id":"W4200621966","doi":"10.1097/coc.0000000000000882","title":"Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"FOLFIRINOX; Pancreatic cancer; Palliative chemotherapy; Chemotherapy; Population; Palliative care; Young adult; MEDLINE","score_opus":0.05427993787854053,"score_gpt":0.46352425922381213,"score_spread":0.4092443213452716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200621966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839649,0.0008858245,0.00049756904,0.013912897,0.00011015245,0.0002870789,0.00001146369,0.0000058729865,0.0003242242],"genre_scores_gemma":[0.95041865,0.03808523,0.009594081,0.0013937781,0.00019091868,0.000022399825,0.00000311891,0.000020849262,0.00027096915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997361,0.00041209304,0.0013513252,0.00027060427,0.00032126973,0.00028372483],"domain_scores_gemma":[0.9934305,0.003928174,0.0014342609,0.00022150537,0.00063401257,0.0003515713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005744636,0.0001966576,0.0028499071,0.000083083636,0.000041800948,0.0000043542705,0.00009396067,0.00012336449,0.00026267327],"category_scores_gemma":[0.00096849375,0.00011761733,0.00023701742,0.00020371047,0.00067534915,0.00005287238,0.00003634669,0.0004089377,0.000001253155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044296673,0.0014950277,0.6605771,0.000049208757,0.0012037079,0.0003494632,0.00076337066,0.0000035309467,0.00002702437,0.0000043931095,0.000017719616,0.33107975],"study_design_scores_gemma":[0.01852076,0.033793144,0.94311625,0.0006906295,0.0007124857,0.0002428368,0.0017181134,0.000092392045,0.00027375572,0.00002042434,0.000714129,0.00010509563],"about_ca_topic_score_codex":0.00025586493,"about_ca_topic_score_gemma":0.0006083455,"teacher_disagreement_score":0.33097467,"about_ca_system_score_codex":0.00020216692,"about_ca_system_score_gemma":0.0015531653,"threshold_uncertainty_score":0.47962955},"labels":[],"label_agreement":null},{"id":"W4210423488","doi":"10.1097/coc.0000000000000891","title":"The Prognostic Impact of Radiotherapy Delays in Oropharynx Carcinoma and the Role of p16 Status","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Positive Living North","funders":"","keywords":"Radiation therapy; Carcinoma; Retrospective cohort study; Risk factor; Karnofsky Performance Status; Overall survival","score_opus":0.030904148224827913,"score_gpt":0.4320641685821482,"score_spread":0.4011600203573203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210423488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982227,0.012965623,0.0000050701074,0.0038997133,0.00015200558,0.00019238265,0.0000061187407,0.0000013082588,0.0005507783],"genre_scores_gemma":[0.9917592,0.007355901,0.00024411822,0.00047677266,0.00013459909,0.000009277473,2.5728008e-7,0.000008902793,0.000011012414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712336,0.0010697416,0.0012644484,0.00009395536,0.00023753248,0.00021097048],"domain_scores_gemma":[0.99201757,0.0063136057,0.0012614841,0.00013984759,0.00014336717,0.00012410499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026222523,0.00008410847,0.0013884668,0.00006461673,0.000068136935,0.0000018753019,0.00014749024,0.000026864602,0.00004208102],"category_scores_gemma":[0.0012465223,0.00003892231,0.00030640082,0.00025037504,0.0016591633,0.000019343965,0.000066029475,0.0006280465,1.2398718e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011305693,0.00029126476,0.6650172,0.000003894293,0.00031007157,0.000045187284,0.0011139422,0.000024668518,0.0001180164,0.00006444363,0.0001794103,0.3215262],"study_design_scores_gemma":[0.008825352,0.042590376,0.9323664,0.000021487047,0.00013765888,0.00025529886,0.0035704407,0.00024232866,0.0000114091845,0.00021469449,0.01172222,0.000042333548],"about_ca_topic_score_codex":0.000609451,"about_ca_topic_score_gemma":0.000046541965,"teacher_disagreement_score":0.32148388,"about_ca_system_score_codex":0.00013535345,"about_ca_system_score_gemma":0.0013919066,"threshold_uncertainty_score":0.6113256},"labels":[],"label_agreement":null},{"id":"W4214511738","doi":"10.1097/coc.0000000000000900","title":"Use of “Repurposed” Drugs in the Treatment of Epithelial Ovarian Cancer","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clinical trial; Ovarian cancer; Observational study; Epithelial ovarian cancer; Randomized controlled trial; Nonsteroidal; MEDLINE","score_opus":0.054969698660248714,"score_gpt":0.4009150864410306,"score_spread":0.3459453877807819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214511738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930589,0.0010591573,0.000032180935,0.0014598849,0.004048941,0.00012753243,0.00005940297,7.34221e-7,0.00015322487],"genre_scores_gemma":[0.98480785,0.008238304,0.00076237525,0.0010397728,0.004991966,0.000021904856,0.0000051201423,0.000011256594,0.00012142781],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727595,0.0010076445,0.0011866613,0.00015686835,0.00021006366,0.00016284325],"domain_scores_gemma":[0.99761635,0.00045363136,0.0014827002,0.00024741245,0.00012487429,0.00007504068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011364694,0.00010100791,0.0007971829,0.00006684423,0.00003054012,0.0000027257267,0.0002898313,0.000062337014,0.0000677474],"category_scores_gemma":[0.00021542418,0.000068490226,0.0004108768,0.000172406,0.0004689155,0.0000039629185,0.000049498754,0.00021692096,2.5662206e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061387247,0.0032421087,0.0389719,0.000005896462,0.00047365372,0.000005077073,0.0020067324,0.0007893882,0.022086388,0.0001395208,0.006280737,0.9198599],"study_design_scores_gemma":[0.002425104,0.016441226,0.03939912,0.000004738697,0.0001156272,0.000042124248,0.0012124303,0.000007725182,0.0009843735,0.00003405746,0.93926144,0.00007201226],"about_ca_topic_score_codex":0.0009602292,"about_ca_topic_score_gemma":0.00022095315,"teacher_disagreement_score":0.9329807,"about_ca_system_score_codex":0.000049514994,"about_ca_system_score_gemma":0.0009586626,"threshold_uncertainty_score":0.27929503},"labels":[],"label_agreement":null},{"id":"W4224240457","doi":"10.1097/coc.0000000000000906","title":"Changes in Survival Outcomes of Patients With Neuroendocrine Neoplasms Over the Past 15 Years","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Confidence interval; Internal medicine; Survival analysis; Comorbidity; Cohort study; Population; Cohort","score_opus":0.043241115950161335,"score_gpt":0.41578084862906867,"score_spread":0.37253973267890733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224240457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854131,0.000025697906,0.0000025535378,0.013591187,0.0004979364,0.00023701238,0.000013225931,0.0000049329315,0.00021438069],"genre_scores_gemma":[0.99679047,0.000118708216,0.00035616898,0.0024181101,0.0001683312,0.000011355529,0.0000022759564,0.000023430364,0.00011117974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996345,0.0011687236,0.0010748142,0.00018869275,0.000878293,0.0003444765],"domain_scores_gemma":[0.99466896,0.0033248763,0.0013565014,0.000261355,0.0001793913,0.00020893317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007917981,0.0001267605,0.0013339157,0.00021950956,0.00003488736,0.000003682505,0.00037029642,0.000004714439,0.0002485951],"category_scores_gemma":[0.0014886623,0.0000747697,0.00018691555,0.00052471366,0.00080205675,0.00005336357,0.0002343386,0.0012903819,0.0000020469465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004887709,0.0012155735,0.93706185,0.000006011848,0.00010879947,0.0037481955,0.00003595897,0.00006315638,0.0000068699774,0.000014043713,0.0005438539,0.052307982],"study_design_scores_gemma":[0.0057387897,0.033066154,0.9105645,0.000008376596,0.000059081314,0.00040456848,0.0005105326,0.000004579424,0.000005802776,0.000018599183,0.049562123,0.00005692326],"about_ca_topic_score_codex":0.00007391318,"about_ca_topic_score_gemma":0.00027730395,"teacher_disagreement_score":0.052251056,"about_ca_system_score_codex":0.00007506778,"about_ca_system_score_gemma":0.00040840538,"threshold_uncertainty_score":0.5606139},"labels":[],"label_agreement":null},{"id":"W4254975047","doi":"10.1097/01.coc.0000214931.01062.01","title":"Natural History and Chemotherapy Effectiveness for Advanced Adenocarcinoma of the Small Bowel: A Retrospective Review of 113 Cases","year":2006,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Irinotecan; Chemotherapy; Regimen; Retrospective cohort study; Adenocarcinoma; Internal medicine; Gemcitabine; Oncology; Chemotherapy regimen; Cancer; Medical record; Proportional hazards model; Surgery; Colorectal cancer","score_opus":0.11064317117632977,"score_gpt":0.480968717011261,"score_spread":0.3703255458349312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254975047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070132515,0.99048334,0.000020890679,0.00043404842,0.00030213533,0.0016062825,0.000025197362,0.0000032680296,0.00011156463],"genre_scores_gemma":[0.009799498,0.98617435,0.0033526875,0.00028615582,0.00023481154,0.000047343343,0.0000065218087,0.000038097012,0.000060563274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99544454,0.0013885931,0.0022948557,0.00029016763,0.00032179986,0.00026005568],"domain_scores_gemma":[0.98596406,0.0071945405,0.005430531,0.00031913875,0.00087851746,0.00021320576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022177773,0.00029972367,0.0063295043,0.00012545665,0.00002127574,0.0000013609655,0.00026255037,0.000099405224,0.000012753474],"category_scores_gemma":[0.006450618,0.00016035918,0.0019455698,0.0002149501,0.0015104178,0.000023926714,0.00005996341,0.0010250399,3.6543585e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002388492,0.0007482718,0.009265991,0.03334135,0.0008209571,0.00034609786,0.0000072403573,4.817057e-8,0.0000023062787,0.000021700156,0.0004910639,0.9525665],"study_design_scores_gemma":[0.007226706,0.08638903,0.11057789,0.16693923,0.005760662,0.0119439,0.000032771663,0.000001184764,0.000008033927,0.00005641382,0.61083215,0.00023199507],"about_ca_topic_score_codex":0.000054471926,"about_ca_topic_score_gemma":0.0000104071005,"teacher_disagreement_score":0.95233446,"about_ca_system_score_codex":0.0007833324,"about_ca_system_score_gemma":0.0027145199,"threshold_uncertainty_score":0.7722458},"labels":[],"label_agreement":null},{"id":"W4282822260","doi":"10.1097/coc.0000000000000925","title":"A Real-World Study of the Incidence and Outcomes of Early-Onset Well-differentiated Neuroendocrine Neoplasms","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Foregut; Hazard ratio; Hindgut; Proportional hazards model; Internal medicine; Incidence (geometry); Midgut; Epidemiology; Confidence interval; Neuroendocrine tumors; Gastroenterology; Pathology; Biology","score_opus":0.05526594234614452,"score_gpt":0.4515410364582003,"score_spread":0.3962750941120558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282822260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943662,0.000028736193,0.0000013657642,0.0045335856,0.00041449646,0.00042363652,0.000008371873,0.0000070453075,0.00021655574],"genre_scores_gemma":[0.9985329,0.00023440018,0.00025647273,0.0005545027,0.000057581743,0.000010649468,4.4887483e-7,0.0000198842,0.00033315242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942083,0.0022673397,0.0021076,0.00024246424,0.00087948487,0.00029485198],"domain_scores_gemma":[0.99191827,0.004380954,0.002727332,0.00041176873,0.00028649557,0.00027515728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087943696,0.00015521058,0.001853596,0.0002651915,0.0000784904,0.0000040577297,0.00050442654,0.000004962595,0.00013724042],"category_scores_gemma":[0.0028178038,0.000096778625,0.00029971433,0.0007451222,0.0010933909,0.00006237831,0.0006233142,0.0013884497,9.329397e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043977704,0.0027392025,0.979431,0.000013946742,0.00027055532,0.002489728,0.0001431129,0.000030175739,0.00020195507,0.000009097925,0.00032662696,0.009946825],"study_design_scores_gemma":[0.004985143,0.054843124,0.9345244,0.000019126013,0.00023878102,0.002138912,0.0016680567,0.000019856336,0.00017057404,0.000059001766,0.0012722224,0.000060777627],"about_ca_topic_score_codex":0.00085260696,"about_ca_topic_score_gemma":0.00043184118,"teacher_disagreement_score":0.052103918,"about_ca_system_score_codex":0.000055095552,"about_ca_system_score_gemma":0.00059579907,"threshold_uncertainty_score":0.60322005},"labels":[],"label_agreement":null},{"id":"W4295066538","doi":"10.1097/coc.0000000000000940","title":"Long-term Locoregional Control With Unilateral Radiation for AJCC-7 T1-2N2b Tonsillar Cancer","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"U.S. Department of Veterans Affairs","keywords":"Medicine; Tonsil; Radiation therapy; Surgery; Cancer; Retrospective cohort study; Clinical endpoint; Internal medicine; Randomized controlled trial","score_opus":0.06536051852036996,"score_gpt":0.46128078286753277,"score_spread":0.3959202643471628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295066538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96437013,0.0006912226,0.00084920233,0.032358047,0.000999649,0.00036537286,0.00002339655,0.000010643695,0.00033236083],"genre_scores_gemma":[0.98436326,0.00073886337,0.0009961555,0.012164946,0.0014316515,0.00007866369,0.0000059059753,0.000021808855,0.00019877173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977762,0.00034747992,0.001056224,0.00019813502,0.00034053889,0.00028141617],"domain_scores_gemma":[0.9964683,0.0015058363,0.0012761274,0.00012144651,0.00035782886,0.00027043297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011137826,0.00013483471,0.0014846423,0.00010092885,0.0001424392,0.0000046969185,0.00012652198,0.0000514474,0.00018569925],"category_scores_gemma":[0.00029785204,0.00009466249,0.00032439287,0.00019502672,0.0005002851,0.000049173228,0.00003164857,0.00060742605,0.0000013563932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016802754,0.00057729904,0.5532389,0.000015828447,0.0008297107,0.00027260275,0.00020324427,0.00019545587,0.00005077557,0.000068592046,0.0045406027,0.42320418],"study_design_scores_gemma":[0.020422246,0.0716171,0.7194738,0.00006526951,0.00071188173,0.0008425351,0.00030628836,0.00017272863,0.00001903971,0.00003986934,0.18615957,0.00016972714],"about_ca_topic_score_codex":0.00004486552,"about_ca_topic_score_gemma":0.000060703296,"teacher_disagreement_score":0.42303446,"about_ca_system_score_codex":0.0003328106,"about_ca_system_score_gemma":0.0020926616,"threshold_uncertainty_score":0.38602242},"labels":[],"label_agreement":null},{"id":"W4295904613","doi":"10.1097/coc.0000000000000942","title":"Tumor Volume Predicts for Pathologic Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Colorectal cancer; Multivariate analysis; Neoadjuvant therapy; Univariate analysis; Receiver operating characteristic; Internal medicine; Oncology; Odds ratio; Cancer; Youden's J statistic; Stage (stratigraphy); Chemoradiotherapy; Retrospective cohort study; Breast cancer","score_opus":0.06226248890684994,"score_gpt":0.40464936423534253,"score_spread":0.3423868753284926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295904613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539727,0.00009021764,0.000018002203,0.0030718227,0.0004169474,0.0007043981,0.00009141316,0.00001624359,0.0001936886],"genre_scores_gemma":[0.99611545,0.00004923414,0.0014012824,0.0018592566,0.00019802211,0.00021688838,0.000026655818,0.000028362327,0.0001048779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961845,0.0012659581,0.0014421374,0.00033243556,0.00043403817,0.00034089969],"domain_scores_gemma":[0.99523973,0.0021452592,0.0017920255,0.0001587445,0.0003575943,0.000306651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019766525,0.00018128939,0.0015648265,0.00021128537,0.00007484672,0.000005132211,0.00016214968,0.000059453883,0.00019883747],"category_scores_gemma":[0.0017181385,0.00013180352,0.00028725684,0.00056452665,0.0003772839,0.00006366313,0.00006516861,0.0006995863,0.000002744866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16613358,0.002108902,0.69486994,0.000006245105,0.00015662135,0.0014587269,0.00013331833,0.00022130429,0.000051702333,0.000001455702,0.00029453295,0.1345637],"study_design_scores_gemma":[0.017948868,0.14806555,0.811355,0.00003839868,0.00020276621,0.00039940627,0.00016743017,0.0004647936,0.000013052084,0.000015319358,0.02121594,0.00011346524],"about_ca_topic_score_codex":0.00013702725,"about_ca_topic_score_gemma":0.000041930485,"teacher_disagreement_score":0.14818472,"about_ca_system_score_codex":0.0011834578,"about_ca_system_score_gemma":0.001331801,"threshold_uncertainty_score":0.53747916},"labels":[],"label_agreement":null},{"id":"W4309648805","doi":"10.1097/coc.0000000000000955","title":"Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Anal cancer; Toxicity; Adverse effect; Oncology; Internal medicine; Cancer","score_opus":0.35342035971078095,"score_gpt":0.546357270421215,"score_spread":0.192936910710434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309648805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99491525,0.00006739338,0.0000047743874,0.0041392166,0.00056337955,0.00019859333,0.0000065940926,0.0000012953075,0.00010352797],"genre_scores_gemma":[0.99741185,0.00006760608,0.000214234,0.0019970543,0.00023222793,0.0000099715535,4.2096414e-7,0.0000066490643,0.00005997768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929454,0.0037857143,0.0024660237,0.00013669695,0.0004899622,0.00017621981],"domain_scores_gemma":[0.9931494,0.0038768593,0.0025857182,0.00012491524,0.00014382879,0.0001192508],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00919289,0.00008488663,0.0016176314,0.00017846702,0.000029581435,6.456459e-7,0.00018801479,0.000050818082,0.00031849372],"category_scores_gemma":[0.008707888,0.000053840537,0.0005253723,0.0006855166,0.00026699968,0.000049714854,0.00015929311,0.0011699636,3.8204442e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006721067,0.00068778655,0.86257875,0.0000045370844,0.00007189472,0.00009369499,0.00018371832,0.0017151645,0.0005635122,0.0000052203263,0.000063844076,0.12731081],"study_design_scores_gemma":[0.0041987766,0.008905856,0.98330134,0.0000720995,0.00011863866,0.000083376784,0.00090524694,0.0010413612,0.00004242237,0.00009694636,0.0011827933,0.000051160092],"about_ca_topic_score_codex":0.00087527535,"about_ca_topic_score_gemma":0.0010501962,"teacher_disagreement_score":0.12725966,"about_ca_system_score_codex":0.00033725228,"about_ca_system_score_gemma":0.00191017,"threshold_uncertainty_score":0.9996422},"labels":[],"label_agreement":null},{"id":"W4310570503","doi":"10.1097/coc.0000000000000961","title":"Impact of Time From Diagnosis to Treatment Start on the Outcomes of Patients With Nonmetastatic Anal Squamous Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Internal medicine; Odds ratio; Survival analysis; Anal cancer; Logistic regression; Pacific islanders; Oncology; Epidemiology; Confidence interval; Cancer; Population","score_opus":0.04224362162302379,"score_gpt":0.36978068598864433,"score_spread":0.3275370643656205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310570503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971834,0.000029878396,0.0000044982103,0.0019529875,0.00009076471,0.00025998722,0.00018344219,0.0000020808086,0.0002929845],"genre_scores_gemma":[0.99860483,0.000009044856,0.00035879863,0.0008643301,0.00007004662,0.000014474363,0.000009963195,0.000014337945,0.000054164477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974247,0.00060148485,0.0011471628,0.00016359884,0.00047776115,0.00018529927],"domain_scores_gemma":[0.9930751,0.004755198,0.0014655257,0.00022021387,0.00020558843,0.00027842168],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049231993,0.00015760605,0.0015770283,0.00013300849,0.00004164192,0.0000020298621,0.00018023289,0.00002521472,0.0010336279],"category_scores_gemma":[0.00042392986,0.00007601741,0.0006694046,0.00028675402,0.00029326553,0.000019601059,0.00006521731,0.00034113272,0.000006816504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010223083,0.0049993284,0.9464327,0.0000022011839,0.0004406794,0.00012177396,0.00036099117,0.00017887235,0.000039791525,0.0000014554819,0.00034173316,0.036857396],"study_design_scores_gemma":[0.0035027505,0.21790045,0.77707195,0.000005426866,0.00048570274,0.0000066908265,0.00034660302,0.000019371008,0.00006567796,0.000009920152,0.00052866497,0.00005675759],"about_ca_topic_score_codex":0.00079104473,"about_ca_topic_score_gemma":0.00003590451,"teacher_disagreement_score":0.21290113,"about_ca_system_score_codex":0.00028214508,"about_ca_system_score_gemma":0.0006889417,"threshold_uncertainty_score":0.99987954},"labels":[],"label_agreement":null},{"id":"W4315436665","doi":"10.1097/coc.0000000000000975","title":"The Impact of Racial Disparities on Outcome in Patients With Stage IIIC Endometrial Carcinoma","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Carcinoma; Oncology; Endometrial cancer; Internal medicine; Outcome (game theory); Gynecology; Cancer","score_opus":0.09073136062926593,"score_gpt":0.4714907019835871,"score_spread":0.3807593413543212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315436665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974179,0.000047406636,0.000003041097,0.000996814,0.0006068259,0.0002464028,0.000024669585,0.0000063984726,0.0006505348],"genre_scores_gemma":[0.9989264,0.00014481059,0.00007315733,0.00023543979,0.00047922027,0.000005445158,0.0000053837293,0.000015577574,0.000114546776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966819,0.0005111664,0.0017838256,0.00015540404,0.00054425996,0.00032339175],"domain_scores_gemma":[0.9904433,0.0073313573,0.0015096529,0.00019399961,0.00025310947,0.0002685775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017064392,0.00015227843,0.001661187,0.00039585558,0.000041978983,0.000006882602,0.00019006844,0.00008388837,0.000052048414],"category_scores_gemma":[0.004851239,0.00007073122,0.00056478166,0.0013088379,0.00065132015,0.000048923226,0.0000438468,0.00063518796,0.000013017723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047486313,0.0009876739,0.8196064,0.0000051525453,0.00030976694,0.00012832692,0.000045095298,0.00003180869,0.000001490364,0.000022265867,0.000103468185,0.13127221],"study_design_scores_gemma":[0.027693843,0.08183734,0.88934225,0.000027348862,0.00010736197,0.000004475923,0.00012062893,0.00000546094,0.000005371104,0.0000425322,0.0007543801,0.000058995654],"about_ca_topic_score_codex":0.00043436766,"about_ca_topic_score_gemma":0.000046389658,"teacher_disagreement_score":0.1312132,"about_ca_system_score_codex":0.00026875426,"about_ca_system_score_gemma":0.0006834837,"threshold_uncertainty_score":0.5807736},"labels":[],"label_agreement":null},{"id":"W4317568116","doi":"10.1097/coc.0000000000000976","title":"Efficacy and Toxicity of Combined Inhibition of EGFR and VEGF in Patients With Advanced Non–small Cell Lung Cancer Harboring Activating EGFR Mutations","year":2023,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Internal medicine; Lung cancer; Hazard ratio; Oncology; Odds ratio; Epidermal growth factor receptor; Adverse effect; Clinical endpoint; Gefitinib; Cancer; Randomized controlled trial; Confidence interval","score_opus":0.051375962068259506,"score_gpt":0.4729018708173301,"score_spread":0.4215259087490706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317568116","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90714914,0.09156993,0.000036088113,0.00012208961,0.0001480386,0.00081597676,0.000033452303,0.000005023702,0.00012023584],"genre_scores_gemma":[0.34618986,0.6507369,0.0028033804,0.0000618717,0.00008764788,0.00003800174,0.000026365762,0.0000396637,0.00001630694],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997241,0.00023970097,0.0019259872,0.00023009637,0.00019318162,0.00017003895],"domain_scores_gemma":[0.99360484,0.0020043855,0.0037877865,0.00012071485,0.00032057555,0.00016172351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042809904,0.00020502639,0.0028639366,0.00027485713,0.00002992718,0.0000039951174,0.00005920374,0.00013527273,0.0000048922398],"category_scores_gemma":[0.00038300635,0.00014466974,0.00017880135,0.00045924747,0.00036714485,0.00007343742,0.000042390027,0.00057200954,1.8840248e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008494488,0.0011117933,0.04603582,0.0027379636,0.00073881785,0.000034791567,0.00037443527,0.000025348008,0.000011102942,0.000003738933,0.0000057473167,0.948071],"study_design_scores_gemma":[0.07274852,0.07312724,0.7203393,0.09554882,0.020049402,0.000057294576,0.0014518052,0.0000851895,0.00011602928,0.00003197363,0.015610489,0.00083391264],"about_ca_topic_score_codex":0.00009234699,"about_ca_topic_score_gemma":0.00003253539,"teacher_disagreement_score":0.9472371,"about_ca_system_score_codex":0.00024917594,"about_ca_system_score_gemma":0.0015467933,"threshold_uncertainty_score":0.5899461},"labels":[],"label_agreement":null},{"id":"W4317678583","doi":"10.1097/coc.0000000000000963","title":"The Effect of Biomarkers on Clinical Trial Risk in Gastric Cancer","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cancer; Internal medicine; Oncology; Clinical trial","score_opus":0.07262873180167413,"score_gpt":0.49118693422079296,"score_spread":0.41855820241911884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317678583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871062,0.0002934833,0.000016763035,0.0071504265,0.003793891,0.00046136006,0.0000050504127,0.0000049371215,0.0011678955],"genre_scores_gemma":[0.9946456,0.0027743417,0.00021383307,0.001146143,0.0010273454,0.000030094563,8.359209e-7,0.00001448737,0.00014731532],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99208325,0.0039013212,0.002961943,0.00021335109,0.0005562435,0.00028387172],"domain_scores_gemma":[0.9796785,0.01606689,0.003708781,0.00026813385,0.000077337296,0.00020034635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014477624,0.00013733635,0.0018220245,0.00024615423,0.00008340966,0.000004761216,0.00036230873,0.00006323345,0.00017175933],"category_scores_gemma":[0.0058171293,0.000080202386,0.0009086978,0.0007400305,0.00075528806,0.00002448123,0.00013459251,0.0016512076,0.00000308772],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14434288,0.00030255946,0.40039986,0.0000027948063,0.00037418865,0.00009175339,0.000010879891,0.000047957707,5.8613483e-7,0.0000053417775,0.0040187975,0.45040238],"study_design_scores_gemma":[0.09355899,0.22103126,0.5612564,0.000025313608,0.0006442795,0.00004175235,0.00033106646,0.000054687567,0.0000025751417,0.000024760615,0.12295854,0.00007034432],"about_ca_topic_score_codex":0.00022185706,"about_ca_topic_score_gemma":0.00005709445,"teacher_disagreement_score":0.45033205,"about_ca_system_score_codex":0.00024279264,"about_ca_system_score_gemma":0.0007622274,"threshold_uncertainty_score":0.7173767},"labels":[],"label_agreement":null},{"id":"W4323535383","doi":"10.1097/coc.0000000000000992","title":"Population-based Long-term Outcomes for Squamous Cell Carcinoma of the Nasal Cavity","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Surgical Oncology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Positive Living North; University of British Columbia","funders":"","keywords":"Medicine; Nasal cavity; Surgery; Hazard ratio; Radiation therapy; Retrospective cohort study; Population; Basal cell; Adjuvant radiotherapy; Proportional hazards model; Internal medicine; Confidence interval","score_opus":0.10433245940342789,"score_gpt":0.4640535484684075,"score_spread":0.3597210890649796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323535383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843,0.000026184622,0.000113036775,0.01328855,0.0015880344,0.0003044684,0.000013560463,0.00001410534,0.00035203455],"genre_scores_gemma":[0.99476904,0.000011996672,0.0008099509,0.0034994178,0.00061460276,0.000007638257,0.000007523732,0.000021964863,0.00025784672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964078,0.0006784874,0.0020480105,0.00019694392,0.00033501428,0.0003337202],"domain_scores_gemma":[0.98582757,0.011267809,0.0019028662,0.00028590183,0.0003786423,0.00033719355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022951819,0.00014858777,0.0020152773,0.00013753971,0.000060096656,0.0000028543086,0.00027075407,0.00021493214,0.00006446041],"category_scores_gemma":[0.0040013366,0.00008632814,0.0010975441,0.00042103135,0.0005720142,0.000031172014,0.00005339665,0.00062203885,0.00001033618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017796708,0.00086651766,0.9444847,0.000041876854,0.000047659083,0.00015780763,0.000032387423,0.000032981177,0.00010129713,0.000026440772,0.00080239907,0.051626265],"study_design_scores_gemma":[0.0066727335,0.013807644,0.97515094,0.000022044293,0.00025261863,0.000060881885,0.000049532853,0.00013165256,0.00012365745,0.000059380403,0.0035868976,0.000082001425],"about_ca_topic_score_codex":0.00009321194,"about_ca_topic_score_gemma":0.00006377777,"teacher_disagreement_score":0.051544264,"about_ca_system_score_codex":0.000115624374,"about_ca_system_score_gemma":0.0015213243,"threshold_uncertainty_score":0.47902626},"labels":[],"label_agreement":null},{"id":"W4386252711","doi":"10.1097/coc.0000000000001039","title":"Geographic Disparities in Access to Cancer Clinical Trials in Canada","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Clinical trial; Medicine; Cancer; Cancer registry; Bladder cancer; Demography; Internal medicine","score_opus":0.8323996274990457,"score_gpt":0.763624699035733,"score_spread":0.06877492846331268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386252711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8460361,0.00015629471,0.000014516721,0.15043654,0.002329241,0.0003903118,0.000012658198,0.000009607131,0.0006147379],"genre_scores_gemma":[0.9557976,0.018125225,0.00063409115,0.023819072,0.0013676442,0.000040871404,0.000002144734,0.000030863757,0.00018245236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97599226,0.009113865,0.011854182,0.000573453,0.0015716798,0.00089453347],"domain_scores_gemma":[0.60636604,0.3852047,0.004233616,0.0007224509,0.0013258229,0.00214735],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.12690097,0.00020170832,0.0054199034,0.0008466778,0.00003116446,0.000026158157,0.0009907937,0.00047249178,0.00022559724],"category_scores_gemma":[0.37039286,0.00015277119,0.0008105674,0.0024970672,0.0012251487,0.000116980795,0.00042249786,0.0074709845,0.000023376348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034446346,0.00037677685,0.7325726,0.000028264325,0.00014580194,0.0016628482,0.000026351188,0.00013483306,0.0000028721497,0.00010534895,0.0060262205,0.25547343],"study_design_scores_gemma":[0.0045635365,0.0056384085,0.96864027,0.0005144616,0.00008202926,0.000026292339,0.00052406086,0.000118299315,0.0000034747438,0.0025229317,0.017223813,0.00014243853],"about_ca_topic_score_codex":0.6694489,"about_ca_topic_score_gemma":0.9631677,"teacher_disagreement_score":0.37609082,"about_ca_system_score_codex":0.0007428938,"about_ca_system_score_gemma":0.033352245,"threshold_uncertainty_score":0.9948188},"labels":[],"label_agreement":null},{"id":"W4387563786","doi":"10.1097/coc.0000000000001049","title":"Treatment of Recurrent Low-grade Serous Ovarian Cancer With MEK Inhibitors","year":2023,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Trillium Health Centre; University Health Network; University of Toronto; Ottawa Hospital; Princess Margaret Cancer Centre; Lakeridge Health","funders":"","keywords":"Medicine; Internal medicine; KRAS; Serous fluid; MEDLINE; Randomized controlled trial; Oncology; Ovarian cancer; Clinical trial; Meta-analysis; Cancer; Colorectal cancer","score_opus":0.2085496925214123,"score_gpt":0.5294789099811842,"score_spread":0.3209292174597719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387563786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018208924,0.9911436,0.000008013835,0.0033173864,0.0022978245,0.0010181023,0.00011842498,0.000021126774,0.00025466073],"genre_scores_gemma":[0.0009982266,0.9944541,0.0014469393,0.00016639211,0.0025008528,0.0001569779,0.000023764676,0.00010702008,0.00014574823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934776,0.00084745226,0.00419199,0.0005122267,0.0005432849,0.00042748472],"domain_scores_gemma":[0.98814434,0.002979029,0.0073498194,0.00047268573,0.00037758658,0.0006765159],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007415771,0.0005746187,0.010054695,0.0003665442,0.000035509274,0.000009233568,0.0002262171,0.00035939986,0.00010120787],"category_scores_gemma":[0.00024309212,0.00031401782,0.0021651543,0.0008030756,0.0007617134,0.000039490038,0.000041492454,0.00081312354,0.0000205472],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010741891,0.0043239715,0.0018468973,0.0014873209,0.0071150837,0.0023503685,0.00009082648,0.0000044155317,3.3905476e-8,0.000017479184,0.00085428316,0.98083514],"study_design_scores_gemma":[0.0059302375,0.07641748,0.0011605707,0.014410799,0.013414873,0.0009383509,0.00009949619,0.0000022088009,0.0000012099243,0.000007890423,0.88737786,0.00023899574],"about_ca_topic_score_codex":0.0004088713,"about_ca_topic_score_gemma":0.0001535466,"teacher_disagreement_score":0.9805961,"about_ca_system_score_codex":0.0013090369,"about_ca_system_score_gemma":0.007188916,"threshold_uncertainty_score":0.9999312},"labels":[],"label_agreement":null},{"id":"W4389306890","doi":"10.1097/coc.0000000000001068","title":"Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2–Positive Metastatic Breast Cancer in Manitoba","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"George & Fay Yee Centre for Healthcare Innovation; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Univariate analysis; Odds ratio; Cohort; Proportional hazards model; Oncology; Breast cancer; Cancer; Survival analysis; Multivariate analysis","score_opus":0.09528721805467023,"score_gpt":0.48239477823000837,"score_spread":0.38710756017533815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389306890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931394,0.000025830108,0.000055440425,0.0053835227,0.0005116691,0.00036909332,0.000059853952,0.000019336918,0.00043586444],"genre_scores_gemma":[0.99711573,0.00034929853,0.00066117593,0.000926799,0.0007693311,0.000028636441,0.00001637743,0.000055817363,0.000076818316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947071,0.0016781988,0.0017346352,0.00034338623,0.00080735894,0.00072929304],"domain_scores_gemma":[0.9944893,0.002496644,0.0012188347,0.00021639295,0.00085832557,0.0007205118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034546475,0.00022147482,0.0017547576,0.0004035431,0.000063630134,0.000016013979,0.00033112007,0.00011718407,0.0005121917],"category_scores_gemma":[0.001059059,0.00016388805,0.00026036246,0.0009730757,0.0014600814,0.00014720597,0.00010492913,0.0016320851,0.000039618255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003317818,0.0009760643,0.8630997,0.000040161958,0.00043570952,0.0021623094,0.00018619979,0.000016878948,0.00003135393,0.000009539961,0.00040247265,0.1293218],"study_design_scores_gemma":[0.006822547,0.011020321,0.98058236,0.00036896407,0.00020835789,0.00020819294,0.00046073654,0.000012801955,0.000024286179,0.000024181525,0.00010802532,0.00015923574],"about_ca_topic_score_codex":0.0016141617,"about_ca_topic_score_gemma":0.003661747,"teacher_disagreement_score":0.12916256,"about_ca_system_score_codex":0.0008763781,"about_ca_system_score_gemma":0.0020825912,"threshold_uncertainty_score":0.7090688},"labels":[],"label_agreement":null},{"id":"W4391941149","doi":"10.1097/coc.0000000000001091","title":"Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Regimen; Radiosurgery; Radiology; Prostate cancer; Esophagus; Surgery; Cancer; Internal medicine","score_opus":0.06591625611906836,"score_gpt":0.47392068387247677,"score_spread":0.4080044277534084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391941149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926828,0.0006066892,0.0021881496,0.0031534787,0.0003566811,0.00023939885,0.0000012233355,0.000019451762,0.0007521339],"genre_scores_gemma":[0.992226,0.00061636016,0.0052790344,0.001325976,0.00044459567,0.000013237143,0.000002796235,0.000021661144,0.00007032401],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99704677,0.00062152254,0.0014214942,0.00025511542,0.00043246945,0.00022262029],"domain_scores_gemma":[0.99763113,0.0007738829,0.0010164464,0.00017954576,0.00013876168,0.00026024555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018461647,0.00015671666,0.0010101742,0.0003354791,0.000024002322,0.00003382284,0.00010548953,0.000035795983,0.0001593027],"category_scores_gemma":[0.00093260553,0.00010599325,0.00021401473,0.0005108217,0.00031064346,0.00033203937,0.00001665055,0.00059225806,0.000012781712],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061158147,0.0008596675,0.14093508,0.000026077914,0.00039141305,0.002392943,0.0002731587,0.000011033869,0.000109868415,0.00008876781,0.00006762583,0.84872854],"study_design_scores_gemma":[0.007827519,0.054668337,0.9194849,0.0003512672,0.00055201777,0.0005015363,0.0013152035,0.00079645927,0.000036496895,0.00006678879,0.014248438,0.00015101254],"about_ca_topic_score_codex":0.00012840124,"about_ca_topic_score_gemma":0.000008992079,"teacher_disagreement_score":0.84857756,"about_ca_system_score_codex":0.0001533717,"about_ca_system_score_gemma":0.0005944165,"threshold_uncertainty_score":0.43222794},"labels":[],"label_agreement":null},{"id":"W4402356242","doi":"10.1097/coc.0000000000001143","title":"Efficacy and Safety of Abemaciclib in Combination With Endocrine Therapy for HR+/HER2− Advanced or Metastatic Breast Cancer","year":2024,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fulvestrant; Internal medicine; Oncology; Hazard ratio; Metastatic breast cancer; Breast cancer; Adverse effect; Combination therapy; Cancer; Confidence interval; Tamoxifen","score_opus":0.1099644072603908,"score_gpt":0.5343017928638563,"score_spread":0.42433738560346546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402356242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002787821,0.99160737,0.00048498076,0.0024530378,0.000596529,0.0018970058,0.00012567603,0.000014007545,0.000033555843],"genre_scores_gemma":[0.0017717787,0.9847918,0.012222975,0.00040938982,0.0004468513,0.00014094797,0.000013054142,0.0000972501,0.00010591097],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99505913,0.0005764754,0.0032983078,0.00041333248,0.00031821834,0.00033451928],"domain_scores_gemma":[0.9899916,0.0049339165,0.004104994,0.00024949198,0.00046449873,0.00025547732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012800627,0.00043219858,0.007010828,0.00038169348,0.000021527841,0.000006823525,0.00021566778,0.00012680702,0.00006713907],"category_scores_gemma":[0.0004616702,0.00023364398,0.00057807425,0.0006964451,0.0010100802,0.00010787747,0.000039431074,0.0011244817,0.000001175006],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03825924,0.0010555057,0.00014672507,0.0029565166,0.0020440004,0.00024338019,0.00008218562,0.000008344392,0.0000015386861,0.00004859827,0.000031067593,0.9551229],"study_design_scores_gemma":[0.027056452,0.037322413,0.0018312464,0.018195415,0.0038365126,0.0041417847,0.00019811848,0.000007792783,0.0000013657403,0.00010101693,0.9070314,0.00027644058],"about_ca_topic_score_codex":0.000028081915,"about_ca_topic_score_gemma":0.000048612248,"teacher_disagreement_score":0.95484644,"about_ca_system_score_codex":0.00034049997,"about_ca_system_score_gemma":0.0033575331,"threshold_uncertainty_score":0.9527725},"labels":[],"label_agreement":null},{"id":"W4403701324","doi":"10.1097/coc.0000000000001150","title":"Efficacy and Safety of Lenvatinib in Combination With Other Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma","year":2024,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Lenvatinib; Medicine; Internal medicine; Renal cell carcinoma; Adverse effect; Oncology; Sorafenib; Hepatocellular carcinoma","score_opus":0.10550136030377723,"score_gpt":0.43960692323035616,"score_spread":0.33410556292657895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403701324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.071219265,0.92558783,0.00013020576,0.0006120203,0.00032742196,0.0017068923,0.000040943065,0.0000064573987,0.000368986],"genre_scores_gemma":[0.074852735,0.9114943,0.012666695,0.00018287747,0.00043292355,0.000051473697,0.0000355661,0.0001138742,0.00016952188],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944017,0.00084391417,0.003757257,0.0003858084,0.00034622865,0.0002651123],"domain_scores_gemma":[0.99050415,0.0046358695,0.0040149773,0.00025140567,0.00029787028,0.00029574498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002211246,0.00040019042,0.0059262067,0.0005180365,0.000018044679,0.000007879421,0.0001435222,0.00019930821,0.000015885167],"category_scores_gemma":[0.0006612799,0.00023368483,0.00079109543,0.0005223487,0.0007557999,0.000043901313,0.000049982515,0.0010299768,0.000003427437],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048910924,0.0018311891,0.0008096102,0.0051656095,0.0006699032,0.0006410145,0.000093804025,0.0000018154357,0.0000054869447,0.000043312797,0.00027443658,0.9855727],"study_design_scores_gemma":[0.023651741,0.12489799,0.0039633936,0.016291264,0.0176574,0.0015295101,0.00018815848,0.000012976873,0.000039780967,0.000053800293,0.81132877,0.00038520846],"about_ca_topic_score_codex":0.00004391816,"about_ca_topic_score_gemma":0.000016282887,"teacher_disagreement_score":0.98518753,"about_ca_system_score_codex":0.0003119196,"about_ca_system_score_gemma":0.002229047,"threshold_uncertainty_score":0.95293903},"labels":[],"label_agreement":null},{"id":"W4404867374","doi":"10.1097/coc.0000000000001157","title":"Phase 2, Multicenter, Open-label, Nonrandomized Study of Neoadjuvant Chemotherapy Liposomal Irinotecan With 5-Fluorouracil, Leucovorin, and Oxaliplatin, Followed by Chemoradiotherapy in Patients With Rectal Cancer in a Watch-and-Wait Program","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Irinotecan; Oxaliplatin; Internal medicine; Fluorouracil; Capecitabine; Phases of clinical research; Clinical endpoint; Colorectal cancer; Chemotherapy; Gastroenterology; Chemoradiotherapy; Neoadjuvant therapy; Surgery; Oncology; Cancer; Clinical trial; Breast cancer","score_opus":0.040096710341763916,"score_gpt":0.4576771838341635,"score_spread":0.4175804734923996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404867374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493325,0.00071918865,0.000009004329,0.0015090557,0.00016358278,0.0025565354,0.000013117117,0.000015571433,0.00008067049],"genre_scores_gemma":[0.995599,0.0010043224,0.0027894787,0.00027507337,0.0000776233,0.00016568505,0.000004051443,0.00004951684,0.000035274054],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99645615,0.0005738145,0.0016919175,0.0004999372,0.0004317203,0.0003464731],"domain_scores_gemma":[0.99714375,0.0011767712,0.0009445875,0.0001814191,0.00021177989,0.00034169306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010527843,0.00031841279,0.0029039995,0.0001604173,0.000023342973,0.000035398414,0.0001831338,0.000115882394,0.00004565446],"category_scores_gemma":[0.00014963631,0.00019439917,0.00009216478,0.00054293737,0.0005098053,0.00018907004,0.00006243505,0.0007743115,2.893903e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1606611,0.025543047,0.3443813,0.000017169588,0.0006827628,0.00042716286,0.0010841422,0.000001919824,0.00008047088,2.8304535e-7,0.000015962436,0.46710467],"study_design_scores_gemma":[0.4603981,0.3241704,0.21154974,0.00062899396,0.0004044628,0.000079169586,0.00049808854,0.00032441644,0.00010634775,0.000002554231,0.0016058717,0.0002318484],"about_ca_topic_score_codex":0.0019696134,"about_ca_topic_score_gemma":0.0010239254,"teacher_disagreement_score":0.46687284,"about_ca_system_score_codex":0.0003343417,"about_ca_system_score_gemma":0.0005912444,"threshold_uncertainty_score":0.7927368},"labels":[],"label_agreement":null},{"id":"W4407300113","doi":"10.1097/coc.0000000000001171","title":"Efficacy and Safety of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Patients with Non-Hodgkin Lymphoma","year":2025,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Internal medicine; Lymphoma; Neutropenia; Adverse effect; Nausea; Chimeric antigen receptor; Hazard ratio; Oncology; Incidence (geometry); Gastroenterology; Chemotherapy; Cancer; Immunotherapy; Confidence interval","score_opus":0.055866799719170517,"score_gpt":0.45606727496103683,"score_spread":0.4002004752418663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407300113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21776132,0.7766122,0.000021633496,0.00027813495,0.0006032401,0.0021692992,0.00002939752,0.000008728987,0.002516004],"genre_scores_gemma":[0.0028073809,0.99415934,0.0019221276,0.00030323913,0.0003599852,0.000012271566,0.000023788038,0.00006677305,0.00034507518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925983,0.0019554917,0.0038632336,0.0004856679,0.0006431095,0.00045421522],"domain_scores_gemma":[0.9880063,0.0063667297,0.004172827,0.0005087703,0.00050596474,0.0004394411],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002748923,0.0004538544,0.008324847,0.00070633757,0.000030312289,0.000008489666,0.00047929565,0.00044339083,0.00039615066],"category_scores_gemma":[0.0008124761,0.0002887363,0.0008730111,0.001243686,0.0013207212,0.000049423557,0.00012279714,0.0014930387,0.0000075336575],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015840214,0.0028045285,0.020980837,0.0009541807,0.00092867017,0.00007183815,0.00006519375,4.0122606e-7,0.000005100677,7.4168304e-7,0.00024075212,0.95810753],"study_design_scores_gemma":[0.022270322,0.054448485,0.07837529,0.007030227,0.00054661,0.000051519357,0.000051585343,6.737368e-7,0.0000040597165,0.0000016459808,0.83697635,0.0002432219],"about_ca_topic_score_codex":0.000067324654,"about_ca_topic_score_gemma":0.0000052343967,"teacher_disagreement_score":0.95786434,"about_ca_system_score_codex":0.00029679184,"about_ca_system_score_gemma":0.005491829,"threshold_uncertainty_score":0.9999565},"labels":[],"label_agreement":null},{"id":"W4407978994","doi":"10.1097/coc.0000000000001179","title":"Impact of Minimal Residual Diseases Status and Depth of Response on Survival Outcomes in Blinatumomab-Treated Acute Lymphoblastic Leukemia","year":2025,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Blinatumomab; Medicine; Lymphoblastic Leukemia; Internal medicine; Meta-analysis; Incidence (geometry); Chemotherapy; Acute lymphocytic leukemia; Malignancy; Leukemia; Oncology; Gastroenterology; Pediatrics","score_opus":0.06679622836495017,"score_gpt":0.5004555254595139,"score_spread":0.43365929709456374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407978994","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7420639,0.2558779,0.0000093159,0.00020091621,0.00036504178,0.00073798833,0.00045605793,0.000011920776,0.00027697685],"genre_scores_gemma":[0.12502852,0.8737224,0.0006286268,0.00008371265,0.00020231884,0.000013588186,0.000031741376,0.000068380265,0.00022075148],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9862744,0.0053558024,0.0059535434,0.00060003734,0.0010401946,0.0007760024],"domain_scores_gemma":[0.930161,0.061963096,0.005595147,0.0006110804,0.00072271924,0.00094698253],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003465596,0.0006716317,0.0133480495,0.0019060379,0.000027847815,0.000010337758,0.0005622489,0.00066174334,0.00004040506],"category_scores_gemma":[0.032695234,0.00042457212,0.0021137772,0.0013964981,0.0025476585,0.000073754665,0.00031083575,0.0018417967,0.0000044601416],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.071326196,0.002087306,0.14791669,0.0021981716,0.0049099615,0.0037170441,0.00004752272,0.0000071383147,0.0000033280069,0.000011596966,0.0004748765,0.7673002],"study_design_scores_gemma":[0.021871055,0.112777255,0.8239114,0.0172873,0.010025479,0.0008640056,0.00016413184,0.000030191173,0.0000022440654,0.00002239028,0.012584284,0.00046022746],"about_ca_topic_score_codex":0.0003707589,"about_ca_topic_score_gemma":0.000035205063,"teacher_disagreement_score":0.7668399,"about_ca_system_score_codex":0.0037941586,"about_ca_system_score_gemma":0.056905698,"threshold_uncertainty_score":0.9998206},"labels":[],"label_agreement":null},{"id":"W4409281052","doi":"10.1097/coc.0000000000001199","title":"Efficacy and Safety of Pegylated Filgrastim as Primary Prophylaxis Following Pediatric Dose-intensive Chemotherapy","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Filgrastim; Medicine; Neutropenia; Chemotherapy; Febrile neutropenia; Adverse effect; Granulocyte colony-stimulating factor; Internal medicine; Surgery; Randomized controlled trial","score_opus":0.02644083628862164,"score_gpt":0.4228698651195398,"score_spread":0.39642902883091813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409281052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876106,0.00047010888,0.00018558213,0.0059323404,0.00083018723,0.00027297126,0.0000017004428,0.00001216916,0.004684366],"genre_scores_gemma":[0.9901156,0.0022505748,0.0014574247,0.005498506,0.00041061157,0.0000031033246,0.0000014561191,0.0000144480055,0.00024831377],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975477,0.0002849425,0.0015567549,0.0002065716,0.00021224188,0.00019178241],"domain_scores_gemma":[0.99566996,0.0021349196,0.0011779873,0.00017434802,0.0006192467,0.00022351716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086316006,0.00014032541,0.0016010575,0.0002312345,0.000051822208,0.0000051622064,0.00011758945,0.00013768705,0.00006923856],"category_scores_gemma":[0.00163163,0.000105120576,0.00045295866,0.0006198774,0.00048149296,0.000051691,0.000045206398,0.0008040563,0.0000046513073],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018160576,0.0010327349,0.31027496,0.000060152473,0.001125122,0.00031139268,0.00019526998,0.000010389883,0.0013098866,0.000064758555,0.0018709028,0.66558385],"study_design_scores_gemma":[0.015098774,0.032192204,0.9313115,0.00015042067,0.0009943031,0.00036627633,0.00035595198,0.0000052400496,0.0001620057,0.00013970038,0.019106003,0.0001176394],"about_ca_topic_score_codex":0.000042410164,"about_ca_topic_score_gemma":0.0000026938928,"teacher_disagreement_score":0.6654662,"about_ca_system_score_codex":0.0001061147,"about_ca_system_score_gemma":0.0018405347,"threshold_uncertainty_score":0.42866927},"labels":[],"label_agreement":null},{"id":"W4410404180","doi":"10.1097/coc.0000000000001215","title":"Metabolic Plasticity in Prostate Cancer","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Sherbrooke","funders":"","keywords":"Warburg effect; Prostate cancer; Medicine; Cancer; Cancer research; Cancer cell; Anaerobic glycolysis; Glycolysis; Prostate; Oxidative phosphorylation; Internal medicine; Oncology; Biology; Metabolism; Biochemistry","score_opus":0.02541152604416668,"score_gpt":0.4167065186115824,"score_spread":0.39129499256741573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410404180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874495,0.0050439415,0.0003633121,0.001994566,0.0034324205,0.000102055696,0.00000946072,0.0000028346901,0.0016018852],"genre_scores_gemma":[0.97148573,0.020709705,0.0013472526,0.0035518701,0.0022621646,0.0000129427,0.000001952141,0.000011829589,0.00061652745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778706,0.00039831034,0.0011970217,0.0002319319,0.00012001467,0.00026563805],"domain_scores_gemma":[0.9984189,0.00024563776,0.0008164403,0.00014484697,0.00022112808,0.00015304096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009029842,0.00012898605,0.00094872736,0.0001257194,0.000024350906,0.000007323407,0.0002660852,0.00012023242,0.000024512163],"category_scores_gemma":[0.0011319844,0.000106035295,0.0002745469,0.0002848061,0.00048208886,0.000005422743,0.00008611512,0.00044562732,0.0000024996127],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026514453,0.0004675336,0.07515137,0.000008228972,0.0003202878,0.00001780933,0.000059613176,0.00026626835,0.011750052,0.00022288894,0.008451907,0.9006326],"study_design_scores_gemma":[0.002400547,0.0014351471,0.14060862,0.000026099595,0.000104368235,0.000023041204,0.00012842436,0.000012598416,0.00208954,0.00013235172,0.8529328,0.00010641698],"about_ca_topic_score_codex":0.0001681946,"about_ca_topic_score_gemma":0.0005071616,"teacher_disagreement_score":0.90052617,"about_ca_system_score_codex":0.000025832278,"about_ca_system_score_gemma":0.0017449064,"threshold_uncertainty_score":0.43239936},"labels":[],"label_agreement":null},{"id":"W4411093414","doi":"10.1097/coc.0000000000001221","title":"Impact of Sequencing of Treatment Modalities on Survival in Nonmetastatic Hepatocellular Carcinoma","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Systemic therapy; Liver transplantation; Liver cancer; Proportional hazards model; Cohort; Liver disease; Oncology; Sorafenib; Malignancy; Gastroenterology; Cancer; Surgery; Transplantation","score_opus":0.1830231610961523,"score_gpt":0.4386759174022137,"score_spread":0.2556527563060614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411093414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964978,0.000321564,0.00008510773,0.0005239506,0.00020891149,0.00027503198,0.000012768913,0.0000036483689,0.0020711878],"genre_scores_gemma":[0.99781406,0.0003266063,0.0015547011,0.00009858056,0.00008334369,0.0000065960453,0.000004861106,0.000013843789,0.0000974265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99615496,0.0008823373,0.0022742257,0.00019284923,0.00024129529,0.0002543385],"domain_scores_gemma":[0.9951905,0.002597466,0.0014880418,0.00026337552,0.0002662505,0.00019439096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014526093,0.00020709877,0.0026002305,0.00046360024,0.000015061465,0.0000026909927,0.00012922076,0.00011367555,0.000060751525],"category_scores_gemma":[0.00063669373,0.00013891885,0.0010681519,0.0004570938,0.0005353747,0.000042439126,0.000024510406,0.00033761314,0.0000022726736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003651037,0.0015108071,0.91959053,0.000040505725,0.0009601166,0.00064679433,0.00036881425,0.000044764667,0.0005354345,0.00012386405,0.000017256147,0.072510056],"study_design_scores_gemma":[0.008956403,0.0977863,0.88601595,0.00029866328,0.0009543181,0.000076414624,0.0011936623,0.0020039638,0.002130595,0.00024215836,0.00022110883,0.00012047379],"about_ca_topic_score_codex":0.0018459692,"about_ca_topic_score_gemma":0.000034548986,"teacher_disagreement_score":0.09627549,"about_ca_system_score_codex":0.0008581849,"about_ca_system_score_gemma":0.0035996018,"threshold_uncertainty_score":0.6385539},"labels":[],"label_agreement":null},{"id":"W4413041068","doi":"10.1097/coc.0000000000001246","title":"Impact of Intensive Multimodal Treatment on the Outcomes of Patients With Anaplastic Thyroid Cancer","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Propensity score matching; Cohort; Cancer; Internal medicine; Radiation therapy; Anaplastic thyroid cancer; Clinical trial; Thyroid cancer; Surgery","score_opus":0.04054436259646686,"score_gpt":0.451152187052796,"score_spread":0.41060782445632915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413041068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929319,0.00019384213,0.000017858172,0.005982967,0.000279719,0.00027636776,0.000041109426,0.0000023730468,0.0002738416],"genre_scores_gemma":[0.9973083,0.00071781216,0.000261911,0.0015803422,0.00006724904,0.000015797314,0.0000020322097,0.000009522988,0.000036991463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981163,0.0002217132,0.0011195282,0.00014611121,0.00023315873,0.00016318537],"domain_scores_gemma":[0.99281627,0.0039787916,0.001719443,0.00022654183,0.0011206085,0.000138326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022887901,0.00016686584,0.0017137647,0.00011853626,0.00002078489,0.0000019141332,0.00011231041,0.000055270437,0.000070061506],"category_scores_gemma":[0.0010842558,0.00006793752,0.00060456555,0.00021323467,0.00065198645,0.000021406415,0.000020518382,0.0002468966,0.0000012798253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011179183,0.003553266,0.84723747,0.000003949833,0.0041716644,0.000026716878,0.00012086447,0.0001484802,0.000008102236,0.00003881809,0.0007887934,0.13272269],"study_design_scores_gemma":[0.009198374,0.11732942,0.87151706,0.00012804064,0.0009796944,0.000003303873,0.000280338,0.000011835493,0.00008982712,0.0000141615,0.00040405075,0.000043895165],"about_ca_topic_score_codex":0.0006246649,"about_ca_topic_score_gemma":0.00011467927,"teacher_disagreement_score":0.13267879,"about_ca_system_score_codex":0.0004398632,"about_ca_system_score_gemma":0.0014537763,"threshold_uncertainty_score":0.27704117},"labels":[],"label_agreement":null},{"id":"W4414084486","doi":"10.1097/coc.0000000000001253","title":"A Phase II Trial to Assess the Evolution of the KRAS Mutation Load by Liquid Biopsy in Patients With Resectable Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant NALIRIFOX","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"KRAS; Pancreatic ductal adenocarcinoma; Liquid biopsy; Neoadjuvant therapy; Adenocarcinoma; Biopsy; Mutation; Phases of clinical research","score_opus":0.04503807221140932,"score_gpt":0.43144048437396826,"score_spread":0.38640241216255894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414084486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99231905,0.0001653619,0.00049800397,0.0048390445,0.00016066335,0.0011720848,0.000010321524,0.000005402635,0.0008300867],"genre_scores_gemma":[0.99795276,0.000027599572,0.000987839,0.00053212314,0.00013164036,0.000040300907,0.00000478161,0.000013884387,0.0003090647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954429,0.0016077589,0.0016338398,0.00026898517,0.00069707964,0.00034938782],"domain_scores_gemma":[0.99458843,0.0024221898,0.0014030017,0.00037266407,0.0009999138,0.00021381538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028408507,0.00017722734,0.00166682,0.00020982524,0.00011870249,0.0000074126133,0.00032646037,0.00014660417,0.00003552954],"category_scores_gemma":[0.0033024389,0.00008172912,0.00017441549,0.0012649318,0.0012400985,0.00007752115,0.000082025224,0.0008573773,0.0000019187055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3191949,0.005148394,0.6676531,0.000013847601,0.0005485002,0.00009641232,0.00024885876,0.000010960971,0.00021393389,0.000030827283,0.00060522486,0.0062350235],"study_design_scores_gemma":[0.12077262,0.23672341,0.6389895,0.00035598179,0.001036697,0.00013238478,0.0012078843,0.00012404537,0.00007377623,0.000023011715,0.0004695242,0.000091170215],"about_ca_topic_score_codex":0.00095629727,"about_ca_topic_score_gemma":0.000155527,"teacher_disagreement_score":0.23157501,"about_ca_system_score_codex":0.0007225225,"about_ca_system_score_gemma":0.005337206,"threshold_uncertainty_score":0.94679743},"labels":[],"label_agreement":null},{"id":"W4417168166","doi":"10.1097/coc.0000000000001265","title":"Immunotherapy in Extensive Stage Small-Cell Lung Cancer in First-Line and Second-Line Setting","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; BC Cancer Agency; London Health Sciences Centre; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Lung cancer; Immunotherapy; Stage (stratigraphy); Respiratory disease; MEDLINE; Neoplasm staging; Retrospective cohort study","score_opus":0.04850980863133062,"score_gpt":0.49210545852412857,"score_spread":0.4435956498927979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417168166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9577342,0.009574196,0.00012905496,0.030421851,0.00038244383,0.00034632444,0.000008763163,0.0000061460614,0.0013970144],"genre_scores_gemma":[0.9647587,0.02497483,0.0016973595,0.0070979465,0.00033682765,0.000022038346,8.219538e-7,0.00001843372,0.0010930706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968555,0.0004882036,0.0017891981,0.00027443253,0.00020404889,0.000388626],"domain_scores_gemma":[0.9946415,0.003711657,0.000914287,0.00018115147,0.00037973138,0.0001717193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002704984,0.00016552446,0.0017082122,0.00037444505,0.00003856137,0.00000831265,0.00016652406,0.00011468782,0.00015557969],"category_scores_gemma":[0.001867417,0.00012764755,0.00016757252,0.00052186626,0.0006518727,0.000060242965,0.0001231044,0.0014693184,9.2198474e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049444316,0.0005653296,0.6190556,0.00015694015,0.00036709558,0.0009062875,0.00066624046,0.00016272698,0.00036542126,0.000013124944,0.00079150073,0.37200528],"study_design_scores_gemma":[0.022623744,0.01063643,0.9144817,0.0011196126,0.00015370862,0.00006683533,0.0025351148,0.0011170702,0.00025533355,0.00012415873,0.04668177,0.00020455077],"about_ca_topic_score_codex":0.00059765804,"about_ca_topic_score_gemma":0.0036934186,"teacher_disagreement_score":0.37180075,"about_ca_system_score_codex":0.00047251224,"about_ca_system_score_gemma":0.0018930542,"threshold_uncertainty_score":0.6383539},"labels":[],"label_agreement":null},{"id":"W987760055","doi":"10.1097/coc.0000000000000205","title":"Defining Eligibility of FOLFIRINOX for First-Line Metastatic Pancreatic Adenocarcinoma (MPC) in the Province of British Columbia","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; FOLFIRINOX; Adenocarcinoma; Metastatic adenocarcinoma; Oncology; Line (geometry); Internal medicine; Oxaliplatin; Cancer","score_opus":0.1317465678737183,"score_gpt":0.4785126894804782,"score_spread":0.3467661216067599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W987760055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99389106,0.0011764473,0.0009196089,0.002179653,0.00013388203,0.0007196154,0.000030039884,0.0000035382102,0.0009461615],"genre_scores_gemma":[0.9773238,0.00042928004,0.021308351,0.0006047858,0.00014769445,0.000029068426,0.000004145418,0.000014885025,0.0001379945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944991,0.0012883996,0.0030825161,0.00023576684,0.00054159516,0.00035265516],"domain_scores_gemma":[0.98258823,0.013435013,0.0023837918,0.0003297606,0.0009467594,0.00031644874],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011311073,0.00011106173,0.00294806,0.00009492291,0.000029640774,0.000008711341,0.00039145423,0.000121877085,0.000033202254],"category_scores_gemma":[0.017443398,0.000098522076,0.00041381907,0.0003720315,0.0017473317,0.00006553099,0.00006363992,0.0006635183,0.0000022726028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031790908,0.0019310681,0.91110456,0.00015388243,0.00035123955,0.00041141023,0.00028377757,0.000012066366,0.000005617999,0.000051873656,0.003406846,0.07910858],"study_design_scores_gemma":[0.011730466,0.05994758,0.9175396,0.00033715134,0.001206489,0.0011851394,0.002657499,0.0004786837,0.0000068053478,0.0024644118,0.0023416835,0.000104481485],"about_ca_topic_score_codex":0.00459633,"about_ca_topic_score_gemma":0.011704607,"teacher_disagreement_score":0.0790041,"about_ca_system_score_codex":0.00014058818,"about_ca_system_score_gemma":0.004488827,"threshold_uncertainty_score":0.9908331},"labels":[],"label_agreement":null}]}